DrugA,DrugB,Interaction,Mechanism,risk_level
Aripiprazole,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Aripiprazole.,increase,risk
Aripiprazole,Venetoclax,The metabolism of Aripiprazole can be decreased when combined with Venetoclax.,decrease,no risk
Aripiprazole,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Aripiprazole is combined with Venlafaxine.,increase,risk
Aripiprazole,Verapamil,The metabolism of Aripiprazole can be decreased when combined with Verapamil.,decrease,no risk
Aripiprazole,Vericiguat,Aripiprazole may increase the hypotensive activities of Vericiguat.,increase,no risk
Aripiprazole,Vernakalant,The metabolism of Aripiprazole can be decreased when combined with Vernakalant.,decrease,no risk
Aripiprazole,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Aripiprazole.,increase,risk
Aripiprazole,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Aripiprazole.,increase,risk
Aripiprazole,Vilazodone,The metabolism of Aripiprazole can be decreased when combined with Vilazodone.,decrease,no risk
Aripiprazole,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Viloxazine,The metabolism of Aripiprazole can be decreased when combined with Viloxazine.,decrease,no risk
Aripiprazole,Vinblastine,The metabolism of Aripiprazole can be increased when combined with Vinblastine.,increase,no risk
Aripiprazole,Vincristine,The metabolism of Vincristine can be decreased when combined with Aripiprazole.,decrease,no risk
Aripiprazole,Vinorelbine,The metabolism of Aripiprazole can be decreased when combined with Vinorelbine.,decrease,no risk
Chlorprothixene,Butylscopolamine,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Butylscopolamine.,increase,risk
Chlorprothixene,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Gabapentin enacarbil.,increase,risk
Chlorprothixene,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Gadobenic acid.,increase,risk
Chlorprothixene,Galantamine,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Galantamine.,decrease,no risk
Chlorprothixene,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Chlorprothixene is combined with Ganaxolone.",increase,risk
Chlorprothixene,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Gemifloxacin.,increase,risk
Chlorprothixene,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Gilteritinib,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Gilteritinib.,decrease,no risk
Chlorprothixene,Ginkgo biloba,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Chlorprothixene,Glasdegib,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Glasdegib.,increase,risk
Chlorprothixene,Glucagon,Chlorprothixene may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Chlorprothixene,Glutethimide,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Glutethimide.,increase,risk
Chlorprothixene,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Glycopyrronium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Glycopyrronium.,increase,risk
Chlorprothixene,Goserelin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Goserelin.,increase,risk
Chlorprothixene,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Grepafloxacin.,increase,risk
Chlorprothixene,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Halofantrine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Halofantrine.,increase,risk
Chlorprothixene,Haloperidol,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Haloperidol.,increase,risk
Chlorprothixene,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Hexocyclium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Hexocyclium.,increase,risk
Chlorprothixene,Histrelin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Histrelin.,increase,risk
Chlorprothixene,Homatropine,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Homatropine.,increase,risk
Chlorprothixene,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Huperzine A,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Huperzine A.,decrease,no risk
Chlorprothixene,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Chlorprothixene.,increase,no risk
Chlorprothixene,Hydrocodone,Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Chlorprothixene,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Chlorprothixene.,increase,no risk
Chlorprothixene,Hydromorphone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Hydromorphone.,increase,risk
Chlorprothixene,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Hydroxychloroquine.,increase,risk
Chlorprothixene,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Hydroxyzine.,increase,risk
Chlorprothixene,Hyoscyamine,Chlorprothixene may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Chlorprothixene,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ketazolam,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Ketazolam.,increase,risk
Chlorprothixene,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.,increase,no risk
Chlorprothixene,Nalbuphine,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Nalbuphine.,increase,risk
Chlorprothixene,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nalidixic acid.,increase,risk
Chlorprothixene,Naloxegol,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Naloxegol.,increase,risk
Chlorprothixene,Naltrexone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Naltrexone.,increase,risk
Chlorprothixene,Naphazoline,The risk or severity of Tachycardia can be increased when Chlorprothixene is combined with Naphazoline.,increase,risk
Chlorprothixene,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Naxitamab,Chlorprothixene may increase the neurotoxic activities of Naxitamab.,increase,no risk
Chlorprothixene,Nefazodone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Nefazodone.,increase,risk
Chlorprothixene,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Neomycin,Neomycin may increase the neurotoxic activities of Chlorprothixene.,increase,no risk
Chlorprothixene,Neostigmine,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Neostigmine.,decrease,no risk
Chlorprothixene,Nialamide,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Nialamide.,increase,risk
Chlorprothixene,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Nifedipine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nifedipine.,increase,risk
Chlorprothixene,Nilotinib,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nilotinib.,increase,risk
Chlorprothixene,Nilvadipine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nilvadipine.,increase,risk
Chlorprothixene,Nimodipine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nimodipine.,increase,risk
Chlorprothixene,Nitrazepam,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Nitrazepam.,increase,risk
Chlorprothixene,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Nitrous oxide,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Nitrous oxide.,increase,risk
Chlorprothixene,Nizatidine,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Nizatidine.,decrease,no risk
Chlorprothixene,Nomifensine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Nomifensine.,increase,risk
Chlorprothixene,Norepinephrine,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Normethadone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Normethadone.,increase,risk
Chlorprothixene,Nortriptyline,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Nylidrin,The risk or severity of Tachycardia can be increased when Chlorprothixene is combined with Nylidrin.,increase,risk
Chlorprothixene,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ofloxacin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ofloxacin.,increase,risk
Chlorprothixene,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlorprothixene is combined with Oliceridine.",increase,risk
Chlorprothixene,Olodaterol,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Olodaterol.,increase,risk
Chlorprothixene,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Opium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Opium.,increase,risk
Chlorprothixene,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Orphenadrine,Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Chlorprothixene,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxatomide,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Oxatomide.,increase,risk
Chlorprothixene,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxitriptan,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Oxitriptan.,increase,risk
Chlorprothixene,Oxprenolol,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Oxprenolol.,increase,risk
Chlorprothixene,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxycodone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Oxycodone.,increase,risk
Chlorprothixene,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxymorphone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Oxymorphone.,increase,risk
Chlorprothixene,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Quazepam,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Quazepam.,increase,risk
Chlorprothixene,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Chlorprothixene.,increase,no risk
Chlorprothixene,Quinidine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Quinidine.,increase,risk
Chlorprothixene,Quinine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Quinine.,increase,risk
Chlorprothixene,Quinupramine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Quinupramine.,increase,risk
Chlorprothixene,Quizartinib,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Quizartinib.,increase,risk
Chlorprothixene,Umeclidinium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Umeclidinium.,increase,risk
Chlorprothixene,Urethane,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Urethane.,increase,risk
Chlorprothixene,Valproate bismuth,Chlorprothixene may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Chlorprothixene,Valproic acid,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Valproic acid.,increase,risk
Chlorprothixene,Vandetanib,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vandetanib.,increase,risk
Chlorprothixene,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vecuronium,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Vecuronium.,increase,risk
Chlorprothixene,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vernakalant,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vernakalant.,increase,risk
Chlorprothixene,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Viloxazine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Viloxazine.,increase,risk
Chlorprothixene,Vincristine,Vincristine may increase the neurotoxic activities of Chlorprothixene.,increase,no risk
Chlorprothixene,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Chlorprothixene.,increase,no risk
Chlorprothixene,Viomycin,Chlorprothixene may increase the neurotoxic activities of Viomycin.,increase,no risk
Chlorprothixene,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vorinostat,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vorinostat.,increase,risk
Chlorprothixene,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Warfarin,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Warfarin.,increase,risk
Chlorprothixene,Xamoterol,The risk or severity of Tachycardia can be increased when Chlorprothixene is combined with Xamoterol.,increase,risk
Chlorprothixene,Xylometazoline,The risk or severity of Tachycardia can be increased when Chlorprothixene is combined with Xylometazoline.,increase,risk
Chlorprothixene,Yohimbine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Yohimbine.,increase,risk
Chlorprothixene,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ziconotide,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Ziconotide.,increase,risk
Chlorprothixene,Zimelidine,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Zimelidine.,increase,risk
Chlorprothixene,Ziprasidone,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ziprasidone.,increase,risk
Chlorprothixene,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Zolpidem,Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Chlorprothixene,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Zopiclone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Zopiclone.,increase,risk
Chlorprothixene,Zotepine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Zotepine.,increase,risk
Chlorprothixene,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Zuclopenthixol.,increase,risk
Chlorprothixene,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Chlorprothixene.,increase,risk
Epoprostenol,Benserazide,Epoprostenol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Epoprostenol,Benzatropine,Benzatropine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Benznidazole,Epoprostenol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Epoprostenol,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Benzthiazide,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Benzthiazide.,increase,no risk
Epoprostenol,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Epoprostenol.,increase,risk
Epoprostenol,Bepotastine,Epoprostenol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bepridil,Epoprostenol may increase the hypotensive activities of Bepridil.,increase,no risk
Epoprostenol,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Epoprostenol.,decrease,no risk
Epoprostenol,Betaxolol,Epoprostenol may increase the hypotensive activities of Betaxolol.,increase,no risk
Epoprostenol,Bethanidine,Epoprostenol may increase the hypotensive activities of Bethanidine.,increase,no risk
Epoprostenol,Betrixaban,The risk or severity of bleeding can be increased when Epoprostenol is combined with Betrixaban.,increase,risk
Epoprostenol,Bexarotene,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bexarotene.,increase,risk
Epoprostenol,Bicisate,Epoprostenol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Bismuth subgallate,Epoprostenol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Epoprostenol.,increase,risk
Epoprostenol,Bisoprolol,Epoprostenol may increase the hypotensive activities of Bisoprolol.,increase,no risk
Epoprostenol,Bisoxatin,Epoprostenol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bivalirudin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bivalirudin.,increase,risk
Epoprostenol,Bleomycin,Bleomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Blinatumomab,The risk or severity of bleeding can be increased when Epoprostenol is combined with Blinatumomab.,increase,risk
Epoprostenol,Bortezomib,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bortezomib.,increase,risk
Epoprostenol,Bosentan,Epoprostenol may increase the hypotensive activities of Bosentan.,increase,no risk
Epoprostenol,Bosutinib,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bosutinib.,increase,risk
Epoprostenol,Bretylium,Epoprostenol may increase the hypotensive activities of Bretylium.,increase,no risk
Epoprostenol,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Brimonidine,Brimonidine may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Brivaracetam,Epoprostenol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bromazepam,Epoprostenol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Budesonide,Budesonide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Epoprostenol.,increase,risk
Epoprostenol,Bumetanide,Bumetanide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Epoprostenol.,increase,risk
Epoprostenol,Bupropion,Bupropion may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Buspirone,Buspirone may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Busulfan,The risk or severity of bleeding can be increased when Epoprostenol is combined with Busulfan.,increase,risk
Epoprostenol,Butabarbital,Butabarbital may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Butalbital,Butalbital may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Gabapentin enacarbil,Epoprostenol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadodiamide,Gadodiamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadofosveset trisodium,Epoprostenol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadoteric acid,Epoprostenol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadoteridol,Gadoteridol may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ganciclovir,Ganciclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gemcitabine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Gemcitabine.,increase,risk
Epoprostenol,Gemfibrozil,Epoprostenol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Gemtuzumab ozogamicin.,increase,risk
Epoprostenol,Gentamicin,Epoprostenol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Epoprostenol.,increase,risk
Epoprostenol,Gimeracil,Epoprostenol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Epoprostenol.,increase,no risk
Epoprostenol,Givosiran,Givosiran may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Glipizide,Glipizide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Glucosamine,Glucosamine may increase the antiplatelet activities of Epoprostenol.,increase,no risk
Epoprostenol,Glycerol phenylbutyrate,Epoprostenol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Epoprostenol.,increase,risk
Epoprostenol,Golodirsen,Epoprostenol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Epoprostenol,Goserelin,Goserelin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Guanabenz,Epoprostenol may increase the hypotensive activities of Guanabenz.,increase,no risk
Epoprostenol,Guanadrel,Epoprostenol may increase the hypotensive activities of Guanadrel.,increase,no risk
Epoprostenol,Guanethidine,Epoprostenol may increase the hypotensive activities of Guanethidine.,increase,no risk
Epoprostenol,Guanfacine,Epoprostenol may increase the hypotensive activities of Guanfacine.,increase,no risk
Epoprostenol,Guanoxan,Epoprostenol may increase the hypotensive activities of Guanoxan.,increase,no risk
Epoprostenol,Haloperidol,Haloperidol may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Halothane,Halothane may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Hemin,Hemin may increase the anticoagulant activities of Epoprostenol.,increase,no risk
Epoprostenol,Heparin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Heparin.,increase,risk
Epoprostenol,Hydralazine,Epoprostenol may increase the hypotensive activities of Hydralazine.,increase,no risk
Epoprostenol,Hydrochlorothiazide,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Epoprostenol,Hydroflumethiazide,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Epoprostenol,Hydromorphone,Hydromorphone may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Hydroxyethyl Starch,Epoprostenol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Epoprostenol,Hydroxyprogesterone caproate,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Epoprostenol,Hydroxyurea,The risk or severity of bleeding can be increased when Epoprostenol is combined with Hydroxyurea.,increase,risk
Epoprostenol,Kanamycin,Epoprostenol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ketamine,Ketamine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ketazolam,Epoprostenol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Epoprostenol.,increase,risk
Epoprostenol,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Epoprostenol.,increase,risk
Epoprostenol,N-acetyltyrosine,Epoprostenol may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Epoprostenol.,increase,risk
Epoprostenol,Nabumetone,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Epoprostenol.,increase,risk
Epoprostenol,Nadolol,Epoprostenol may increase the hypotensive activities of Nadolol.,increase,no risk
Epoprostenol,Nadroparin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Nadroparin.,increase,risk
Epoprostenol,Naldemedine,Epoprostenol may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nalmefene,Epoprostenol may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Epoprostenol,Naloxone,Naloxone may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Naphazoline,Naphazoline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Naproxen,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Epoprostenol.,increase,risk
Epoprostenol,Naratriptan,Naratriptan may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Nateglinide,Nateglinide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Naxitamab,Naxitamab may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Nebivolol,Epoprostenol may increase the hypotensive activities of Nebivolol.,increase,no risk
Epoprostenol,Nedaplatin,Epoprostenol may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nedocromil,Nedocromil may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nefazodone,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Epoprostenol.,increase,risk
Epoprostenol,Nelarabine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Nelarabine.,increase,risk
Epoprostenol,Neomycin,Epoprostenol may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nesiritide,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Nesiritide.,increase,risk
Epoprostenol,Netilmicin,Epoprostenol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nialamide,Nialamide may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Nicardipine,Epoprostenol may increase the hypotensive activities of Nicardipine.,increase,no risk
Epoprostenol,Nicergoline,Nicergoline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Nicorandil,Nicorandil may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Nifedipine,The risk or severity of adverse effects can be increased when Nifedipine is combined with Epoprostenol.,increase,risk
Epoprostenol,Nilotinib,The risk or severity of bleeding can be increased when Epoprostenol is combined with Nilotinib.,increase,risk
Epoprostenol,Nilutamide,Nilutamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nilvadipine,Epoprostenol may increase the hypotensive activities of Nilvadipine.,increase,no risk
Epoprostenol,Nimesulide,The risk or severity of bleeding and hemorrhage can be increased when Nimesulide is combined with Epoprostenol.,increase,risk
Epoprostenol,Nimodipine,Epoprostenol may increase the hypotensive activities of Nimodipine.,increase,no risk
Epoprostenol,Nintedanib,The risk or severity of bleeding can be increased when Nintedanib is combined with Epoprostenol.,increase,risk
Epoprostenol,Nisoldipine,Epoprostenol may increase the hypotensive activities of Nisoldipine.,increase,no risk
Epoprostenol,Nitrendipine,Epoprostenol may increase the hypotensive activities of Nitrendipine.,increase,no risk
Epoprostenol,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Epoprostenol.,increase,risk
Epoprostenol,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Nitroglycerin,Epoprostenol may increase the hypotensive activities of Nitroglycerin.,increase,no risk
Epoprostenol,Nitroprusside,Epoprostenol may increase the hypotensive activities of Nitroprusside.,increase,no risk
Epoprostenol,Nitrous acid,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Nitrous acid.,increase,risk
Epoprostenol,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Nomegestrol,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Nomegestrol.,decrease,no risk
Epoprostenol,Nomegestrol acetate,The risk or severity of adverse effects can be increased when Nomegestrol acetate is combined with Epoprostenol.,increase,risk
Epoprostenol,Nonacog beta pegol,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Epoprostenol.,decrease,no risk
Epoprostenol,Norelgestromin,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Norelgestromin.,decrease,no risk
Epoprostenol,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Norethisterone,The risk or severity of adverse effects can be increased when Norethisterone is combined with Epoprostenol.,increase,risk
Epoprostenol,Norethynodrel,The risk or severity of adverse effects can be increased when Norethynodrel is combined with Epoprostenol.,increase,risk
Epoprostenol,Norgestimate,The risk or severity of adverse effects can be increased when Norgestimate is combined with Epoprostenol.,increase,risk
Epoprostenol,Norgestrel,The risk or severity of adverse effects can be increased when Norgestrel is combined with Epoprostenol.,increase,risk
Epoprostenol,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Nylidrin,Nylidrin may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Obeticholic acid,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Obeticholic acid.,increase,risk
Epoprostenol,Obinutuzumab,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Obinutuzumab.,increase,risk
Epoprostenol,Octinoxate,Epoprostenol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Epoprostenol.,increase,risk
Epoprostenol,Olaparib,The risk or severity of bleeding can be increased when Epoprostenol is combined with Olaparib.,increase,risk
Epoprostenol,Olive oil,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Olive oil.,decrease,no risk
Epoprostenol,Olmesartan,Epoprostenol may increase the hypotensive activities of Olmesartan.,increase,no risk
Epoprostenol,Olodaterol,Olodaterol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Epoprostenol.,increase,risk
Epoprostenol,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Epoprostenol is combined with Omacetaxine mepesuccinate.,increase,risk
Epoprostenol,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Epoprostenol.,increase,no risk
Epoprostenol,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Epoprostenol.,increase,risk
Epoprostenol,Omega-3-carboxylic acids,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Epoprostenol,Opicapone,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Opicapone.,increase,risk
Epoprostenol,Opium,Epoprostenol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Epoprostenol,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Oseltamivir,Oseltamivir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxacillin,Oxacillin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Epoprostenol.,increase,risk
Epoprostenol,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Epoprostenol.,increase,risk
Epoprostenol,Oxazepam,Oxazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxprenolol,Epoprostenol may increase the hypotensive activities of Oxprenolol.,increase,no risk
Epoprostenol,Oxybenzone,Epoprostenol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxymetazoline,Oxymetazoline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Epoprostenol.,increase,risk
Epoprostenol,Oxyquinoline,Epoprostenol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Epoprostenol,Quetiapine,Quetiapine may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Quinapril,Epoprostenol may increase the hypotensive activities of Quinapril.,increase,no risk
Epoprostenol,Quinestrol,Quinestrol may decrease the anticoagulant activities of Epoprostenol.,decrease,no risk
Epoprostenol,Quinethazone,Quinethazone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Quinidine,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Quinidine.,increase,no risk
Epoprostenol,Quinine,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Quinine.,increase,no risk
Epoprostenol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Udenafil,Udenafil may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Ulipristal,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Ulipristal.,decrease,no risk
Epoprostenol,Unoprostone,Epoprostenol may increase the hypotensive activities of Unoprostone.,increase,no risk
Epoprostenol,Urokinase,Urokinase may increase the anticoagulant activities of Epoprostenol.,increase,no risk
Epoprostenol,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Ursodeoxycholic acid.,increase,risk
Epoprostenol,Vaborbactam,Epoprostenol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valaciclovir,Valaciclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valbenazine,Epoprostenol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Epoprostenol.,increase,risk
Epoprostenol,Valganciclovir,Epoprostenol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valsartan,Epoprostenol may increase the hypotensive activities of Valsartan.,increase,no risk
Epoprostenol,Vancomycin,Epoprostenol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Vardenafil,Vardenafil may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Varenicline,Epoprostenol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Epoprostenol,Venlafaxine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Venlafaxine.,increase,risk
Epoprostenol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Epoprostenol.,increase,risk
Epoprostenol,Vericiguat,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Vericiguat.,increase,risk
Epoprostenol,Vilanterol,Vilanterol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Vilazodone,Vilazodone may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Viloxazine,Epoprostenol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Vinblastine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vinblastine.,increase,risk
Epoprostenol,Vindesine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vindesine.,increase,risk
Epoprostenol,Vinorelbine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vinorelbine.,increase,risk
Epoprostenol,Vitamin E,Vitamin E may increase the antiplatelet activities of Epoprostenol.,increase,no risk
Epoprostenol,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Epoprostenol.,decrease,no risk
Epoprostenol,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Epoprostenol.,increase,risk
Epoprostenol,Vorinostat,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vorinostat.,increase,risk
Epoprostenol,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Epoprostenol.,increase,risk
Epoprostenol,Warfarin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Warfarin.,increase,risk
Epoprostenol,Xamoterol,Xamoterol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Ximelagatran,The risk or severity of bleeding can be increased when Epoprostenol is combined with Ximelagatran.,increase,risk
Epoprostenol,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Zaleplon,Zaleplon may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Zanamivir,Zanamivir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Zidovudine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Zidovudine.,increase,risk
Epoprostenol,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Epoprostenol.,increase,risk
Epoprostenol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Zofenopril,Epoprostenol may increase the hypotensive activities of Zofenopril.,increase,no risk
Epoprostenol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Zonisamide,Zonisamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Gemfibrozil,Bepotastine,Gemfibrozil may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Berotralstat,The metabolism of Gemfibrozil can be decreased when combined with Berotralstat.,decrease,no risk
Gemfibrozil,Betamethasone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bezafibrate,The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Bezafibrate.,increase,risk
Gemfibrozil,Bicisate,Gemfibrozil may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bismuth subgallate,Gemfibrozil may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bisoprolol,Bisoprolol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bisoxatin,Gemfibrozil may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bleomycin,Bleomycin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Boceprevir,The metabolism of Gemfibrozil can be decreased when combined with Boceprevir.,decrease,no risk
Gemfibrozil,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bosentan,The metabolism of Bosentan can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bromotheophylline,Bromotheophylline may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemfibrozil,Budesonide,Budesonide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bumadizone,Bumadizone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bumetanide,The excretion of Bumetanide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bupropion,The metabolism of Bupropion can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Buspirone,Buspirone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Butabarbital,Butabarbital may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gabapentin enacarbil,Gemfibrozil may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadodiamide,Gadodiamide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadofosveset trisodium,Gemfibrozil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadoteric acid,Gemfibrozil may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadoteridol,Gadoteridol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Gemcitabine,Gemcitabine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gentamicin,Gemfibrozil may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gimeracil,Gemfibrozil may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Givosiran,Givosiran may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glecaprevir,The metabolism of Gemfibrozil can be decreased when combined with Glecaprevir.,decrease,no risk
Gemfibrozil,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glipizide,The metabolism of Glipizide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glofitamab,The serum concentration of Gemfibrozil can be increased when it is combined with Glofitamab.,increase,no risk
Gemfibrozil,Glyburide,The metabolism of Glyburide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glycerol phenylbutyrate,Gemfibrozil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Golodirsen,Gemfibrozil may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Goserelin,Goserelin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Guanethidine,Guanethidine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Guanfacine,Guanfacine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Halothane,The metabolism of Halothane can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydralazine,Gemfibrozil may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemfibrozil,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydroxyethyl Starch,Gemfibrozil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Kanamycin,Gemfibrozil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Ketamine,The metabolism of Ketamine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ketazolam,Gemfibrozil may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Ketoconazole,The metabolism of Gemfibrozil can be decreased when combined with Ketoconazole.,decrease,no risk
Gemfibrozil,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,N-acetyltyrosine,Gemfibrozil may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nabilone,The metabolism of Nabilone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nabumetone,The metabolism of Nabumetone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nadolol,Nadolol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Naldemedine,Gemfibrozil may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nalmefene,Gemfibrozil may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Naloxone,The metabolism of Naloxone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Naproxen,The metabolism of Naproxen can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nedaplatin,Gemfibrozil may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nedocromil,Nedocromil may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nefazodone,The metabolism of Gemfibrozil can be decreased when combined with Nefazodone.,decrease,no risk
Gemfibrozil,Nelfinavir,The metabolism of Gemfibrozil can be decreased when combined with Nelfinavir.,decrease,no risk
Gemfibrozil,Neomycin,Gemfibrozil may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Netilmicin,Gemfibrozil may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Netupitant,The metabolism of Netupitant can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nicorandil,Gemfibrozil may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nilotinib,The metabolism of Gemfibrozil can be decreased when combined with Nilotinib.,decrease,no risk
Gemfibrozil,Nilutamide,The metabolism of Nilutamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nilvadipine,The metabolism of Gemfibrozil can be decreased when combined with Nilvadipine.,decrease,no risk
Gemfibrozil,Nimesulide,Nimesulide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Nisoldipine,Nisoldipine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nitroprusside,Nitroprusside may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Norfloxacin is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Gemfibrozil,Octinoxate,Gemfibrozil may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Olsalazine,Olsalazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Omaveloxolone,The serum concentration of Gemfibrozil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Gemfibrozil,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Opium,Gemfibrozil may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ouabain,The excretion of Ouabain can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Oxacillin,Oxacillin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxaprozin,Oxaprozin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxazepam,Oxazepam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Oxybenzone,Gemfibrozil may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxyquinoline,Gemfibrozil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Quetiapine,Quetiapine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Quinapril,The excretion of Quinapril can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Quinethazone,Quinethazone may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemfibrozil,Quinidine,Gemfibrozil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Quinine,The metabolism of Quinine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Quizartinib,The metabolism of Gemfibrozil can be decreased when combined with Quizartinib.,decrease,no risk
Gemfibrozil,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Gemfibrozil is combined with Ubidecarenone.",increase,risk
Gemfibrozil,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Gemfibrozil,Vaborbactam,Gemfibrozil may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Valbenazine,Gemfibrozil may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Valganciclovir,Gemfibrozil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Valsartan,The metabolism of Valsartan can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Vancomycin,Gemfibrozil may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Varenicline,Gemfibrozil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Venetoclax,The metabolism of Gemfibrozil can be decreased when combined with Venetoclax.,decrease,no risk
Gemfibrozil,Venlafaxine,Venlafaxine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Verapamil,The metabolism of Gemfibrozil can be decreased when combined with Verapamil.,decrease,no risk
Gemfibrozil,Vilanterol,Gemfibrozil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Viloxazine,The metabolism of Gemfibrozil can be decreased when combined with Viloxazine.,decrease,no risk
Gemfibrozil,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Voriconazole,The metabolism of Gemfibrozil can be decreased when combined with Voriconazole.,decrease,no risk
Gemfibrozil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Warfarin,The metabolism of Warfarin can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zaleplon,Zaleplon may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Zanamivir,Zanamivir may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zileuton,The metabolism of Zileuton can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zimelidine,The metabolism of Gemfibrozil can be decreased when combined with Zimelidine.,decrease,no risk
Gemfibrozil,Ziprasidone,The metabolism of Gemfibrozil can be decreased when combined with Ziprasidone.,decrease,no risk
Gemfibrozil,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zotepine,The metabolism of Zotepine can be decreased when combined with Gemfibrozil.,decrease,no risk
Clomipramine,Bacitracin,Bacitracin may decrease the excretion rate of Clomipramine which could result in a higher serum level.,decrease,no risk
Clomipramine,Baclofen,The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Clomipramine.,increase,risk
Clomipramine,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Balsalazide.,increase,risk
Clomipramine,Baricitinib,Clomipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Clomipramine,Beclomethasone dipropionate,The metabolism of Clomipramine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Clomipramine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Bedaquiline.,increase,risk
Clomipramine,Belinostat,The metabolism of Clomipramine can be increased when combined with Belinostat.,increase,no risk
Clomipramine,Belladonna,The risk or severity of adverse effects can be increased when Belladonna is combined with Clomipramine.,increase,risk
Clomipramine,Belzutifan,The serum concentration of Clomipramine can be decreased when it is combined with Belzutifan.,decrease,no risk
Clomipramine,Benazepril,Clomipramine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Clomipramine,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Clomipramine.,decrease,no risk
Clomipramine,Bendazac,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bendazac.,increase,risk
Clomipramine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Benorilate.,increase,risk
Clomipramine,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Benoxaprofen.,increase,risk
Clomipramine,Benperidol,The risk or severity of adverse effects can be increased when Clomipramine is combined with Benperidol.,increase,risk
Clomipramine,Benserazide,Clomipramine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Clomipramine,Benzatropine,The metabolism of Clomipramine can be decreased when combined with Benzatropine.,decrease,no risk
Clomipramine,Benznidazole,Clomipramine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Clomipramine,Benzocaine,The metabolism of Clomipramine can be decreased when combined with Benzocaine.,decrease,no risk
Clomipramine,Benzphetamine,The therapeutic efficacy of Clomipramine can be increased when used in combination with Benzphetamine.,increase,no risk
Clomipramine,Benzthiazide,Benzthiazide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Benzydamine.,increase,risk
Clomipramine,Benzyl alcohol,The metabolism of Clomipramine can be decreased when combined with Benzyl alcohol.,decrease,no risk
Clomipramine,Bepotastine,Clomipramine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Clomipramine,Bepridil,The metabolism of Clomipramine can be decreased when combined with Bepridil.,decrease,no risk
Clomipramine,Berotralstat,The serum concentration of Clomipramine can be increased when it is combined with Berotralstat.,increase,no risk
Clomipramine,Betamethasone,The metabolism of Clomipramine can be increased when combined with Betamethasone.,increase,no risk
Clomipramine,Betamethasone phosphate,The metabolism of Clomipramine can be increased when combined with Betamethasone phosphate.,increase,no risk
Clomipramine,Betaxolol,The metabolism of Clomipramine can be decreased when combined with Betaxolol.,decrease,no risk
Clomipramine,Bethanidine,The risk or severity of hypertension can be increased when Clomipramine is combined with Bethanidine.,increase,risk
Clomipramine,Betulinic Acid,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Betulinic Acid.,increase,risk
Clomipramine,Bexagliflozin,Clomipramine may decrease the hypoglycemic activities of Bexagliflozin.,decrease,no risk
Clomipramine,Bexarotene,The metabolism of Clomipramine can be increased when combined with Bexarotene.,increase,no risk
Clomipramine,Bicalutamide,The metabolism of Clomipramine can be decreased when combined with Bicalutamide.,decrease,no risk
Clomipramine,Bicisate,Clomipramine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Clomipramine,Bifonazole,The metabolism of Clomipramine can be decreased when combined with Bifonazole.,decrease,no risk
Clomipramine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Clomipramine.,increase,risk
Clomipramine,Bimekizumab,The metabolism of Clomipramine can be increased when combined with Bimekizumab.,increase,no risk
Clomipramine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Clomipramine.,decrease,no risk
Clomipramine,Biperiden,The metabolism of Clomipramine can be decreased when combined with Biperiden.,decrease,no risk
Clomipramine,Bismuth subcitrate potassium,Clomipramine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Clomipramine,Bismuth subgallate,Clomipramine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Clomipramine,Bismuth subnitrate,Clomipramine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Clomipramine,Bisoprolol,Clomipramine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Clomipramine,Bisoxatin,Clomipramine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Clomipramine,Bleomycin,Bleomycin may decrease the excretion rate of Clomipramine which could result in a higher serum level.,decrease,no risk
Clomipramine,Boceprevir,The metabolism of Clomipramine can be decreased when combined with Boceprevir.,decrease,no risk
Clomipramine,Bortezomib,The metabolism of Clomipramine can be decreased when combined with Bortezomib.,decrease,no risk
Clomipramine,Bosentan,The metabolism of Clomipramine can be increased when combined with Bosentan.,increase,no risk
Clomipramine,Bosutinib,The metabolism of Clomipramine can be decreased when combined with Bosutinib.,decrease,no risk
Clomipramine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Clomipramine.,increase,risk
Clomipramine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Clomipramine.,increase,risk
Clomipramine,Brentuximab vedotin,The serum concentration of Clomipramine can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Clomipramine,Bretylium,Clomipramine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Clomipramine,Brexanolone,The risk or severity of CNS depression can be increased when Clomipramine is combined with Brexanolone.,increase,risk
Clomipramine,Brexpiprazole,The metabolism of Clomipramine can be decreased when combined with Brexpiprazole.,decrease,no risk
Clomipramine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.,increase,no risk
Clomipramine,Brivaracetam,The risk or severity of CNS depression can be increased when Clomipramine is combined with Brivaracetam.,increase,risk
Clomipramine,Bromazepam,The risk or severity of CNS depression can be increased when Clomipramine is combined with Bromazepam.,increase,risk
Clomipramine,Bromfenac,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bromfenac.,increase,risk
Clomipramine,Bromocriptine,Clomipramine may increase the vasopressor activities of Bromocriptine.,increase,no risk
Clomipramine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Bromperidol,The risk or severity of adverse effects can be increased when Clomipramine is combined with Bromperidol.,increase,risk
Clomipramine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Clomipramine.,increase,risk
Clomipramine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Clomipramine.,increase,risk
Clomipramine,Budesonide,The metabolism of Clomipramine can be increased when combined with Budesonide.,increase,no risk
Clomipramine,Bufexamac,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bufexamac.,increase,risk
Clomipramine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bumadizone.,increase,risk
Clomipramine,Bumetanide,Bumetanide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Bupivacaine,The metabolism of Clomipramine can be decreased when combined with Bupivacaine.,decrease,no risk
Clomipramine,Buprenorphine,Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Clomipramine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Clomipramine.,increase,risk
Clomipramine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Clomipramine.,increase,risk
Clomipramine,Buspirone,The metabolism of Clomipramine can be decreased when combined with Buspirone.,decrease,no risk
Clomipramine,Butabarbital,The metabolism of Clomipramine can be increased when combined with Butabarbital.,increase,no risk
Clomipramine,Butalbital,The metabolism of Clomipramine can be increased when combined with Butalbital.,increase,no risk
Clomipramine,Butaperazine,"The serum concentration of desmethylclomipramine, an active metabolite of Clomipramine, can be increased when used in combination with Butaperazine.",increase,no risk
Clomipramine,Butobarbital,The risk or severity of CNS depression can be increased when Clomipramine is combined with Butobarbital.,increase,risk
Clomipramine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Clomipramine.,increase,risk
Clomipramine,Butriptyline,The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Butriptyline.,increase,risk
Clomipramine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Clomipramine.,increase,risk
Bepridil,Bioallethrin,Bepridil may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Bepridil,Biperiden,The metabolism of Bepridil can be decreased when combined with Biperiden.,decrease,no risk
Bepridil,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Bisoprolol,The therapeutic efficacy of Bepridil can be increased when used in combination with Bisoprolol.,increase,no risk
Bepridil,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Boceprevir,The serum concentration of Bepridil can be increased when it is combined with Boceprevir.,increase,no risk
Bepridil,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bepridil.,increase,risk
Bepridil,Bosentan,Bosentan may increase the hypotensive activities of Bepridil.,increase,no risk
Bepridil,Bretylium,Bretylium may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Bepridil,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Brimonidine,Brimonidine may increase the antihypertensive activities of Bepridil.,increase,no risk
Bepridil,Bromocriptine,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Bromocriptine.,increase,risk
Bepridil,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Bepridil.,increase,risk
Bepridil,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Bepridil.,increase,risk
Bepridil,Bumadizone,The therapeutic efficacy of Bepridil can be decreased when used in combination with Bumadizone.,decrease,no risk
Bepridil,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Bepridil.,increase,risk
Bepridil,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Bupropion,The metabolism of Bepridil can be decreased when combined with Bupropion.,decrease,no risk
Bepridil,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Bepridil.,increase,risk
Bepridil,Buspirone,The metabolism of Buspirone can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Butabarbital,Butabarbital may increase the hypotensive activities of Bepridil.,increase,no risk
Bepridil,Butalbital,Butalbital may increase the hypotensive activities of Bepridil.,increase,no risk
Bepridil,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Bepridil.,increase,risk
Bepridil,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Bepridil.,increase,risk
Bepridil,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Bepridil.,increase,risk
Bepridil,Gallamine triethiodide,Bepridil may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Bepridil,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Bepridil.,increase,risk
Bepridil,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Bepridil.,increase,risk
Bepridil,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Bepridil.,increase,risk
Bepridil,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Bepridil.,increase,risk
Bepridil,Givosiran,The serum concentration of Bepridil can be increased when it is combined with Givosiran.,increase,no risk
Bepridil,Glasdegib,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Glasdegib.,increase,risk
Bepridil,Gliclazide,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Gliclazide.,increase,risk
Bepridil,Glimepiride,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Glimepiride.,increase,risk
Bepridil,Glipizide,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Glipizide.,increase,risk
Bepridil,Gliquidone,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Gliquidone.,increase,risk
Bepridil,Glofitamab,The serum concentration of Bepridil can be increased when it is combined with Glofitamab.,increase,no risk
Bepridil,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Glyburide,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Glyburide.,increase,risk
Bepridil,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Glycerol phenylbutyrate,The metabolism of Bepridil can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Decamethonium,Gabapentin,Furosemide may decrease the neuromuscular blocking activities of Decamethonium.,decrease,no risk
Decamethonium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin is combined with Decamethonium.,increase,risk
Decamethonium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Decamethonium is combined with Gabapentin enacarbil.,increase,risk
Decamethonium,Ganaxolone,The risk or severity of CNS depression can be increased when Decamethonium is combined with gamma-Hydroxybutyric acid.,increase,risk
Decamethonium,Gentamicin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Decamethonium is combined with Ganaxolone.",increase,risk
Decamethonium,Gepirone,The therapeutic efficacy of Decamethonium can be increased when used in combination with Gentamicin.,increase,no risk
Decamethonium,Glutethimide,The risk or severity of CNS depression can be increased when Decamethonium is combined with Gepirone.,increase,risk
Decamethonium,Glycopyrronium,The risk or severity of CNS depression can be increased when Decamethonium is combined with Glutethimide.,increase,risk
Decamethonium,Granisetron,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Guanfacine,The risk or severity of CNS depression can be increased when Granisetron is combined with Decamethonium.,increase,risk
Decamethonium,Halazepam,The risk or severity of CNS depression can be increased when Guanfacine is combined with Decamethonium.,increase,risk
Decamethonium,Haloperidol,The risk or severity of CNS depression can be increased when Halazepam is combined with Decamethonium.,increase,risk
Decamethonium,Halothane,The risk or severity of CNS depression can be increased when Haloperidol is combined with Decamethonium.,increase,risk
Decamethonium,Hexafluronium,The risk or severity of CNS depression can be increased when Halothane is combined with Decamethonium.,increase,risk
Decamethonium,Hexocyclium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Decamethonium.,increase,risk
Decamethonium,Homatropine methylbromide,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Hydrocodone,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Hydrocortisone,Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Decamethonium,Hydrocortisone acetate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Decamethonium,Hydrocortisone butyrate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Decamethonium,Hydrocortisone cypionate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Decamethonium,Hydrocortisone succinate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Decamethonium,Hydromorphone,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Decamethonium,Hydroxyzine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Decamethonium.,increase,risk
Decamethonium,Hyoscyamine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Decamethonium.,increase,no risk
Decamethonium,Kanamycin,The therapeutic efficacy of Isopropamide can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Ketamine,The therapeutic efficacy of Decamethonium can be increased when used in combination with Kanamycin.,increase,no risk
Decamethonium,Ketazolam,The risk or severity of CNS depression can be increased when Ketamine is combined with Decamethonium.,increase,risk
Decamethonium,Ketoconazole,The risk or severity of CNS depression can be increased when Decamethonium is combined with Ketazolam.,increase,risk
Decamethonium,Nabilone,Decamethonium may increase the neuromuscular blocking activities of Moxisylyte.,increase,no risk
Decamethonium,Nadolol,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Decamethonium.,increase,no risk
Decamethonium,Nalbuphine,Decamethonium may increase the bradycardic activities of Nadolol.,increase,no risk
Decamethonium,Naratriptan,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Decamethonium.,increase,risk
Decamethonium,Naxitamab,The risk or severity of CNS depression can be increased when Naratriptan is combined with Decamethonium.,increase,risk
Decamethonium,Nebivolol,Decamethonium may increase the neurotoxic activities of Naxitamab.,increase,no risk
Decamethonium,Nefazodone,Decamethonium may increase the bradycardic activities of Nebivolol.,increase,no risk
Decamethonium,Neomycin,The risk or severity of adverse effects can be increased when Decamethonium is combined with Nefazodone.,increase,risk
Decamethonium,Netilmicin,The therapeutic efficacy of Decamethonium can be increased when used in combination with Neomycin.,increase,no risk
Decamethonium,Nialamide,The therapeutic efficacy of Decamethonium can be increased when used in combination with Netilmicin.,increase,no risk
Decamethonium,Nicardipine,The risk or severity of CNS depression can be increased when Decamethonium is combined with Nialamide.,increase,risk
Decamethonium,Nicotine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Nitrazepam,The risk or severity of adverse effects can be increased when Decamethonium is combined with Nicotine.,increase,risk
Decamethonium,Nitrous oxide,The risk or severity of CNS depression can be increased when Decamethonium is combined with Nitrazepam.,increase,risk
Decamethonium,Nomifensine,The risk or severity of CNS depression can be increased when Decamethonium is combined with Nitrous oxide.,increase,risk
Decamethonium,Normethadone,The risk or severity of CNS depression can be increased when Decamethonium is combined with Nomifensine.,increase,risk
Decamethonium,Nortriptyline,The risk or severity of CNS depression can be increased when Decamethonium is combined with Normethadone.,increase,risk
Decamethonium,Olanzapine,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Decamethonium.,increase,risk
Decamethonium,Oliceridine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Decamethonium.,increase,risk
Decamethonium,Ondansetron,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Decamethonium is combined with Oliceridine.",increase,risk
Decamethonium,Opium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Decamethonium.,increase,risk
Decamethonium,Orphenadrine,The risk or severity of CNS depression can be increased when Decamethonium is combined with Opium.,increase,risk
Decamethonium,Ouabain,Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Decamethonium,Oxazepam,The risk or severity of Cardiac Arrhythmia can be increased when Decamethonium is combined with Ouabain.,increase,risk
Decamethonium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Decamethonium.,increase,risk
Decamethonium,Oxitriptan,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Decamethonium.,increase,risk
Decamethonium,Oxprenolol,The risk or severity of CNS depression can be increased when Decamethonium is combined with Oxitriptan.,increase,risk
Decamethonium,Oxybuprocaine,Decamethonium may increase the bradycardic activities of Oxprenolol.,increase,no risk
Decamethonium,Oxybutynin,Decamethonium may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Decamethonium,Oxycodone,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Oxymorphone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Decamethonium.,increase,risk
Decamethonium,Oxyphencyclimine,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Decamethonium.,increase,risk
Decamethonium,Oxyphenonium,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Oxytetracycline,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Quazepam,The risk or severity of CNS depression can be increased when Decamethonium is combined with Pyrantel.,increase,risk
Decamethonium,Quetiapine,The risk or severity of CNS depression can be increased when Decamethonium is combined with Quazepam.,increase,risk
Decamethonium,Quinidine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Decamethonium.,increase,risk
Decamethonium,Quinine,The therapeutic efficacy of Decamethonium can be increased when used in combination with Quinidine.,increase,no risk
Decamethonium,Quinupramine,The therapeutic efficacy of Decamethonium can be increased when used in combination with Quinine.,increase,no risk
Alimemazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Alimemazine.,increase,risk
Alimemazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Alimemazine is combined with Gabapentin enacarbil.,increase,risk
Alimemazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Gadobenic acid.,increase,risk
Alimemazine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Alimemazine.,increase,risk
Alimemazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Alimemazine.,increase,risk
Alimemazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Alimemazine is combined with Ganaxolone.",increase,risk
Alimemazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Alimemazine.,increase,risk
Alimemazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Gemifloxacin.,increase,risk
Alimemazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Alimemazine.,increase,risk
Alimemazine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Gilteritinib.,increase,risk
Alimemazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Glasdegib.,increase,risk
Alimemazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Glutethimide,The risk or severity of CNS depression can be increased when Alimemazine is combined with Glutethimide.,increase,risk
Alimemazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Goserelin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Goserelin.,increase,risk
Alimemazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Alimemazine.,increase,risk
Alimemazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Grepafloxacin.,increase,risk
Alimemazine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Alimemazine.,increase,risk
Alimemazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Alimemazine.,increase,risk
Alimemazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Alimemazine.,increase,risk
Alimemazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Haloperidol.,increase,risk
Alimemazine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Alimemazine.,increase,risk
Alimemazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Alimemazine.,increase,risk
Alimemazine,Histrelin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Histrelin.,increase,risk
Alimemazine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Alimemazine.,increase,risk
Alimemazine,Hydrocodone,Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Alimemazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Hydromorphone.,increase,risk
Alimemazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Alimemazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Alimemazine.,increase,risk
Alimemazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Hydroxyzine.,increase,risk
Alimemazine,Hyoscyamine,Alimemazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Alimemazine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Alimemazine.,increase,risk
Alimemazine,Ketazolam,The risk or severity of CNS depression can be increased when Alimemazine is combined with Ketazolam.,increase,risk
Alimemazine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Alimemazine.,increase,risk
Alimemazine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Alimemazine.,increase,no risk
Alimemazine,Nadolol,The serum concentration of Nadolol can be increased when it is combined with Alimemazine.,increase,no risk
Alimemazine,Nalbuphine,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Nalbuphine.,increase,risk
Alimemazine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Nalidixic acid.,increase,risk
Alimemazine,Naloxegol,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Naloxegol.,increase,risk
Alimemazine,Naltrexone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Naltrexone.,increase,risk
Alimemazine,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Alimemazine.,increase,risk
Alimemazine,Naxitamab,Alimemazine may increase the neurotoxic activities of Naxitamab.,increase,no risk
Alimemazine,Nebivolol,The serum concentration of Nebivolol can be increased when it is combined with Alimemazine.,increase,no risk
Alimemazine,Nefazodone,The risk or severity of adverse effects can be increased when Alimemazine is combined with Nefazodone.,increase,risk
Alimemazine,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Alimemazine.,increase,risk
Alimemazine,Neomycin,Neomycin may increase the neurotoxic activities of Alimemazine.,increase,no risk
Alimemazine,Nialamide,The risk or severity of extrapyramidal symptoms can be increased when Nialamide is combined with Alimemazine.,increase,risk
Alimemazine,Nicardipine,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Alimemazine.,increase,risk
Alimemazine,Nifedipine,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Nifedipine.,increase,risk
Alimemazine,Nilotinib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Nilotinib.,increase,risk
Alimemazine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Nilvadipine.,increase,risk
Alimemazine,Nimodipine,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Nimodipine.,increase,risk
Alimemazine,Nitrazepam,The risk or severity of CNS depression can be increased when Alimemazine is combined with Nitrazepam.,increase,risk
Alimemazine,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Alimemazine.,increase,risk
Alimemazine,Nitrous oxide,The risk or severity of CNS depression can be increased when Alimemazine is combined with Nitrous oxide.,increase,risk
Alimemazine,Nomifensine,The risk or severity of CNS depression can be increased when Alimemazine is combined with Nomifensine.,increase,risk
Alimemazine,Norepinephrine,The therapeutic efficacy of Norepinephrine can be increased when used in combination with Alimemazine.,increase,no risk
Alimemazine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Alimemazine.,increase,risk
Alimemazine,Normethadone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Normethadone.,increase,risk
Alimemazine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Alimemazine.,increase,no risk
Alimemazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Alimemazine.,increase,risk
Alimemazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Ofloxacin.,increase,risk
Alimemazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Alimemazine.,increase,risk
Alimemazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Alimemazine is combined with Oliceridine.",increase,risk
Alimemazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Olodaterol.,increase,risk
Alimemazine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Alimemazine.,increase,risk
Alimemazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Opium.,increase,risk
Alimemazine,Orphenadrine,Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Alimemazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Alimemazine.,increase,risk
Alimemazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Oxatomide.,increase,risk
Alimemazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Alimemazine.,increase,risk
Alimemazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Alimemazine.,increase,risk
Alimemazine,Oxitriptan,The risk or severity of CNS depression can be increased when Alimemazine is combined with Oxitriptan.,increase,risk
Alimemazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Alimemazine.,increase,no risk
Alimemazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Alimemazine.,increase,risk
Alimemazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Oxycodone.,increase,risk
Alimemazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Oxymorphone.,increase,risk
Alimemazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Alimemazine.,increase,risk
Alimemazine,Quazepam,The risk or severity of CNS depression can be increased when Alimemazine is combined with Quazepam.,increase,risk
Alimemazine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Alimemazine.,increase,risk
Alimemazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Alimemazine.,increase,risk
Alimemazine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Alimemazine.,increase,risk
Alimemazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Alimemazine.,increase,no risk
Alimemazine,Quizartinib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Quizartinib.,increase,risk
Alimemazine,Urethane,The risk or severity of CNS depression can be increased when Alimemazine is combined with Urethane.,increase,risk
Alimemazine,Valproate bismuth,Alimemazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Alimemazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Valproic acid.,increase,risk
Alimemazine,Vandetanib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vandetanib.,increase,risk
Alimemazine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Alimemazine.,increase,risk
Alimemazine,Vecuronium,The risk or severity of CNS depression can be increased when Alimemazine is combined with Vecuronium.,increase,risk
Alimemazine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Alimemazine.,increase,risk
Alimemazine,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alimemazine.,increase,risk
Alimemazine,Vernakalant,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vernakalant.,increase,risk
Alimemazine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Alimemazine.,increase,risk
Alimemazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Alimemazine.,increase,risk
Alimemazine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Alimemazine.,increase,risk
Alimemazine,Viloxazine,The risk or severity of CNS depression can be increased when Alimemazine is combined with Viloxazine.,increase,risk
Alimemazine,Vincristine,Vincristine may increase the neurotoxic activities of Alimemazine.,increase,no risk
Alimemazine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Alimemazine.,increase,no risk
Alimemazine,Viomycin,Alimemazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Alimemazine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Alimemazine.,increase,risk
Alimemazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vorinostat.,increase,risk
Alimemazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Alimemazine.,increase,risk
Alimemazine,Yohimbine,The risk or severity of CNS depression can be increased when Alimemazine is combined with Yohimbine.,increase,risk
Alimemazine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Alimemazine.,increase,risk
Alimemazine,Ziconotide,The risk or severity of CNS depression can be increased when Alimemazine is combined with Ziconotide.,increase,risk
Alimemazine,Zimelidine,The risk or severity of adverse effects can be increased when Alimemazine is combined with Zimelidine.,increase,risk
Alimemazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Ziprasidone.,increase,risk
Alimemazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alimemazine.,increase,risk
Alimemazine,Zolpidem,Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Alimemazine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Alimemazine.,increase,risk
Alimemazine,Zopiclone,The risk or severity of adverse effects can be increased when Alimemazine is combined with Zopiclone.,increase,risk
Alimemazine,Zotepine,The risk or severity of CNS depression can be increased when Alimemazine is combined with Zotepine.,increase,risk
Alimemazine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Zuclopenthixol.,increase,risk
Alimemazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Alimemazine.,increase,risk
Isocarboxazid,Bromocriptine,Isocarboxazid may increase the hypertensive activities of Bromocriptine.,increase,no risk
Isocarboxazid,Bromperidol,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Bromperidol.,increase,risk
Isocarboxazid,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Isocarboxazid.,increase,risk
Isocarboxazid,Bumadizone,The risk or severity of hypertension can be increased when Isocarboxazid is combined with Bumadizone.,increase,risk
Isocarboxazid,Bumetanide,Isocarboxazid may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Isocarboxazid,Bupivacaine,Isocarboxazid may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Isocarboxazid,Buprenorphine,Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Isocarboxazid,Bupropion,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Bupropion.,increase,risk
Isocarboxazid,Buspirone,The risk or severity of hypertension can be increased when Isocarboxazid is combined with Buspirone.,increase,risk
Isocarboxazid,Butabarbital,Butabarbital may increase the hypotensive activities of Isocarboxazid.,increase,no risk
Isocarboxazid,Butalbital,Butalbital may increase the hypotensive activities of Isocarboxazid.,increase,no risk
Isocarboxazid,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Isocarboxazid is combined with Butaperazine.,increase,risk
Isocarboxazid,Butobarbital,The risk or severity of CNS depression can be increased when Isocarboxazid is combined with Butobarbital.,increase,risk
Isocarboxazid,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Isocarboxazid.,increase,risk
Isocarboxazid,Butriptyline,Isocarboxazid may increase the serotonergic activities of Butriptyline.,increase,no risk
Docetaxel,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Docetaxel.,increase,risk
Docetaxel,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Docetaxel.,increase,risk
Docetaxel,Bexarotene,The metabolism of Docetaxel can be increased when combined with Bexarotene.,increase,no risk
Docetaxel,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Docetaxel is combined with Bezafibrate.",increase,risk
Docetaxel,Bicalutamide,The metabolism of Docetaxel can be decreased when combined with Bicalutamide.,decrease,no risk
Docetaxel,Bifonazole,The metabolism of Docetaxel can be decreased when combined with Bifonazole.,decrease,no risk
Docetaxel,Bimekizumab,The metabolism of Docetaxel can be increased when combined with Bimekizumab.,increase,no risk
Docetaxel,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Docetaxel.,increase,risk
Docetaxel,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Docetaxel.,increase,risk
Docetaxel,Blinatumomab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Blinatumomab.,increase,risk
Docetaxel,Boceprevir,The metabolism of Docetaxel can be decreased when combined with Boceprevir.,decrease,no risk
Docetaxel,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Docetaxel.",decrease,no risk
Docetaxel,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Bosentan,The metabolism of Docetaxel can be increased when combined with Bosentan.,increase,no risk
Docetaxel,Bosutinib,The metabolism of Docetaxel can be decreased when combined with Bosutinib.,decrease,no risk
Docetaxel,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Brodalumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Brodalumab.,increase,risk
Docetaxel,Budesonide,The metabolism of Docetaxel can be increased when combined with Budesonide.,increase,no risk
Docetaxel,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Docetaxel.",increase,risk
Docetaxel,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Bupivacaine.,increase,risk
Docetaxel,Buprenorphine,The metabolism of Docetaxel can be decreased when combined with Buprenorphine.,decrease,no risk
Docetaxel,Buspirone,The metabolism of Docetaxel can be decreased when combined with Buspirone.,decrease,no risk
Docetaxel,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Butacaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Butacaine.,increase,risk
Docetaxel,Butalbital,The metabolism of Docetaxel can be increased when combined with Butalbital.,increase,no risk
Docetaxel,Butamben,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Butamben.,increase,risk
Docetaxel,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Docetaxel.",increase,risk
Docetaxel,Gefitinib,The metabolism of Docetaxel can be decreased when combined with Gefitinib.,decrease,no risk
Docetaxel,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Docetaxel.,increase,risk
Docetaxel,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Gemfibrozil is combined with Docetaxel.",increase,risk
Docetaxel,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Docetaxel.,increase,risk
Docetaxel,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Gilteritinib,The metabolism of Docetaxel can be decreased when combined with Gilteritinib.,decrease,no risk
Docetaxel,Ginkgo biloba,The metabolism of Docetaxel can be decreased when combined with Ginkgo biloba.,decrease,no risk
Docetaxel,Glatiramer,The risk or severity of adverse effects can be increased when Docetaxel is combined with Glatiramer.,increase,risk
Docetaxel,Glecaprevir,The metabolism of Docetaxel can be decreased when combined with Glecaprevir.,decrease,no risk
Docetaxel,Glofitamab,The serum concentration of Docetaxel can be increased when it is combined with Glofitamab.,increase,no risk
Docetaxel,Glyburide,The metabolism of Docetaxel can be decreased when combined with Glyburide.,decrease,no risk
Docetaxel,Glycerol phenylbutyrate,The metabolism of Docetaxel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Docetaxel,Golimumab,The metabolism of Docetaxel can be increased when combined with Golimumab.,increase,no risk
Docetaxel,Grapefruit,The serum concentration of Docetaxel can be increased when it is combined with Grapefruit.,increase,no risk
Docetaxel,Griseofulvin,The metabolism of Docetaxel can be increased when combined with Griseofulvin.,increase,no risk
Docetaxel,Guselkumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Guselkumab.,increase,risk
Docetaxel,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Halofantrine,The metabolism of Docetaxel can be decreased when combined with Halofantrine.,decrease,no risk
Docetaxel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Docetaxel.,increase,risk
Docetaxel,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Docetaxel.,increase,risk
Docetaxel,Hydralazine,The serum concentration of Docetaxel can be increased when it is combined with Hydralazine.,increase,no risk
Docetaxel,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Docetaxel.,increase,risk
Docetaxel,Hydrocortamate,The metabolism of Docetaxel can be increased when combined with Hydrocortamate.,increase,no risk
Docetaxel,Hydrocortisone,The metabolism of Docetaxel can be increased when combined with Hydrocortisone.,increase,no risk
Docetaxel,Hydrocortisone acetate,The metabolism of Docetaxel can be increased when combined with Hydrocortisone acetate.,increase,no risk
Docetaxel,Hydrocortisone butyrate,The metabolism of Docetaxel can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Docetaxel,Hydrocortisone cypionate,The metabolism of Docetaxel can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Docetaxel,Hydrocortisone phosphate,The metabolism of Docetaxel can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Docetaxel,Hydrocortisone succinate,The metabolism of Docetaxel can be increased when combined with Hydrocortisone succinate.,increase,no risk
Docetaxel,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Docetaxel.,increase,risk
Docetaxel,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Docetaxel is combined with Hydroxychloroquine.,increase,risk
Docetaxel,Hydroxyprogesterone caproate,The metabolism of Docetaxel can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Docetaxel,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Docetaxel.,increase,risk
Docetaxel,Hydroxyzine,The metabolism of Docetaxel can be decreased when combined with Hydroxyzine.,decrease,no risk
Docetaxel,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Ketazolam,The serum concentration of Docetaxel can be increased when it is combined with Ketazolam.,increase,no risk
Docetaxel,Ketoconazole,The metabolism of Docetaxel can be decreased when combined with Ketoconazole.,decrease,no risk
Docetaxel,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Docetaxel.,increase,risk
Docetaxel,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Docetaxel.",increase,risk
Docetaxel,Nafcillin,The metabolism of Docetaxel can be increased when combined with Nafcillin.,increase,no risk
Docetaxel,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Docetaxel.",increase,risk
Docetaxel,Natalizumab,The risk or severity of immunosuppression can be increased when Docetaxel is combined with Natalizumab.,increase,risk
Docetaxel,Nateglinide,The metabolism of Docetaxel can be decreased when combined with Nateglinide.,decrease,no risk
Docetaxel,Nedaplatin,The risk or severity of adverse effects can be increased when Nedaplatin is combined with Docetaxel.,increase,risk
Docetaxel,Nefazodone,The metabolism of Docetaxel can be decreased when combined with Nefazodone.,decrease,no risk
Docetaxel,Nelarabine,The risk or severity of adverse effects can be increased when Docetaxel is combined with Nelarabine.,increase,risk
Docetaxel,Nelfinavir,The metabolism of Docetaxel can be decreased when combined with Nelfinavir.,decrease,no risk
Docetaxel,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Netupitant,The metabolism of Docetaxel can be decreased when combined with Netupitant.,decrease,no risk
Docetaxel,Nevirapine,The metabolism of Docetaxel can be decreased when combined with Nevirapine.,decrease,no risk
Docetaxel,Niacin,The serum concentration of Docetaxel can be increased when it is combined with Niacin.,increase,no risk
Docetaxel,Nicardipine,The metabolism of Docetaxel can be decreased when combined with Nicardipine.,decrease,no risk
Docetaxel,Nifedipine,The metabolism of Docetaxel can be decreased when combined with Nifedipine.,decrease,no risk
Docetaxel,Nilotinib,The metabolism of Docetaxel can be decreased when combined with Nilotinib.,decrease,no risk
Docetaxel,Nilvadipine,The metabolism of Docetaxel can be decreased when combined with Nilvadipine.,decrease,no risk
Docetaxel,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Docetaxel.,increase,risk
Docetaxel,Nintedanib,The metabolism of Docetaxel can be decreased when combined with Nintedanib.,decrease,no risk
Docetaxel,Nisoldipine,The metabolism of Docetaxel can be decreased when combined with Nisoldipine.,decrease,no risk
Docetaxel,Nitrendipine,The metabolism of Docetaxel can be decreased when combined with Nitrendipine.,decrease,no risk
Docetaxel,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Docetaxel.",increase,risk
Docetaxel,Norethisterone,The metabolism of Docetaxel can be decreased when combined with Norethisterone.,decrease,no risk
Docetaxel,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Norfloxacin is combined with Docetaxel.",increase,risk
Docetaxel,Norgestimate,The metabolism of Docetaxel can be increased when combined with Norgestimate.,increase,no risk
Docetaxel,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Noscapine,The serum concentration of Docetaxel can be increased when it is combined with Noscapine.,increase,no risk
Docetaxel,Novobiocin,The excretion of Docetaxel can be decreased when combined with Novobiocin.,decrease,no risk
Docetaxel,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Nystatin,The excretion of Docetaxel can be decreased when combined with Nystatin.,decrease,no risk
Docetaxel,Obinutuzumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Obinutuzumab.,increase,risk
Docetaxel,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Docetaxel.,increase,no risk
Docetaxel,Octreotide,The serum concentration of Docetaxel can be increased when it is combined with Octreotide.,increase,no risk
Docetaxel,Ofatumumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Ofatumumab.,increase,risk
Docetaxel,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Docetaxel.",increase,risk
Docetaxel,Olaparib,The metabolism of Docetaxel can be decreased when combined with Olaparib.,decrease,no risk
Docetaxel,Olutasidenib,The metabolism of Docetaxel can be increased when combined with Olutasidenib.,increase,no risk
Docetaxel,Omaveloxolone,The serum concentration of Docetaxel can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Docetaxel,Ondansetron,The metabolism of Docetaxel can be decreased when combined with Ondansetron.,decrease,no risk
Docetaxel,Oritavancin,The metabolism of Docetaxel can be increased when combined with Oritavancin.,increase,no risk
Docetaxel,Orphenadrine,The metabolism of Docetaxel can be decreased when combined with Orphenadrine.,decrease,no risk
Docetaxel,Osilodrostat,The metabolism of Docetaxel can be decreased when combined with Osilodrostat.,decrease,no risk
Docetaxel,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Ouabain,Ouabain may decrease the cardiotoxic activities of Docetaxel.,decrease,no risk
Docetaxel,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Docetaxel.,increase,risk
Docetaxel,Oxcarbazepine,The metabolism of Docetaxel can be increased when combined with Oxcarbazepine.,increase,no risk
Docetaxel,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Oxetacaine.,increase,risk
Docetaxel,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Oxybuprocaine.,increase,risk
Docetaxel,Oxybutynin,The serum concentration of Docetaxel can be increased when it is combined with Oxybutynin.,increase,no risk
Docetaxel,Oxycodone,The metabolism of Docetaxel can be decreased when combined with Oxycodone.,decrease,no risk
Docetaxel,Ozanimod,The risk or severity of adverse effects can be increased when Docetaxel is combined with Ozanimod.,increase,risk
Docetaxel,Quetiapine,The metabolism of Docetaxel can be decreased when combined with Quetiapine.,decrease,no risk
Docetaxel,Quinidine,The metabolism of Docetaxel can be decreased when combined with Quinidine.,decrease,no risk
Docetaxel,Quinine,The metabolism of Docetaxel can be increased when combined with Quinine.,increase,no risk
Docetaxel,Quinupristin,The metabolism of Docetaxel can be decreased when combined with Quinupristin.,decrease,no risk
Docetaxel,Quizartinib,The metabolism of Docetaxel can be decreased when combined with Quizartinib.,decrease,no risk
Docetaxel,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Docetaxel is combined with Ubidecarenone.",increase,risk
Docetaxel,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Docetaxel.,increase,risk
Docetaxel,Udenafil,The metabolism of Docetaxel can be decreased when combined with Udenafil.,decrease,no risk
Docetaxel,Upadacitinib,The risk or severity of adverse effects can be increased when Docetaxel is combined with Upadacitinib.,increase,risk
Docetaxel,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Docetaxel.,increase,risk
Docetaxel,Vadadustat,The serum concentration of Docetaxel can be increased when it is combined with Vadadustat.,increase,no risk
Docetaxel,Valbenazine,The metabolism of Docetaxel can be decreased when combined with Valbenazine.,decrease,no risk
Docetaxel,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Valproic acid,The serum concentration of Docetaxel can be increased when it is combined with Valproic acid.,increase,no risk
Docetaxel,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Docetaxel.,decrease,no risk
Docetaxel,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Docetaxel.,increase,risk
Docetaxel,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Vedolizumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vedolizumab.,increase,risk
Docetaxel,Velpatasvir,The excretion of Docetaxel can be decreased when combined with Velpatasvir.,decrease,no risk
Docetaxel,Vemurafenib,The metabolism of Docetaxel can be increased when combined with Vemurafenib.,increase,no risk
Docetaxel,Venetoclax,The metabolism of Docetaxel can be decreased when combined with Venetoclax.,decrease,no risk
Docetaxel,Verapamil,The metabolism of Docetaxel can be decreased when combined with Verapamil.,decrease,no risk
Docetaxel,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Vilanterol,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vilanterol.,increase,risk
Docetaxel,Viloxazine,The metabolism of Docetaxel can be decreased when combined with Viloxazine.,decrease,no risk
Docetaxel,Vinblastine,The metabolism of Docetaxel can be increased when combined with Vinblastine.,increase,no risk
Docetaxel,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vitamin E,The metabolism of Docetaxel can be increased when combined with Vitamin E.,increase,no risk
Docetaxel,Voclosporin,The risk or severity of adverse effects can be increased when Docetaxel is combined with Voclosporin.,increase,risk
Docetaxel,Vonoprazan,The metabolism of Docetaxel can be decreased when combined with Vonoprazan.,decrease,no risk
Docetaxel,Vorapaxar,The metabolism of Docetaxel can be decreased when combined with Vorapaxar.,decrease,no risk
Docetaxel,Voriconazole,The metabolism of Docetaxel can be decreased when combined with Voriconazole.,decrease,no risk
Docetaxel,Vorinostat,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vorinostat.,increase,risk
Docetaxel,Vortioxetine,The metabolism of Docetaxel can be decreased when combined with Vortioxetine.,decrease,no risk
Docetaxel,Voxelotor,The serum concentration of Docetaxel can be increased when it is combined with Voxelotor.,increase,no risk
Docetaxel,Voxilaprevir,The excretion of Docetaxel can be decreased when combined with Voxilaprevir.,decrease,no risk
Docetaxel,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Docetaxel.,increase,risk
Docetaxel,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Docetaxel.,increase,risk
Docetaxel,Zafirlukast,The serum concentration of Docetaxel can be increased when it is combined with Zafirlukast.,increase,no risk
Docetaxel,Zaleplon,The metabolism of Docetaxel can be decreased when combined with Zaleplon.,decrease,no risk
Docetaxel,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Docetaxel.,increase,risk
Docetaxel,Zimelidine,The metabolism of Docetaxel can be decreased when combined with Zimelidine.,decrease,no risk
Docetaxel,Ziprasidone,The metabolism of Docetaxel can be decreased when combined with Ziprasidone.,decrease,no risk
Docetaxel,Zonisamide,The metabolism of Docetaxel can be decreased when combined with Zonisamide.,decrease,no risk
Docetaxel,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Docetaxel.,decrease,no risk
Docetaxel,Zuclopenthixol,The metabolism of Docetaxel can be decreased when combined with Zuclopenthixol.,decrease,no risk
Iodixanol,Gabapentin enacarbil,Iodixanol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadodiamide,Gadodiamide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadofosveset trisodium,Iodixanol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadoteric acid,Iodixanol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadoteridol,Gadoteridol may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Ganciclovir,Ganciclovir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gemcitabine,Gemcitabine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gentamicin,Iodixanol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Iodixanol,Gimeracil,Iodixanol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Iodixanol,Givosiran,Givosiran may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Glipizide,Glipizide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Glycerol phenylbutyrate,Iodixanol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Iodixanol,Golodirsen,Iodixanol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Iodixanol,Goserelin,Goserelin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Guanethidine,Guanethidine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Guanfacine,Guanfacine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Haloperidol,Haloperidol may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydralazine,Iodixanol may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Iodixanol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Iodixanol,Hydromorphone,Hydromorphone may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydroxyethyl Starch,Iodixanol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Iodixanol,Kanamycin,Iodixanol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketamine,Ketamine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketazolam,Iodixanol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketoprofen,Ketoprofen may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketorolac,Ketorolac may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,N-acetyltyrosine,Iodixanol may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Iodixanol,Nabumetone,Nabumetone may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nadolol,Nadolol may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Naldemedine,Iodixanol may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Iodixanol,Nalmefene,Iodixanol may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Iodixanol,Naloxone,Naloxone may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Naproxen,Naproxen may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nateglinide,Nateglinide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nedaplatin,Iodixanol may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Iodixanol,Nedocromil,Nedocromil may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nefazodone,Nefazodone may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Neomycin,Iodixanol may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Iodixanol,Netilmicin,Iodixanol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Iodixanol,Nicorandil,Iodixanol may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Iodixanol,Nifedipine,Nifedipine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nilutamide,Nilutamide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nimesulide,Nimesulide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nisoldipine,Nisoldipine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Nitroprusside,Nitroprusside may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Octinoxate,Iodixanol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Iodixanol,Olsalazine,Olsalazine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Opium,Iodixanol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Iodixanol,Oseltamivir,Oseltamivir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxacillin,Oxacillin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxaprozin,Oxaprozin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxazepam,Oxazepam may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxybenzone,Iodixanol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxyquinoline,Iodixanol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Iodixanol,Quetiapine,Quetiapine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Quinethazone,Quinethazone may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Iodixanol,Quinidine,Iodixanol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Iodixanol,Vaborbactam,Iodixanol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Iodixanol,Valaciclovir,Valaciclovir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Valbenazine,Iodixanol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Iodixanol,Valdecoxib,Valdecoxib may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Valganciclovir,Iodixanol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Iodixanol,Vancomycin,Iodixanol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Iodixanol,Varenicline,Iodixanol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Iodixanol,Venlafaxine,Venlafaxine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Verapamil,Verapamil may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Vilanterol,Iodixanol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Iodixanol,Viloxazine,Iodixanol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Iodixanol,Vortioxetine,Iodixanol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Iodixanol,Warfarin,Iodixanol may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Iodixanol,Zaleplon,Zaleplon may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Zanamivir,Zanamivir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Zonisamide,Zonisamide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Olsalazine,Gabapentin enacarbil,Olsalazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadobenic acid,Olsalazine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadodiamide,Olsalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadofosveset trisodium,Olsalazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadopentetic acid,Olsalazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadoteric acid,Olsalazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadoteridol,Olsalazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Olsalazine,Ganciclovir,Olsalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Olsalazine,Gemcitabine,Olsalazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Olsalazine,Gemfibrozil,Olsalazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Olsalazine,Gentamicin,The risk or severity of nephrotoxicity can be increased when Gentamicin is combined with Olsalazine.,increase,risk
Olsalazine,Gimeracil,Olsalazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Olsalazine,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Olsalazine.,increase,risk
Olsalazine,Givosiran,The risk or severity of nephrotoxicity can be increased when Givosiran is combined with Olsalazine.,increase,risk
Olsalazine,Gliclazide,Olsalazine may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Olsalazine,Glimepiride,Olsalazine may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Olsalazine,Glipizide,Olsalazine may increase the hypoglycemic activities of Glipizide.,increase,no risk
Olsalazine,Gliquidone,Olsalazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Olsalazine,Glyburide,Olsalazine may increase the hypoglycemic activities of Glyburide.,increase,no risk
Olsalazine,Glycerol phenylbutyrate,Olsalazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Olsalazine,Glymidine,Olsalazine may increase the hypoglycemic activities of Glymidine.,increase,no risk
Olsalazine,Golodirsen,Olsalazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Olsalazine,Goserelin,Olsalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Olsalazine,Guanethidine,Olsalazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Olsalazine,Guanfacine,Olsalazine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Olsalazine,Haloperidol,Olsalazine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Olsalazine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Olsalazine.,increase,risk
Olsalazine,Hydralazine,Olsalazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Olsalazine,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Olsalazine.,increase,risk
Olsalazine,Hydrocortisone,The serum concentration of Olsalazine can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Olsalazine,Hydromorphone,Olsalazine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Olsalazine,Hydroxocobalamin,Olsalazine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Olsalazine,Hydroxyethyl Starch,Olsalazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Olsalazine,Kanamycin,The risk or severity of nephrotoxicity can be increased when Kanamycin is combined with Olsalazine.,increase,risk
Olsalazine,Ketamine,Olsalazine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Olsalazine,Ketazolam,Olsalazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Olsalazine,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Olsalazine.,increase,risk
Olsalazine,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Olsalazine.,increase,risk
Olsalazine,N-acetyltyrosine,Olsalazine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Olsalazine,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Olsalazine.,increase,risk
Olsalazine,Nadolol,Olsalazine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Olsalazine,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Olsalazine.,increase,risk
Olsalazine,Naldemedine,Olsalazine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Olsalazine,Nalmefene,Olsalazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Olsalazine,Naloxone,Olsalazine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Olsalazine,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Olsalazine.,increase,risk
Olsalazine,Nateglinide,Olsalazine may increase the hypoglycemic activities of Nateglinide.,increase,no risk
Olsalazine,Nedaplatin,Olsalazine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Olsalazine,Nedocromil,Olsalazine may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Olsalazine,Nefazodone,Olsalazine may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Olsalazine,Neomycin,The risk or severity of nephrotoxicity can be increased when Olsalazine is combined with Neomycin.,increase,risk
Olsalazine,Nepafenac,The risk or severity of nephrotoxicity can be increased when Nepafenac is combined with Olsalazine.,increase,risk
Olsalazine,Netilmicin,The risk or severity of nephrotoxicity can be increased when Netilmicin is combined with Olsalazine.,increase,risk
Olsalazine,Nicorandil,Olsalazine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Olsalazine,Nifedipine,Olsalazine may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Olsalazine,Nilutamide,Olsalazine may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Olsalazine,Nimesulide,The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Olsalazine.,increase,risk
Olsalazine,Nisoldipine,Olsalazine may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Olsalazine,Nitric Oxide,Olsalazine may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Olsalazine,Nitrofurantoin,Olsalazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Olsalazine,Nitroprusside,Olsalazine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Olsalazine,Octinoxate,Olsalazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Olsalazine,Opium,Olsalazine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Olsalazine,Oseltamivir,Olsalazine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Olsalazine,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Olsalazine.,decrease,no risk
Olsalazine,Oxacillin,Olsalazine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Olsalazine,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Olsalazine.,increase,risk
Olsalazine,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Olsalazine.,increase,risk
Olsalazine,Oxazepam,Olsalazine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Olsalazine,Oxybenzone,Olsalazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Olsalazine,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Olsalazine.,increase,risk
Olsalazine,Oxyquinoline,Olsalazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Olsalazine,Quetiapine,Olsalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Olsalazine,Quinapril,The risk or severity of renal failure can be increased when Olsalazine is combined with Quinapril.,increase,risk
Olsalazine,Quinidine,Olsalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Olsalazine,Quinine,Olsalazine may increase the hypoglycemic activities of Quinine.,increase,no risk
Olsalazine,Urokinase,The risk or severity of bleeding can be increased when Olsalazine is combined with Urokinase.,increase,risk
Olsalazine,Vaborbactam,Olsalazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Olsalazine,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Olsalazine.,increase,risk
Olsalazine,Valbenazine,Olsalazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Olsalazine,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Olsalazine.,increase,risk
Olsalazine,Valganciclovir,Olsalazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Olsalazine,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Olsalazine.,increase,no risk
Olsalazine,Vancomycin,The risk or severity of nephrotoxicity can be increased when Vancomycin is combined with Olsalazine.,increase,risk
Olsalazine,Varenicline,Olsalazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Olsalazine,Varicella zoster vaccine (live/attenuated),The risk or severity of Reye's syndrome can be increased when Varicella zoster vaccine (live/attenuated) is combined with Olsalazine.,increase,risk
Olsalazine,Venlafaxine,Olsalazine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Olsalazine,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Olsalazine.,increase,risk
Olsalazine,Vilanterol,Olsalazine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Olsalazine,Vildagliptin,Olsalazine may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Olsalazine,Viloxazine,Olsalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Olsalazine,Vorapaxar,The risk or severity of bleeding can be increased when Olsalazine is combined with Vorapaxar.,increase,risk
Olsalazine,Vortioxetine,Olsalazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Olsalazine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Olsalazine.,increase,risk
Olsalazine,Ximelagatran,The risk or severity of bleeding can be increased when Olsalazine is combined with Ximelagatran.,increase,risk
Olsalazine,Zaleplon,Olsalazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Olsalazine,Zanamivir,Olsalazine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Olsalazine,Zofenopril,The risk or severity of renal failure can be increased when Olsalazine is combined with Zofenopril.,increase,risk
Olsalazine,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Olsalazine is combined with Zoledronic acid.,increase,risk
Olsalazine,Zonisamide,The risk or severity of adverse effects can be increased when Olsalazine is combined with Zonisamide.,increase,risk
Gliquidone,Gatifloxacin,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Furosemide.,decrease,no risk
Gliquidone,Gefapixant,The therapeutic efficacy of Gliquidone can be increased when used in combination with Gatifloxacin.,increase,no risk
Gliquidone,Gemfibrozil,The therapeutic efficacy of Gliquidone can be increased when used in combination with Gefapixant.,increase,no risk
Gliquidone,Gemifloxacin,The metabolism of Gliquidone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gliquidone,Gestrinone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Gemifloxacin.,increase,no risk
Gliquidone,Ginkgo biloba,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Gestrinone.,decrease,no risk
Gliquidone,Gliclazide,The metabolism of Gliquidone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Gliquidone,Glimepiride,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Gliquidone.,increase,risk
Gliquidone,Glipizide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Gliquidone.,increase,risk
Gliquidone,Glofitamab,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Gliquidone.,increase,risk
Gliquidone,Glyburide,The serum concentration of Gliquidone can be increased when it is combined with Glofitamab.,increase,no risk
Gliquidone,Glycol salicylate,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Gliquidone.,increase,risk
Gliquidone,Glymidine,The protein binding of Gliquidone can be decreased when combined with Glycol salicylate.,decrease,no risk
Gliquidone,Golimumab,The therapeutic efficacy of Gliquidone can be increased when used in combination with Glymidine.,increase,no risk
Gliquidone,Goserelin,The metabolism of Gliquidone can be increased when combined with Golimumab.,increase,no risk
Gliquidone,Grepafloxacin,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Goserelin.,decrease,no risk
Gliquidone,Halcinonide,The therapeutic efficacy of Gliquidone can be increased when used in combination with Grepafloxacin.,increase,no risk
Gliquidone,Haloperidol,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Gliquidone.,increase,risk
Gliquidone,Halothane,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Haloperidol.,decrease,no risk
Gliquidone,Histrelin,The metabolism of Gliquidone can be decreased when combined with Halothane.,decrease,no risk
Gliquidone,Hydrochlorothiazide,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Histrelin.,decrease,no risk
Gliquidone,Hydrocortisone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Gliquidone,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Gliquidone.,increase,risk
Gliquidone,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Gliquidone.,increase,risk
Gliquidone,Hydromorphone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Gliquidone,Hydroxychloroquine,The metabolism of Gliquidone can be decreased when combined with Hydromorphone.,decrease,no risk
Gliquidone,Hydroxyprogesterone caproate,The therapeutic efficacy of Gliquidone can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Gliquidone,Ketamine,The metabolism of Gliquidone can be increased when combined with Ivosidenib.,increase,no risk
Gliquidone,Ketoprofen,The metabolism of Gliquidone can be decreased when combined with Ketamine.,decrease,no risk
Gliquidone,Ketorolac,The protein binding of Gliquidone can be decreased when combined with Ketoprofen.,decrease,no risk
Gliquidone,Ketotifen,The protein binding of Gliquidone can be decreased when combined with Ketorolac.,decrease,no risk
Gliquidone,Nabilone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Moxifloxacin.,increase,no risk
Gliquidone,Nabumetone,The metabolism of Gliquidone can be decreased when combined with Nabilone.,decrease,no risk
Gliquidone,Nadolol,The protein binding of Gliquidone can be decreased when combined with Nabumetone.,decrease,no risk
Gliquidone,Nalidixic acid,The therapeutic efficacy of Gliquidone can be increased when used in combination with Nadolol.,increase,no risk
Gliquidone,Nandrolone decanoate,The therapeutic efficacy of Gliquidone can be increased when used in combination with Nalidixic acid.,increase,no risk
Gliquidone,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Gliquidone,Naproxen,Nandrolone phenpropionate may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Gliquidone,Nateglinide,The protein binding of Gliquidone can be decreased when combined with Naproxen.,decrease,no risk
Gliquidone,Nebivolol,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Gliquidone.,increase,risk
Gliquidone,Nefazodone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Nebivolol.,increase,no risk
Gliquidone,Nelfinavir,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Gliquidone.,increase,risk
Gliquidone,Netupitant,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nelfinavir.,decrease,no risk
Gliquidone,Nevirapine,The metabolism of Netupitant can be decreased when combined with Gliquidone.,decrease,no risk
Gliquidone,Niacin,The metabolism of Gliquidone can be decreased when combined with Nevirapine.,decrease,no risk
Gliquidone,Nialamide,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Niacin.,decrease,no risk
Gliquidone,Nicardipine,Nialamide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Gliquidone,Niclosamide,The metabolism of Gliquidone can be decreased when combined with Nicardipine.,decrease,no risk
Gliquidone,Nifedipine,The metabolism of Niclosamide can be decreased when combined with Gliquidone.,decrease,no risk
Gliquidone,Nilotinib,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Gliquidone.,increase,risk
Gliquidone,Nilutamide,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nilotinib.,decrease,no risk
Gliquidone,Nilvadipine,The metabolism of Gliquidone can be decreased when combined with Nilutamide.,decrease,no risk
Gliquidone,Nimesulide,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Gliquidone.,increase,risk
Gliquidone,Nimodipine,The protein binding of Gliquidone can be decreased when combined with Nimesulide.,decrease,no risk
Gliquidone,Nirogacestat,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Gliquidone.,increase,risk
Gliquidone,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Gliquidone.,decrease,no risk
Gliquidone,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Gliquidone.,increase,risk
Gliquidone,Nomegestrol,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Gliquidone.,increase,risk
Gliquidone,Nomegestrol acetate,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nomegestrol.,decrease,no risk
Gliquidone,Nonoxynol-9,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nomegestrol acetate.,decrease,no risk
Gliquidone,Norelgestromin,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Gliquidone,Norethisterone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norelgestromin.,decrease,no risk
Gliquidone,Norethynodrel,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norethisterone.,decrease,no risk
Gliquidone,Norfloxacin,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norethynodrel.,decrease,no risk
Gliquidone,Norgestimate,The therapeutic efficacy of Gliquidone can be increased when used in combination with Norfloxacin.,increase,no risk
Gliquidone,Norgestrel,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norgestimate.,decrease,no risk
Gliquidone,Nortriptyline,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norgestrel.,decrease,no risk
Gliquidone,Noscapine,Nortriptyline may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Gliquidone,Novobiocin,The metabolism of Gliquidone can be decreased when combined with Noscapine.,decrease,no risk
Gliquidone,Nylidrin,The therapeutic efficacy of Gliquidone can be increased when used in combination with Novobiocin.,increase,no risk
Gliquidone,Octreotide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Gliquidone.,increase,risk
Gliquidone,Ofloxacin,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Octreotide.,decrease,no risk
Gliquidone,Olanzapine,The therapeutic efficacy of Gliquidone can be increased when used in combination with Ofloxacin.,increase,no risk
Gliquidone,Olodaterol,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Olanzapine.,decrease,no risk
Gliquidone,Olsalazine,The metabolism of Olodaterol can be decreased when combined with Gliquidone.,decrease,no risk
Gliquidone,Ondansetron,Olsalazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Gliquidone,Oritavancin,The metabolism of Gliquidone can be decreased when combined with Ondansetron.,decrease,no risk
Gliquidone,Ospemifene,The metabolism of Gliquidone can be decreased when combined with Oritavancin.,decrease,no risk
Gliquidone,Oxandrolone,The metabolism of Ospemifene can be decreased when combined with Gliquidone.,decrease,no risk
Gliquidone,Oxaprozin,The metabolism of Gliquidone can be decreased when combined with Oxandrolone.,decrease,no risk
Gliquidone,Oxprenolol,The protein binding of Gliquidone can be decreased when combined with Oxaprozin.,decrease,no risk
Gliquidone,Oxymetholone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Oxprenolol.,increase,no risk
Gliquidone,Oxyphenbutazone,Oxymetholone may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Mitiglinide,Gatifloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Gatifloxacin.,increase,no risk
Mitiglinide,Gefapixant,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Gefapixant.,increase,no risk
Mitiglinide,Gemfibrozil,The metabolism of Mitiglinide can be decreased when combined with Gemfibrozil.,decrease,no risk
Mitiglinide,Gemifloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Gemifloxacin.,increase,no risk
Mitiglinide,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Mitiglinide.,increase,risk
Mitiglinide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Mitiglinide.,increase,risk
Mitiglinide,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Mitiglinide.,increase,risk
Mitiglinide,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Mitiglinide.,increase,risk
Mitiglinide,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Mitiglinide.,increase,risk
Mitiglinide,Glymidine,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Glymidine.,increase,no risk
Mitiglinide,Goserelin,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Goserelin.,decrease,no risk
Mitiglinide,Grepafloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Grepafloxacin.,increase,no risk
Mitiglinide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Mitiglinide.,increase,risk
Mitiglinide,Haloperidol,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Haloperidol.,decrease,no risk
Mitiglinide,Histrelin,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Histrelin.,decrease,no risk
Mitiglinide,Hydrochlorothiazide,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Mitiglinide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydroflumethiazide,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Mitiglinide,Hydroxychloroquine,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Mitiglinide,Hydroxyprogesterone caproate,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Mitiglinide,Ketoconazole,The metabolism of Mitiglinide can be decreased when combined with Ketoconazole.,decrease,no risk
Mitiglinide,Ketotifen,The risk or severity of thrombocytopenia can be increased when Mitiglinide is combined with Ketotifen.,increase,risk
Mitiglinide,Nadolol,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Nadolol.,increase,no risk
Mitiglinide,Nalidixic acid,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Nalidixic acid.,increase,no risk
Mitiglinide,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Mitiglinide.,increase,risk
Mitiglinide,Nebivolol,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Nebivolol.,increase,no risk
Mitiglinide,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Mitiglinide.,increase,risk
Mitiglinide,Nelfinavir,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Nelfinavir.,decrease,no risk
Mitiglinide,Niacin,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Niacin.,decrease,no risk
Mitiglinide,Nialamide,Nialamide may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Mitiglinide.,increase,risk
Mitiglinide,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Mitiglinide.,increase,risk
Mitiglinide,Nilotinib,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Nilotinib.,decrease,no risk
Mitiglinide,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Mitiglinide.,increase,risk
Mitiglinide,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Mitiglinide.,increase,risk
Mitiglinide,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Mitiglinide.,increase,risk
Mitiglinide,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Mitiglinide.,increase,risk
Mitiglinide,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Mitiglinide.,increase,risk
Mitiglinide,Norethisterone,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Norethisterone.,decrease,no risk
Mitiglinide,Norfloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Norfloxacin.,increase,no risk
Mitiglinide,Norgestimate,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Norgestimate.,decrease,no risk
Mitiglinide,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Mitiglinide.,decrease,no risk
Mitiglinide,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Mitiglinide.,increase,risk
Mitiglinide,Octreotide,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Octreotide.,decrease,no risk
Mitiglinide,Ofloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Ofloxacin.,increase,no risk
Mitiglinide,Olanzapine,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Olanzapine.,decrease,no risk
Mitiglinide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Oxprenolol,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Oxprenolol.,increase,no risk
Mitiglinide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Quetiapine,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Quetiapine.,decrease,no risk
Mitiglinide,Quinethazone,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Quinethazone.,decrease,no risk
Mitiglinide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Mitiglinide.,increase,risk
Mitiglinide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Mitiglinide.,decrease,no risk
Mitiglinide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Mitiglinide.,increase,risk
Mitiglinide,Udenafil,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Udenafil.,increase,no risk
Mitiglinide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mitiglinide.,increase,risk
Mitiglinide,Valdecoxib,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Valdecoxib.,increase,no risk
Mitiglinide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Mitiglinide.,increase,risk
Mitiglinide,Vemurafenib,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Vemurafenib.,increase,no risk
Mitiglinide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mitiglinide.,increase,risk
Mitiglinide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Mitiglinide.,increase,risk
Mitiglinide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Mitiglinide is combined with Vildagliptin.,increase,risk
Mitiglinide,Vorinostat,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Vorinostat.,decrease,no risk
Mitiglinide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Mitiglinide.,increase,risk
Ergometrine,Butriptyline,Butriptyline may increase the vasopressor activities of Ergometrine.,increase,no risk
Ergometrine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Ergometrine is combined with Butylscopolamine.,increase,risk
Ergometrine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ergometrine.,increase,risk
Ergometrine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ergometrine is combined with Gabapentin enacarbil.,increase,risk
Ergometrine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ergometrine.,increase,risk
Ergometrine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ergometrine is combined with Ganaxolone.",increase,risk
Ergometrine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Ergometrine.,increase,risk
Ergometrine,Gilteritinib,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Ergometrine,Glofitamab,The serum concentration of Ergometrine can be increased when it is combined with Glofitamab.,increase,no risk
Ergometrine,Glutethimide,The risk or severity of CNS depression can be increased when Ergometrine is combined with Glutethimide.,increase,risk
Ergometrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ergometrine.,increase,risk
Ergometrine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Ergometrine.,increase,risk
Ergometrine,Guanabenz,Ergometrine may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Ergometrine,Guanadrel,Ergometrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Ergometrine,Guanethidine,Ergometrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Ergometrine,Guanfacine,Ergometrine may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Ergometrine,Guanoxan,Ergometrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Ergometrine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ergometrine.,increase,risk
Ergometrine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ergometrine.,increase,risk
Ergometrine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Ergometrine.,increase,risk
Ergometrine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ergometrine.,increase,risk
Ergometrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Ergometrine is combined with Hexocyclium.,increase,risk
Ergometrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Ergometrine.,increase,risk
Ergometrine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Ergometrine.,increase,risk
Ergometrine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Ergometrine.,increase,risk
Ergometrine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Ergometrine.,increase,risk
Ergometrine,Hydralazine,Ergometrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ergometrine,Hydrochlorothiazide,Ergometrine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Ergometrine,Hydrocodone,Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ergometrine,Hydroflumethiazide,Ergometrine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Ergometrine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ergometrine.,increase,risk
Ergometrine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ergometrine.,increase,no risk
Ergometrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ergometrine.,increase,risk
Ergometrine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Ergometrine.,increase,risk
Ergometrine,Ketazolam,The risk or severity of CNS depression can be increased when Ergometrine is combined with Ketazolam.,increase,risk
Ergometrine,Ketoconazole,The serum concentration of Ergometrine can be increased when it is combined with Ketoconazole.,increase,no risk
Ergometrine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Ergometrine.,increase,risk
Ergometrine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Ergometrine.,increase,risk
Ergometrine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ergometrine.,increase,no risk
Ergometrine,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Ergometrine.,increase,risk
Ergometrine,Nadolol,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Nadolol.,decrease,no risk
Ergometrine,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Ergometrine.,increase,risk
Ergometrine,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ergometrine.,increase,risk
Ergometrine,Naphazoline,Ergometrine may increase the hypertensive and vasoconstricting activities of Naphazoline.,increase,no risk
Ergometrine,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Ergometrine.,increase,risk
Ergometrine,Naratriptan,Ergometrine may increase the vasoconstricting activities of Naratriptan.,increase,no risk
Ergometrine,Naxitamab,The risk or severity of hypertension can be increased when Ergometrine is combined with Naxitamab.,increase,risk
Ergometrine,Nebivolol,Ergometrine may increase the hypertensive and vasoconstricting activities of Nebivolol.,increase,no risk
Ergometrine,Nefazodone,The serum concentration of Ergometrine can be increased when it is combined with Nefazodone.,increase,no risk
Ergometrine,Nelfinavir,The serum concentration of Ergometrine can be increased when it is combined with Nelfinavir.,increase,no risk
Ergometrine,Netupitant,The metabolism of Ergometrine can be decreased when combined with Netupitant.,decrease,no risk
Ergometrine,Nialamide,Nialamide may increase the hypertensive activities of Ergometrine.,increase,no risk
Ergometrine,Nicardipine,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Nicardipine.,decrease,no risk
Ergometrine,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Ergometrine.,increase,no risk
Ergometrine,Nicorandil,Ergometrine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Ergometrine,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Ergometrine.,increase,risk
Ergometrine,Nilotinib,The serum concentration of Ergometrine can be increased when it is combined with Nilotinib.,increase,no risk
Ergometrine,Nilvadipine,The metabolism of Ergometrine can be decreased when combined with Nilvadipine.,decrease,no risk
Ergometrine,Nimesulide,The risk or severity of hypertension can be increased when Ergometrine is combined with Nimesulide.,increase,risk
Ergometrine,Nimodipine,Ergometrine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Ergometrine,Nisoldipine,Ergometrine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Ergometrine,Nitrazepam,The risk or severity of CNS depression can be increased when Ergometrine is combined with Nitrazepam.,increase,risk
Ergometrine,Nitrendipine,Ergometrine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Ergometrine,Nitroglycerin,The bioavailability of Ergometrine can be increased when combined with Nitroglycerin.,increase,no risk
Ergometrine,Nitroprusside,Ergometrine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Ergometrine,Nitrous oxide,The risk or severity of CNS depression can be increased when Ergometrine is combined with Nitrous oxide.,increase,risk
Ergometrine,Nomifensine,The risk or severity of CNS depression can be increased when Ergometrine is combined with Nomifensine.,increase,risk
Ergometrine,Norepinephrine,Ergometrine may increase the hypertensive and vasoconstricting activities of Norepinephrine.,increase,no risk
Ergometrine,Normethadone,The risk or severity of CNS depression can be increased when Ergometrine is combined with Normethadone.,increase,risk
Ergometrine,Nortriptyline,Nortriptyline may increase the vasopressor activities of Ergometrine.,increase,no risk
Ergometrine,Nylidrin,Ergometrine may increase the hypertensive and vasoconstricting activities of Nylidrin.,increase,no risk
Ergometrine,Olanzapine,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Ergometrine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ergometrine is combined with Oliceridine.",increase,risk
Ergometrine,Olmesartan,Ergometrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Ergometrine,Olodaterol,Ergometrine may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Ergometrine,Omaveloxolone,The serum concentration of Ergometrine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ergometrine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ergometrine.,increase,risk
Ergometrine,Opium,The risk or severity of CNS depression can be increased when Ergometrine is combined with Opium.,increase,risk
Ergometrine,Orciprenaline,Ergometrine may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Ergometrine,Orphenadrine,Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ergometrine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Ergometrine.,increase,risk
Ergometrine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ergometrine.,increase,risk
Ergometrine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ergometrine.,increase,risk
Ergometrine,Oxitriptan,The risk or severity of CNS depression can be increased when Ergometrine is combined with Oxitriptan.,increase,risk
Ergometrine,Oxprenolol,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Ergometrine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ergometrine.,increase,risk
Ergometrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Ergometrine.,increase,risk
Ergometrine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Ergometrine.,increase,risk
Ergometrine,Oxymetazoline,Ergometrine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Ergometrine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Ergometrine.,increase,risk
Ergometrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Ergometrine is combined with Oxyphenbutazone.,increase,risk
Ergometrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Ergometrine.,increase,risk
Ergometrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ergometrine.,increase,risk
Ergometrine,Quazepam,The risk or severity of CNS depression can be increased when Ergometrine is combined with Quazepam.,increase,risk
Ergometrine,Quetiapine,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Quetiapine.,decrease,no risk
Ergometrine,Quinapril,Ergometrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Ergometrine,Quinidine,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Quinidine.,decrease,no risk
Ergometrine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Ergometrine.,increase,risk
Ergometrine,Quinupramine,Quinupramine may increase the vasopressor activities of Ergometrine.,increase,no risk
Ergometrine,Umeclidinium,The risk or severity of Tachycardia can be increased when Ergometrine is combined with Umeclidinium.,increase,risk
Ergometrine,Urethane,The risk or severity of CNS depression can be increased when Ergometrine is combined with Urethane.,increase,risk
Ergometrine,Vadadustat,The serum concentration of Ergometrine can be increased when it is combined with Vadadustat.,increase,no risk
Ergometrine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Ergometrine.,increase,risk
Ergometrine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Ergometrine is combined with Valproate bismuth.,increase,risk
Ergometrine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Ergometrine.,increase,risk
Ergometrine,Valsartan,Ergometrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Ergometrine,Vecuronium,The risk or severity of CNS depression can be increased when Ergometrine is combined with Vecuronium.,increase,risk
Ergometrine,Venetoclax,The metabolism of Ergometrine can be decreased when combined with Venetoclax.,decrease,no risk
Ergometrine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Ergometrine is combined with Venlafaxine.,increase,risk
Ergometrine,Verapamil,The metabolism of Ergometrine can be decreased when combined with Verapamil.,decrease,no risk
Ergometrine,Vibegron,Ergometrine may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Ergometrine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Ergometrine.,increase,risk
Ergometrine,Vilanterol,Ergometrine may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Ergometrine,Vilazodone,Ergometrine may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Ergometrine,Viloxazine,The metabolism of Ergometrine can be decreased when combined with Viloxazine.,decrease,no risk
Ergometrine,Voriconazole,The serum concentration of Ergometrine can be increased when it is combined with Voriconazole.,increase,no risk
Ergometrine,Vortioxetine,Ergometrine may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Ergometrine,Warfarin,The risk or severity of adverse effects can be increased when Ergometrine is combined with Warfarin.,increase,risk
Ergometrine,Xamoterol,Ergometrine may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Ergometrine,Xylometazoline,Ergometrine may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Ergometrine,Yohimbine,The risk or severity of CNS depression can be increased when Ergometrine is combined with Yohimbine.,increase,risk
Ergometrine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ergometrine.,increase,risk
Ergometrine,Ziconotide,The risk or severity of CNS depression can be increased when Ergometrine is combined with Ziconotide.,increase,risk
Ergometrine,Zimelidine,The risk or severity of adverse effects can be increased when Ergometrine is combined with Zimelidine.,increase,risk
Ergometrine,Ziprasidone,The risk or severity of adverse effects can be increased when Ergometrine is combined with Ziprasidone.,increase,risk
Ergometrine,Zofenopril,Ergometrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Ergometrine,Zolmitriptan,Ergometrine may increase the vasoconstricting activities of Zolmitriptan.,increase,no risk
Ergometrine,Zolpidem,Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ergometrine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ergometrine.,increase,risk
Ergometrine,Zopiclone,The risk or severity of adverse effects can be increased when Ergometrine is combined with Zopiclone.,increase,risk
Ergometrine,Zotepine,The risk or severity of adverse effects can be increased when Ergometrine is combined with Zotepine.,increase,risk
Ergometrine,Zuclopenthixol,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Ergometrine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ergometrine.,increase,risk
Dasatinib,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Dasatinib.,increase,risk
Dasatinib,Baricitinib,The risk or severity of adverse effects can be increased when Dasatinib is combined with Baricitinib.,increase,risk
Dasatinib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Dasatinib.,increase,risk
Dasatinib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Dasatinib.,increase,risk
Dasatinib,Beclomethasone dipropionate,The metabolism of Dasatinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Dasatinib,Bedaquiline,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bedaquiline.,increase,risk
Dasatinib,Belantamab mafodotin,The serum concentration of Dasatinib can be increased when it is combined with Belantamab mafodotin.,increase,no risk
Dasatinib,Belatacept,The risk or severity of adverse effects can be increased when Dasatinib is combined with Belatacept.,increase,risk
Dasatinib,Belimumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Belimumab.,increase,risk
Dasatinib,Belinostat,The risk or severity of adverse effects can be increased when Dasatinib is combined with Belinostat.,increase,risk
Dasatinib,Belumosudil,The serum concentration of Dasatinib can be increased when it is combined with Belumosudil.,increase,no risk
Dasatinib,Belzutifan,The serum concentration of Dasatinib can be decreased when it is combined with Belzutifan.,decrease,no risk
Dasatinib,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Bemiparin.,increase,risk
Dasatinib,Bendamustine,The risk or severity of adverse effects can be increased when Dasatinib is combined with Bendamustine.,increase,risk
Dasatinib,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Dasatinib.,increase,risk
Dasatinib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dasatinib.,increase,risk
Dasatinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Benzocaine.,increase,risk
Dasatinib,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Dasatinib.,increase,risk
Dasatinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Benzyl alcohol.,increase,risk
Dasatinib,Bepridil,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bepridil.,increase,risk
Dasatinib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Dasatinib.,increase,no risk
Dasatinib,Betamethasone,The metabolism of Dasatinib can be increased when combined with Betamethasone.,increase,no risk
Dasatinib,Betamethasone phosphate,The metabolism of Dasatinib can be increased when combined with Betamethasone phosphate.,increase,no risk
Dasatinib,Betaxolol,The metabolism of Dasatinib can be decreased when combined with Betaxolol.,decrease,no risk
Dasatinib,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Betrixaban.,increase,risk
Dasatinib,Bexarotene,The metabolism of Dasatinib can be increased when combined with Bexarotene.,increase,no risk
Dasatinib,Bicalutamide,The metabolism of Dasatinib can be decreased when combined with Bicalutamide.,decrease,no risk
Dasatinib,Bifonazole,The metabolism of Dasatinib can be decreased when combined with Bifonazole.,decrease,no risk
Dasatinib,Bilastine,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bilastine.,increase,risk
Dasatinib,Bimekizumab,The metabolism of Dasatinib can be increased when combined with Bimekizumab.,increase,no risk
Dasatinib,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Bisoprolol,The serum concentration of Dasatinib can be increased when it is combined with Bisoprolol.,increase,no risk
Dasatinib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Bivalirudin.,increase,risk
Dasatinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Dasatinib.,increase,risk
Dasatinib,Blinatumomab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Blinatumomab.,increase,risk
Dasatinib,Boceprevir,The metabolism of Dasatinib can be decreased when combined with Boceprevir.,decrease,no risk
Dasatinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Dasatinib.",decrease,no risk
Dasatinib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bosentan,The metabolism of Dasatinib can be increased when combined with Bosentan.,increase,no risk
Dasatinib,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dasatinib.,increase,risk
Dasatinib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Brodalumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Brodalumab.,increase,risk
Dasatinib,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Dasatinib.,increase,risk
Dasatinib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Dasatinib.,increase,risk
Dasatinib,Budesonide,The metabolism of Dasatinib can be increased when combined with Budesonide.,increase,no risk
Dasatinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Bupivacaine.,increase,risk
Dasatinib,Buprenorphine,The metabolism of Dasatinib can be decreased when combined with Buprenorphine.,decrease,no risk
Dasatinib,Buserelin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Buserelin.,increase,risk
Dasatinib,Buspirone,The metabolism of Dasatinib can be decreased when combined with Buspirone.,decrease,no risk
Dasatinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Butacaine.,increase,risk
Dasatinib,Butalbital,The metabolism of Dasatinib can be increased when combined with Butalbital.,increase,no risk
Dasatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Butamben.,increase,risk
Dasatinib,Butriptyline,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Butriptyline.,increase,risk
Dasatinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Gadobenic acid.,increase,risk
Dasatinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dasatinib.,increase,risk
Dasatinib,Gatifloxacin,The metabolism of Dasatinib can be decreased when combined with Gatifloxacin.,decrease,no risk
Dasatinib,Gefitinib,The metabolism of Dasatinib can be decreased when combined with Gefitinib.,decrease,no risk
Dasatinib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dasatinib.,increase,risk
Dasatinib,Gemfibrozil,The metabolism of Dasatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Dasatinib,Gemifloxacin,The metabolism of Dasatinib can be decreased when combined with Gemifloxacin.,decrease,no risk
Dasatinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dasatinib.,increase,risk
Dasatinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dasatinib.,increase,no risk
Dasatinib,Gilteritinib,The metabolism of Dasatinib can be decreased when combined with Gilteritinib.,decrease,no risk
Dasatinib,Ginkgo biloba,The metabolism of Dasatinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dasatinib,Givosiran,The serum concentration of Dasatinib can be increased when it is combined with Givosiran.,increase,no risk
Dasatinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Glasdegib.,increase,risk
Dasatinib,Glatiramer,The risk or severity of adverse effects can be increased when Dasatinib is combined with Glatiramer.,increase,risk
Dasatinib,Glecaprevir,The serum concentration of Dasatinib can be increased when it is combined with Glecaprevir.,increase,no risk
Dasatinib,Glofitamab,The serum concentration of Dasatinib can be increased when it is combined with Glofitamab.,increase,no risk
Dasatinib,Glyburide,The metabolism of Dasatinib can be decreased when combined with Glyburide.,decrease,no risk
Dasatinib,Glycerol phenylbutyrate,The metabolism of Dasatinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Dasatinib,Golimumab,The metabolism of Dasatinib can be increased when combined with Golimumab.,increase,no risk
Dasatinib,Goserelin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Goserelin.,increase,risk
Dasatinib,Granisetron,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Granisetron.,increase,risk
Dasatinib,Grapefruit,The serum concentration of Dasatinib can be increased when it is combined with Grapefruit.,increase,no risk
Dasatinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Dasatinib which could result in a higher serum level.,decrease,no risk
Dasatinib,Grepafloxacin,The metabolism of Dasatinib can be decreased when combined with Grepafloxacin.,decrease,no risk
Dasatinib,Griseofulvin,The metabolism of Dasatinib can be increased when combined with Griseofulvin.,increase,no risk
Dasatinib,Guanabenz,The metabolism of Dasatinib can be decreased when combined with Guanabenz.,decrease,no risk
Dasatinib,Guselkumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Guselkumab.,increase,risk
Dasatinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Halofantrine,The metabolism of Dasatinib can be decreased when combined with Halofantrine.,decrease,no risk
Dasatinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Haloperidol.,increase,risk
Dasatinib,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Heparin.,increase,risk
Dasatinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Histrelin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Histrelin.,increase,risk
Dasatinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Dasatinib.,increase,risk
Dasatinib,Hydralazine,The serum concentration of Dasatinib can be increased when it is combined with Hydralazine.,increase,no risk
Dasatinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Dasatinib.,increase,risk
Dasatinib,Hydrocortamate,The metabolism of Dasatinib can be increased when combined with Hydrocortamate.,increase,no risk
Dasatinib,Hydrocortisone,The metabolism of Dasatinib can be increased when combined with Hydrocortisone.,increase,no risk
Dasatinib,Hydrocortisone acetate,The metabolism of Dasatinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Dasatinib,Hydrocortisone butyrate,The metabolism of Dasatinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Dasatinib,Hydrocortisone cypionate,The metabolism of Dasatinib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Dasatinib,Hydrocortisone phosphate,The metabolism of Dasatinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Dasatinib,Hydrocortisone succinate,The metabolism of Dasatinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Dasatinib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Dasatinib.,increase,risk
Dasatinib,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Dasatinib is combined with Hydroxychloroquine.,increase,risk
Dasatinib,Hydroxyprogesterone caproate,The metabolism of Dasatinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Dasatinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dasatinib.,increase,risk
Dasatinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Hydroxyzine.,increase,risk
Dasatinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dasatinib.,increase,risk
Dasatinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Ketazolam,The serum concentration of Dasatinib can be increased when it is combined with Ketazolam.,increase,no risk
Dasatinib,Ketoconazole,The metabolism of Dasatinib can be decreased when combined with Ketoconazole.,decrease,no risk
Dasatinib,Nabumetone,The metabolism of Dasatinib can be decreased when combined with Nabumetone.,decrease,no risk
Dasatinib,Nadroparin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Nadroparin.,increase,risk
Dasatinib,Nafcillin,The metabolism of Dasatinib can be increased when combined with Nafcillin.,increase,no risk
Dasatinib,Nalidixic acid,The metabolism of Dasatinib can be decreased when combined with Nalidixic acid.,decrease,no risk
Dasatinib,Naproxen,The metabolism of Dasatinib can be decreased when combined with Naproxen.,decrease,no risk
Dasatinib,Natalizumab,The risk or severity of immunosuppression can be increased when Dasatinib is combined with Natalizumab.,increase,risk
Dasatinib,Nateglinide,The metabolism of Dasatinib can be decreased when combined with Nateglinide.,decrease,no risk
Dasatinib,Nefazodone,The metabolism of Dasatinib can be decreased when combined with Nefazodone.,decrease,no risk
Dasatinib,Nelarabine,The risk or severity of adverse effects can be increased when Dasatinib is combined with Nelarabine.,increase,risk
Dasatinib,Nelfinavir,The metabolism of Dasatinib can be decreased when combined with Nelfinavir.,decrease,no risk
Dasatinib,Neratinib,The serum concentration of Dasatinib can be increased when it is combined with Neratinib.,increase,no risk
Dasatinib,Netupitant,The serum concentration of Dasatinib can be increased when it is combined with Netupitant.,increase,no risk
Dasatinib,Nevirapine,The metabolism of Dasatinib can be decreased when combined with Nevirapine.,decrease,no risk
Dasatinib,Niacin,The serum concentration of Dasatinib can be increased when it is combined with Niacin.,increase,no risk
Dasatinib,Nicardipine,The metabolism of Dasatinib can be decreased when combined with Nicardipine.,decrease,no risk
Dasatinib,Niclosamide,The metabolism of Dasatinib can be decreased when combined with Niclosamide.,decrease,no risk
Dasatinib,Nifedipine,The metabolism of Dasatinib can be decreased when combined with Nifedipine.,decrease,no risk
Dasatinib,Nilotinib,The metabolism of Dasatinib can be decreased when combined with Nilotinib.,decrease,no risk
Dasatinib,Nilvadipine,The metabolism of Dasatinib can be decreased when combined with Nilvadipine.,decrease,no risk
Dasatinib,Nimesulide,Dasatinib may increase the anticoagulant activities of Nimesulide.,increase,no risk
Dasatinib,Nimodipine,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Nimodipine.,increase,risk
Dasatinib,Nintedanib,The metabolism of Dasatinib can be decreased when combined with Nintedanib.,decrease,no risk
Dasatinib,Nirogacestat,The serum concentration of Dasatinib can be increased when it is combined with Nirogacestat.,increase,no risk
Dasatinib,Nisoldipine,The metabolism of Dasatinib can be decreased when combined with Nisoldipine.,decrease,no risk
Dasatinib,Nitrendipine,The metabolism of Dasatinib can be decreased when combined with Nitrendipine.,decrease,no risk
Dasatinib,Nitrofurantoin,Dasatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Dasatinib,Nizatidine,Nizatidine can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Norethisterone,The metabolism of Dasatinib can be decreased when combined with Norethisterone.,decrease,no risk
Dasatinib,Norfloxacin,The metabolism of Dasatinib can be decreased when combined with Norfloxacin.,decrease,no risk
Dasatinib,Norgestimate,The serum concentration of Dasatinib can be increased when it is combined with Norgestimate.,increase,no risk
Dasatinib,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Noscapine,The serum concentration of Dasatinib can be increased when it is combined with Noscapine.,increase,no risk
Dasatinib,Novobiocin,Novobiocin may decrease the excretion rate of Dasatinib which could result in a higher serum level.,decrease,no risk
Dasatinib,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Dasatinib.,increase,risk
Dasatinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Obinutuzumab.,increase,risk
Dasatinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Ocrelizumab.,increase,risk
Dasatinib,Octreotide,The serum concentration of Dasatinib can be increased when it is combined with Octreotide.,increase,no risk
Dasatinib,Ofatumumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Ofatumumab.,increase,risk
Dasatinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Ofloxacin.,increase,risk
Dasatinib,Olanzapine,Olanzapine can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Olodaterol,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Olodaterol.,increase,risk
Dasatinib,Olutasidenib,The therapeutic efficacy of Dasatinib can be decreased when used in combination with Olutasidenib.,decrease,no risk
Dasatinib,Omadacycline,The serum concentration of Dasatinib can be increased when it is combined with Omadacycline.,increase,no risk
Dasatinib,Omaveloxolone,The serum concentration of Dasatinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dasatinib,Ombitasvir,Dasatinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Dasatinib,Omeprazole,Omeprazole can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Ondansetron,The metabolism of Dasatinib can be decreased when combined with Ondansetron.,decrease,no risk
Dasatinib,Oritavancin,The metabolism of Dasatinib can be increased when combined with Oritavancin.,increase,no risk
Dasatinib,Orphenadrine,The metabolism of Dasatinib can be decreased when combined with Orphenadrine.,decrease,no risk
Dasatinib,Osilodrostat,The serum concentration of Dasatinib can be increased when it is combined with Osilodrostat.,increase,no risk
Dasatinib,Osimertinib,The serum concentration of Dasatinib can be decreased when it is combined with Osimertinib.,decrease,no risk
Dasatinib,Oteseconazole,The serum concentration of Dasatinib can be increased when it is combined with Oteseconazole.,increase,no risk
Dasatinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Dasatinib.,increase,risk
Dasatinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Oxatomide.,increase,risk
Dasatinib,Oxcarbazepine,The metabolism of Dasatinib can be increased when combined with Oxcarbazepine.,increase,no risk
Dasatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Oxetacaine.,increase,risk
Dasatinib,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Oxybuprocaine.,increase,risk
Dasatinib,Oxybutynin,The serum concentration of Dasatinib can be increased when it is combined with Oxybutynin.,increase,no risk
Dasatinib,Oxycodone,The metabolism of Dasatinib can be decreased when combined with Oxycodone.,decrease,no risk
Dasatinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dasatinib.,increase,risk
Dasatinib,Ozanimod,Dasatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Dasatinib,Quetiapine,The metabolism of Dasatinib can be decreased when combined with Quetiapine.,decrease,no risk
Dasatinib,Quinidine,The serum concentration of Dasatinib can be increased when it is combined with Quinidine.,increase,no risk
Dasatinib,Quinine,The serum concentration of Dasatinib can be increased when it is combined with Quinine.,increase,no risk
Dasatinib,Quinupristin,The metabolism of Dasatinib can be decreased when combined with Quinupristin.,decrease,no risk
Dasatinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Quizartinib.,increase,risk
Dasatinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Dasatinib.,increase,risk
Dasatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dasatinib.,increase,no risk
Dasatinib,Udenafil,The metabolism of Dasatinib can be decreased when combined with Udenafil.,decrease,no risk
Dasatinib,Umbralisib,The serum concentration of Dasatinib can be increased when it is combined with Umbralisib.,increase,no risk
Dasatinib,Umeclidinium,The serum concentration of Dasatinib can be increased when it is combined with Umeclidinium.,increase,no risk
Dasatinib,Upadacitinib,The risk or severity of adverse effects can be increased when Dasatinib is combined with Upadacitinib.,increase,risk
Dasatinib,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Urokinase.,increase,risk
Dasatinib,Vadadustat,The serum concentration of Dasatinib can be increased when it is combined with Vadadustat.,increase,no risk
Dasatinib,Valbenazine,The metabolism of Dasatinib can be decreased when combined with Valbenazine.,decrease,no risk
Dasatinib,Valproic acid,The serum concentration of Dasatinib can be increased when it is combined with Valproic acid.,increase,no risk
Dasatinib,Vandetanib,The serum concentration of Dasatinib can be increased when it is combined with Vandetanib.,increase,no risk
Dasatinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dasatinib.,increase,risk
Dasatinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Vedolizumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Vedolizumab.,increase,risk
Dasatinib,Velpatasvir,The serum concentration of Dasatinib can be increased when it is combined with Velpatasvir.,increase,no risk
Dasatinib,Vemurafenib,The serum concentration of Dasatinib can be increased when it is combined with Vemurafenib.,increase,no risk
Dasatinib,Venetoclax,The serum concentration of Dasatinib can be increased when it is combined with Venetoclax.,increase,no risk
Dasatinib,Venlafaxine,Venlafaxine may increase the excretion rate of Dasatinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dasatinib,Verapamil,The serum concentration of Dasatinib can be increased when it is combined with Verapamil.,increase,no risk
Dasatinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Vernakalant.,increase,risk
Dasatinib,Verteporfin,Dasatinib may increase the photosensitizing activities of Verteporfin.,increase,no risk
Dasatinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Dasatinib.,increase,risk
Dasatinib,Viloxazine,The metabolism of Dasatinib can be decreased when combined with Viloxazine.,decrease,no risk
Dasatinib,Vinblastine,The metabolism of Dasatinib can be increased when combined with Vinblastine.,increase,no risk
Dasatinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vismodegib,Vismodegib may decrease the excretion rate of Dasatinib which could result in a higher serum level.,decrease,no risk
Dasatinib,Vitamin E,The metabolism of Dasatinib can be increased when combined with Vitamin E.,increase,no risk
Dasatinib,Voclosporin,The serum concentration of Dasatinib can be increased when it is combined with Voclosporin.,increase,no risk
Dasatinib,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Vorapaxar.,increase,risk
Dasatinib,Voriconazole,The metabolism of Dasatinib can be decreased when combined with Voriconazole.,decrease,no risk
Dasatinib,Vorinostat,The risk or severity of adverse effects can be increased when Dasatinib is combined with Vorinostat.,increase,risk
Dasatinib,Vortioxetine,The metabolism of Dasatinib can be decreased when combined with Vortioxetine.,decrease,no risk
Dasatinib,Voxelotor,The serum concentration of Dasatinib can be increased when it is combined with Voxelotor.,increase,no risk
Dasatinib,Voxilaprevir,The serum concentration of Dasatinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Dasatinib,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin.,increase,risk
Dasatinib,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Ximelagatran.,increase,risk
Dasatinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Dasatinib.,increase,risk
Dasatinib,Zafirlukast,The serum concentration of Dasatinib can be increased when it is combined with Zafirlukast.,increase,no risk
Dasatinib,Zaleplon,The metabolism of Dasatinib can be decreased when combined with Zaleplon.,decrease,no risk
Dasatinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Dasatinib.,increase,risk
Dasatinib,Zileuton,The metabolism of Dasatinib can be decreased when combined with Zileuton.,decrease,no risk
Dasatinib,Zimelidine,The metabolism of Dasatinib can be decreased when combined with Zimelidine.,decrease,no risk
Dasatinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Ziprasidone.,increase,risk
Dasatinib,Zolmitriptan,The metabolism of Dasatinib can be decreased when combined with Zolmitriptan.,decrease,no risk
Dasatinib,Zolpidem,The metabolism of Dasatinib can be decreased when combined with Zolpidem.,decrease,no risk
Dasatinib,Zonisamide,The serum concentration of Dasatinib can be increased when it is combined with Zonisamide.,increase,no risk
Dasatinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Zotepine,The metabolism of Zotepine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Zuclopenthixol,The metabolism of Dasatinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Lisdexamfetamine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Gefitinib,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Gefitinib.",increase,no risk
Lisdexamfetamine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Glutamic acid,The serum concentration of Lisdexamfetamine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Lisdexamfetamine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Lisdexamfetamine.,decrease,no risk
Lisdexamfetamine,Glycerol phenylbutyrate,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Glycerol phenylbutyrate.",increase,no risk
Lisdexamfetamine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Guanabenz,Lisdexamfetamine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Lisdexamfetamine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Lisdexamfetamine.,decrease,no risk
Lisdexamfetamine,Guanethidine,The serum concentration of Lisdexamfetamine can be decreased when it is combined with Guanethidine.,decrease,no risk
Lisdexamfetamine,Guanfacine,Lisdexamfetamine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Lisdexamfetamine,Guanoxan,Lisdexamfetamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Lisdexamfetamine,Halofantrine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Halofantrine.",increase,no risk
Lisdexamfetamine,Haloperidol,The therapeutic efficacy of Lisdexamfetamine can be decreased when used in combination with Haloperidol.,decrease,no risk
Lisdexamfetamine,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hexocyclium,The risk or severity of Tachycardia can be increased when Lisdexamfetamine is combined with Hexocyclium.,increase,risk
Lisdexamfetamine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydralazine,Lisdexamfetamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Lisdexamfetamine,Hydrochlorothiazide,Lisdexamfetamine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Lisdexamfetamine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydroflumethiazide,Lisdexamfetamine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Lisdexamfetamine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydrotalcite,The serum concentration of Lisdexamfetamine can be increased when it is combined with Hydrotalcite.,increase,no risk
Lisdexamfetamine,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydroxychloroquine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Hydroxychloroquine.",increase,no risk
Lisdexamfetamine,Hydroxyurea,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Hydroxyurea.",increase,no risk
Lisdexamfetamine,Hydroxyzine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Hydroxyzine.",increase,no risk
Lisdexamfetamine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketoconazole,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Ketoconazole.",increase,no risk
Lisdexamfetamine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketotifen,Lisdexamfetamine may decrease the sedative activities of Ketotifen.,decrease,no risk
Lisdexamfetamine,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Nadolol,The therapeutic efficacy of Nadolol can be decreased when used in combination with Lisdexamfetamine.,decrease,no risk
Lisdexamfetamine,Nalbuphine,The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Naloxegol,Lisdexamfetamine may increase the analgesic activities of Naloxegol.,increase,no risk
Lisdexamfetamine,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Naphazoline,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Naphazoline.,increase,risk
Lisdexamfetamine,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Naratriptan,The risk or severity of serotonin syndrome can be increased when Naratriptan is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Naxitamab,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Naxitamab.,increase,risk
Lisdexamfetamine,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Lisdexamfetamine.,decrease,no risk
Lisdexamfetamine,Nefazodone,The risk or severity of serotonin syndrome can be increased when Nefazodone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Nevirapine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Nevirapine.",increase,no risk
Lisdexamfetamine,Niacin,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Niacin.",increase,no risk
Lisdexamfetamine,Niacinamide ascorbate,The serum concentration of Lisdexamfetamine can be decreased when it is combined with Niacinamide ascorbate.,decrease,no risk
Lisdexamfetamine,Nialamide,The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Nicardipine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Nicardipine.",increase,no risk
Lisdexamfetamine,Nicergoline,The therapeutic efficacy of Nicergoline can be decreased when used in combination with Lisdexamfetamine.,decrease,no risk
Lisdexamfetamine,Nicorandil,Lisdexamfetamine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Lisdexamfetamine,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Nilvadipine,Lisdexamfetamine may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Lisdexamfetamine,Nimesulide,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Nimesulide.,increase,risk
Lisdexamfetamine,Nimodipine,Lisdexamfetamine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Lisdexamfetamine,Nisoldipine,Lisdexamfetamine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Lisdexamfetamine,Nitrendipine,Lisdexamfetamine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Lisdexamfetamine,Nitroglycerin,Lisdexamfetamine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Lisdexamfetamine,Nitroprusside,Lisdexamfetamine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Lisdexamfetamine,Nitrous oxide,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Nitrous oxide.,increase,risk
Lisdexamfetamine,Nizatidine,Lisdexamfetamine may decrease the sedative activities of Nizatidine.,decrease,no risk
Lisdexamfetamine,Norepinephrine,The therapeutic efficacy of Lisdexamfetamine can be increased when used in combination with Norepinephrine.,increase,no risk
Lisdexamfetamine,Normethadone,The risk or severity of serotonin syndrome can be increased when Normethadone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Nortriptyline,The risk or severity of serotonin syndrome can be increased when Nortriptyline is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Nylidrin,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Nylidrin.,increase,risk
Lisdexamfetamine,Olanzapine,The risk or severity of serotonin syndrome can be increased when Olanzapine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Oliceridine.,increase,risk
Lisdexamfetamine,Olmesartan,Lisdexamfetamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Lisdexamfetamine,Olodaterol,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Olodaterol.,increase,risk
Lisdexamfetamine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oritavancin,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oritavancin.",increase,no risk
Lisdexamfetamine,Orphenadrine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Orphenadrine.",increase,no risk
Lisdexamfetamine,Osilodrostat,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Osilodrostat.",increase,no risk
Lisdexamfetamine,Ospemifene,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Ospemifene.",increase,no risk
Lisdexamfetamine,Oxamniquine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxamniquine.",increase,no risk
Lisdexamfetamine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxatomide,Lisdexamfetamine may decrease the sedative activities of Oxatomide.,decrease,no risk
Lisdexamfetamine,Oxprenolol,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxprenolol.",increase,no risk
Lisdexamfetamine,Oxtriphylline,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Oxtriphylline.,increase,risk
Lisdexamfetamine,Oxybutynin,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxybutynin.",increase,no risk
Lisdexamfetamine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxymetholone,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxymetholone.",increase,no risk
Lisdexamfetamine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Oxyphenbutazone.,increase,risk
Lisdexamfetamine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Quetiapine,The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Quinapril,Lisdexamfetamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Lisdexamfetamine,Quinidine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Quinidine.",increase,no risk
Lisdexamfetamine,Quinine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Quinine.",increase,no risk
Lisdexamfetamine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Quinupramine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Umeclidinium,The risk or severity of Tachycardia can be increased when Lisdexamfetamine is combined with Umeclidinium.,increase,risk
Lisdexamfetamine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproate bismuth is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Valsartan,Lisdexamfetamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Lisdexamfetamine,Vemurafenib,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vemurafenib.",increase,no risk
Lisdexamfetamine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Verapamil,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Verapamil.",increase,no risk
Lisdexamfetamine,Vernakalant,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vernakalant.",increase,no risk
Lisdexamfetamine,Vilanterol,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Vilanterol.,increase,risk
Lisdexamfetamine,Vilazodone,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Viloxazine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Viloxazine.",increase,no risk
Lisdexamfetamine,Vinblastine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vinblastine.",increase,no risk
Lisdexamfetamine,Vinorelbine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vinorelbine.",increase,no risk
Lisdexamfetamine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Xamoterol,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Xamoterol.,increase,risk
Lisdexamfetamine,Xylometazoline,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Xylometazoline.,increase,risk
Lisdexamfetamine,Yohimbine,The risk or severity of serotonin syndrome can be increased when Yohimbine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zinc ascorbate,The serum concentration of Lisdexamfetamine can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Lisdexamfetamine,Ziprasidone,The risk or severity of serotonin syndrome can be increased when Ziprasidone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zofenopril,Lisdexamfetamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Lisdexamfetamine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zonisamide,Zonisamide may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level.,decrease,no risk
Lisdexamfetamine,Zotepine,The risk or severity of serotonin syndrome can be increased when Zotepine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zuclopenthixol,The risk or severity of serotonin syndrome can be increased when Zuclopenthixol is combined with Lisdexamfetamine.,increase,risk
Retapamulin,Glofitamab,The serum concentration of Retapamulin can be increased when it is combined with Glofitamab.,increase,no risk
Retapamulin,Glyburide,The metabolism of Retapamulin can be decreased when combined with Glyburide.,decrease,no risk
Retapamulin,Glycerol phenylbutyrate,The metabolism of Retapamulin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Retapamulin,Griseofulvin,The metabolism of Retapamulin can be increased when combined with Griseofulvin.,increase,no risk
Retapamulin,Haloperidol,The metabolism of Retapamulin can be decreased when combined with Haloperidol.,decrease,no risk
Retapamulin,Hydralazine,The metabolism of Retapamulin can be decreased when combined with Hydralazine.,decrease,no risk
Retapamulin,Hydrocortamate,The metabolism of Retapamulin can be increased when combined with Hydrocortamate.,increase,no risk
Retapamulin,Hydrocortisone,The metabolism of Retapamulin can be increased when combined with Hydrocortisone.,increase,no risk
Retapamulin,Hydrocortisone acetate,The metabolism of Retapamulin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Retapamulin,Hydrocortisone butyrate,The metabolism of Retapamulin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Retapamulin,Hydrocortisone succinate,The metabolism of Retapamulin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Retapamulin,Ketamine,The metabolism of Retapamulin can be increased when combined with Ketamine.,increase,no risk
Retapamulin,Ketazolam,The metabolism of Retapamulin can be decreased when combined with Ketazolam.,decrease,no risk
Retapamulin,Ketoconazole,The metabolism of Retapamulin can be decreased when combined with Ketoconazole.,decrease,no risk
Retapamulin,Nafcillin,The metabolism of Retapamulin can be increased when combined with Nafcillin.,increase,no risk
Retapamulin,Nefazodone,The metabolism of Retapamulin can be decreased when combined with Nefazodone.,decrease,no risk
Retapamulin,Nelfinavir,The metabolism of Retapamulin can be decreased when combined with Nelfinavir.,decrease,no risk
Retapamulin,Netupitant,The metabolism of Retapamulin can be decreased when combined with Netupitant.,decrease,no risk
Retapamulin,Nicardipine,The metabolism of Retapamulin can be decreased when combined with Nicardipine.,decrease,no risk
Retapamulin,Nifedipine,The metabolism of Retapamulin can be increased when combined with Nifedipine.,increase,no risk
Retapamulin,Nilotinib,The metabolism of Retapamulin can be decreased when combined with Nilotinib.,decrease,no risk
Retapamulin,Nilvadipine,The metabolism of Retapamulin can be decreased when combined with Nilvadipine.,decrease,no risk
Retapamulin,Nitric Oxide,The metabolism of Retapamulin can be decreased when combined with Nitric Oxide.,decrease,no risk
Retapamulin,Norfloxacin,The metabolism of Retapamulin can be decreased when combined with Norfloxacin.,decrease,no risk
Retapamulin,Norgestimate,The metabolism of Retapamulin can be increased when combined with Norgestimate.,increase,no risk
Retapamulin,Noscapine,The metabolism of Retapamulin can be decreased when combined with Noscapine.,decrease,no risk
Retapamulin,Octreotide,The metabolism of Retapamulin can be decreased when combined with Octreotide.,decrease,no risk
Retapamulin,Olaparib,The metabolism of Retapamulin can be decreased when combined with Olaparib.,decrease,no risk
Retapamulin,Olutasidenib,The metabolism of Retapamulin can be increased when combined with Olutasidenib.,increase,no risk
Retapamulin,Omaveloxolone,The metabolism of Retapamulin can be increased when combined with Omaveloxolone.,increase,no risk
Retapamulin,Oritavancin,The metabolism of Retapamulin can be increased when combined with Oritavancin.,increase,no risk
Retapamulin,Orphenadrine,The metabolism of Retapamulin can be decreased when combined with Orphenadrine.,decrease,no risk
Retapamulin,Osilodrostat,The metabolism of Retapamulin can be decreased when combined with Osilodrostat.,decrease,no risk
Retapamulin,Oxcarbazepine,The metabolism of Retapamulin can be increased when combined with Oxcarbazepine.,increase,no risk
Retapamulin,Oxetacaine,The metabolism of Retapamulin can be decreased when combined with Oxetacaine.,decrease,no risk
Retapamulin,Oxybutynin,The metabolism of Retapamulin can be decreased when combined with Oxybutynin.,decrease,no risk
Retapamulin,Oxymetholone,The metabolism of Retapamulin can be decreased when combined with Oxymetholone.,decrease,no risk
Retapamulin,Quinidine,The metabolism of Retapamulin can be decreased when combined with Quinidine.,decrease,no risk
Retapamulin,Quinine,The metabolism of Retapamulin can be decreased when combined with Quinine.,decrease,no risk
Retapamulin,Quinupristin,The metabolism of Retapamulin can be decreased when combined with Quinupristin.,decrease,no risk
Retapamulin,Vadadustat,The serum concentration of Retapamulin can be increased when it is combined with Vadadustat.,increase,no risk
Retapamulin,Valproic acid,The metabolism of Retapamulin can be decreased when combined with Valproic acid.,decrease,no risk
Retapamulin,Vemurafenib,The metabolism of Retapamulin can be increased when combined with Vemurafenib.,increase,no risk
Retapamulin,Venetoclax,The metabolism of Retapamulin can be decreased when combined with Venetoclax.,decrease,no risk
Retapamulin,Verapamil,The metabolism of Retapamulin can be decreased when combined with Verapamil.,decrease,no risk
Retapamulin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Retapamulin.,decrease,no risk
Retapamulin,Viloxazine,The metabolism of Retapamulin can be decreased when combined with Viloxazine.,decrease,no risk
Retapamulin,Vinblastine,The metabolism of Retapamulin can be decreased when combined with Vinblastine.,decrease,no risk
Retapamulin,Vitamin E,The metabolism of Retapamulin can be increased when combined with Vitamin E.,increase,no risk
Retapamulin,Voriconazole,The metabolism of Retapamulin can be decreased when combined with Voriconazole.,decrease,no risk
Retapamulin,Warfarin,The metabolism of Retapamulin can be increased when combined with Warfarin.,increase,no risk
Retapamulin,Zafirlukast,The metabolism of Retapamulin can be decreased when combined with Zafirlukast.,decrease,no risk
Retapamulin,Zimelidine,The metabolism of Retapamulin can be decreased when combined with Zimelidine.,decrease,no risk
Retapamulin,Ziprasidone,The metabolism of Retapamulin can be decreased when combined with Ziprasidone.,decrease,no risk
Eculizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Galcanezumab.,increase,risk
Eculizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Eculizumab.,increase,risk
Eculizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Eculizumab.,increase,risk
Eculizumab,Glatiramer,The risk or severity of adverse effects can be increased when Eculizumab is combined with Glatiramer.,increase,risk
Eculizumab,Glofitamab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Glofitamab.,increase,risk
Eculizumab,Golimumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Golimumab.,increase,risk
Eculizumab,Guselkumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Guselkumab.,increase,risk
Eculizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hepatitis B immune globulin.,increase,risk
Eculizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Eculizumab.,increase,risk
Eculizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Eculizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eculizumab.,increase,risk
Eculizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Human Rho(D) immune globulin.,increase,risk
Eculizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Eculizumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydrocortisone acetate.,increase,risk
Eculizumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydrocortisone butyrate.,increase,risk
Eculizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydrocortisone succinate.,increase,risk
Eculizumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydroxychloroquine.,increase,risk
Eculizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Eculizumab.,increase,risk
Eculizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Natalizumab,The risk or severity of immunosuppression can be increased when Eculizumab is combined with Natalizumab.,increase,risk
Eculizumab,Necitumumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Necitumumab.,increase,risk
Eculizumab,Nelarabine,The risk or severity of adverse effects can be increased when Eculizumab is combined with Nelarabine.,increase,risk
Eculizumab,Nilotinib,The risk or severity of adverse effects can be increased when Eculizumab is combined with Nilotinib.,increase,risk
Eculizumab,Nivolumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Nivolumab.,increase,risk
Eculizumab,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Obiltoxaximab.,increase,risk
Eculizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Obinutuzumab.,increase,risk
Eculizumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Eculizumab.,increase,no risk
Eculizumab,Odesivimab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Odesivimab.,increase,risk
Eculizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Ofatumumab.,increase,risk
Eculizumab,Olaparib,The risk or severity of adverse effects can be increased when Eculizumab is combined with Olaparib.,increase,risk
Eculizumab,Olaratumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Olaratumab.,increase,risk
Eculizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eculizumab.,increase,risk
Eculizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Eculizumab.,increase,risk
Eculizumab,Ozanimod,The risk or severity of adverse effects can be increased when Eculizumab is combined with Ozanimod.,increase,risk
Eculizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Eculizumab.,increase,no risk
Eculizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Eculizumab.,increase,risk
Eculizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Eculizumab is combined with Upadacitinib.,increase,risk
Eculizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Ustekinumab.,increase,risk
Eculizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Eculizumab.,increase,risk
Eculizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Vedolizumab.,increase,risk
Eculizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Vilanterol,The risk or severity of adverse effects can be increased when Eculizumab is combined with Vilanterol.,increase,risk
Eculizumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Eculizumab.,increase,risk
Eculizumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Eculizumab.,increase,risk
Eculizumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Eculizumab.,increase,risk
Eculizumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Eculizumab.,increase,risk
Eculizumab,Voclosporin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Voclosporin.,increase,risk
Eculizumab,Vorinostat,The risk or severity of adverse effects can be increased when Eculizumab is combined with Vorinostat.,increase,risk
Eculizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Eculizumab.,increase,risk
Eculizumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Eculizumab.,increase,risk
Aliskiren,Glofitamab,The serum concentration of Aliskiren can be increased when it is combined with Glofitamab.,increase,no risk
Aliskiren,Glycol salicylate,The risk or severity of renal failure and hypertension can be increased when Glycol salicylate is combined with Aliskiren.,increase,risk
Aliskiren,Guanabenz,Guanabenz may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Guanadrel,Guanadrel may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Guanethidine,Guanethidine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Guanfacine,Guanfacine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Guanoxan,Aliskiren may increase the hypotensive activities of Guanoxan.,increase,no risk
Aliskiren,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Aliskiren.,increase,no risk
Aliskiren,Halothane,Halothane may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Aliskiren.,increase,risk
Aliskiren,Hydralazine,Hydralazine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Hydroflumethiazide,The therapeutic efficacy of Aliskiren can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Aliskiren,Ketoconazole,The serum concentration of Aliskiren can be increased when it is combined with Ketoconazole.,increase,no risk
Aliskiren,Ketoprofen,The risk or severity of renal failure and hypertension can be increased when Ketoprofen is combined with Aliskiren.,increase,risk
Aliskiren,Ketorolac,The risk or severity of renal failure and hypertension can be increased when Ketorolac is combined with Aliskiren.,increase,risk
Aliskiren,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Aliskiren.,increase,risk
Aliskiren,Nabumetone,The risk or severity of renal failure and hypertension can be increased when Nabumetone is combined with Aliskiren.,increase,risk
Aliskiren,Nadolol,Nadolol may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nadroparin,The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Aliskiren.,increase,risk
Aliskiren,Naphazoline,Naphazoline may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Naproxen,The risk or severity of renal failure and hypertension can be increased when Naproxen is combined with Aliskiren.,increase,risk
Aliskiren,Naratriptan,Naratriptan may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Naxitamab,Naxitamab may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Nebivolol,Nebivolol may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nefazodone,The metabolism of Aliskiren can be decreased when combined with Nefazodone.,decrease,no risk
Aliskiren,Nelfinavir,The metabolism of Aliskiren can be decreased when combined with Nelfinavir.,decrease,no risk
Aliskiren,Nesiritide,The risk or severity of adverse effects can be increased when Nesiritide is combined with Aliskiren.,increase,risk
Aliskiren,Netupitant,The metabolism of Aliskiren can be decreased when combined with Netupitant.,decrease,no risk
Aliskiren,Nialamide,Nialamide may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nicardipine,The metabolism of Aliskiren can be decreased when combined with Nicardipine.,decrease,no risk
Aliskiren,Nicergoline,Nicergoline may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Nicorandil,Nicorandil may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nifedipine,The risk or severity of adverse effects can be increased when Nifedipine is combined with Aliskiren.,increase,risk
Aliskiren,Nilotinib,The metabolism of Aliskiren can be decreased when combined with Nilotinib.,decrease,no risk
Aliskiren,Nilvadipine,The metabolism of Aliskiren can be decreased when combined with Nilvadipine.,decrease,no risk
Aliskiren,Nimesulide,The risk or severity of renal failure and hypertension can be increased when Nimesulide is combined with Aliskiren.,increase,risk
Aliskiren,Nimodipine,Nimodipine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nisoldipine,Nisoldipine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nitrendipine,Nitrendipine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Aliskiren.,increase,risk
Aliskiren,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Aliskiren.,increase,risk
Aliskiren,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nitroprusside,Nitroprusside may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Nitrous acid,The risk or severity of adverse effects can be increased when Aliskiren is combined with Nitrous acid.,increase,risk
Aliskiren,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Nylidrin,Nylidrin may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Obinutuzumab,Aliskiren may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Aliskiren,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Aliskiren.,increase,risk
Aliskiren,Olmesartan,The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Olmesartan.,increase,risk
Aliskiren,Olodaterol,Olodaterol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Omaveloxolone,The serum concentration of Aliskiren can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Aliskiren,Opicapone,The risk or severity of adverse effects can be increased when Aliskiren is combined with Opicapone.,increase,risk
Aliskiren,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Oxaprozin,The risk or severity of renal failure and hypertension can be increased when Oxaprozin is combined with Aliskiren.,increase,risk
Aliskiren,Oxprenolol,Oxprenolol may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Oxymetazoline,The therapeutic efficacy of Aliskiren can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Aliskiren,Oxyphenbutazone,The risk or severity of renal failure and hypertension can be increased when Oxyphenbutazone is combined with Aliskiren.,increase,risk
Aliskiren,Quetiapine,Quetiapine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Quinapril,"The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Quinapril.",increase,risk
Aliskiren,Quinidine,Quinidine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Quinine,Quinine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Quinupramine,Quinupramine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Udenafil,Udenafil may increase the antihypertensive activities of Aliskiren.,increase,no risk
Aliskiren,Unoprostone,Unoprostone may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Vadadustat,The serum concentration of Aliskiren can be increased when it is combined with Vadadustat.,increase,no risk
Aliskiren,Valdecoxib,The risk or severity of renal failure and hypertension can be increased when Valdecoxib is combined with Aliskiren.,increase,risk
Aliskiren,Vardenafil,Vardenafil may increase the antihypertensive activities of Aliskiren.,increase,no risk
Aliskiren,Venetoclax,The metabolism of Aliskiren can be decreased when combined with Venetoclax.,decrease,no risk
Aliskiren,Verapamil,The metabolism of Aliskiren can be decreased when combined with Verapamil.,decrease,no risk
Aliskiren,Vericiguat,The risk or severity of adverse effects can be increased when Aliskiren is combined with Vericiguat.,increase,risk
Aliskiren,Vilanterol,Vilanterol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Vilazodone,Vilazodone may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Viloxazine,The metabolism of Aliskiren can be decreased when combined with Viloxazine.,decrease,no risk
Aliskiren,Voriconazole,The metabolism of Aliskiren can be decreased when combined with Voriconazole.,decrease,no risk
Aliskiren,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Xamoterol,Xamoterol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Yohimbine,Yohimbine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Zimelidine,The metabolism of Aliskiren can be decreased when combined with Zimelidine.,decrease,no risk
Aliskiren,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Aliskiren.,increase,no risk
Aliskiren,Zofenopril,"The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Zofenopril.",increase,risk
Aliskiren,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Aliskiren.,increase,risk
Aliskiren,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Lapatinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Butacaine.,increase,risk
Lapatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Butamben.,increase,risk
Lapatinib,Butriptyline,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Butriptyline.,increase,risk
Lapatinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gadobenic acid.,increase,risk
Lapatinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lapatinib.,increase,risk
Lapatinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lapatinib.,increase,risk
Lapatinib,Gefitinib,The metabolism of Lapatinib can be decreased when combined with Gefitinib.,decrease,no risk
Lapatinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Gemfibrozil,The metabolism of Lapatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Lapatinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gemifloxacin.,increase,risk
Lapatinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Glasdegib.,increase,risk
Lapatinib,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Gliclazide,The metabolism of Lapatinib can be decreased when combined with Gliclazide.,decrease,no risk
Lapatinib,Glofitamab,The serum concentration of Lapatinib can be increased when it is combined with Glofitamab.,increase,no risk
Lapatinib,Glyburide,The metabolism of Lapatinib can be decreased when combined with Glyburide.,decrease,no risk
Lapatinib,Golimumab,The metabolism of Lapatinib can be increased when combined with Golimumab.,increase,no risk
Lapatinib,Goserelin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Goserelin.,increase,risk
Lapatinib,Granisetron,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Granisetron.,increase,risk
Lapatinib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Grepafloxacin.,increase,risk
Lapatinib,Halofantrine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Halofantrine.,increase,risk
Lapatinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Haloperidol.,increase,risk
Lapatinib,Histrelin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Histrelin.,increase,risk
Lapatinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Lapatinib.,increase,risk
Lapatinib,Hydrocortisone,The metabolism of Lapatinib can be increased when combined with Hydrocortisone.,increase,no risk
Lapatinib,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Hydroxyzine.,increase,risk
Lapatinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lapatinib.,increase,risk
Lapatinib,Ketamine,The metabolism of Lapatinib can be decreased when combined with Ketamine.,decrease,no risk
Lapatinib,Ketoconazole,The metabolism of Lapatinib can be decreased when combined with Ketoconazole.,decrease,no risk
Lapatinib,Ketoprofen,The metabolism of Lapatinib can be decreased when combined with Ketoprofen.,decrease,no risk
Lapatinib,Ketorolac,The metabolism of Lapatinib can be decreased when combined with Ketorolac.,decrease,no risk
Lapatinib,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nalidixic acid.,increase,risk
Lapatinib,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Naproxen,The metabolism of Lapatinib can be decreased when combined with Naproxen.,decrease,no risk
Lapatinib,Nateglinide,The metabolism of Lapatinib can be decreased when combined with Nateglinide.,decrease,no risk
Lapatinib,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Nefazodone,The metabolism of Lapatinib can be decreased when combined with Nefazodone.,decrease,no risk
Lapatinib,Nelfinavir,The metabolism of Lapatinib can be decreased when combined with Nelfinavir.,decrease,no risk
Lapatinib,Neratinib,The metabolism of Neratinib can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Netupitant,The metabolism of Lapatinib can be decreased when combined with Netupitant.,decrease,no risk
Lapatinib,Nevirapine,The metabolism of Lapatinib can be decreased when combined with Nevirapine.,decrease,no risk
Lapatinib,Nicardipine,The metabolism of Lapatinib can be decreased when combined with Nicardipine.,decrease,no risk
Lapatinib,Nifedipine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nifedipine.,increase,risk
Lapatinib,Nilotinib,The metabolism of Lapatinib can be decreased when combined with Nilotinib.,decrease,no risk
Lapatinib,Nilutamide,The metabolism of Lapatinib can be decreased when combined with Nilutamide.,decrease,no risk
Lapatinib,Nilvadipine,The metabolism of Lapatinib can be decreased when combined with Nilvadipine.,decrease,no risk
Lapatinib,Nimodipine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nimodipine.,increase,risk
Lapatinib,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Nisoldipine,The metabolism of Lapatinib can be decreased when combined with Nisoldipine.,decrease,no risk
Lapatinib,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Lapatinib.,increase,risk
Lapatinib,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Lapatinib.,increase,risk
Lapatinib,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lapatinib.,increase,risk
Lapatinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ofloxacin.,increase,risk
Lapatinib,Olanzapine,The metabolism of Lapatinib can be decreased when combined with Olanzapine.,decrease,no risk
Lapatinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Omaveloxolone,The serum concentration of Lapatinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lapatinib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Omeprazole,The metabolism of Lapatinib can be decreased when combined with Omeprazole.,decrease,no risk
Lapatinib,Ondansetron,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ondansetron.,increase,risk
Lapatinib,Oritavancin,The metabolism of Lapatinib can be decreased when combined with Oritavancin.,decrease,no risk
Lapatinib,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Lapatinib.,increase,risk
Lapatinib,Osilodrostat,The metabolism of Lapatinib can be decreased when combined with Osilodrostat.,decrease,no risk
Lapatinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Lapatinib.,increase,risk
Lapatinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxatomide.,increase,risk
Lapatinib,Oxcarbazepine,The metabolism of Lapatinib can be increased when combined with Oxcarbazepine.,increase,no risk
Lapatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Oxetacaine.,increase,risk
Lapatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Oxybuprocaine.,increase,risk
Lapatinib,Oxybutynin,The metabolism of Lapatinib can be decreased when combined with Oxybutynin.,decrease,no risk
Lapatinib,Oxycodone,The metabolism of Lapatinib can be decreased when combined with Oxycodone.,decrease,no risk
Lapatinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lapatinib.,increase,risk
Lapatinib,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Quetiapine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Quetiapine.,increase,risk
Lapatinib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Quinine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Quinine.,increase,risk
Lapatinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Quizartinib.,increase,risk
Lapatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Udenafil,The metabolism of Udenafil can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vadadustat,The serum concentration of Lapatinib can be increased when it is combined with Vadadustat.,increase,no risk
Lapatinib,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Lapatinib.,decrease,no risk
Lapatinib,Valproic acid,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Valproic acid.,increase,risk
Lapatinib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Lapatinib.,increase,risk
Lapatinib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Verapamil,The metabolism of Lapatinib can be decreased when combined with Verapamil.,decrease,no risk
Lapatinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vernakalant.,increase,risk
Lapatinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Lapatinib.,increase,risk
Lapatinib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Viloxazine,The metabolism of Lapatinib can be decreased when combined with Viloxazine.,decrease,no risk
Lapatinib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vincristine,The excretion of Vincristine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vonoprazan,The metabolism of Lapatinib can be decreased when combined with Vonoprazan.,decrease,no risk
Lapatinib,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Voriconazole,The metabolism of Lapatinib can be decreased when combined with Voriconazole.,decrease,no risk
Lapatinib,Vorinostat,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vorinostat.,increase,risk
Lapatinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Zafirlukast,The metabolism of Lapatinib can be decreased when combined with Zafirlukast.,decrease,no risk
Lapatinib,Zaleplon,The metabolism of Lapatinib can be decreased when combined with Zaleplon.,decrease,no risk
Lapatinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Zidovudine,The metabolism of Lapatinib can be decreased when combined with Zidovudine.,decrease,no risk
Lapatinib,Zimelidine,The metabolism of Lapatinib can be decreased when combined with Zimelidine.,decrease,no risk
Lapatinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ziprasidone.,increase,risk
Lapatinib,Zolpidem,The metabolism of Lapatinib can be decreased when combined with Zolpidem.,decrease,no risk
Lapatinib,Zonisamide,The metabolism of Lapatinib can be decreased when combined with Zonisamide.,decrease,no risk
Lapatinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Zuclopenthixol.,increase,risk
Desonide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Desonide.,increase,risk
Desonide,Vadadustat,The serum concentration of Desonide can be increased when it is combined with Vadadustat.,increase,no risk
Desonide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Desonide.,decrease,no risk
Desonide,Vildagliptin,The risk or severity of hyperglycemia can be increased when Desonide is combined with Vildagliptin.,increase,risk
Desonide,Viloxazine,The metabolism of Desonide can be decreased when combined with Viloxazine.,decrease,no risk
Desonide,Voriconazole,The serum concentration of Desonide can be increased when it is combined with Voriconazole.,increase,no risk
Desonide,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Desonide.,decrease,no risk
Sitagliptin,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bendroflumethiazide,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Sitagliptin,Benorilate,Benorilate may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benserazide,Sitagliptin may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benzatropine,Benzatropine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benznidazole,Sitagliptin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benzoic acid,The excretion of Sitagliptin can be decreased when combined with Benzoic acid.,decrease,no risk
Sitagliptin,Benzthiazide,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Benzthiazide.,decrease,no risk
Sitagliptin,Benzydamine,Benzydamine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Sitagliptin.,decrease,no risk
Sitagliptin,Benzylpenicillin,The excretion of Sitagliptin can be decreased when combined with Benzylpenicillin.,decrease,no risk
Sitagliptin,Bepotastine,Sitagliptin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bepridil,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Sitagliptin.,increase,risk
Sitagliptin,Berotralstat,The metabolism of Sitagliptin can be decreased when combined with Berotralstat.,decrease,no risk
Sitagliptin,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Sitagliptin.,increase,risk
Sitagliptin,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Sitagliptin.,increase,risk
Sitagliptin,Betaxolol,The therapeutic efficacy of Sitagliptin can be increased when used in combination with Betaxolol.,increase,no risk
Sitagliptin,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Sitagliptin.,increase,no risk
Sitagliptin,Bexarotene,The metabolism of Sitagliptin can be decreased when combined with Bexarotene.,decrease,no risk
Sitagliptin,Bezafibrate,The metabolism of Sitagliptin can be decreased when combined with Bezafibrate.,decrease,no risk
Sitagliptin,Bicisate,Sitagliptin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bimekizumab,The metabolism of Sitagliptin can be increased when combined with Bimekizumab.,increase,no risk
Sitagliptin,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bismuth subgallate,Sitagliptin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Sitagliptin.,increase,no risk
Sitagliptin,Bisoprolol,The therapeutic efficacy of Sitagliptin can be increased when used in combination with Bisoprolol.,increase,no risk
Sitagliptin,Bisoxatin,Sitagliptin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bleomycin,Bleomycin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Boceprevir,The metabolism of Sitagliptin can be decreased when combined with Boceprevir.,decrease,no risk
Sitagliptin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bosentan,The therapeutic efficacy of Sitagliptin can be increased when used in combination with Bosentan.,increase,no risk
Sitagliptin,Bosutinib,The metabolism of Sitagliptin can be decreased when combined with Bosutinib.,decrease,no risk
Sitagliptin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Brexpiprazole,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Sitagliptin,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Sitagliptin.,decrease,no risk
Sitagliptin,Brivaracetam,Sitagliptin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bromazepam,Sitagliptin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bromocriptine,The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Bromocriptine.,increase,risk
Sitagliptin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Sitagliptin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sitagliptin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Sitagliptin.,increase,risk
Sitagliptin,Bumadizone,Bumadizone may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bumetanide,The excretion of Sitagliptin can be decreased when combined with Bumetanide.,decrease,no risk
Sitagliptin,Buprenorphine,The metabolism of Sitagliptin can be decreased when combined with Buprenorphine.,decrease,no risk
Sitagliptin,Bupropion,Bupropion may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Buserelin,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Buserelin.,decrease,no risk
Sitagliptin,Buspirone,Buspirone may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Butabarbital,Butabarbital may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Sitagliptin.,decrease,no risk
Decitabine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Decitabine.,increase,risk
Decitabine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Decitabine.,increase,risk
Decitabine,Glatiramer,The risk or severity of adverse effects can be increased when Decitabine is combined with Glatiramer.,increase,risk
Decitabine,Golimumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Golimumab.,increase,risk
Decitabine,Guselkumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Guselkumab.,increase,risk
Decitabine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Decitabine.,increase,risk
Decitabine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Decitabine.,increase,risk
Decitabine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Decitabine.,increase,risk
Decitabine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydrocortisone acetate.,increase,risk
Decitabine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydrocortisone butyrate.,increase,risk
Decitabine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydrocortisone succinate.,increase,risk
Decitabine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Decitabine.,increase,risk
Decitabine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydroxychloroquine.,increase,risk
Decitabine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Decitabine.,increase,risk
Decitabine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Decitabine.,increase,risk
Decitabine,Natalizumab,The risk or severity of immunosuppression can be increased when Decitabine is combined with Natalizumab.,increase,risk
Decitabine,Nelarabine,The risk or severity of adverse effects can be increased when Decitabine is combined with Nelarabine.,increase,risk
Decitabine,Nilotinib,The risk or severity of adverse effects can be increased when Decitabine is combined with Nilotinib.,increase,risk
Decitabine,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Decitabine.,increase,risk
Decitabine,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Obinutuzumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Obinutuzumab.,increase,risk
Decitabine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Decitabine.,increase,no risk
Decitabine,Ofatumumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Ofatumumab.,increase,risk
Decitabine,Olaparib,The risk or severity of adverse effects can be increased when Decitabine is combined with Olaparib.,increase,risk
Decitabine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Decitabine.,increase,risk
Decitabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Decitabine is combined with Oxetacaine.,increase,risk
Decitabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Decitabine is combined with Oxybuprocaine.,increase,risk
Decitabine,Ozanimod,The risk or severity of adverse effects can be increased when Decitabine is combined with Ozanimod.,increase,risk
Decitabine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Decitabine.,increase,risk
Decitabine,Upadacitinib,The risk or severity of adverse effects can be increased when Decitabine is combined with Upadacitinib.,increase,risk
Decitabine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Decitabine.,increase,risk
Decitabine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Decitabine.,increase,risk
Decitabine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Vedolizumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Vedolizumab.,increase,risk
Decitabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Vilanterol,The risk or severity of adverse effects can be increased when Decitabine is combined with Vilanterol.,increase,risk
Decitabine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Decitabine.,increase,risk
Decitabine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Decitabine.,increase,risk
Decitabine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Decitabine.,increase,risk
Decitabine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Decitabine.,increase,risk
Decitabine,Voclosporin,The risk or severity of adverse effects can be increased when Decitabine is combined with Voclosporin.,increase,risk
Decitabine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Decitabine.,increase,risk
Decitabine,Vorinostat,The risk or severity of adverse effects can be increased when Decitabine is combined with Vorinostat.,increase,risk
Decitabine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Decitabine.,increase,risk
Decitabine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Decitabine.,increase,risk
Decitabine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Decitabine.,increase,risk
Decitabine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Decitabine.,increase,risk
Posaconazole,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Posaconazole.,increase,risk
Posaconazole,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Posaconazole.,increase,risk
Posaconazole,Budesonide,The metabolism of Budesonide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Buserelin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Buserelin.,increase,risk
Posaconazole,Buspirone,The metabolism of Buspirone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Busulfan,The metabolism of Busulfan can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Butriptyline,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Butriptyline.,increase,risk
Posaconazole,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Gadobenic acid.,increase,risk
Posaconazole,Galantamine,The metabolism of Galantamine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Posaconazole.,increase,risk
Posaconazole,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Gemifloxacin.,increase,risk
Posaconazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Glecaprevir,The serum concentration of Posaconazole can be increased when it is combined with Glecaprevir.,increase,no risk
Posaconazole,Glofitamab,The serum concentration of Posaconazole can be increased when it is combined with Glofitamab.,increase,no risk
Posaconazole,Glyburide,The metabolism of Glyburide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Goserelin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Goserelin.,increase,risk
Posaconazole,Granisetron,The metabolism of Granisetron can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Haloperidol.,increase,risk
Posaconazole,Histrelin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Histrelin.,increase,risk
Posaconazole,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Posaconazole.,increase,risk
Posaconazole,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Posaconazole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Hydroxyzine.,increase,risk
Posaconazole,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Posaconazole.,increase,risk
Posaconazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ketoconazole,The metabolism of Posaconazole can be decreased when combined with Ketoconazole.,decrease,no risk
Posaconazole,Nabilone,The metabolism of Nabilone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nalidixic acid.,increase,risk
Posaconazole,Naloxegol,The metabolism of Naloxegol can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nefazodone,The metabolism of Posaconazole can be decreased when combined with Nefazodone.,decrease,no risk
Posaconazole,Nelfinavir,The metabolism of Posaconazole can be decreased when combined with Nelfinavir.,decrease,no risk
Posaconazole,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Netupitant,The metabolism of Netupitant can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nimesulide,The metabolism of Nimesulide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nimodipine,The metabolism of Nimodipine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Nisoldipine,The metabolism of Nisoldipine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nizatidine,Nizatidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Posaconazole,Nomegestrol,The metabolism of Nomegestrol can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Norelgestromin,The metabolism of Norelgestromin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Norethynodrel,The metabolism of Norethynodrel can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Posaconazole.,increase,risk
Posaconazole,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Norgestrel,The metabolism of Norgestrel can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Nylidrin,The metabolism of Nylidrin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Posaconazole.,increase,risk
Posaconazole,Ofloxacin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ofloxacin.,increase,risk
Posaconazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Posaconazole,Olaparib,The metabolism of Olaparib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Olodaterol,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Olodaterol.,increase,risk
Posaconazole,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Omeprazole,Omeprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Posaconazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Opium,The metabolism of Opium can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Posaconazole.,increase,risk
Posaconazole,Oxatomide,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxatomide.,increase,risk
Posaconazole,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Posaconazole.,increase,risk
Posaconazole,Quazepam,The metabolism of Quazepam can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Quinidine,The metabolism of Quinidine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Quinine,The metabolism of Quinine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Udenafil,The metabolism of Udenafil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Umbralisib,The serum concentration of Posaconazole can be increased when it is combined with Umbralisib.,increase,no risk
Posaconazole,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vadadustat,The serum concentration of Posaconazole can be increased when it is combined with Vadadustat.,increase,no risk
Posaconazole,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Valproic acid,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Valproic acid.,increase,risk
Posaconazole,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vemurafenib,The serum concentration of Posaconazole can be increased when it is combined with Vemurafenib.,increase,no risk
Posaconazole,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Verapamil,The metabolism of Verapamil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vernakalant,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vernakalant.,increase,risk
Posaconazole,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Viloxazine,The metabolism of Posaconazole can be decreased when combined with Viloxazine.,decrease,no risk
Posaconazole,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vincristine,The metabolism of Vincristine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vindesine,The metabolism of Vindesine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Voriconazole,The metabolism of Posaconazole can be decreased when combined with Voriconazole.,decrease,no risk
Posaconazole,Vorinostat,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vorinostat.,increase,risk
Posaconazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Warfarin,The metabolism of Warfarin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Xylometazoline,The therapeutic efficacy of Posaconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Posaconazole,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ziconotide,The therapeutic efficacy of Posaconazole can be increased when used in combination with Ziconotide.,increase,no risk
Posaconazole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zimelidine,The metabolism of Posaconazole can be decreased when combined with Zimelidine.,decrease,no risk
Posaconazole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ziprasidone.,increase,risk
Posaconazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zotepine,The metabolism of Zotepine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Posaconazole.,increase,no risk
Darunavir,Boceprevir,The serum concentration of Darunavir can be decreased when it is combined with Boceprevir.,decrease,no risk
Darunavir,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Bosentan,The serum concentration of Darunavir can be decreased when it is combined with Bosentan.,decrease,no risk
Darunavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Budesonide,The metabolism of Budesonide can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Butriptyline,The risk or severity of adverse effects can be increased when Darunavir is combined with Butriptyline.,increase,risk
Darunavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Garlic,Garlic can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Darunavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Glecaprevir,The serum concentration of Darunavir can be increased when it is combined with Glecaprevir.,increase,no risk
Darunavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Glofitamab,The serum concentration of Darunavir can be increased when it is combined with Glofitamab.,increase,no risk
Darunavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Darunavir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ketoconazole,The serum concentration of Darunavir can be increased when it is combined with Ketoconazole.,increase,no risk
Darunavir,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Darunavir.,increase,risk
Darunavir,Nabilone,The metabolism of Nabilone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nadolol,The metabolism of Nadolol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Naloxegol,The metabolism of Naloxegol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nefazodone,The metabolism of Darunavir can be decreased when combined with Nefazodone.,decrease,no risk
Darunavir,Nelfinavir,The metabolism of Darunavir can be decreased when combined with Nelfinavir.,decrease,no risk
Darunavir,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Netupitant,The metabolism of Netupitant can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nevirapine,The serum concentration of Nevirapine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nicardipine,The serum concentration of Nicardipine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nicotine,The risk or severity of adverse effects can be increased when Darunavir is combined with Nicotine.,increase,risk
Darunavir,Nifedipine,The serum concentration of Nifedipine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nilvadipine,The serum concentration of Nilvadipine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nimesulide,The serum concentration of Nimesulide can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nimodipine,The serum concentration of Nimodipine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nisoldipine,The serum concentration of Nisoldipine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nitrendipine,The serum concentration of Nitrendipine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nizatidine,Nizatidine can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Darunavir,Nomegestrol,The metabolism of Nomegestrol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Nomegestrol acetate,The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Norelgestromin,The metabolism of Norelgestromin can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Norethisterone,The serum concentration of Norethisterone can be decreased when it is combined with Darunavir.,decrease,no risk
Darunavir,Norethynodrel,The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Norgestimate,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Norgestrel,The therapeutic efficacy of Norgestrel can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Nylidrin,The serum concentration of Nylidrin can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Olutasidenib,The therapeutic efficacy of Darunavir can be decreased when used in combination with Olutasidenib.,decrease,no risk
Darunavir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Omeprazole,Omeprazole can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Darunavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Opium,The metabolism of Opium can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ouabain,The excretion of Ouabain can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Quazepam,The metabolism of Quazepam can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Quinine,The metabolism of Quinine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Quinupramine,The risk or severity of adverse effects can be increased when Darunavir is combined with Quinupramine.,increase,risk
Darunavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Udenafil,The metabolism of Udenafil can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Umbralisib,The serum concentration of Darunavir can be increased when it is combined with Umbralisib.,increase,no risk
Darunavir,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vadadustat,The serum concentration of Darunavir can be increased when it is combined with Vadadustat.,increase,no risk
Darunavir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Valsartan,The excretion of Valsartan can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Viloxazine,The metabolism of Darunavir can be decreased when combined with Viloxazine.,decrease,no risk
Darunavir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Darunavir.,decrease,no risk
Darunavir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Xylometazoline,The serum concentration of Xylometazoline can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ziconotide,The serum concentration of Ziconotide can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zileuton,The metabolism of Zileuton can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zimelidine,The metabolism of Darunavir can be decreased when combined with Zimelidine.,decrease,no risk
Darunavir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zotepine,The metabolism of Zotepine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Darunavir.,increase,no risk
Telbivudine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Ganciclovir,The risk or severity of cytopenia can be increased when Ganciclovir is combined with Telbivudine.,increase,risk
Telbivudine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Valganciclovir,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Telbivudine.,increase,risk
Telbivudine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Telbivudine.,decrease,no risk
Paliperidone,Bacitracin,Bacitracin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.,increase,no risk
Paliperidone,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Paliperidone.,increase,risk
Paliperidone,Baricitinib,Paliperidone may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Paliperidone,Beclomethasone dipropionate,The metabolism of Paliperidone can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Paliperidone,Bedaquiline,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Bedaquiline.,increase,risk
Paliperidone,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Belumosudil,The serum concentration of Paliperidone can be increased when it is combined with Belumosudil.,increase,no risk
Paliperidone,Benazepril,Paliperidone may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Paliperidone,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Benorilate,The risk or severity of hypertension can be increased when Paliperidone is combined with Benorilate.,increase,risk
Paliperidone,Benoxaprofen,The risk or severity of hypertension can be increased when Paliperidone is combined with Benoxaprofen.,increase,risk
Paliperidone,Benperidol,The risk or severity of CNS depression can be increased when Paliperidone is combined with Benperidol.,increase,risk
Paliperidone,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Benzatropine,The risk or severity of adverse effects can be increased when Paliperidone is combined with Benzatropine.,increase,risk
Paliperidone,Benznidazole,Paliperidone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Paliperidone,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Paliperidone.,increase,risk
Paliperidone,Benzphetamine,The therapeutic efficacy of Paliperidone can be decreased when used in combination with Benzphetamine.,decrease,no risk
Paliperidone,Benzthiazide,Benzthiazide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Benzydamine,The risk or severity of hypertension can be increased when Paliperidone is combined with Benzydamine.,increase,risk
Paliperidone,Benzyl alcohol,The risk or severity of CNS depression can be increased when Paliperidone is combined with Benzyl alcohol.,increase,risk
Paliperidone,Bepotastine,Paliperidone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Paliperidone,Bepridil,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Paliperidone.,increase,risk
Paliperidone,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Betamethasone,The metabolism of Paliperidone can be increased when combined with Betamethasone.,increase,no risk
Paliperidone,Betamethasone phosphate,The metabolism of Paliperidone can be increased when combined with Betamethasone phosphate.,increase,no risk
Paliperidone,Betaxolol,Betaxolol may increase the orthostatic hypotensive activities of Paliperidone.,increase,no risk
Paliperidone,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Bicisate,Paliperidone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Paliperidone,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Paliperidone.,increase,risk
Paliperidone,Bimekizumab,The metabolism of Paliperidone can be increased when combined with Bimekizumab.,increase,no risk
Paliperidone,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Bismuth subcitrate potassium,Paliperidone may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Paliperidone,Bismuth subgallate,Paliperidone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Paliperidone,Bismuth subnitrate,Paliperidone may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Paliperidone,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Paliperidone.,increase,no risk
Paliperidone,Bisoxatin,Paliperidone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Paliperidone,Bleomycin,Bleomycin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Boceprevir,The metabolism of Paliperidone can be decreased when combined with Boceprevir.,decrease,no risk
Paliperidone,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bosentan,Paliperidone may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Paliperidone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Paliperidone.,increase,risk
Paliperidone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Paliperidone.,increase,risk
Paliperidone,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Paliperidone.,increase,risk
Paliperidone,Brexanolone,The risk or severity of CNS depression can be increased when Paliperidone is combined with Brexanolone.,increase,risk
Paliperidone,Brexpiprazole,"Paliperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Paliperidone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.,increase,no risk
Paliperidone,Brivaracetam,The risk or severity of CNS depression can be increased when Paliperidone is combined with Brivaracetam.,increase,risk
Paliperidone,Bromazepam,The risk or severity of CNS depression can be increased when Paliperidone is combined with Bromazepam.,increase,risk
Paliperidone,Bromocriptine,"Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.",increase,no risk
Paliperidone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Bromperidol,The risk or severity of CNS depression can be increased when Paliperidone is combined with Bromperidol.,increase,risk
Paliperidone,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Paliperidone.,increase,risk
Paliperidone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Paliperidone.,increase,risk
Paliperidone,Budesonide,The metabolism of Paliperidone can be increased when combined with Budesonide.,increase,no risk
Paliperidone,Bumadizone,The risk or severity of hypertension can be increased when Paliperidone is combined with Bumadizone.,increase,risk
Paliperidone,Bumetanide,Bumetanide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Paliperidone.,increase,risk
Paliperidone,Buprenorphine,Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Paliperidone,Bupropion,The metabolism of Paliperidone can be decreased when combined with Bupropion.,decrease,no risk
Paliperidone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Paliperidone.,increase,risk
Paliperidone,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Paliperidone.,increase,risk
Paliperidone,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Paliperidone.,increase,risk
Paliperidone,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Paliperidone.,increase,risk
Paliperidone,Butaperazine,The risk or severity of CNS depression can be increased when Paliperidone is combined with Butaperazine.,increase,risk
Paliperidone,Butobarbital,The risk or severity of CNS depression can be increased when Paliperidone is combined with Butobarbital.,increase,risk
Paliperidone,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Paliperidone.,increase,risk
Paliperidone,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Paliperidone.,increase,risk
Paliperidone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Paliperidone.,increase,risk
Paliperidone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Paliperidone is combined with Gabapentin enacarbil.,increase,risk
Paliperidone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Paliperidone.,increase,risk
Paliperidone,Gadodiamide,Gadodiamide may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadofosveset trisodium,Paliperidone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadoteric acid,Paliperidone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadoteridol,Gadoteridol may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Paliperidone.,increase,risk
Paliperidone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Paliperidone.,increase,risk
Paliperidone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Paliperidone is combined with Ganaxolone.",increase,risk
Paliperidone,Ganciclovir,Ganciclovir may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Gefitinib,The metabolism of Paliperidone can be decreased when combined with Gefitinib.,decrease,no risk
Paliperidone,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Gentamicin,Paliperidone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Paliperidone,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Paliperidone.,increase,risk
Paliperidone,Gilteritinib,The therapeutic efficacy of Paliperidone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Paliperidone,Gimeracil,Paliperidone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Paliperidone,Givosiran,The serum concentration of Paliperidone can be increased when it is combined with Givosiran.,increase,no risk
Paliperidone,Glasdegib,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Glasdegib.,increase,risk
Paliperidone,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glofitamab,The serum concentration of Paliperidone can be increased when it is combined with Glofitamab.,increase,no risk
Paliperidone,Glutethimide,The risk or severity of CNS depression can be increased when Paliperidone is combined with Glutethimide.,increase,risk
Paliperidone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glycerol phenylbutyrate,The metabolism of Paliperidone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Paliperidone,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Golimumab,The metabolism of Paliperidone can be increased when combined with Golimumab.,increase,no risk
Paliperidone,Golodirsen,Paliperidone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Paliperidone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Paliperidone.,increase,risk
Paliperidone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Paliperidone.,increase,risk
Paliperidone,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Guanadrel,Paliperidone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Paliperidone,Guanethidine,Paliperidone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Paliperidone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Guanoxan,Paliperidone may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Paliperidone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Paliperidone.,increase,risk
Paliperidone,Halofantrine,The metabolism of Paliperidone can be decreased when combined with Halofantrine.,decrease,no risk
Paliperidone,Haloperidol,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Haloperidol.,increase,risk
Paliperidone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Paliperidone.,increase,risk
Paliperidone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Paliperidone.,increase,risk
Paliperidone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Paliperidone.,increase,risk
Paliperidone,Hydralazine,Paliperidone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Paliperidone,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Paliperidone.,increase,risk
Paliperidone,Hydrocodone,Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Paliperidone,Hydrocortisone,The metabolism of Paliperidone can be decreased when combined with Hydrocortisone.,decrease,no risk
Paliperidone,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Paliperidone.,increase,risk
Paliperidone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Paliperidone.,increase,risk
Paliperidone,Hydroxyethyl Starch,Paliperidone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Paliperidone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Hydroxyzine.,increase,risk
Paliperidone,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Paliperidone.,increase,risk
Paliperidone,Kanamycin,Paliperidone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Paliperidone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Paliperidone.,increase,risk
Paliperidone,Ketazolam,The risk or severity of CNS depression can be increased when Paliperidone is combined with Ketazolam.,increase,risk
Paliperidone,Ketoconazole,The metabolism of Paliperidone can be decreased when combined with Ketoconazole.,decrease,no risk
Paliperidone,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Paliperidone.,increase,risk
Paliperidone,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Paliperidone.,increase,risk
Paliperidone,N-acetyltyrosine,Paliperidone may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Paliperidone,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.,increase,no risk
Paliperidone,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Paliperidone.,increase,risk
Paliperidone,Nadolol,Nadolol may increase the orthostatic hypotensive activities of Paliperidone.,increase,no risk
Paliperidone,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Paliperidone.,increase,risk
Paliperidone,Naldemedine,Paliperidone may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Paliperidone,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Paliperidone.,increase,risk
Paliperidone,Nalmefene,Paliperidone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Paliperidone,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Naloxone,Naloxone may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Paliperidone.,increase,risk
Paliperidone,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Paliperidone.,increase,risk
Paliperidone,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Paliperidone.,increase,risk
Paliperidone,Nateglinide,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Naxitamab,The risk or severity of hypertension can be increased when Paliperidone is combined with Naxitamab.,increase,risk
Paliperidone,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Nedaplatin,Paliperidone may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Paliperidone,Nedocromil,Nedocromil may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Nefazodone,The metabolism of Paliperidone can be decreased when combined with Nefazodone.,decrease,no risk
Paliperidone,Nelfinavir,The metabolism of Paliperidone can be decreased when combined with Nelfinavir.,decrease,no risk
Paliperidone,Neomycin,Paliperidone may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Paliperidone,Neratinib,The serum concentration of Paliperidone can be increased when it is combined with Neratinib.,increase,no risk
Paliperidone,Netilmicin,Paliperidone may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Paliperidone,Netupitant,The metabolism of Paliperidone can be decreased when combined with Netupitant.,decrease,no risk
Paliperidone,Nevirapine,The metabolism of Paliperidone can be decreased when combined with Nevirapine.,decrease,no risk
Paliperidone,Niacin,The metabolism of Paliperidone can be decreased when combined with Niacin.,decrease,no risk
Paliperidone,Nialamide,The risk or severity of CNS depression can be increased when Paliperidone is combined with Nialamide.,increase,risk
Paliperidone,Nicardipine,The metabolism of Paliperidone can be decreased when combined with Nicardipine.,decrease,no risk
Paliperidone,Nicergoline,"Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.",increase,no risk
Paliperidone,Nicorandil,Paliperidone may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Paliperidone,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Paliperidone.,increase,risk
Paliperidone,Nilotinib,The metabolism of Paliperidone can be decreased when combined with Nilotinib.,decrease,no risk
Paliperidone,Nilutamide,Nilutamide may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Nilvadipine,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Paliperidone.,increase,risk
Paliperidone,Nimesulide,The risk or severity of hypertension can be increased when Paliperidone is combined with Nimesulide.,increase,risk
Paliperidone,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Paliperidone.,increase,risk
Paliperidone,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Nisoldipine,Paliperidone may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Paliperidone,Nitrazepam,The risk or severity of CNS depression can be increased when Paliperidone is combined with Nitrazepam.,increase,risk
Paliperidone,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Paliperidone.,increase,risk
Paliperidone,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Nitroglycerin,Paliperidone may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Paliperidone,Nitroprusside,Paliperidone may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Paliperidone,Nitrous oxide,The risk or severity of CNS depression can be increased when Paliperidone is combined with Nitrous oxide.,increase,risk
Paliperidone,Nomifensine,The risk or severity of CNS depression can be increased when Paliperidone is combined with Nomifensine.,increase,risk
Paliperidone,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Norethisterone,The metabolism of Paliperidone can be decreased when combined with Norethisterone.,decrease,no risk
Paliperidone,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Norgestimate,The serum concentration of Paliperidone can be increased when it is combined with Norgestimate.,increase,no risk
Paliperidone,Normethadone,The risk or severity of CNS depression can be increased when Paliperidone is combined with Normethadone.,increase,risk
Paliperidone,Nortriptyline,"Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.",increase,no risk
Paliperidone,Nylidrin,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Octinoxate,Paliperidone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Paliperidone,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Paliperidone.,increase,risk
Paliperidone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.",increase,no risk
Paliperidone,Olaparib,The metabolism of Olaparib can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Paliperidone is combined with Oliceridine.",increase,risk
Paliperidone,Olmesartan,Paliperidone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Paliperidone,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Olsalazine,Olsalazine may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Omaveloxolone,The serum concentration of Paliperidone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Paliperidone,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Paliperidone.,increase,risk
Paliperidone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Opium,The risk or severity of CNS depression can be increased when Paliperidone is combined with Opium.,increase,risk
Paliperidone,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Oritavancin,The metabolism of Paliperidone can be decreased when combined with Oritavancin.,decrease,no risk
Paliperidone,Orphenadrine,Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Paliperidone,Oseltamivir,Oseltamivir may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Osilodrostat,The metabolism of Paliperidone can be decreased when combined with Osilodrostat.,decrease,no risk
Paliperidone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Ospemifene,The metabolism of Paliperidone can be decreased when combined with Ospemifene.,decrease,no risk
Paliperidone,Oxacillin,Oxacillin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Paliperidone.,increase,risk
Sunitinib,Bedaquiline,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bedaquiline.,increase,risk
Sunitinib,Belatacept,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belatacept.,increase,risk
Sunitinib,Belimumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belimumab.,increase,risk
Sunitinib,Belinostat,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belinostat.,increase,risk
Sunitinib,Belumosudil,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belumosudil.,increase,risk
Sunitinib,Belzutifan,The serum concentration of Sunitinib can be decreased when it is combined with Belzutifan.,decrease,no risk
Sunitinib,Benazepril,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Sunitinib.,increase,risk
Sunitinib,Bendamustine,The risk or severity of adverse effects can be increased when Sunitinib is combined with Bendamustine.,increase,risk
Sunitinib,Bendroflumethiazide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Sunitinib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sunitinib.,increase,risk
Sunitinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Benzocaine.,increase,risk
Sunitinib,Benzthiazide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Benzthiazide.,decrease,no risk
Sunitinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Benzyl alcohol.,increase,risk
Sunitinib,Bepridil,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bepridil.,increase,risk
Sunitinib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Sunitinib.,increase,risk
Sunitinib,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Sunitinib.,increase,risk
Sunitinib,Betaxolol,The therapeutic efficacy of Sunitinib can be increased when used in combination with Betaxolol.,increase,no risk
Sunitinib,Bevacizumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Bevacizumab.,increase,risk
Sunitinib,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Bexarotene,The metabolism of Sunitinib can be increased when combined with Bexarotene.,increase,no risk
Sunitinib,Bicalutamide,The metabolism of Sunitinib can be decreased when combined with Bicalutamide.,decrease,no risk
Sunitinib,Bifonazole,The metabolism of Sunitinib can be decreased when combined with Bifonazole.,decrease,no risk
Sunitinib,Bilastine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bilastine.,increase,risk
Sunitinib,Bimekizumab,The metabolism of Sunitinib can be increased when combined with Bimekizumab.,increase,no risk
Sunitinib,Binimetinib,Sunitinib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Sunitinib,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Bisoprolol,The therapeutic efficacy of Sunitinib can be increased when used in combination with Bisoprolol.,increase,no risk
Sunitinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Sunitinib.,increase,risk
Sunitinib,Blinatumomab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Blinatumomab.,increase,risk
Sunitinib,Boceprevir,The metabolism of Sunitinib can be decreased when combined with Boceprevir.,decrease,no risk
Sunitinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Sunitinib.",decrease,no risk
Sunitinib,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Sunitinib.,increase,risk
Sunitinib,Bosentan,The metabolism of Sunitinib can be increased when combined with Bosentan.,increase,no risk
Sunitinib,Bosutinib,The metabolism of Sunitinib can be decreased when combined with Bosutinib.,decrease,no risk
Sunitinib,Brentuximab vedotin,The serum concentration of Sunitinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Sunitinib,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sunitinib.,increase,risk
Sunitinib,Brexpiprazole,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Sunitinib,Brigatinib,Sunitinib may decrease the excretion rate of Brigatinib which could result in a higher serum level.,decrease,no risk
Sunitinib,Brodalumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Brodalumab.,increase,risk
Sunitinib,Bromocriptine,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Bromocriptine.,increase,risk
Sunitinib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Sunitinib.,increase,risk
Sunitinib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Sunitinib.,increase,risk
Sunitinib,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Sunitinib.,increase,risk
Sunitinib,Bumetanide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Bumetanide.,decrease,no risk
Sunitinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Bupivacaine.,increase,risk
Sunitinib,Buprenorphine,The metabolism of Sunitinib can be decreased when combined with Buprenorphine.,decrease,no risk
Sunitinib,Buserelin,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Buserelin.,decrease,no risk
Sunitinib,Buspirone,The metabolism of Sunitinib can be decreased when combined with Buspirone.,decrease,no risk
Sunitinib,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Sunitinib.,increase,risk
Sunitinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Butacaine.,increase,risk
Sunitinib,Butalbital,The metabolism of Sunitinib can be increased when combined with Butalbital.,increase,no risk
Sunitinib,Butamben,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Butamben.,increase,risk
Sunitinib,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Sunitinib.,decrease,no risk
Sunitinib,Gadobenic acid,The metabolism of Sunitinib can be decreased when combined with Fusidic acid.,decrease,no risk
Sunitinib,Galantamine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Gadobenic acid.,increase,risk
Sunitinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sunitinib.,increase,risk
Sunitinib,Gefapixant,The therapeutic efficacy of Sunitinib can be increased when used in combination with Gatifloxacin.,increase,no risk
Sunitinib,Gefitinib,The therapeutic efficacy of Sunitinib can be increased when used in combination with Gefapixant.,increase,no risk
Sunitinib,Gemcitabine,The metabolism of Sunitinib can be decreased when combined with Gefitinib.,decrease,no risk
Sunitinib,Gemifloxacin,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sunitinib.,increase,risk
Sunitinib,Gemtuzumab ozogamicin,The therapeutic efficacy of Sunitinib can be increased when used in combination with Gemifloxacin.,increase,no risk
Sunitinib,Gepirone,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sunitinib.,increase,risk
Sunitinib,Gilteritinib,The serum concentration of Gepirone can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Ginkgo biloba,The metabolism of Sunitinib can be decreased when combined with Gilteritinib.,decrease,no risk
Sunitinib,Glasdegib,The metabolism of Sunitinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sunitinib,Glatiramer,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Glasdegib.,increase,risk
Sunitinib,Glecaprevir,The risk or severity of adverse effects can be increased when Sunitinib is combined with Glatiramer.,increase,risk
Sunitinib,Gliclazide,The metabolism of Sunitinib can be decreased when combined with Glecaprevir.,decrease,no risk
Sunitinib,Glimepiride,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Sunitinib.,increase,risk
Sunitinib,Glipizide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Sunitinib.,increase,risk
Sunitinib,Gliquidone,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Sunitinib.,increase,risk
Sunitinib,Glofitamab,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Gliquidone.,increase,risk
Sunitinib,Glyburide,The serum concentration of Sunitinib can be increased when it is combined with Glofitamab.,increase,no risk
Sunitinib,Glycerol phenylbutyrate,The metabolism of Sunitinib can be decreased when combined with Glyburide.,decrease,no risk
Sunitinib,Glymidine,The metabolism of Sunitinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Sunitinib,Golimumab,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Glymidine.,increase,risk
Sunitinib,Goserelin,The metabolism of Sunitinib can be increased when combined with Golimumab.,increase,no risk
Sunitinib,Granisetron,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Goserelin.,decrease,no risk
Sunitinib,Grapefruit,The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Granisetron.,increase,risk
Sunitinib,Grepafloxacin,The serum concentration of Sunitinib can be increased when it is combined with Grapefruit.,increase,no risk
Sunitinib,Griseofulvin,The therapeutic efficacy of Sunitinib can be increased when used in combination with Grepafloxacin.,increase,no risk
Sunitinib,Guselkumab,The metabolism of Sunitinib can be increased when combined with Griseofulvin.,increase,no risk
Sunitinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The risk or severity of adverse effects can be increased when Sunitinib is combined with Guselkumab.,increase,risk
Sunitinib,Halcinonide,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Halofantrine,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Sunitinib.,increase,risk
Sunitinib,Haloperidol,The metabolism of Sunitinib can be decreased when combined with Halofantrine.,decrease,no risk
Sunitinib,Hepatitis A Vaccine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Haloperidol.,increase,risk
Sunitinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Histrelin,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Histrelin.,decrease,no risk
Sunitinib,Hydralazine,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Sunitinib.,increase,risk
Sunitinib,Hydrochlorothiazide,The serum concentration of Sunitinib can be increased when it is combined with Hydralazine.,increase,no risk
Sunitinib,Hydrocortamate,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Sunitinib,Hydrocortisone,The metabolism of Sunitinib can be increased when combined with Hydrocortamate.,increase,no risk
Sunitinib,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone phosphate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone probutate,The metabolism of Sunitinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Sunitinib,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Sunitinib.,increase,risk
Sunitinib,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Sunitinib.,increase,risk
Sunitinib,Hydroxychloroquine,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Sunitinib,Hydroxyprogesterone caproate,The therapeutic efficacy of Sunitinib can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Sunitinib,Hydroxyurea,The metabolism of Sunitinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Sunitinib,Hydroxyzine,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Sunitinib.,increase,risk
Sunitinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Hydroxyzine.,increase,risk
Sunitinib,Janssen COVID-19 Vaccine,The risk or severity of adverse effects can be increased when Sunitinib is combined with Ixekizumab.,increase,risk
Sunitinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Ketazolam,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Ketoconazole,The serum concentration of Sunitinib can be increased when it is combined with Ketazolam.,increase,no risk
Sunitinib,Nadolol,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Sunitinib.,increase,risk
Sunitinib,Nafcillin,The therapeutic efficacy of Sunitinib can be increased when used in combination with Nadolol.,increase,no risk
Sunitinib,Nalidixic acid,The metabolism of Sunitinib can be increased when combined with Nafcillin.,increase,no risk
Sunitinib,Nandrolone decanoate,The therapeutic efficacy of Sunitinib can be increased when used in combination with Nalidixic acid.,increase,no risk
Sunitinib,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Natalizumab,Nandrolone phenpropionate may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Nateglinide,The risk or severity of immunosuppression can be increased when Sunitinib is combined with Natalizumab.,increase,risk
Sunitinib,Nebivolol,The metabolism of Sunitinib can be decreased when combined with Nateglinide.,decrease,no risk
Sunitinib,Nefazodone,The therapeutic efficacy of Sunitinib can be increased when used in combination with Nebivolol.,increase,no risk
Sunitinib,Nelarabine,The metabolism of Sunitinib can be decreased when combined with Nefazodone.,decrease,no risk
Sunitinib,Nelfinavir,The risk or severity of adverse effects can be increased when Sunitinib is combined with Nelarabine.,increase,risk
Sunitinib,Netupitant,The metabolism of Sunitinib can be decreased when combined with Nelfinavir.,decrease,no risk
Sunitinib,Nevirapine,The metabolism of Sunitinib can be decreased when combined with Netupitant.,decrease,no risk
Sunitinib,Niacin,The metabolism of Sunitinib can be decreased when combined with Nevirapine.,decrease,no risk
Sunitinib,Nialamide,The serum concentration of Sunitinib can be increased when it is combined with Niacin.,increase,no risk
Sunitinib,Nicardipine,Nialamide may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Nifedipine,The metabolism of Sunitinib can be decreased when combined with Nicardipine.,decrease,no risk
Sunitinib,Nilotinib,The metabolism of Sunitinib can be decreased when combined with Nifedipine.,decrease,no risk
Sunitinib,Nilvadipine,The metabolism of Sunitinib can be decreased when combined with Nilotinib.,decrease,no risk
Sunitinib,Nimesulide,The metabolism of Sunitinib can be decreased when combined with Nilvadipine.,decrease,no risk
Sunitinib,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Sunitinib.,increase,risk
Sunitinib,Nintedanib,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Sunitinib.,increase,risk
Sunitinib,Nisoldipine,The metabolism of Sunitinib can be decreased when combined with Nintedanib.,decrease,no risk
Sunitinib,Nitrendipine,The metabolism of Sunitinib can be decreased when combined with Nisoldipine.,decrease,no risk
Sunitinib,Nitrofurantoin,The metabolism of Sunitinib can be decreased when combined with Nitrendipine.,decrease,no risk
Sunitinib,Norethisterone,Sunitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Sunitinib,Norfloxacin,The metabolism of Sunitinib can be decreased when combined with Norethisterone.,decrease,no risk
Sunitinib,Norgestimate,The therapeutic efficacy of Sunitinib can be increased when used in combination with Norfloxacin.,increase,no risk
Sunitinib,Nortriptyline,The metabolism of Sunitinib can be increased when combined with Norgestimate.,increase,no risk
Sunitinib,Noscapine,Nortriptyline may decrease the hypoglycemic activities of Sunitinib.,decrease,no risk
Sunitinib,Nuvaxovid,The serum concentration of Sunitinib can be increased when it is combined with Noscapine.,increase,no risk
Sunitinib,Nylidrin,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Obinutuzumab,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Sunitinib.,increase,risk
Sunitinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Obinutuzumab.,increase,risk
Sunitinib,Octreotide,The risk or severity of adverse effects can be increased when Sunitinib is combined with Ocrelizumab.,increase,risk
Sunitinib,Ofatumumab,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Octreotide.,decrease,no risk
Sunitinib,Ofloxacin,The risk or severity of adverse effects can be increased when Sunitinib is combined with Ofatumumab.,increase,risk
Sunitinib,Olanzapine,The therapeutic efficacy of Sunitinib can be increased when used in combination with Ofloxacin.,increase,no risk
Sunitinib,Olaparib,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Olanzapine.,decrease,no risk
Sunitinib,Olodaterol,The metabolism of Sunitinib can be decreased when combined with Olaparib.,decrease,no risk
Sunitinib,Olsalazine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Olodaterol.,increase,risk
Sunitinib,Olutasidenib,Olsalazine may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Omaveloxolone,The metabolism of Sunitinib can be increased when combined with Olutasidenib.,increase,no risk
Sunitinib,Ombitasvir,The serum concentration of Sunitinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sunitinib,Ondansetron,Sunitinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Sunitinib,Oritavancin,The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Ondansetron.,increase,risk
Sunitinib,Orphenadrine,The metabolism of Sunitinib can be increased when combined with Oritavancin.,increase,no risk
Sunitinib,Osilodrostat,The metabolism of Sunitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Sunitinib,Osimertinib,The metabolism of Sunitinib can be decreased when combined with Osilodrostat.,decrease,no risk
Sunitinib,Oxaliplatin,The metabolism of Sunitinib can be decreased when combined with Osimertinib.,decrease,no risk
Sunitinib,Oxandrolone,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sunitinib.,increase,risk
Sunitinib,Oxatomide,Oxandrolone may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Oxcarbazepine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Oxatomide.,increase,risk
Sunitinib,Oxetacaine,The metabolism of Sunitinib can be increased when combined with Oxcarbazepine.,increase,no risk
Sunitinib,Oxprenolol,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Oxetacaine.,increase,risk
Sunitinib,Oxybuprocaine,The therapeutic efficacy of Sunitinib can be increased when used in combination with Oxprenolol.,increase,no risk
Sunitinib,Oxybutynin,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Oxybuprocaine.,increase,risk
Sunitinib,Oxycodone,The serum concentration of Sunitinib can be increased when it is combined with Oxybutynin.,increase,no risk
Sunitinib,Oxymetholone,The metabolism of Sunitinib can be decreased when combined with Oxycodone.,decrease,no risk
Sunitinib,Oxytocin,Oxymetholone may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Ozanimod,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sunitinib.,increase,risk
Sunitinib,Quetiapine,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Pseudoephedrine.,decrease,no risk
Sunitinib,Quinethazone,The metabolism of Sunitinib can be decreased when combined with Quetiapine.,decrease,no risk
Sunitinib,Quinidine,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Quinethazone.,decrease,no risk
Sunitinib,Quinine,The metabolism of Sunitinib can be decreased when combined with Quinidine.,decrease,no risk
Sunitinib,Quinupramine,The metabolism of Sunitinib can be increased when combined with Quinine.,increase,no risk
Sunitinib,Quinupristin,Quinupramine may decrease the hypoglycemic activities of Sunitinib.,decrease,no risk
Sunitinib,Quizartinib,The metabolism of Sunitinib can be decreased when combined with Quinupristin.,decrease,no risk
Sunitinib,Ubidecarenone,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Ublituximab,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sunitinib.,increase,risk
Sunitinib,Ubrogepant,The risk or severity of infection can be increased when Ublituximab is combined with Sunitinib.,increase,risk
Sunitinib,Udenafil,The serum concentration of Ubrogepant can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Ulobetasol,The metabolism of Sunitinib can be decreased when combined with Udenafil.,decrease,no risk
Sunitinib,Upadacitinib,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sunitinib.,increase,risk
Sunitinib,Vadadustat,The risk or severity of adverse effects can be increased when Sunitinib is combined with Upadacitinib.,increase,risk
Sunitinib,Valbenazine,The serum concentration of Sunitinib can be increased when it is combined with Vadadustat.,increase,no risk
Sunitinib,Valdecoxib,The metabolism of Sunitinib can be decreased when combined with Valbenazine.,decrease,no risk
Sunitinib,Valoctocogene roxaparvovec,The therapeutic efficacy of Sunitinib can be increased when used in combination with Valdecoxib.,increase,no risk
Sunitinib,Valproic acid,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Vamorolone,The serum concentration of Sunitinib can be increased when it is combined with Valproic acid.,increase,no risk
Sunitinib,Vandetanib,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Sunitinib.,increase,risk
Sunitinib,Vardenafil,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Vandetanib.,increase,risk
Sunitinib,Varicella zoster vaccine (live/attenuated),The metabolism of Vardenafil can be decreased when combined with Sunitinib.,decrease,no risk
Sunitinib,Varicella zoster vaccine (recombinant),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Sunitinib.,increase,risk
Sunitinib,Vedolizumab,The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Velpatasvir,The risk or severity of adverse effects can be increased when Sunitinib is combined with Vedolizumab.,increase,risk
Sunitinib,Vemurafenib,Sunitinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Sunitinib,Venetoclax,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Sunitinib.,increase,risk
Sunitinib,Venlafaxine,The metabolism of Sunitinib can be decreased when combined with Venetoclax.,decrease,no risk
Sunitinib,Verapamil,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sunitinib.,increase,risk
Sunitinib,Vernakalant,The metabolism of Sunitinib can be decreased when combined with Verapamil.,decrease,no risk
Sunitinib,Vibrio cholerae CVD 103-HgR strain live antigen,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Vernakalant.,increase,risk
Sunitinib,Vilanterol,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Vildagliptin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sunitinib.,increase,risk
Sunitinib,Viloxazine,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Vildagliptin.,increase,risk
Sunitinib,Vinblastine,The metabolism of Sunitinib can be decreased when combined with Viloxazine.,decrease,no risk
Sunitinib,Vincristine,The metabolism of Sunitinib can be increased when combined with Vinblastine.,increase,no risk
Sunitinib,Vindesine,The metabolism of Sunitinib can be decreased when combined with Vincristine.,decrease,no risk
Sunitinib,Vinorelbine,The risk or severity of adverse effects can be increased when Vindesine is combined with Sunitinib.,increase,risk
Sunitinib,Vitamin E,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sunitinib.,increase,risk
Sunitinib,Voclosporin,The metabolism of Sunitinib can be increased when combined with Vitamin E.,increase,no risk
Sunitinib,Vonoprazan,The risk or severity of adverse effects can be increased when Sunitinib is combined with Voclosporin.,increase,risk
Sunitinib,Vorapaxar,The metabolism of Sunitinib can be decreased when combined with Vonoprazan.,decrease,no risk
Sunitinib,Voriconazole,The metabolism of Sunitinib can be decreased when combined with Vorapaxar.,decrease,no risk
Sunitinib,Vorinostat,The serum concentration of Sunitinib can be increased when it is combined with Voriconazole.,increase,no risk
Sunitinib,Vortioxetine,The risk or severity of adverse effects can be increased when Sunitinib is combined with Vorinostat.,increase,risk
Sunitinib,Voxelotor,The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Vortioxetine.,increase,risk
Sunitinib,Voxilaprevir,The serum concentration of Sunitinib can be increased when it is combined with Voxelotor.,increase,no risk
Sunitinib,Warfarin,Sunitinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Sunitinib,Xylometazoline,The serum concentration of Warfarin can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Yellow fever vaccine,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Sunitinib.,increase,risk
Sunitinib,Zafirlukast,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Sunitinib.,increase,risk
Sunitinib,Zaleplon,The serum concentration of Sunitinib can be increased when it is combined with Zafirlukast.,increase,no risk
Sunitinib,Ziconotide,The metabolism of Sunitinib can be decreased when combined with Zaleplon.,decrease,no risk
Sunitinib,Zidovudine,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Sunitinib.,increase,risk
Sunitinib,Zimelidine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Sunitinib.,increase,risk
Sunitinib,Ziprasidone,The metabolism of Sunitinib can be decreased when combined with Zimelidine.,decrease,no risk
Sunitinib,Zoledronic acid,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ziprasidone.,increase,risk
Sunitinib,Zonisamide,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Zoledronic acid.,increase,risk
Sunitinib,Zopiclone,The metabolism of Sunitinib can be decreased when combined with Zonisamide.,decrease,no risk
Sunitinib,Zuclopenthixol,The metabolism of Zopiclone can be decreased when combined with Sunitinib.,decrease,no risk
Panitumumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Panitumumab is combined with Human varicella-zoster immune globulin.,increase,risk
Panitumumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Panitumumab.,increase,risk
Panitumumab,Necitumumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Necitumumab.,increase,risk
Panitumumab,Nivolumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Nivolumab.,increase,risk
Panitumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Obiltoxaximab.,increase,risk
Panitumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Obinutuzumab.,increase,risk
Panitumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ocrelizumab.,increase,risk
Panitumumab,Odesivimab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Odesivimab.,increase,risk
Panitumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ofatumumab.,increase,risk
Panitumumab,Olaratumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Olaratumab.,increase,risk
Panitumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Panitumumab.,increase,risk
Panitumumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Panitumumab is combined with Oxetacaine.,increase,risk
Panitumumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Panitumumab is combined with Oxybuprocaine.,increase,risk
Panitumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Panitumumab.,increase,no risk
Panitumumab,Ublituximab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ublituximab.,increase,risk
Panitumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ustekinumab.,increase,risk
Panitumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Vedolizumab.,increase,risk
Ranibizumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Ranibizumab.,increase,risk
Ranibizumab,Necitumumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Necitumumab.,increase,risk
Ranibizumab,Nivolumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Nivolumab.,increase,risk
Ranibizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Obiltoxaximab.,increase,risk
Ranibizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Obinutuzumab.,increase,risk
Ranibizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ocrelizumab.,increase,risk
Ranibizumab,Odesivimab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Odesivimab.,increase,risk
Ranibizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ofatumumab.,increase,risk
Ranibizumab,Olaratumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Olaratumab.,increase,risk
Ranibizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ranibizumab.,increase,risk
Ranibizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ranibizumab.,increase,no risk
Ranibizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ublituximab.,increase,risk
Ranibizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ustekinumab.,increase,risk
Ranibizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Vedolizumab.,increase,risk
Ranibizumab,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Ranibizumab is combined with Zoledronic acid.,increase,risk
Varenicline,Gabapentin enacarbil,Varenicline may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Varenicline,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gadodiamide,Gadodiamide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gadofosveset trisodium,Varenicline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Varenicline,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gadoteric acid,Varenicline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Varenicline,Gadoteridol,Gadoteridol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Varenicline.,increase,risk
Varenicline,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Varenicline.,increase,risk
Varenicline,Ganciclovir,Ganciclovir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gemcitabine,Gemcitabine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Varenicline.,increase,no risk
Varenicline,Gimeracil,Varenicline may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Varenicline,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Varenicline.,increase,risk
Varenicline,Givosiran,Givosiran may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Glipizide,Glipizide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Glycerol phenylbutyrate,Varenicline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Varenicline,Golodirsen,Varenicline may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Varenicline,Goserelin,Goserelin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Grepafloxacin,The excretion of Varenicline can be decreased when combined with Grepafloxacin.,decrease,no risk
Varenicline,Guanethidine,Guanethidine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Guanfacine,Guanfacine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Guanidine,The excretion of Varenicline can be decreased when combined with Guanidine.,decrease,no risk
Varenicline,Haloperidol,Haloperidol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Varenicline.,increase,risk
Varenicline,Histamine,The excretion of Varenicline can be decreased when combined with Histamine.,decrease,no risk
Varenicline,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Varenicline.,increase,risk
Varenicline,Hydralazine,Varenicline may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Varenicline,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Varenicline,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Varenicline,Hydromorphone,Hydromorphone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Hydroxyethyl Starch,Varenicline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Varenicline,Kanamycin,Varenicline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Varenicline,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Varenicline.,increase,risk
Varenicline,Ketazolam,Varenicline may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Varenicline,Ketoprofen,Ketoprofen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Ketorolac,Ketorolac may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,N-acetyltyrosine,Varenicline may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Varenicline,Nabumetone,Nabumetone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nadolol,The risk or severity of adverse effects can be increased when Nadolol is combined with Varenicline.,increase,risk
Varenicline,Naldemedine,Varenicline may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Varenicline,Nalmefene,Varenicline may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Varenicline,Naloxone,Naloxone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Naproxen,Naproxen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nateglinide,Nateglinide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nebivolol,The risk or severity of adverse effects can be increased when Nebivolol is combined with Varenicline.,increase,risk
Varenicline,Nedaplatin,Varenicline may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Varenicline,Nedocromil,Nedocromil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nefazodone,Nefazodone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Neomycin,Varenicline may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Varenicline,Neostigmine,The risk or severity of adverse effects can be increased when Neostigmine is combined with Varenicline.,increase,risk
Varenicline,Netilmicin,Varenicline may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Varenicline,Nicorandil,Varenicline may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Varenicline,Nicotine,The risk or severity of adverse effects can be increased when Varenicline is combined with Nicotine.,increase,risk
Varenicline,Nifedipine,Nifedipine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nilutamide,Nilutamide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nimesulide,Nimesulide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nisoldipine,Nisoldipine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nitroprusside,Nitroprusside may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Nizatidine,The risk or severity of adverse effects can be increased when Nizatidine is combined with Varenicline.,increase,risk
Varenicline,Norepinephrine,The excretion of Varenicline can be decreased when combined with Norepinephrine.,decrease,no risk
Varenicline,Octinoxate,Varenicline may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Varenicline,Olsalazine,Olsalazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Opium,Varenicline may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Varenicline,Oseltamivir,Oseltamivir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxacillin,Oxacillin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Varenicline.,increase,no risk
Varenicline,Oxaprozin,Oxaprozin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxazepam,Oxazepam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxprenolol,The excretion of Varenicline can be decreased when combined with Oxprenolol.,decrease,no risk
Varenicline,Oxybenzone,Varenicline may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Varenicline,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxyquinoline,Varenicline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Varenicline,Quetiapine,Quetiapine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Quinethazone,Quinethazone may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Varenicline,Quinidine,The excretion of Varenicline can be decreased when combined with Quinidine.,decrease,no risk
Varenicline,Quinine,The excretion of Varenicline can be decreased when combined with Quinine.,decrease,no risk
Varenicline,Vaborbactam,Varenicline may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Varenicline,Valaciclovir,Valaciclovir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Valbenazine,Varenicline may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Varenicline,Valdecoxib,Valdecoxib may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Valganciclovir,Varenicline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Varenicline,Vancomycin,Varenicline may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Varenicline,Vandetanib,The excretion of Varenicline can be decreased when combined with Vandetanib.,decrease,no risk
Varenicline,Venlafaxine,Venlafaxine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Verapamil,Verapamil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Vilanterol,Varenicline may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Varenicline,Viloxazine,Varenicline may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Varenicline,Vortioxetine,Varenicline may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Varenicline,Warfarin,Varenicline may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Varenicline,Zaleplon,Zaleplon may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Zanamivir,Zanamivir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Zonisamide,Zonisamide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arformoterol,Bacitracin,Bacitracin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Baclofen,Baclofen may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Arformoterol.,increase,risk
Arformoterol,Baricitinib,Arformoterol may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Arformoterol,Beclomethasone dipropionate,The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Arformoterol.,increase,risk
Arformoterol,Bedaquiline,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Bedaquiline.,increase,risk
Arformoterol,Benazepril,Arformoterol may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Arformoterol,Bendroflumethiazide,The risk or severity of hypokalemia can be increased when Arformoterol is combined with Bendroflumethiazide.,increase,risk
Arformoterol,Benorilate,The risk or severity of hypertension can be increased when Arformoterol is combined with Benorilate.,increase,risk
Arformoterol,Benoxaprofen,The risk or severity of hypertension can be increased when Arformoterol is combined with Benoxaprofen.,increase,risk
Arformoterol,Benserazide,Arformoterol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Arformoterol,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Arformoterol.,increase,risk
Arformoterol,Benznidazole,Arformoterol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Arformoterol,Benzocaine,The metabolism of Arformoterol can be decreased when combined with Benzocaine.,decrease,no risk
Arformoterol,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Arformoterol.,increase,risk
Arformoterol,Benzthiazide,The risk or severity of hypokalemia can be increased when Arformoterol is combined with Benzthiazide.,increase,risk
Arformoterol,Benzydamine,The risk or severity of hypertension can be increased when Arformoterol is combined with Benzydamine.,increase,risk
Arformoterol,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Arformoterol.,decrease,no risk
Arformoterol,Benzylpenicilloyl polylysine,Arformoterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Arformoterol,Bepotastine,Arformoterol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Arformoterol,Bepridil,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Bepridil.,increase,risk
Arformoterol,Berotralstat,The metabolism of Arformoterol can be decreased when combined with Berotralstat.,decrease,no risk
Arformoterol,Betahistine,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Betahistine.,decrease,no risk
Arformoterol,Betamethasone,The risk or severity of hypokalemia can be increased when Betamethasone is combined with Arformoterol.,increase,risk
Arformoterol,Betamethasone phosphate,The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Arformoterol.,increase,risk
Arformoterol,Betaxolol,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Betaxolol.,decrease,no risk
Arformoterol,Bethanidine,Arformoterol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Arformoterol,Bexarotene,The metabolism of Arformoterol can be decreased when combined with Bexarotene.,decrease,no risk
Arformoterol,Bicisate,Arformoterol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Arformoterol,Bilastine,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Bilastine.,increase,risk
Arformoterol,Bimekizumab,The metabolism of Arformoterol can be increased when combined with Bimekizumab.,increase,no risk
Arformoterol,Biperiden,The metabolism of Arformoterol can be decreased when combined with Biperiden.,decrease,no risk
Arformoterol,Bismuth subgallate,Arformoterol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Arformoterol,Bisoprolol,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Arformoterol,Bisoxatin,Arformoterol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Arformoterol,Bleomycin,Bleomycin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Arformoterol.,increase,risk
Arformoterol,Bosentan,The metabolism of Arformoterol can be increased when combined with Bosentan.,increase,no risk
Arformoterol,Bretylium,Arformoterol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Arformoterol,Brexpiprazole,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Arformoterol,Brivaracetam,Arformoterol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Arformoterol,Bromazepam,Arformoterol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Arformoterol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Arformoterol.,increase,no risk
Arformoterol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Arformoterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arformoterol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Arformoterol.,increase,risk
Arformoterol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Arformoterol.,increase,risk
Arformoterol,Bumadizone,The risk or severity of hypertension can be increased when Arformoterol is combined with Bumadizone.,increase,risk
Arformoterol,Bumetanide,The risk or severity of hypokalemia can be increased when Arformoterol is combined with Bumetanide.,increase,risk
Arformoterol,Bupivacaine,The metabolism of Arformoterol can be decreased when combined with Bupivacaine.,decrease,no risk
Arformoterol,Buprenorphine,The metabolism of Arformoterol can be decreased when combined with Buprenorphine.,decrease,no risk
Arformoterol,Bupropion,The metabolism of Arformoterol can be decreased when combined with Bupropion.,decrease,no risk
Arformoterol,Buserelin,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Buserelin.,increase,risk
Arformoterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Arformoterol.,increase,risk
Arformoterol,Butabarbital,Butabarbital may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Arformoterol.,increase,risk
Arformoterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Arformoterol is combined with Butylscopolamine.,increase,risk
Hydralazine,Bisoprolol,Bisoprolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Bisoxatin,Hydralazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Hydralazine,Bleomycin,Bleomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Bosentan,Bosentan may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Bretylium,Bretylium may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Brimonidine,Brimonidine may increase the antihypertensive activities of Hydralazine.,increase,no risk
Hydralazine,Brivaracetam,Hydralazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Hydralazine,Bromazepam,Hydralazine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Hydralazine,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydralazine,Budesonide,Budesonide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Bumadizone,Bumadizone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Bumetanide,Bumetanide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydralazine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydralazine.,increase,risk
Hydralazine,Bupropion,Bupropion may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Buspirone,Buspirone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Butabarbital,Butabarbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Butalbital,Butalbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Butriptyline,Butriptyline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Gabapentin enacarbil,Hydralazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadodiamide,Gadodiamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadofosveset trisodium,Hydralazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Exenatide,Gatifloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Gatifloxacin.,increase,no risk
Exenatide,Gefapixant,The therapeutic efficacy of Exenatide can be increased when used in combination with Gefapixant.,increase,no risk
Exenatide,Gemifloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Gemifloxacin.,increase,no risk
Exenatide,Gestrinone,Exenatide can cause a decrease in the absorption of Gestrinone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Gliclazide,Exenatide may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Exenatide,Glimepiride,Exenatide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Exenatide,Glipizide,Exenatide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Exenatide,Gliquidone,Exenatide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Exenatide,Glyburide,Exenatide may increase the hypoglycemic activities of Glyburide.,increase,no risk
Exenatide,Glymidine,The risk or severity of hypoglycemia can be increased when Exenatide is combined with Glymidine.,increase,risk
Exenatide,Goserelin,The therapeutic efficacy of Exenatide can be decreased when used in combination with Goserelin.,decrease,no risk
Exenatide,Grepafloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Grepafloxacin.,increase,no risk
Exenatide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Exenatide.,increase,risk
Exenatide,Haloperidol,The therapeutic efficacy of Exenatide can be decreased when used in combination with Haloperidol.,decrease,no risk
Exenatide,Histrelin,The therapeutic efficacy of Exenatide can be decreased when used in combination with Histrelin.,decrease,no risk
Exenatide,Hydrochlorothiazide,The therapeutic efficacy of Exenatide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Exenatide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Exenatide.,increase,risk
Exenatide,Hydroflumethiazide,The therapeutic efficacy of Exenatide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Exenatide,Hydroxychloroquine,The therapeutic efficacy of Exenatide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Exenatide,Hydroxyprogesterone caproate,Exenatide can cause a decrease in the absorption of Hydroxyprogesterone caproate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Nadolol,The therapeutic efficacy of Exenatide can be increased when used in combination with Nadolol.,increase,no risk
Exenatide,Nalidixic acid,The therapeutic efficacy of Exenatide can be increased when used in combination with Nalidixic acid.,increase,no risk
Exenatide,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Exenatide.,increase,risk
Exenatide,Nebivolol,The therapeutic efficacy of Exenatide can be increased when used in combination with Nebivolol.,increase,no risk
Exenatide,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Exenatide.,increase,risk
Exenatide,Nelfinavir,The therapeutic efficacy of Exenatide can be decreased when used in combination with Nelfinavir.,decrease,no risk
Exenatide,Niacin,The therapeutic efficacy of Exenatide can be decreased when used in combination with Niacin.,decrease,no risk
Exenatide,Nialamide,Nialamide may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Exenatide.,increase,risk
Exenatide,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Exenatide.,increase,risk
Exenatide,Nilotinib,The therapeutic efficacy of Exenatide can be decreased when used in combination with Nilotinib.,decrease,no risk
Exenatide,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Exenatide.,increase,risk
Exenatide,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Exenatide.,increase,risk
Exenatide,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Exenatide.,increase,risk
Exenatide,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Exenatide.,increase,risk
Exenatide,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Exenatide.,increase,risk
Exenatide,Nomegestrol,Exenatide can cause a decrease in the absorption of Nomegestrol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Nomegestrol acetate,Exenatide can cause a decrease in the absorption of Nomegestrol acetate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Norelgestromin,Exenatide can cause a decrease in the absorption of Norelgestromin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Norethisterone,Exenatide can cause a decrease in the absorption of Norethisterone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Norethynodrel,Exenatide can cause a decrease in the absorption of Norethynodrel resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Norfloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Norfloxacin.,increase,no risk
Exenatide,Norgestimate,Exenatide can cause a decrease in the absorption of Norgestimate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Norgestrel,Exenatide can cause a decrease in the absorption of Norgestrel resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Exenatide.,decrease,no risk
Exenatide,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Exenatide.,increase,risk
Exenatide,Octreotide,The therapeutic efficacy of Exenatide can be decreased when used in combination with Octreotide.,decrease,no risk
Exenatide,Ofloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Ofloxacin.,increase,no risk
Exenatide,Olanzapine,The therapeutic efficacy of Exenatide can be decreased when used in combination with Olanzapine.,decrease,no risk
Exenatide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Oxprenolol,The therapeutic efficacy of Exenatide can be increased when used in combination with Oxprenolol.,increase,no risk
Exenatide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Quetiapine,The therapeutic efficacy of Exenatide can be decreased when used in combination with Quetiapine.,decrease,no risk
Exenatide,Quinethazone,The therapeutic efficacy of Exenatide can be decreased when used in combination with Quinethazone.,decrease,no risk
Exenatide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Exenatide.,increase,risk
Exenatide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Exenatide.,decrease,no risk
Exenatide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Exenatide.,increase,risk
Exenatide,Udenafil,The therapeutic efficacy of Exenatide can be increased when used in combination with Udenafil.,increase,no risk
Exenatide,Ulipristal,Exenatide can cause a decrease in the absorption of Ulipristal resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Exenatide.,increase,risk
Exenatide,Valdecoxib,The therapeutic efficacy of Exenatide can be increased when used in combination with Valdecoxib.,increase,no risk
Exenatide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Exenatide.,increase,risk
Exenatide,Vemurafenib,The therapeutic efficacy of Exenatide can be increased when used in combination with Vemurafenib.,increase,no risk
Exenatide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Exenatide.,increase,risk
Exenatide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Exenatide.,increase,risk
Exenatide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Exenatide is combined with Vildagliptin.,increase,risk
Exenatide,Vorinostat,The therapeutic efficacy of Exenatide can be decreased when used in combination with Vorinostat.,decrease,no risk
Exenatide,Warfarin,Exenatide can cause an increase in the absorption of Warfarin resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Exenatide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Exenatide.,increase,risk
Exenatide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Exenatide.,increase,risk
Exenatide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Exenatide.,increase,risk
Exenatide,Ziprasidone,The therapeutic efficacy of Exenatide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Exenatide,Zonisamide,The therapeutic efficacy of Exenatide can be increased when used in combination with Zonisamide.,increase,no risk
Mecasermin,Gatifloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Gatifloxacin.,increase,no risk
Mecasermin,Gefapixant,The therapeutic efficacy of Mecasermin can be increased when used in combination with Gefapixant.,increase,no risk
Mecasermin,Gemifloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Gemifloxacin.,increase,no risk
Mecasermin,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Mecasermin.,increase,risk
Mecasermin,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Mecasermin.,increase,risk
Mecasermin,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Mecasermin.,increase,risk
Mecasermin,Gliquidone,The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Gliquidone.,increase,risk
Mecasermin,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Mecasermin.,increase,risk
Mecasermin,Glymidine,The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Glymidine.,increase,risk
Mecasermin,Goserelin,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Goserelin.,decrease,no risk
Mecasermin,Grepafloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Grepafloxacin.,increase,no risk
Mecasermin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Mecasermin.,increase,risk
Mecasermin,Haloperidol,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Haloperidol.,decrease,no risk
Mecasermin,Histrelin,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Histrelin.,decrease,no risk
Mecasermin,Hydrochlorothiazide,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Mecasermin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Mecasermin.,increase,risk
Mecasermin,Hydroflumethiazide,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Mecasermin,Hydroxychloroquine,The therapeutic efficacy of Mecasermin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Mecasermin,Hydroxyprogesterone caproate,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Mecasermin,Nadolol,The therapeutic efficacy of Mecasermin can be increased when used in combination with Nadolol.,increase,no risk
Mecasermin,Nalidixic acid,The therapeutic efficacy of Mecasermin can be increased when used in combination with Nalidixic acid.,increase,no risk
Mecasermin,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Mecasermin.,increase,risk
Mecasermin,Nebivolol,The therapeutic efficacy of Mecasermin can be increased when used in combination with Nebivolol.,increase,no risk
Mecasermin,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Mecasermin.,increase,risk
Mecasermin,Nelfinavir,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Nelfinavir.,decrease,no risk
Mecasermin,Niacin,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Niacin.,decrease,no risk
Mecasermin,Nialamide,Nialamide may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Mecasermin.,increase,risk
Mecasermin,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Mecasermin.,increase,risk
Mecasermin,Nilotinib,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Nilotinib.,decrease,no risk
Mecasermin,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Mecasermin.,increase,risk
Mecasermin,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Mecasermin.,increase,risk
Mecasermin,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Mecasermin.,increase,risk
Mecasermin,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Mecasermin.,increase,risk
Mecasermin,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Mecasermin.,increase,risk
Mecasermin,Norethisterone,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Norethisterone.,decrease,no risk
Mecasermin,Norfloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Norfloxacin.,increase,no risk
Mecasermin,Norgestimate,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Norgestimate.,decrease,no risk
Mecasermin,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Mecasermin.,decrease,no risk
Mecasermin,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Mecasermin.,increase,risk
Mecasermin,Octreotide,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Octreotide.,decrease,no risk
Mecasermin,Ofloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Ofloxacin.,increase,no risk
Mecasermin,Olanzapine,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Olanzapine.,decrease,no risk
Mecasermin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Oxprenolol,The therapeutic efficacy of Mecasermin can be increased when used in combination with Oxprenolol.,increase,no risk
Mecasermin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Quetiapine,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Quetiapine.,decrease,no risk
Mecasermin,Quinethazone,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Quinethazone.,decrease,no risk
Mecasermin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Mecasermin.,increase,risk
Mecasermin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Mecasermin.,decrease,no risk
Mecasermin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Mecasermin.,increase,risk
Mecasermin,Udenafil,The therapeutic efficacy of Mecasermin can be increased when used in combination with Udenafil.,increase,no risk
Mecasermin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mecasermin.,increase,risk
Mecasermin,Valdecoxib,The therapeutic efficacy of Mecasermin can be increased when used in combination with Valdecoxib.,increase,no risk
Mecasermin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Mecasermin.,increase,risk
Mecasermin,Vemurafenib,The therapeutic efficacy of Mecasermin can be increased when used in combination with Vemurafenib.,increase,no risk
Mecasermin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mecasermin.,increase,risk
Mecasermin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Mecasermin.,increase,risk
Mecasermin,Vildagliptin,The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Vildagliptin.,increase,risk
Mecasermin,Vorinostat,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Vorinostat.,decrease,no risk
Mecasermin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Mecasermin.,increase,risk
Mecasermin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Mecasermin.,increase,risk
Mecasermin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Mecasermin.,increase,risk
Mecasermin,Ziprasidone,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Mecasermin,Zonisamide,The therapeutic efficacy of Mecasermin can be increased when used in combination with Zonisamide.,increase,no risk
Pramlintide,Gallamine triethiodide,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Gallamine triethiodide.,increase,risk
Pramlintide,Gatifloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Gatifloxacin.,increase,no risk
Pramlintide,Gefapixant,The therapeutic efficacy of Pramlintide can be increased when used in combination with Gefapixant.,increase,no risk
Pramlintide,Gemifloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Gemifloxacin.,increase,no risk
Pramlintide,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Pramlintide.,increase,risk
Pramlintide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Pramlintide.,increase,risk
Pramlintide,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Pramlintide.,increase,risk
Pramlintide,Gliquidone,The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Gliquidone.,increase,risk
Pramlintide,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Pramlintide.,increase,risk
Pramlintide,Glycopyrronium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Glycopyrronium.,increase,risk
Pramlintide,Glymidine,The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Glymidine.,increase,risk
Pramlintide,Goserelin,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Goserelin.,decrease,no risk
Pramlintide,Grepafloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Grepafloxacin.,increase,no risk
Pramlintide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Pramlintide.,increase,risk
Pramlintide,Haloperidol,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Haloperidol.,decrease,no risk
Pramlintide,Hexocyclium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Hexocyclium.,increase,risk
Pramlintide,Histrelin,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Histrelin.,decrease,no risk
Pramlintide,Homatropine methylbromide,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Homatropine methylbromide.,increase,risk
Pramlintide,Hydrochlorothiazide,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Pramlintide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Pramlintide.,increase,risk
Pramlintide,Hydroflumethiazide,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Pramlintide,Hydroxychloroquine,The therapeutic efficacy of Pramlintide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Pramlintide,Hydroxyprogesterone caproate,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Pramlintide,Hyoscyamine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Hyoscyamine.,increase,risk
Pramlintide,Nadolol,The therapeutic efficacy of Pramlintide can be increased when used in combination with Nadolol.,increase,no risk
Pramlintide,Nalidixic acid,The therapeutic efficacy of Pramlintide can be increased when used in combination with Nalidixic acid.,increase,no risk
Pramlintide,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Pramlintide.,increase,risk
Pramlintide,Nebivolol,The therapeutic efficacy of Pramlintide can be increased when used in combination with Nebivolol.,increase,no risk
Pramlintide,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Pramlintide.,increase,risk
Pramlintide,Nelfinavir,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Nelfinavir.,decrease,no risk
Pramlintide,Niacin,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Niacin.,decrease,no risk
Pramlintide,Nialamide,Nialamide may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Nicardipine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Nicardipine.,increase,risk
Pramlintide,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Pramlintide.,increase,risk
Pramlintide,Nilotinib,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Nilotinib.,decrease,no risk
Pramlintide,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Pramlintide.,increase,risk
Pramlintide,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Pramlintide.,increase,risk
Pramlintide,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Pramlintide.,increase,risk
Pramlintide,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Pramlintide.,increase,risk
Pramlintide,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Pramlintide.,increase,risk
Pramlintide,Norethisterone,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Norethisterone.,decrease,no risk
Pramlintide,Norfloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Norfloxacin.,increase,no risk
Pramlintide,Norgestimate,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Norgestimate.,decrease,no risk
Pramlintide,Nortriptyline,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Nortriptyline.,increase,risk
Pramlintide,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Pramlintide.,increase,risk
Pramlintide,Octreotide,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Octreotide.,decrease,no risk
Pramlintide,Ofloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Ofloxacin.,increase,no risk
Pramlintide,Olanzapine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Olanzapine.,increase,risk
Pramlintide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Orphenadrine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Orphenadrine.,increase,risk
Pramlintide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Oxprenolol,The therapeutic efficacy of Pramlintide can be increased when used in combination with Oxprenolol.,increase,no risk
Pramlintide,Oxybutynin,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxybutynin.,increase,risk
Pramlintide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Oxyphencyclimine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxyphencyclimine.,increase,risk
Pramlintide,Oxyphenonium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxyphenonium.,increase,risk
Pramlintide,Quetiapine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Quetiapine.,increase,risk
Pramlintide,Quinethazone,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Quinethazone.,decrease,no risk
Pramlintide,Quinidine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Quinidine.,increase,risk
Pramlintide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Pramlintide.,increase,risk
Pramlintide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Pramlintide.,decrease,no risk
Pramlintide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Pramlintide.,increase,risk
Pramlintide,Udenafil,The therapeutic efficacy of Pramlintide can be increased when used in combination with Udenafil.,increase,no risk
Pramlintide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Pramlintide.,increase,risk
Pramlintide,Umeclidinium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Umeclidinium.,increase,risk
Pramlintide,Valdecoxib,The therapeutic efficacy of Pramlintide can be increased when used in combination with Valdecoxib.,increase,no risk
Pramlintide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Pramlintide.,increase,risk
Pramlintide,Vemurafenib,The therapeutic efficacy of Pramlintide can be increased when used in combination with Vemurafenib.,increase,no risk
Pramlintide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pramlintide.,increase,risk
Pramlintide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Pramlintide.,increase,risk
Pramlintide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Vildagliptin.,increase,risk
Pramlintide,Vorinostat,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Vorinostat.,decrease,no risk
Pramlintide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Pramlintide.,increase,risk
Pramlintide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Pramlintide.,increase,risk
Pramlintide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Pramlintide.,increase,risk
Pramlintide,Ziprasidone,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Ziprasidone.,increase,risk
Pramlintide,Zonisamide,The therapeutic efficacy of Pramlintide can be increased when used in combination with Zonisamide.,increase,no risk
Nelarabine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Nelarabine.,increase,risk
Nelarabine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Nelarabine.,increase,risk
Nelarabine,Glatiramer,The risk or severity of adverse effects can be increased when Nelarabine is combined with Glatiramer.,increase,risk
Nelarabine,Golimumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Golimumab.,increase,risk
Nelarabine,Guselkumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Guselkumab.,increase,risk
Nelarabine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Nelarabine.,increase,risk
Nelarabine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Nelarabine.,increase,risk
Nelarabine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Nelarabine.,increase,risk
Nelarabine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydrocortisone acetate.,increase,risk
Nelarabine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydrocortisone butyrate.,increase,risk
Nelarabine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydrocortisone succinate.,increase,risk
Nelarabine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Nelarabine.,increase,risk
Nelarabine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydroxychloroquine.,increase,risk
Nelarabine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Nelarabine.,increase,risk
Nelarabine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Nelarabine.,increase,risk
Nelarabine,Natalizumab,The risk or severity of immunosuppression can be increased when Nelarabine is combined with Natalizumab.,increase,risk
Nelarabine,Nedaplatin,The risk or severity of adverse effects can be increased when Nelarabine is combined with Nedaplatin.,increase,risk
Nelarabine,Nilotinib,The risk or severity of adverse effects can be increased when Nelarabine is combined with Nilotinib.,increase,risk
Nelarabine,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Nelarabine.,increase,risk
Nelarabine,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Obinutuzumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Obinutuzumab.,increase,risk
Nelarabine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Nelarabine.,increase,no risk
Nelarabine,Ofatumumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Ofatumumab.,increase,risk
Nelarabine,Olaparib,The risk or severity of adverse effects can be increased when Nelarabine is combined with Olaparib.,increase,risk
Nelarabine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Nelarabine.,increase,risk
Nelarabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Oxetacaine.,increase,risk
Nelarabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Oxybuprocaine.,increase,risk
Nelarabine,Ozanimod,The risk or severity of adverse effects can be increased when Nelarabine is combined with Ozanimod.,increase,risk
Nelarabine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Nelarabine.,increase,risk
Nelarabine,Upadacitinib,The risk or severity of adverse effects can be increased when Nelarabine is combined with Upadacitinib.,increase,risk
Nelarabine,Uracil mustard,The risk or severity of adverse effects can be increased when Nelarabine is combined with Uracil mustard.,increase,risk
Nelarabine,Urethane,The risk or severity of adverse effects can be increased when Nelarabine is combined with Urethane.,increase,risk
Nelarabine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Nelarabine.,increase,risk
Nelarabine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Nelarabine.,increase,risk
Nelarabine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Vedolizumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vedolizumab.,increase,risk
Nelarabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Vilanterol,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vilanterol.,increase,risk
Nelarabine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Nelarabine.,increase,risk
Nelarabine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Nelarabine.,increase,risk
Nelarabine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Nelarabine.,increase,risk
Nelarabine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Nelarabine.,increase,risk
Nelarabine,Voclosporin,The risk or severity of adverse effects can be increased when Nelarabine is combined with Voclosporin.,increase,risk
Nelarabine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Nelarabine.,increase,risk
Nelarabine,Vorinostat,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vorinostat.,increase,risk
Nelarabine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Nelarabine.,increase,risk
Nelarabine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Nelarabine.,increase,risk
Nelarabine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Nelarabine.,increase,risk
Nelarabine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Nelarabine.,increase,risk
Abatacept,Bosutinib,The metabolism of Bosutinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brigatinib,The metabolism of Brigatinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brodalumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Brodalumab.,increase,risk
Abatacept,Bromazepam,The metabolism of Bromazepam can be increased when combined with Abatacept.,increase,no risk
Abatacept,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.,increase,risk
Abatacept,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Bupropion,The metabolism of Bupropion can be increased when combined with Abatacept.,increase,no risk
Abatacept,Buspirone,The metabolism of Buspirone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Busulfan,The metabolism of Busulfan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Galantamine,The metabolism of Galantamine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Gefitinib,The metabolism of Gefitinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Abatacept.,increase,risk
Abatacept,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Abatacept.,increase,risk
Abatacept,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glasdegib,The metabolism of Glasdegib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glatiramer,The risk or severity of adverse effects can be increased when Abatacept is combined with Glatiramer.,increase,risk
Abatacept,Gliclazide,The metabolism of Gliclazide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glimepiride,The metabolism of Glimepiride can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glipizide,The metabolism of Glipizide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Gliquidone,The metabolism of Gliquidone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glyburide,The metabolism of Glyburide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Golimumab,The risk or severity of infection can be increased when Golimumab is combined with Abatacept.,increase,risk
Abatacept,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Guanabenz,The metabolism of Guanabenz can be increased when combined with Abatacept.,increase,no risk
Abatacept,Guselkumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Guselkumab.,increase,risk
Abatacept,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Halofantrine,The metabolism of Halofantrine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Haloperidol,The metabolism of Haloperidol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Halothane,The metabolism of Halothane can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Abatacept.,increase,risk
Abatacept,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Abatacept is combined with Hydrocortisone succinate.,increase,risk
Abatacept,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Abatacept.,increase,risk
Abatacept,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Ketamine,The metabolism of Ketamine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ketorolac,The metabolism of Ketorolac can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nabilone,The metabolism of Nabilone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nabumetone,The metabolism of Nabumetone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nadolol,The metabolism of Nadolol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Naproxen,The metabolism of Naproxen can be increased when combined with Abatacept.,increase,no risk
Abatacept,Natalizumab,The risk or severity of immunosuppression can be increased when Abatacept is combined with Natalizumab.,increase,risk
Abatacept,Nateglinide,The metabolism of Nateglinide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nebivolol,The metabolism of Nebivolol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nefazodone,The metabolism of Nefazodone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Abatacept.,increase,risk
Abatacept,Nelfinavir,The metabolism of Nelfinavir can be increased when combined with Abatacept.,increase,no risk
Abatacept,Neratinib,The metabolism of Neratinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Netupitant,The metabolism of Netupitant can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nevirapine,The metabolism of Nevirapine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nicardipine,The metabolism of Nicardipine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nicergoline,The metabolism of Nicergoline can be increased when combined with Abatacept.,increase,no risk
Abatacept,Niclosamide,The metabolism of Niclosamide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nicotine,The metabolism of Nicotine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nifedipine,The metabolism of Nifedipine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nilotinib,The metabolism of Nilotinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nilutamide,The metabolism of Nilutamide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nilvadipine,The metabolism of Nilvadipine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nintedanib,The metabolism of Nintedanib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nirogacestat,The metabolism of Nirogacestat can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nisoldipine,The metabolism of Nisoldipine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nitrendipine,The metabolism of Nitrendipine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Norethisterone,The metabolism of Norethisterone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Norgestimate,The metabolism of Norgestimate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Abatacept.,increase,no risk
Abatacept,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Obinutuzumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Obinutuzumab.,increase,risk
Abatacept,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Abatacept.,increase,no risk
Abatacept,Ofatumumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Ofatumumab.,increase,risk
Abatacept,Olanzapine,The metabolism of Olanzapine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Olaparib,The metabolism of Olaparib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oliceridine,The metabolism of Oliceridine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Olodaterol,The metabolism of Olodaterol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Abatacept.,increase,no risk
Abatacept,Omeprazole,The metabolism of Omeprazole can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ondansetron,The metabolism of Ondansetron can be increased when combined with Abatacept.,increase,no risk
Abatacept,Opium,The metabolism of Opium can be increased when combined with Abatacept.,increase,no risk
Abatacept,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Abatacept.,increase,no risk
Abatacept,Osimertinib,The metabolism of Osimertinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ospemifene,The metabolism of Ospemifene can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Abatacept.,increase,risk
Abatacept,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxycodone,The metabolism of Oxycodone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ozanimod,The risk or severity of adverse effects can be increased when Abatacept is combined with Ozanimod.,increase,risk
Abatacept,Quetiapine,The metabolism of Quetiapine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Quinidine,The metabolism of Quinidine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Quinine,The metabolism of Quinine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Quizartinib,The metabolism of Quizartinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Abatacept.,increase,risk
Abatacept,Udenafil,The metabolism of Udenafil can be increased when combined with Abatacept.,increase,no risk
Abatacept,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Abatacept.,increase,no risk
Abatacept,Upadacitinib,The risk or severity of adverse effects can be increased when Abatacept is combined with Upadacitinib.,increase,risk
Abatacept,Valbenazine,The metabolism of Valbenazine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Valproic acid,The metabolism of Valproic acid can be increased when combined with Abatacept.,increase,no risk
Abatacept,Valsartan,The metabolism of Valsartan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vandetanib,The metabolism of Vandetanib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vardenafil,The metabolism of Vardenafil can be increased when combined with Abatacept.,increase,no risk
Abatacept,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Abatacept.,increase,risk
Abatacept,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Vedolizumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Vedolizumab.,increase,risk
Abatacept,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Venetoclax,The metabolism of Venetoclax can be increased when combined with Abatacept.,increase,no risk
Abatacept,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Verapamil,The metabolism of Verapamil can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vernakalant,The metabolism of Vernakalant can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Vilanterol,The risk or severity of adverse effects can be increased when Abatacept is combined with Vilanterol.,increase,risk
Abatacept,Vilazodone,The metabolism of Vilazodone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vinblastine,The metabolism of Vinblastine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vincristine,The metabolism of Vincristine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vindesine,The metabolism of Vindesine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vinflunine,The metabolism of Vinflunine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voclosporin,The risk or severity of adverse effects can be increased when Abatacept is combined with Voclosporin.,increase,risk
Abatacept,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voriconazole,The metabolism of Voriconazole can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vorinostat,The risk or severity of adverse effects can be increased when Abatacept is combined with Vorinostat.,increase,risk
Abatacept,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voxelotor,The metabolism of Voxelotor can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Abatacept.,increase,no risk
Abatacept,Warfarin,The metabolism of Warfarin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Abatacept.,increase,no risk
Abatacept,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Abatacept.,increase,risk
Abatacept,Yohimbine,The metabolism of Yohimbine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zaleplon,The metabolism of Zaleplon can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zidovudine,The metabolism of Zidovudine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zileuton,The metabolism of Zileuton can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zolpidem,The metabolism of Zolpidem can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zonisamide,The metabolism of Zonisamide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zopiclone,The metabolism of Zopiclone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zotepine,The metabolism of Zotepine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Abatacept.,increase,no risk
Carbetocin,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Carbetocin.,increase,risk
Carbetocin,Nadolol,The risk or severity of adverse effects can be increased when Nadolol is combined with Carbetocin.,increase,risk
Carbetocin,Nebivolol,The risk or severity of adverse effects can be increased when Carbetocin is combined with Nebivolol.,increase,risk
Carbetocin,Nesiritide,The risk or severity of adverse effects can be increased when Carbetocin is combined with Nesiritide.,increase,risk
Carbetocin,Nialamide,Nialamide may increase the orthostatic hypotensive activities of Carbetocin.,increase,no risk
Carbetocin,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Carbetocin.,increase,risk
Carbetocin,Nicorandil,Nicorandil may increase the hypotensive activities of Carbetocin.,increase,no risk
Carbetocin,Nifedipine,The risk or severity of adverse effects can be increased when Nifedipine is combined with Carbetocin.,increase,risk
Carbetocin,Nilvadipine,The risk or severity of adverse effects can be increased when Carbetocin is combined with Nilvadipine.,increase,risk
Carbetocin,Nimodipine,The risk or severity of adverse effects can be increased when Nimodipine is combined with Carbetocin.,increase,risk
Carbetocin,Nisoldipine,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Carbetocin.,increase,risk
Carbetocin,Nitrendipine,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Carbetocin.,increase,risk
Carbetocin,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Carbetocin.,increase,risk
Carbetocin,Nitroglycerin,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Carbetocin.,increase,risk
Carbetocin,Nitroprusside,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Carbetocin.,increase,risk
Carbetocin,Nitrous acid,The risk or severity of adverse effects can be increased when Carbetocin is combined with Nitrous acid.,increase,risk
Carbetocin,Obinutuzumab,The risk or severity of adverse effects can be increased when Carbetocin is combined with Obinutuzumab.,increase,risk
Carbetocin,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Carbetocin.,increase,risk
Carbetocin,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Carbetocin.,increase,risk
Carbetocin,Opicapone,The risk or severity of adverse effects can be increased when Carbetocin is combined with Opicapone.,increase,risk
Carbetocin,Oxprenolol,The risk or severity of adverse effects can be increased when Carbetocin is combined with Oxprenolol.,increase,risk
Carbetocin,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Carbetocin.,increase,risk
Carbetocin,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Carbetocin.,increase,risk
Carbetocin,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Carbetocin.,increase,risk
Carbetocin,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Carbetocin.,increase,risk
Carbetocin,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Carbetocin.,increase,risk
Carbetocin,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Carbetocin.,increase,risk
Carbetocin,Vericiguat,The risk or severity of adverse effects can be increased when Carbetocin is combined with Vericiguat.,increase,risk
Carbetocin,Zofenopril,Carbetocin may increase the hypotensive activities of Zofenopril.,increase,no risk
Lumiracoxib,Bendazac,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Bendazac.,increase,risk
Lumiracoxib,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Benorilate,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Benorilate.,increase,risk
Lumiracoxib,Benoxaprofen,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Benoxaprofen.,increase,risk
Lumiracoxib,Benserazide,Lumiracoxib may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Benzatropine,Lumiracoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Benznidazole,Lumiracoxib may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Benzydamine,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Benzydamine.,increase,risk
Lumiracoxib,Bepotastine,Lumiracoxib may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Betaxolol,Lumiracoxib may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Lumiracoxib,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Betulinic Acid,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Betulinic Acid.,increase,risk
Lumiracoxib,Bexarotene,The metabolism of Lumiracoxib can be decreased when combined with Bexarotene.,decrease,no risk
Lumiracoxib,Bicisate,Lumiracoxib may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Bimekizumab,The metabolism of Lumiracoxib can be increased when combined with Bimekizumab.,increase,no risk
Lumiracoxib,Bismuth subgallate,Lumiracoxib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bisoprolol,Lumiracoxib may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Lumiracoxib,Bisoxatin,Lumiracoxib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Bivalirudin.,increase,risk
Lumiracoxib,Bleomycin,Lumiracoxib may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bortezomib,The metabolism of Lumiracoxib can be decreased when combined with Bortezomib.,decrease,no risk
Lumiracoxib,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Brexpiprazole,The risk or severity of hypertension can be increased when Lumiracoxib is combined with Brexpiprazole.,increase,risk
Lumiracoxib,Brivaracetam,Lumiracoxib may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bromazepam,Lumiracoxib may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Bufexamac,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Bufexamac.,increase,risk
Lumiracoxib,Bumadizone,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Bumadizone.,increase,risk
Lumiracoxib,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Buprenorphine,The metabolism of Lumiracoxib can be decreased when combined with Buprenorphine.,decrease,no risk
Lumiracoxib,Bupropion,Lumiracoxib may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Butabarbital,Lumiracoxib may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Gabapentin enacarbil,The therapeutic efficacy of Furosemide can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Gadobenic acid,Lumiracoxib may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadodiamide,Lumiracoxib may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadofosveset trisodium,Lumiracoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadopentetic acid,Lumiracoxib may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadoteric acid,Lumiracoxib may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadoteridol,Lumiracoxib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Ganciclovir,Lumiracoxib may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gatifloxacin,Lumiracoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gemcitabine,Lumiracoxib may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Lumiracoxib,Gemfibrozil,Lumiracoxib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gemifloxacin,The metabolism of Lumiracoxib can be decreased when combined with Gemfibrozil.,decrease,no risk
Lumiracoxib,Gentamicin,Lumiracoxib may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Lumiracoxib,Gimeracil,Lumiracoxib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Ginkgo biloba,Lumiracoxib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Givosiran,The metabolism of Lumiracoxib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Lumiracoxib,Gliclazide,The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Givosiran.,increase,risk
Lumiracoxib,Glimepiride,The protein binding of Gliclazide can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glipizide,The protein binding of Glimepiride can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Gliquidone,The protein binding of Glipizide can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glofitamab,The protein binding of Gliquidone can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glyburide,The serum concentration of Lumiracoxib can be increased when it is combined with Glofitamab.,increase,no risk
Lumiracoxib,Glycerol phenylbutyrate,The protein binding of Glyburide can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glycol salicylate,Lumiracoxib may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Golimumab,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Glycol salicylate.,increase,risk
Lumiracoxib,Golodirsen,The metabolism of Lumiracoxib can be increased when combined with Golimumab.,increase,no risk
Lumiracoxib,Goserelin,Lumiracoxib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tetracosactide,Brexanolone,The risk or severity of liver damage can be increased when Tetracosactide is combined with Brexanolone.,increase,risk
Tetracosactide,Brivaracetam,The risk or severity of liver damage can be increased when Tetracosactide is combined with Brivaracetam.,increase,risk
Tetracosactide,Butalbital,The risk or severity of liver damage can be increased when Tetracosactide is combined with Butalbital.,increase,risk
Tetracosactide,Gabapentin,The risk or severity of liver damage can be increased when Tetracosactide is combined with Gabapentin.,increase,risk
Tetracosactide,Ganaxolone,The risk or severity of liver damage can be increased when Tetracosactide is combined with Ganaxolone.,increase,risk
Tetracosactide,Nitrazepam,The serum concentration of Nitrazepam can be increased when it is combined with Tetracosactide.,increase,no risk
Tetracosactide,Oxcarbazepine,The risk or severity of liver damage can be increased when Tetracosactide is combined with Oxcarbazepine.,increase,risk
Tetracosactide,Valproic acid,Tetracosactide may increase the hepatotoxic activities of Valproic acid.,increase,no risk
Tetracosactide,Vigabatrin,The risk or severity of liver damage can be increased when Tetracosactide is combined with Vigabatrin.,increase,risk
Tetracosactide,Zaleplon,The risk or severity of liver damage can be increased when Tetracosactide is combined with Zaleplon.,increase,risk
Tetracosactide,Zonisamide,The risk or severity of liver damage can be increased when Tetracosactide is combined with Zonisamide.,increase,risk
Corticotropin,Bromocriptine,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Bromocriptine.,increase,risk
Corticotropin,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Corticotropin.,increase,risk
Corticotropin,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Bumadizone.,increase,risk
Corticotropin,Bumetanide,The risk or severity of hypokalemia can be increased when Corticotropin is combined with Bumetanide.,increase,risk
Corticotropin,Busulfan,The metabolism of Busulfan can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Gatifloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Gatifloxacin.,increase,risk
Corticotropin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Corticotropin.,increase,risk
Corticotropin,Gemifloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Gemifloxacin.,increase,risk
Corticotropin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Corticotropin.,increase,risk
Corticotropin,Gestrinone,The serum concentration of Corticotropin can be increased when it is combined with Gestrinone.,increase,no risk
Corticotropin,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Glatiramer,The risk or severity of adverse effects can be increased when Corticotropin is combined with Glatiramer.,increase,risk
Corticotropin,Gliclazide,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Gliclazide.,increase,risk
Corticotropin,Glimepiride,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glimepiride.,increase,risk
Corticotropin,Glipizide,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glipizide.,increase,risk
Corticotropin,Gliquidone,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Gliquidone.,increase,risk
Corticotropin,Glofitamab,The serum concentration of Corticotropin can be increased when it is combined with Glofitamab.,increase,no risk
Corticotropin,Glyburide,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glyburide.,increase,risk
Corticotropin,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Glycol salicylate.,increase,risk
Corticotropin,Glymidine,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glymidine.,increase,risk
Corticotropin,Golimumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Golimumab.,increase,risk
Corticotropin,Grepafloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Grepafloxacin.,increase,risk
Corticotropin,Guselkumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Guselkumab.,increase,risk
Corticotropin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Corticotropin.,increase,no risk
Corticotropin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Corticotropin is combined with Hydrochlorothiazide.,increase,risk
Corticotropin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydrocortisone acetate.,increase,risk
Corticotropin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydrocortisone butyrate.,increase,risk
Corticotropin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydrocortisone succinate.,increase,risk
Corticotropin,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Corticotropin is combined with Hydroflumethiazide.,increase,risk
Corticotropin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydroxychloroquine.,increase,risk
Corticotropin,Hydroxyprogesterone caproate,The serum concentration of Corticotropin can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Corticotropin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Corticotropin.,increase,risk
Corticotropin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Ketoconazole,The metabolism of Corticotropin can be decreased when combined with Ketoconazole.,decrease,no risk
Corticotropin,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Ketoprofen.,increase,risk
Corticotropin,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Ketorolac.,increase,risk
Corticotropin,Nabumetone,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Nabumetone.,increase,risk
Corticotropin,Nalidixic acid,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Nalidixic acid.,increase,risk
Corticotropin,Nandrolone decanoate,The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Corticotropin.,increase,risk
Corticotropin,Nandrolone phenpropionate,The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Corticotropin.,increase,risk
Corticotropin,Naproxen,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Naproxen.,increase,risk
Corticotropin,Natalizumab,The risk or severity of immunosuppression can be increased when Corticotropin is combined with Natalizumab.,increase,risk
Corticotropin,Nateglinide,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Nateglinide.,increase,risk
Corticotropin,Nefazodone,The metabolism of Corticotropin can be decreased when combined with Nefazodone.,decrease,no risk
Corticotropin,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Corticotropin.,increase,risk
Corticotropin,Nelfinavir,The metabolism of Corticotropin can be decreased when combined with Nelfinavir.,decrease,no risk
Corticotropin,Neostigmine,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Neratinib,The metabolism of Neratinib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Netupitant,The metabolism of Corticotropin can be decreased when combined with Netupitant.,decrease,no risk
Corticotropin,Nicardipine,The metabolism of Corticotropin can be decreased when combined with Nicardipine.,decrease,no risk
Corticotropin,Nicorandil,The risk or severity of ulceration can be increased when Corticotropin is combined with Nicorandil.,increase,risk
Corticotropin,Nilotinib,The metabolism of Corticotropin can be decreased when combined with Nilotinib.,decrease,no risk
Corticotropin,Nilvadipine,The metabolism of Corticotropin can be decreased when combined with Nilvadipine.,decrease,no risk
Corticotropin,Nimesulide,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Nimesulide.,increase,risk
Corticotropin,Nintedanib,The metabolism of Nintedanib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Nizatidine,The therapeutic efficacy of Nizatidine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Nomegestrol,The serum concentration of Corticotropin can be increased when it is combined with Nomegestrol.,increase,no risk
Corticotropin,Nomegestrol acetate,The serum concentration of Corticotropin can be increased when it is combined with Nomegestrol acetate.,increase,no risk
Corticotropin,Norelgestromin,The serum concentration of Corticotropin can be increased when it is combined with Norelgestromin.,increase,no risk
Corticotropin,Norepinephrine,The risk or severity of hypokalemia can be increased when Corticotropin is combined with Norepinephrine.,increase,risk
Corticotropin,Norethisterone,The serum concentration of Corticotropin can be increased when it is combined with Norethisterone.,increase,no risk
Corticotropin,Norethynodrel,The serum concentration of Corticotropin can be increased when it is combined with Norethynodrel.,increase,no risk
Corticotropin,Norfloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Norfloxacin.,increase,risk
Corticotropin,Norgestimate,The serum concentration of Corticotropin can be increased when it is combined with Norgestimate.,increase,no risk
Corticotropin,Norgestrel,The serum concentration of Corticotropin can be increased when it is combined with Norgestrel.,increase,no risk
Corticotropin,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Obinutuzumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Obinutuzumab.,increase,risk
Corticotropin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Corticotropin.,increase,no risk
Corticotropin,Ofatumumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Ofatumumab.,increase,risk
Corticotropin,Ofloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Ofloxacin.,increase,risk
Corticotropin,Olaparib,The metabolism of Olaparib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Corticotropin.,decrease,no risk
Corticotropin,Olodaterol,The risk or severity of hypokalemia can be increased when Corticotropin is combined with Olodaterol.,increase,risk
Corticotropin,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Corticotropin.,decrease,no risk
Corticotropin,Omaveloxolone,The serum concentration of Corticotropin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Corticotropin,Orciprenaline,The risk or severity of hypokalemia can be increased when Corticotropin is combined with Orciprenaline.,increase,risk
Corticotropin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Corticotropin.,increase,risk
Corticotropin,Oxandrolone,The risk or severity of fluid retention can be increased when Corticotropin is combined with Oxandrolone.,increase,risk
Corticotropin,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Oxaprozin.,increase,risk
Corticotropin,Oxymetholone,The risk or severity of fluid retention can be increased when Corticotropin is combined with Oxymetholone.,increase,risk
Corticotropin,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Oxyphenbutazone.,increase,risk
Corticotropin,Ozanimod,The risk or severity of adverse effects can be increased when Corticotropin is combined with Ozanimod.,increase,risk
Corticotropin,Quinestrol,The serum concentration of Corticotropin can be increased when it is combined with Quinestrol.,increase,no risk
Corticotropin,Quinethazone,Corticotropin may increase the hypokalemic activities of Quinethazone.,increase,no risk
Corticotropin,Quinidine,The metabolism of Quinidine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Quinine,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Quinine.,increase,risk
Corticotropin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Corticotropin.,increase,risk
Corticotropin,Ulipristal,The serum concentration of Corticotropin can be increased when it is combined with Ulipristal.,increase,no risk
Corticotropin,Upadacitinib,The risk or severity of adverse effects can be increased when Corticotropin is combined with Upadacitinib.,increase,risk
Corticotropin,Vadadustat,The serum concentration of Corticotropin can be increased when it is combined with Vadadustat.,increase,no risk
Corticotropin,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Valdecoxib.,increase,risk
Corticotropin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Corticotropin.,increase,risk
Corticotropin,Vedolizumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Vedolizumab.,increase,risk
Corticotropin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Verapamil,The metabolism of Corticotropin can be decreased when combined with Verapamil.,decrease,no risk
Corticotropin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Vilanterol,The risk or severity of adverse effects can be increased when Corticotropin is combined with Vilanterol.,increase,risk
Corticotropin,Vildagliptin,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Vildagliptin.,increase,risk
Corticotropin,Viloxazine,The metabolism of Corticotropin can be decreased when combined with Viloxazine.,decrease,no risk
Corticotropin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vincristine,The metabolism of Vincristine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vindesine,The metabolism of Vindesine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Voclosporin,The risk or severity of adverse effects can be increased when Corticotropin is combined with Voclosporin.,increase,risk
Corticotropin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Voriconazole,The serum concentration of Corticotropin can be increased when it is combined with Voriconazole.,increase,no risk
Corticotropin,Vorinostat,The risk or severity of adverse effects can be increased when Corticotropin is combined with Vorinostat.,increase,risk
Corticotropin,Warfarin,Corticotropin may increase the anticoagulant activities of Warfarin.,increase,no risk
Corticotropin,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Corticotropin.,increase,risk
Corticotropin,Zimelidine,The metabolism of Corticotropin can be decreased when combined with Zimelidine.,decrease,no risk
Corticotropin,Ziprasidone,The metabolism of Corticotropin can be decreased when combined with Ziprasidone.,decrease,no risk
Corticotropin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Corticotropin.,decrease,no risk
Fenoterol,Galantamine,The risk or severity of hypokalemia can be increased when Fenoterol is combined with Furosemide.,increase,risk
Fenoterol,Gallamine triethiodide,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Galantamine.,decrease,no risk
Fenoterol,Ginkgo biloba,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Fenoterol.,increase,risk
Fenoterol,Glyburide,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Fenoterol,Glycerin,The therapeutic efficacy of Glyburide can be decreased when used in combination with Fenoterol.,decrease,no risk
Fenoterol,Glycopyrronium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Fenoterol.,decrease,no risk
Fenoterol,Guanabenz,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Fenoterol.,increase,risk
Fenoterol,Guanadrel,Fenoterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Fenoterol,Guanethidine,Fenoterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Fenoterol,Guanfacine,Fenoterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Fenoterol,Guanoxan,Fenoterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Fenoterol,Halothane,Fenoterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Fenoterol,Hexafluronium,The risk or severity of hypertension can be increased when Halothane is combined with Fenoterol.,increase,risk
Fenoterol,Hexocyclium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Fenoterol.,increase,risk
Fenoterol,Homatropine,The risk or severity of adverse effects can be increased when Fenoterol is combined with Hexocyclium.,increase,risk
Fenoterol,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Fenoterol is combined with Homatropine.,increase,risk
Fenoterol,Huperzine A,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Fenoterol.,increase,risk
Fenoterol,Hydralazine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Huperzine A.,decrease,no risk
Fenoterol,Hydrochlorothiazide,Fenoterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Fenoterol,Hydrocodone,The risk or severity of hypokalemia can be increased when Fenoterol is combined with Hydrochlorothiazide.,increase,risk
Fenoterol,Hydrocortisone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Hydrocodone.,increase,risk
Fenoterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Fenoterol.,increase,risk
Fenoterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Fenoterol.,increase,risk
Fenoterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Fenoterol.,increase,risk
Fenoterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Fenoterol.,increase,risk
Fenoterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Fenoterol.,increase,risk
Fenoterol,Hydromorphone,The risk or severity of hypokalemia can be increased when Fenoterol is combined with Hydroflumethiazide.,increase,risk
Fenoterol,Hyoscyamine,The risk or severity of adverse effects can be increased when Fenoterol is combined with Hydromorphone.,increase,risk
Fenoterol,Ketamine,Fenoterol may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Fenoterol,Ketoprofen,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Ketamine.,decrease,no risk
Fenoterol,Ketorolac,The risk or severity of hypertension can be increased when Ketoprofen is combined with Fenoterol.,increase,risk
Fenoterol,Nabilone,Fenoterol may decrease the antihypertensive activities of Muzolimine.,decrease,no risk
Fenoterol,Nabumetone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Fenoterol.,increase,risk
Fenoterol,Nadolol,The risk or severity of hypertension can be increased when Nabumetone is combined with Fenoterol.,increase,risk
Fenoterol,Nalbuphine,Nadolol may decrease the bronchodilatory activities of Fenoterol.,decrease,no risk
Fenoterol,Naloxegol,The risk or severity of adverse effects can be increased when Fenoterol is combined with Nalbuphine.,increase,risk
Fenoterol,Naltrexone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Naloxegol.,increase,risk
Fenoterol,Naphazoline,The risk or severity of adverse effects can be increased when Fenoterol is combined with Naltrexone.,increase,risk
Fenoterol,Naproxen,The risk or severity of hypertension can be increased when Fenoterol is combined with Naphazoline.,increase,risk
Fenoterol,Naratriptan,The risk or severity of hypertension can be increased when Naproxen is combined with Fenoterol.,increase,risk
Fenoterol,Naxitamab,The risk or severity of hypertension can be increased when Naratriptan is combined with Fenoterol.,increase,risk
Fenoterol,Nebivolol,The risk or severity of hypertension can be increased when Fenoterol is combined with Naxitamab.,increase,risk
Fenoterol,Nefazodone,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Fenoterol,Neostigmine,Nefazodone may increase the tachycardic activities of Fenoterol.,increase,no risk
Fenoterol,Nialamide,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Neostigmine.,decrease,no risk
Fenoterol,Nicardipine,The risk or severity of hypertension can be increased when Fenoterol is combined with Nialamide.,increase,risk
Fenoterol,Nicergoline,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Nicardipine.,decrease,no risk
Fenoterol,Nicorandil,Nicergoline may increase the hypertensive and vasoconstricting activities of Fenoterol.,increase,no risk
Fenoterol,Nicotine,Fenoterol may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Fenoterol,Nilvadipine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Fenoterol.,increase,risk
Fenoterol,Nimesulide,Fenoterol may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Fenoterol,Nimodipine,The risk or severity of hypertension can be increased when Fenoterol is combined with Nimesulide.,increase,risk
Fenoterol,Nisoldipine,Fenoterol may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Fenoterol,Nitrendipine,Fenoterol may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Fenoterol,Nitroglycerin,Fenoterol may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Fenoterol,Nitroprusside,Fenoterol may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Fenoterol,Nitrous oxide,Fenoterol may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Fenoterol,Nizatidine,The risk or severity of hypertension can be increased when Fenoterol is combined with Nitrous oxide.,increase,risk
Fenoterol,Norepinephrine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Nizatidine.,decrease,no risk
Fenoterol,Normethadone,The therapeutic efficacy of Fenoterol can be increased when used in combination with Norepinephrine.,increase,no risk
Fenoterol,Nortriptyline,The risk or severity of adverse effects can be increased when Fenoterol is combined with Normethadone.,increase,risk
Fenoterol,Nylidrin,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Nortriptyline.,decrease,no risk
Fenoterol,Olanzapine,The risk or severity of hypertension can be increased when Fenoterol is combined with Nylidrin.,increase,risk
Fenoterol,Oliceridine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Fenoterol,Olmesartan,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Fenoterol is combined with Oliceridine.",increase,risk
Fenoterol,Olodaterol,Fenoterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Fenoterol,Opium,The risk or severity of adverse effects can be increased when Fenoterol is combined with Olodaterol.,increase,risk
Fenoterol,Orciprenaline,The risk or severity of adverse effects can be increased when Fenoterol is combined with Opium.,increase,risk
Fenoterol,Orphenadrine,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Fenoterol.,increase,risk
Fenoterol,Oxaprozin,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Fenoterol.,increase,risk
Fenoterol,Oxprenolol,The risk or severity of hypertension can be increased when Oxaprozin is combined with Fenoterol.,increase,risk
Fenoterol,Oxtriphylline,Oxprenolol may decrease the bronchodilatory activities of Fenoterol.,decrease,no risk
Fenoterol,Oxybutynin,The risk or severity of adverse effects can be increased when Fenoterol is combined with Oxtriphylline.,increase,risk
Fenoterol,Oxycodone,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Fenoterol.,increase,risk
Fenoterol,Oxymetazoline,The risk or severity of adverse effects can be increased when Fenoterol is combined with Oxycodone.,increase,risk
Fenoterol,Oxymorphone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Fenoterol.,increase,risk
Fenoterol,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Oxymorphone.,increase,risk
Fenoterol,Oxyphencyclimine,The risk or severity of hypertension can be increased when Fenoterol is combined with Oxyphenbutazone.,increase,risk
Fenoterol,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Fenoterol.,increase,risk
Fenoterol,Oxyphenonium,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Fenoterol.,decrease,no risk
Fenoterol,Quetiapine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Pyridostigmine.,decrease,no risk
Fenoterol,Quinapril,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Fenoterol,Quinethazone,Fenoterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Fenoterol,Quinidine,The serum concentration of Quinethazone can be increased when it is combined with Fenoterol.,increase,no risk
Fenoterol,Quinupramine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Quinidine.,decrease,no risk
Fenoterol,Umeclidinium,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Tyrothricin.,decrease,no risk
Fenoterol,Valdecoxib,The risk or severity of adverse effects can be increased when Fenoterol is combined with Umeclidinium.,increase,risk
Fenoterol,Valsartan,The risk or severity of hypertension can be increased when Valdecoxib is combined with Fenoterol.,increase,risk
Fenoterol,Vamorolone,Fenoterol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Fenoterol,Vecuronium,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Fenoterol.,increase,risk
Fenoterol,Venlafaxine,The risk or severity of adverse effects can be increased when Fenoterol is combined with Vecuronium.,increase,risk
Fenoterol,Verapamil,Venlafaxine may increase the tachycardic activities of Fenoterol.,increase,no risk
Fenoterol,Vilanterol,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Verapamil.,decrease,no risk
Fenoterol,Vilazodone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Vilanterol.,increase,risk
Fenoterol,Vortioxetine,The risk or severity of hypertension can be increased when Fenoterol is combined with Vilazodone.,increase,risk
Fenoterol,Xamoterol,The risk or severity of hypertension can be increased when Fenoterol is combined with Vortioxetine.,increase,risk
Fenoterol,Xylometazoline,The risk or severity of hypertension can be increased when Fenoterol is combined with Xamoterol.,increase,risk
Fenoterol,Yohimbine,The risk or severity of hypertension can be increased when Fenoterol is combined with Xylometazoline.,increase,risk
Fenoterol,Ziprasidone,The risk or severity of hypertension can be increased when Fenoterol is combined with Yohimbine.,increase,risk
Fenoterol,Zofenopril,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Fenoterol,Zolmitriptan,Fenoterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Fenoterol,Zuclopenthixol,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenoterol.,increase,risk
Glisoxepide,Gatifloxacin,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Furosemide.,decrease,no risk
Glisoxepide,Gefapixant,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gatifloxacin.,increase,no risk
Glisoxepide,Gemfibrozil,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gefapixant.,increase,no risk
Glisoxepide,Gemifloxacin,The metabolism of Glisoxepide can be decreased when combined with Gemfibrozil.,decrease,no risk
Glisoxepide,Gestrinone,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gemifloxacin.,increase,no risk
Glisoxepide,Ginkgo biloba,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Gestrinone.,decrease,no risk
Glisoxepide,Gliclazide,The metabolism of Glisoxepide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Glisoxepide,Glimepiride,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Glisoxepide.,increase,risk
Glisoxepide,Glipizide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Glisoxepide.,increase,risk
Glisoxepide,Gliquidone,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Glisoxepide.,increase,risk
Glisoxepide,Glofitamab,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Glisoxepide.,increase,risk
Glisoxepide,Glyburide,The serum concentration of Glisoxepide can be increased when it is combined with Glofitamab.,increase,no risk
Glisoxepide,Glycol salicylate,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Glisoxepide.,increase,risk
Glisoxepide,Glymidine,The protein binding of Glisoxepide can be decreased when combined with Glycol salicylate.,decrease,no risk
Glisoxepide,Golimumab,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Glymidine.,increase,no risk
Glisoxepide,Goserelin,The metabolism of Glisoxepide can be increased when combined with Golimumab.,increase,no risk
Glisoxepide,Grepafloxacin,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Goserelin.,decrease,no risk
Glisoxepide,Halcinonide,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Grepafloxacin.,increase,no risk
Glisoxepide,Haloperidol,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Glisoxepide.,increase,risk
Glisoxepide,Halothane,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Haloperidol.,decrease,no risk
Glisoxepide,Histrelin,The metabolism of Glisoxepide can be decreased when combined with Halothane.,decrease,no risk
Glisoxepide,Hydrochlorothiazide,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Histrelin.,decrease,no risk
Glisoxepide,Hydrocortisone,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Glisoxepide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydromorphone,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Glisoxepide,Hydroxychloroquine,The metabolism of Glisoxepide can be decreased when combined with Hydromorphone.,decrease,no risk
Glisoxepide,Hydroxyprogesterone caproate,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Glisoxepide,Ketamine,The metabolism of Glisoxepide can be increased when combined with Ivosidenib.,increase,no risk
Glisoxepide,Ketoprofen,The metabolism of Glisoxepide can be decreased when combined with Ketamine.,decrease,no risk
Glisoxepide,Ketorolac,The protein binding of Glisoxepide can be decreased when combined with Ketoprofen.,decrease,no risk
Glisoxepide,Ketotifen,The protein binding of Glisoxepide can be decreased when combined with Ketorolac.,decrease,no risk
Glisoxepide,Nabilone,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Moxifloxacin.,increase,no risk
Glisoxepide,Nabumetone,The metabolism of Glisoxepide can be decreased when combined with Nabilone.,decrease,no risk
Glisoxepide,Nadolol,The protein binding of Glisoxepide can be decreased when combined with Nabumetone.,decrease,no risk
Glisoxepide,Nalidixic acid,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Nadolol.,increase,no risk
Glisoxepide,Nandrolone decanoate,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Nalidixic acid.,increase,no risk
Glisoxepide,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Glisoxepide.,increase,no risk
Glisoxepide,Naproxen,Nandrolone phenpropionate may increase the hypoglycemic activities of Glisoxepide.,increase,no risk
Glisoxepide,Nateglinide,The protein binding of Glisoxepide can be decreased when combined with Naproxen.,decrease,no risk
Glisoxepide,Nebivolol,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Glisoxepide.,increase,risk
Glisoxepide,Nefazodone,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Nebivolol.,increase,no risk
Glisoxepide,Nelfinavir,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Glisoxepide.,increase,risk
Glisoxepide,Netupitant,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Nelfinavir.,decrease,no risk
Glisoxepide,Nevirapine,The metabolism of Netupitant can be decreased when combined with Glisoxepide.,decrease,no risk
Glisoxepide,Niacin,The metabolism of Glisoxepide can be decreased when combined with Nevirapine.,decrease,no risk
Glisoxepide,Nialamide,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Niacin.,decrease,no risk
Glisoxepide,Nicardipine,Nialamide may increase the hypoglycemic activities of Glisoxepide.,increase,no risk
Glisoxepide,Niclosamide,The metabolism of Glisoxepide can be decreased when combined with Nicardipine.,decrease,no risk
Glisoxepide,Nifedipine,The metabolism of Niclosamide can be decreased when combined with Glisoxepide.,decrease,no risk
Glisoxepide,Nilotinib,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Glisoxepide.,increase,risk
Glisoxepide,Nilutamide,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Nilotinib.,decrease,no risk
Glisoxepide,Nilvadipine,The metabolism of Glisoxepide can be decreased when combined with Nilutamide.,decrease,no risk
Glisoxepide,Nimesulide,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Glisoxepide.,increase,risk
Glisoxepide,Nimodipine,The protein binding of Glisoxepide can be decreased when combined with Nimesulide.,decrease,no risk
Glisoxepide,Nirogacestat,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Glisoxepide.,increase,risk
Glisoxepide,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Glisoxepide.,decrease,no risk
Glisoxepide,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Glisoxepide.,increase,risk
Glisoxepide,Nomegestrol,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Glisoxepide.,increase,risk
Glisoxepide,Nomegestrol acetate,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Nomegestrol.,decrease,no risk
Glisoxepide,Nonoxynol-9,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Nomegestrol acetate.,decrease,no risk
Glisoxepide,Norelgestromin,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Glisoxepide,Norethisterone,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Norelgestromin.,decrease,no risk
Glisoxepide,Norethynodrel,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Norethisterone.,decrease,no risk
Glisoxepide,Norfloxacin,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Norethynodrel.,decrease,no risk
Glisoxepide,Norgestimate,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Norfloxacin.,increase,no risk
Glisoxepide,Norgestrel,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Norgestimate.,decrease,no risk
Glisoxepide,Nortriptyline,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Norgestrel.,decrease,no risk
Glisoxepide,Noscapine,Nortriptyline may decrease the hypoglycemic activities of Glisoxepide.,decrease,no risk
Glisoxepide,Novobiocin,The metabolism of Glisoxepide can be decreased when combined with Noscapine.,decrease,no risk
Glisoxepide,Nylidrin,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Novobiocin.,increase,no risk
Glisoxepide,Octreotide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glisoxepide.,increase,risk
Glisoxepide,Ofloxacin,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Octreotide.,decrease,no risk
Glisoxepide,Olanzapine,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Ofloxacin.,increase,no risk
Glisoxepide,Olodaterol,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Olanzapine.,decrease,no risk
Glisoxepide,Olsalazine,The metabolism of Olodaterol can be decreased when combined with Glisoxepide.,decrease,no risk
Glisoxepide,Ondansetron,Olsalazine may increase the hypoglycemic activities of Glisoxepide.,increase,no risk
Glisoxepide,Oritavancin,The metabolism of Glisoxepide can be decreased when combined with Ondansetron.,decrease,no risk
Glisoxepide,Ospemifene,The metabolism of Glisoxepide can be decreased when combined with Oritavancin.,decrease,no risk
Glisoxepide,Oxandrolone,The metabolism of Ospemifene can be decreased when combined with Glisoxepide.,decrease,no risk
Glisoxepide,Oxaprozin,The metabolism of Glisoxepide can be decreased when combined with Oxandrolone.,decrease,no risk
Glisoxepide,Oxprenolol,The protein binding of Glisoxepide can be decreased when combined with Oxaprozin.,decrease,no risk
Glisoxepide,Oxymetholone,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Oxprenolol.,increase,no risk
Glisoxepide,Oxyphenbutazone,Oxymetholone may increase the hypoglycemic activities of Glisoxepide.,increase,no risk
Pirbuterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Pirbuterol.,increase,risk
Pirbuterol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Pirbuterol.,increase,risk
Pirbuterol,Guanabenz,Pirbuterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Pirbuterol,Guanadrel,Pirbuterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Pirbuterol,Guanethidine,Pirbuterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Pirbuterol,Guanfacine,Pirbuterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Pirbuterol,Guanoxan,Pirbuterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Pirbuterol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Pirbuterol.,increase,risk
Pirbuterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Pirbuterol is combined with Hexocyclium.,increase,risk
Pirbuterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydralazine,Pirbuterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Pirbuterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Pirbuterol is combined with Hydrochlorothiazide.,increase,risk
Pirbuterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Pirbuterol is combined with Hydroflumethiazide.,increase,risk
Pirbuterol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Pirbuterol.,increase,risk
Pirbuterol,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Pirbuterol.,increase,risk
Pirbuterol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Pirbuterol.,increase,risk
Pirbuterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Pirbuterol.,increase,risk
Pirbuterol,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Pirbuterol.,increase,risk
Pirbuterol,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Pirbuterol.,increase,risk
Pirbuterol,Nadolol,Nadolol may decrease the bronchodilatory activities of Pirbuterol.,decrease,no risk
Pirbuterol,Naphazoline,The risk or severity of hypertension can be increased when Pirbuterol is combined with Naphazoline.,increase,risk
Pirbuterol,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Pirbuterol.,increase,risk
Pirbuterol,Naratriptan,The risk or severity of hypertension can be increased when Naratriptan is combined with Pirbuterol.,increase,risk
Pirbuterol,Naxitamab,The risk or severity of hypertension can be increased when Pirbuterol is combined with Naxitamab.,increase,risk
Pirbuterol,Nebivolol,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Pirbuterol,Nefazodone,Nefazodone may increase the tachycardic activities of Pirbuterol.,increase,no risk
Pirbuterol,Nialamide,The risk or severity of hypertension can be increased when Pirbuterol is combined with Nialamide.,increase,risk
Pirbuterol,Nicardipine,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Nicardipine.,decrease,no risk
Pirbuterol,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Pirbuterol.,increase,no risk
Pirbuterol,Nicorandil,Pirbuterol may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Pirbuterol,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Pirbuterol.,increase,risk
Pirbuterol,Nilvadipine,Pirbuterol may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Pirbuterol,Nimesulide,The risk or severity of hypertension can be increased when Pirbuterol is combined with Nimesulide.,increase,risk
Pirbuterol,Nimodipine,Pirbuterol may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Pirbuterol,Nisoldipine,Pirbuterol may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Pirbuterol,Nitrendipine,Pirbuterol may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Pirbuterol,Nitroglycerin,Pirbuterol may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Pirbuterol,Nitroprusside,Pirbuterol may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Pirbuterol,Nitrous oxide,The risk or severity of hypertension can be increased when Pirbuterol is combined with Nitrous oxide.,increase,risk
Pirbuterol,Norepinephrine,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Pirbuterol.,increase,risk
Pirbuterol,Nortriptyline,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Nortriptyline.,decrease,no risk
Pirbuterol,Nylidrin,The risk or severity of hypertension can be increased when Pirbuterol is combined with Nylidrin.,increase,risk
Pirbuterol,Olanzapine,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Pirbuterol,Olmesartan,Pirbuterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Pirbuterol,Olodaterol,The risk or severity of adverse effects can be increased when Pirbuterol is combined with Olodaterol.,increase,risk
Pirbuterol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Pirbuterol.,increase,risk
Pirbuterol,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Pirbuterol.,decrease,no risk
Pirbuterol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Pirbuterol is combined with Oxyphenbutazone.,increase,risk
Pirbuterol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Pirbuterol.,increase,risk
Pirbuterol,Quetiapine,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Pirbuterol,Quinapril,Pirbuterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Pirbuterol,Quinethazone,Pirbuterol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Pirbuterol,Quinidine,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Quinidine.,decrease,no risk
Pirbuterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Pirbuterol.,increase,risk
Pirbuterol,Umeclidinium,The risk or severity of Tachycardia can be increased when Pirbuterol is combined with Umeclidinium.,increase,risk
Pirbuterol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Pirbuterol.,increase,risk
Pirbuterol,Valsartan,Pirbuterol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Pirbuterol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Pirbuterol.,increase,risk
Pirbuterol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Pirbuterol.,increase,no risk
Pirbuterol,Verapamil,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Verapamil.,decrease,no risk
Pirbuterol,Vilanterol,The risk or severity of adverse effects can be increased when Pirbuterol is combined with Vilanterol.,increase,risk
Pirbuterol,Vilazodone,The risk or severity of hypertension can be increased when Pirbuterol is combined with Vilazodone.,increase,risk
Pirbuterol,Vortioxetine,The risk or severity of hypertension can be increased when Pirbuterol is combined with Vortioxetine.,increase,risk
Pirbuterol,Xamoterol,The risk or severity of hypertension can be increased when Pirbuterol is combined with Xamoterol.,increase,risk
Pirbuterol,Xylometazoline,The risk or severity of hypertension can be increased when Pirbuterol is combined with Xylometazoline.,increase,risk
Pirbuterol,Yohimbine,The risk or severity of hypertension can be increased when Pirbuterol is combined with Yohimbine.,increase,risk
Pirbuterol,Ziprasidone,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Pirbuterol,Zofenopril,Pirbuterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Pirbuterol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Pirbuterol.,increase,risk
Pirbuterol,Zuclopenthixol,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Bismuth subsalicylate,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Bismuth subsalicylate.,increase,risk
Bismuth subsalicylate,Gliclazide,Bismuth subsalicylate may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Bismuth subsalicylate,Glimepiride,Bismuth subsalicylate may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Bismuth subsalicylate,Glipizide,Bismuth subsalicylate may increase the hypoglycemic activities of Glipizide.,increase,no risk
Bismuth subsalicylate,Gliquidone,Bismuth subsalicylate may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Bismuth subsalicylate,Glyburide,Bismuth subsalicylate may increase the hypoglycemic activities of Glyburide.,increase,no risk
Bismuth subsalicylate,Glymidine,Bismuth subsalicylate may increase the hypoglycemic activities of Glymidine.,increase,no risk
Bismuth subsalicylate,Heparin,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Heparin.,increase,risk
Bismuth subsalicylate,Hydrocortisone,The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Bismuth subsalicylate,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Ketoprofen.,increase,risk
Bismuth subsalicylate,Ketorolac,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Ketorolac.,decrease,no risk
Bismuth subsalicylate,Nabumetone,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nabumetone.,decrease,no risk
Bismuth subsalicylate,Nadroparin,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Nadroparin.,increase,risk
Bismuth subsalicylate,Naproxen,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Naproxen.,decrease,no risk
Bismuth subsalicylate,Nateglinide,Bismuth subsalicylate may increase the hypoglycemic activities of Nateglinide.,increase,no risk
Bismuth subsalicylate,Nepafenac,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nepafenac.,decrease,no risk
Bismuth subsalicylate,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Bismuth subsalicylate.,increase,risk
Bismuth subsalicylate,Olsalazine,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Olsalazine is combined with Bismuth subsalicylate.",increase,risk
Bismuth subsalicylate,Omadacycline,The serum concentration of Omadacycline can be decreased when it is combined with Bismuth subsalicylate.,decrease,no risk
Bismuth subsalicylate,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Bismuth subsalicylate.,decrease,no risk
Bismuth subsalicylate,Oxaprozin,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Oxaprozin.,decrease,no risk
Bismuth subsalicylate,Oxytetracycline,The serum concentration of Oxytetracycline can be decreased when it is combined with Bismuth subsalicylate.,decrease,no risk
Bismuth subsalicylate,Quinapril,The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinapril.,increase,risk
Bismuth subsalicylate,Quinine,Bismuth subsalicylate may increase the hypoglycemic activities of Quinine.,increase,no risk
Bismuth subsalicylate,Urokinase,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Urokinase.,increase,risk
Bismuth subsalicylate,Valproate bismuth,Bismuth subsalicylate may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Bismuth subsalicylate,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Bismuth subsalicylate.,increase,no risk
Bismuth subsalicylate,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Bismuth subsalicylate,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Bismuth subsalicylate.,increase,risk
Bismuth subsalicylate,Vildagliptin,Bismuth subsalicylate may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Bismuth subsalicylate,Vorapaxar,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Vorapaxar.,increase,risk
Bismuth subsalicylate,Warfarin,Bismuth subsalicylate may increase the anticoagulant activities of Warfarin.,increase,no risk
Bismuth subsalicylate,Ximelagatran,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ximelagatran.,increase,risk
Bismuth subsalicylate,Zofenopril,The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Zofenopril.,increase,risk
Bismuth subsalicylate,Zonisamide,The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Zonisamide.,increase,risk
Bevantolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Bevantolol is combined with Bromotheophylline.,increase,risk
Bevantolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Bumetanide,Bumetanide may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Bevantolol.,increase,no risk
Bevantolol,Buprenorphine,The metabolism of Bevantolol can be decreased when combined with Buprenorphine.,decrease,no risk
Bevantolol,Bupropion,The metabolism of Bevantolol can be decreased when combined with Bupropion.,decrease,no risk
Bevantolol,Buspirone,Buspirone may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Butabarbital,The serum concentration of Bevantolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Bevantolol,Butalbital,The serum concentration of Bevantolol can be decreased when it is combined with Butalbital.,decrease,no risk
Bevantolol,Butaperazine,The serum concentration of Bevantolol can be increased when it is combined with Butaperazine.,increase,no risk
Bevantolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Galantamine,Galantamine may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Gefitinib,The metabolism of Bevantolol can be decreased when combined with Gefitinib.,decrease,no risk
Bevantolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Givosiran,The serum concentration of Bevantolol can be increased when it is combined with Givosiran.,increase,no risk
Bevantolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glucagon,The therapeutic efficacy of Bevantolol can be decreased when used in combination with Glucagon.,decrease,no risk
Bevantolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glycerol phenylbutyrate,The metabolism of Bevantolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Bevantolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Golimumab,The metabolism of Bevantolol can be increased when combined with Golimumab.,increase,no risk
Bevantolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Guanadrel,Guanadrel may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Guanethidine,Guanethidine may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Guanoxan,Bevantolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Bevantolol,Halofantrine,The metabolism of Bevantolol can be decreased when combined with Halofantrine.,decrease,no risk
Bevantolol,Haloperidol,The serum concentration of Bevantolol can be increased when it is combined with Haloperidol.,increase,no risk
Bevantolol,Halothane,Halothane may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Bevantolol.,increase,risk
Bevantolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Huperzine A,Huperzine A may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Hydralazine,Hydralazine may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Hydrochlorothiazide,The therapeutic efficacy of Bevantolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Bevantolol,Hydroflumethiazide,The therapeutic efficacy of Bevantolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Bevantolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bevantolol.,decrease,risk
Bevantolol,Hydroxyzine,The metabolism of Bevantolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Bevantolol,Ketamine,Ketamine may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Ketoconazole,The metabolism of Bevantolol can be decreased when combined with Ketoconazole.,decrease,no risk
Bevantolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Nabilone,Nabilone may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Nabumetone,Nabumetone may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Nadolol,Nadolol may increase the orthostatic hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Nadroparin,The risk or severity of hyperkalemia can be increased when Bevantolol is combined with Nadroparin.,increase,risk
Bevantolol,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Naproxen,Naproxen may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Naratriptan,Naratriptan may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Nateglinide,The therapeutic efficacy of Nateglinide can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Naxitamab,Naxitamab may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Nefazodone,"Nefazodone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bevantolol.",increase,no risk
Bevantolol,Neostigmine,Neostigmine may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Nesiritide,Nesiritide may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Netupitant,The metabolism of Netupitant can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Nevirapine,The metabolism of Bevantolol can be decreased when combined with Nevirapine.,decrease,no risk
Bevantolol,Niacin,The metabolism of Bevantolol can be decreased when combined with Niacin.,decrease,no risk
Bevantolol,Nialamide,Nialamide may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Nicardipine,The risk or severity of bradycardia can be increased when Nicardipine is combined with Bevantolol.,increase,risk
Bevantolol,Nicergoline,"Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bevantolol.",increase,no risk
Bevantolol,Nicorandil,Bevantolol may increase the hypotensive activities of Nicorandil.,increase,no risk
Bevantolol,Nicotine,The risk or severity of adverse effects can be increased when Bevantolol is combined with Nicotine.,increase,risk
Bevantolol,Nifedipine,The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bevantolol.,increase,risk
Bevantolol,Nilvadipine,The risk or severity of bradycardia can be increased when Nilvadipine is combined with Bevantolol.,increase,risk
Bevantolol,Nimesulide,Nimesulide may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Nimodipine,The risk or severity of bradycardia can be increased when Nimodipine is combined with Bevantolol.,increase,risk
Bevantolol,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Nisoldipine,The risk or severity of bradycardia can be increased when Nisoldipine is combined with Bevantolol.,increase,risk
Bevantolol,Nitrendipine,The risk or severity of bradycardia can be increased when Nitrendipine is combined with Bevantolol.,increase,risk
Bevantolol,Nitric Oxide,Nitric Oxide may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bevantolol.,increase,risk
Bevantolol,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Nitroprusside,Nitroprusside may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Nitrous acid,Nitrous acid may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Nizatidine,Nizatidine may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Nortriptyline,"Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bevantolol.",increase,no risk
Bevantolol,Nylidrin,The risk or severity of bradycardia can be increased when Nylidrin is combined with Bevantolol.,increase,risk
Bevantolol,Obinutuzumab,Bevantolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Bevantolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Bevantolol.,increase,no risk
Bevantolol,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bevantolol.",increase,no risk
Bevantolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Olmesartan,Olmesartan may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Ondansetron,The metabolism of Bevantolol can be decreased when combined with Ondansetron.,decrease,no risk
Bevantolol,Opicapone,Opicapone may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Opium,The metabolism of Opium can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Oritavancin,The metabolism of Bevantolol can be decreased when combined with Oritavancin.,decrease,no risk
Bevantolol,Orphenadrine,The metabolism of Bevantolol can be decreased when combined with Orphenadrine.,decrease,no risk
Bevantolol,Osilodrostat,The metabolism of Bevantolol can be decreased when combined with Osilodrostat.,decrease,no risk
Bevantolol,Ospemifene,The metabolism of Bevantolol can be decreased when combined with Ospemifene.,decrease,no risk
Bevantolol,Ouabain,Bevantolol may increase the bradycardic activities of Ouabain.,increase,no risk
Bevantolol,Oxamniquine,The metabolism of Bevantolol can be decreased when combined with Oxamniquine.,decrease,no risk
Bevantolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Bevantolol is combined with Oxtriphylline.,increase,risk
Bevantolol,Oxybutynin,The metabolism of Bevantolol can be decreased when combined with Oxybutynin.,decrease,no risk
Bevantolol,Oxycodone,The metabolism of Bevantolol can be decreased when combined with Oxycodone.,decrease,no risk
Bevantolol,Oxymetazoline,The therapeutic efficacy of Bevantolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Bevantolol,Oxymorphone,The metabolism of Bevantolol can be decreased when combined with Oxymorphone.,decrease,no risk
Bevantolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Quetiapine,Quetiapine may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Quinapril,Quinapril may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bevantolol.",increase,no risk
Bevantolol,Quinine,The metabolism of Bevantolol can be decreased when combined with Quinine.,decrease,no risk
Bevantolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Bevantolol.,increase,risk
Bevantolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Unoprostone,Bevantolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Bevantolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Valsartan,Valsartan may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Bevantolol.,increase,risk
Bevantolol,Varenicline,The risk or severity of adverse effects can be increased when Bevantolol is combined with Varenicline.,increase,risk
Bevantolol,Vemurafenib,The metabolism of Bevantolol can be decreased when combined with Vemurafenib.,decrease,no risk
Bevantolol,Venlafaxine,The metabolism of Bevantolol can be decreased when combined with Venlafaxine.,decrease,no risk
Bevantolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Bevantolol.,increase,risk
Bevantolol,Vericiguat,Vericiguat may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Vilazodone,The metabolism of Bevantolol can be decreased when combined with Vilazodone.,decrease,no risk
Bevantolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Viloxazine,The metabolism of Bevantolol can be decreased when combined with Viloxazine.,decrease,no risk
Bevantolol,Vinblastine,The metabolism of Bevantolol can be decreased when combined with Vinblastine.,decrease,no risk
Bevantolol,Vinorelbine,The metabolism of Bevantolol can be decreased when combined with Vinorelbine.,decrease,no risk
Bevantolol,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Xylometazoline,The risk or severity of bradycardia can be increased when Xylometazoline is combined with Bevantolol.,increase,risk
Bevantolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Ziconotide,The risk or severity of bradycardia can be increased when Ziconotide is combined with Bevantolol.,increase,risk
Bevantolol,Zimelidine,The serum concentration of Bevantolol can be increased when it is combined with Zimelidine.,increase,no risk
Bevantolol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Bevantolol.,increase,no risk
Bevantolol,Zofenopril,Bevantolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Bevantolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Zolpidem,The metabolism of Bevantolol can be decreased when combined with Zolpidem.,decrease,no risk
Bevantolol,Zonisamide,The risk or severity of bradycardia can be increased when Zonisamide is combined with Bevantolol.,increase,risk
Bevantolol,Zuclopenthixol,"Bevantolol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Glucosamine,Nimesulide,Glucosamine may increase the antiplatelet activities of Nimesulide.,increase,no risk
Glucosamine,Vorapaxar,Glucosamine may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Glucosamine,Warfarin,Glucosamine may increase the anticoagulant activities of Warfarin.,increase,no risk
Practolol,Brexpiprazole,Practolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Practolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Practolol.,increase,no risk
Practolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Practolol.,increase,no risk
Practolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Practolol is combined with Bromotheophylline.,increase,risk
Practolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Bumetanide,Bumetanide may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Practolol.,increase,no risk
Practolol,Buprenorphine,The metabolism of Practolol can be decreased when combined with Buprenorphine.,decrease,no risk
Practolol,Bupropion,The metabolism of Practolol can be decreased when combined with Bupropion.,decrease,no risk
Practolol,Buspirone,Buspirone may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Butabarbital,The serum concentration of Practolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Practolol,Butalbital,The serum concentration of Practolol can be decreased when it is combined with Butalbital.,decrease,no risk
Practolol,Butaperazine,The serum concentration of Practolol can be increased when it is combined with Butaperazine.,increase,no risk
Practolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Galantamine,Galantamine may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Gefitinib,The metabolism of Practolol can be decreased when combined with Gefitinib.,decrease,no risk
Practolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Givosiran,The serum concentration of Practolol can be increased when it is combined with Givosiran.,increase,no risk
Practolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Practolol.,increase,no risk
Practolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glucagon,The therapeutic efficacy of Practolol can be decreased when used in combination with Glucagon.,decrease,no risk
Practolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glycerol phenylbutyrate,The metabolism of Practolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Practolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Practolol.,increase,no risk
Practolol,Golimumab,The metabolism of Practolol can be increased when combined with Golimumab.,increase,no risk
Practolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Guanadrel,Guanadrel may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Guanethidine,Guanethidine may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Guanoxan,Practolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Practolol,Halofantrine,The metabolism of Practolol can be decreased when combined with Halofantrine.,decrease,no risk
Practolol,Haloperidol,The serum concentration of Practolol can be increased when it is combined with Haloperidol.,increase,no risk
Practolol,Halothane,Halothane may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Practolol.,increase,risk
Practolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Huperzine A,Huperzine A may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Hydralazine,Hydralazine may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Hydrochlorothiazide,The therapeutic efficacy of Practolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Practolol,Hydroflumethiazide,The therapeutic efficacy of Practolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Practolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Practolol.,decrease,risk
Practolol,Hydroxyzine,The metabolism of Practolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Practolol,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Ketamine,Ketamine may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Ketoconazole,The metabolism of Practolol can be decreased when combined with Ketoconazole.,decrease,no risk
Practolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Nabilone,Nabilone may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Nabumetone,Nabumetone may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Nadolol,Nadolol may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Nadroparin,The risk or severity of hyperkalemia can be increased when Practolol is combined with Nadroparin.,increase,risk
Practolol,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Naproxen,Naproxen may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Naratriptan,Naratriptan may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Nateglinide,The therapeutic efficacy of Nateglinide can be increased when used in combination with Practolol.,increase,no risk
Practolol,Naxitamab,Naxitamab may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Nebivolol,Practolol may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Practolol,Nefazodone,The serum concentration of Practolol can be increased when it is combined with Nefazodone.,increase,no risk
Practolol,Neostigmine,Neostigmine may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Nesiritide,Nesiritide may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Netupitant,The metabolism of Netupitant can be decreased when combined with Practolol.,decrease,no risk
Practolol,Nevirapine,The metabolism of Practolol can be decreased when combined with Nevirapine.,decrease,no risk
Practolol,Niacin,The metabolism of Practolol can be decreased when combined with Niacin.,decrease,no risk
Practolol,Nialamide,Nialamide may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Nicergoline,Practolol may increase the vasoconstricting activities of Nicergoline.,increase,no risk
Practolol,Nicorandil,Practolol may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Practolol,Nicotine,The risk or severity of adverse effects can be increased when Practolol is combined with Nicotine.,increase,risk
Practolol,Nifedipine,The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Practolol.,increase,risk
Practolol,Nilvadipine,Practolol may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Practolol,Nimesulide,Nimesulide may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Practolol.,decrease,no risk
Practolol,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Nitrendipine,Nitrendipine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Nitric Oxide,Nitric Oxide may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Practolol.,increase,risk
Practolol,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Nitroprusside,Nitroprusside may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Nitrous acid,Nitrous acid may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Nizatidine,Nizatidine may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Practolol.,decrease,no risk
Practolol,Nylidrin,Practolol may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Practolol,Obinutuzumab,Practolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Practolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Practolol.,increase,no risk
Practolol,Olanzapine,Practolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Practolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Practolol.,decrease,no risk
Practolol,Olmesartan,Olmesartan may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Ondansetron,The metabolism of Practolol can be decreased when combined with Ondansetron.,decrease,no risk
Practolol,Opicapone,Opicapone may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Opium,The metabolism of Opium can be decreased when combined with Practolol.,decrease,no risk
Practolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Oritavancin,The metabolism of Practolol can be decreased when combined with Oritavancin.,decrease,no risk
Practolol,Orphenadrine,The metabolism of Practolol can be decreased when combined with Orphenadrine.,decrease,no risk
Practolol,Osilodrostat,The metabolism of Practolol can be decreased when combined with Osilodrostat.,decrease,no risk
Practolol,Ospemifene,The metabolism of Practolol can be decreased when combined with Ospemifene.,decrease,no risk
Practolol,Ouabain,Practolol may increase the bradycardic activities of Ouabain.,increase,no risk
Practolol,Oxamniquine,The metabolism of Practolol can be decreased when combined with Oxamniquine.,decrease,no risk
Practolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Oxprenolol,Practolol may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Practolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Practolol is combined with Oxtriphylline.,increase,risk
Practolol,Oxybutynin,The metabolism of Practolol can be decreased when combined with Oxybutynin.,decrease,no risk
Practolol,Oxycodone,The metabolism of Practolol can be decreased when combined with Oxycodone.,decrease,no risk
Practolol,Oxymetazoline,The therapeutic efficacy of Practolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Practolol,Oxymorphone,The metabolism of Practolol can be decreased when combined with Oxymorphone.,decrease,no risk
Practolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Quetiapine,Quetiapine may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Quinapril,Quinapril may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Quinidine,Quinidine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Quinine,The metabolism of Practolol can be decreased when combined with Quinine.,decrease,no risk
Practolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Udenafil,Udenafil may increase the antihypertensive activities of Practolol.,increase,no risk
Practolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Practolol.,decrease,no risk
Practolol,Unoprostone,Practolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Practolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Practolol.,decrease,no risk
Practolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Valsartan,Valsartan may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Practolol.,increase,no risk
Practolol,Varenicline,The risk or severity of adverse effects can be increased when Practolol is combined with Varenicline.,increase,risk
Practolol,Vemurafenib,The metabolism of Practolol can be decreased when combined with Vemurafenib.,decrease,no risk
Practolol,Venlafaxine,The metabolism of Practolol can be decreased when combined with Venlafaxine.,decrease,no risk
Practolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Practolol.,increase,risk
Practolol,Vericiguat,Vericiguat may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Vernakalant,Practolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Practolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Vilazodone,The metabolism of Practolol can be decreased when combined with Vilazodone.,decrease,no risk
Practolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Practolol.,increase,no risk
Practolol,Viloxazine,The metabolism of Practolol can be decreased when combined with Viloxazine.,decrease,no risk
Practolol,Vinblastine,The metabolism of Practolol can be decreased when combined with Vinblastine.,decrease,no risk
Practolol,Vinorelbine,The metabolism of Practolol can be decreased when combined with Vinorelbine.,decrease,no risk
Practolol,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Xylometazoline,Practolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Practolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Ziconotide,Practolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Practolol,Zimelidine,The serum concentration of Practolol can be increased when it is combined with Zimelidine.,increase,no risk
Practolol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Practolol.,increase,no risk
Practolol,Zofenopril,Practolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Practolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Zolpidem,The metabolism of Practolol can be decreased when combined with Zolpidem.,decrease,no risk
Practolol,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Zuclopenthixol,Practolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Sulfacytine,Benzylpenicillin,Sulfacytine may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Sulfacytine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfacytine.,increase,risk
Sulfacytine,Nateglinide,The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Nicotine,The risk or severity of adverse effects can be increased when Sulfacytine is combined with Nicotine.,increase,risk
Sulfacytine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfacytine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfacytine.,increase,no risk
Sulfadoxine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Sulfadoxine.,increase,no risk
Sulfadoxine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Sulfadoxine.,increase,risk
Sulfadoxine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfadoxine.,increase,no risk
Rolitetracycline,Nafcillin,The therapeutic efficacy of Nafcillin can be decreased when used in combination with Rolitetracycline.,decrease,no risk
Rolitetracycline,Neomycin,The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Rolitetracycline.,increase,risk
Rolitetracycline,Netilmicin,The risk or severity of neuromuscular blockade can be increased when Netilmicin is combined with Rolitetracycline.,increase,risk
Rolitetracycline,Nicotine,The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Nicotine.,increase,risk
Rolitetracycline,Nomegestrol,The serum concentration of Nomegestrol can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Norelgestromin,The serum concentration of Norelgestromin can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Norethisterone,The serum concentration of Norethisterone can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Norethynodrel,The serum concentration of Norethynodrel can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Norgestimate,The serum concentration of Norgestimate can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Norgestrel,The serum concentration of Norgestrel can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Oxacillin,The therapeutic efficacy of Oxacillin can be decreased when used in combination with Rolitetracycline.,decrease,no risk
Rolitetracycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rolitetracycline is combined with Oxetacaine.,increase,risk
Rolitetracycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rolitetracycline is combined with Oxybuprocaine.,increase,risk
Rolitetracycline,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Rolitetracycline.,increase,risk
Rolitetracycline,Quinidine,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Rolitetracycline.,increase,risk
Rolitetracycline,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Rolitetracycline.,increase,risk
Rolitetracycline,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Rolitetracycline.,decrease,no risk
Rolitetracycline,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Rolitetracycline.,increase,risk
Rolitetracycline,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Rolitetracycline.,increase,no risk
Rolitetracycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rolitetracycline.,decrease,no risk
Rolitetracycline,Viomycin,The risk or severity of neuromuscular blockade can be increased when Rolitetracycline is combined with Viomycin.,increase,risk
Rolitetracycline,Vitamin A,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Rolitetracycline.,increase,risk
Rolitetracycline,Warfarin,Rolitetracycline may increase the anticoagulant activities of Warfarin.,increase,no risk
Rolitetracycline,Zinc,Zinc can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rolitetracycline,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rolitetracycline,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rolitetracycline,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rolitetracycline,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rolitetracycline,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rolitetracycline,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rolitetracycline,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Oxtriphylline,Gabapentin,Gabapentin may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxtriphylline,Ganaxolone,Ganaxolone may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxtriphylline,Gatifloxacin,The metabolism of Oxtriphylline can be decreased when combined with Gatifloxacin.,decrease,no risk
Oxtriphylline,Gemfibrozil,The metabolism of Oxtriphylline can be decreased when combined with Gemfibrozil.,decrease,no risk
Oxtriphylline,Gemifloxacin,The metabolism of Oxtriphylline can be decreased when combined with Gemifloxacin.,decrease,no risk
Oxtriphylline,Givosiran,The serum concentration of Oxtriphylline can be increased when it is combined with Givosiran.,increase,no risk
Oxtriphylline,Glofitamab,The serum concentration of Oxtriphylline can be increased when it is combined with Glofitamab.,increase,no risk
Oxtriphylline,Golimumab,The metabolism of Oxtriphylline can be increased when combined with Golimumab.,increase,no risk
Oxtriphylline,Grepafloxacin,The metabolism of Oxtriphylline can be decreased when combined with Grepafloxacin.,decrease,no risk
Oxtriphylline,Guanabenz,The metabolism of Oxtriphylline can be decreased when combined with Guanabenz.,decrease,no risk
Oxtriphylline,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Oxtriphylline,Haloperidol,The metabolism of Oxtriphylline can be decreased when combined with Haloperidol.,decrease,no risk
Oxtriphylline,Human interferon beta,The metabolism of Oxtriphylline can be decreased when combined with Human interferon beta.,decrease,no risk
Oxtriphylline,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Oxtriphylline,Ketoconazole,The metabolism of Oxtriphylline can be decreased when combined with Ketoconazole.,decrease,no risk
Oxtriphylline,Nabumetone,The metabolism of Oxtriphylline can be decreased when combined with Nabumetone.,decrease,no risk
Oxtriphylline,Nafcillin,The metabolism of Oxtriphylline can be increased when combined with Nafcillin.,increase,no risk
Oxtriphylline,Nalidixic acid,The metabolism of Oxtriphylline can be decreased when combined with Nalidixic acid.,decrease,no risk
Oxtriphylline,Naphazoline,The risk or severity of adverse effects can be increased when Naphazoline is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Naproxen,The metabolism of Oxtriphylline can be decreased when combined with Naproxen.,decrease,no risk
Oxtriphylline,Nebivolol,The risk or severity of adverse effects can be increased when Nebivolol is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Nevirapine,The metabolism of Oxtriphylline can be decreased when combined with Nevirapine.,decrease,no risk
Oxtriphylline,Niclosamide,The metabolism of Oxtriphylline can be decreased when combined with Niclosamide.,decrease,no risk
Oxtriphylline,Nifedipine,The metabolism of Oxtriphylline can be decreased when combined with Nifedipine.,decrease,no risk
Oxtriphylline,Nitrazepam,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Oxtriphylline,Norepinephrine,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Norfloxacin,The metabolism of Oxtriphylline can be decreased when combined with Norfloxacin.,decrease,no risk
Oxtriphylline,Nylidrin,The risk or severity of adverse effects can be increased when Nylidrin is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Obeticholic acid,The metabolism of Oxtriphylline can be decreased when combined with Obeticholic acid.,decrease,no risk
Oxtriphylline,Ofloxacin,The metabolism of Oxtriphylline can be decreased when combined with Ofloxacin.,decrease,no risk
Oxtriphylline,Olanzapine,The metabolism of Oxtriphylline can be decreased when combined with Olanzapine.,decrease,no risk
Oxtriphylline,Olodaterol,Oxtriphylline may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Oxtriphylline,Ondansetron,The metabolism of Oxtriphylline can be decreased when combined with Ondansetron.,decrease,no risk
Oxtriphylline,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Orphenadrine,The metabolism of Oxtriphylline can be decreased when combined with Orphenadrine.,decrease,no risk
Oxtriphylline,Osilodrostat,The metabolism of Oxtriphylline can be decreased when combined with Osilodrostat.,decrease,no risk
Oxtriphylline,Osimertinib,The serum concentration of Oxtriphylline can be decreased when it is combined with Osimertinib.,decrease,no risk
Oxtriphylline,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Oxtriphylline,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxtriphylline,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Oxtriphylline.,increase,risk
Oxtriphylline,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Oxtriphylline,Quinidine,The serum concentration of Oxtriphylline can be increased when it is combined with Quinidine.,increase,no risk
Oxtriphylline,Quinine,The serum concentration of Oxtriphylline can be increased when it is combined with Quinine.,increase,no risk
Oxtriphylline,Valproic acid,Valproic acid may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxtriphylline,Vemurafenib,The serum concentration of Oxtriphylline can be increased when it is combined with Vemurafenib.,increase,no risk
Oxtriphylline,Verapamil,The metabolism of Oxtriphylline can be decreased when combined with Verapamil.,decrease,no risk
Oxtriphylline,Vigabatrin,Vigabatrin may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxtriphylline,Vilanterol,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Vilanterol.,increase,risk
Oxtriphylline,Viloxazine,The metabolism of Oxtriphylline can be decreased when combined with Viloxazine.,decrease,no risk
Oxtriphylline,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Oxtriphylline.,decrease,no risk
Oxtriphylline,Warfarin,The metabolism of Oxtriphylline can be decreased when combined with Warfarin.,decrease,no risk
Oxtriphylline,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Oxtriphylline.,decrease,no risk
Oxtriphylline,Zaleplon,Zaleplon may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxtriphylline,Zileuton,The metabolism of Oxtriphylline can be decreased when combined with Zileuton.,decrease,no risk
Oxtriphylline,Zolmitriptan,The metabolism of Oxtriphylline can be decreased when combined with Zolmitriptan.,decrease,no risk
Oxtriphylline,Zolpidem,The metabolism of Oxtriphylline can be decreased when combined with Zolpidem.,decrease,no risk
Oxtriphylline,Zonisamide,Zonisamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxtriphylline,Zotepine,The metabolism of Zotepine can be decreased when combined with Oxtriphylline.,decrease,no risk
Insulin aspart,Gatifloxacin,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Gatifloxacin.,increase,no risk
Insulin aspart,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with Insulin aspart.,increase,risk
Insulin aspart,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with Insulin aspart.,increase,risk
Insulin aspart,Gemifloxacin,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Gemifloxacin.,increase,no risk
Insulin aspart,Gestrinone,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Gestrinone.,decrease,no risk
Insulin aspart,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin aspart.,increase,risk
Insulin aspart,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin aspart.,increase,risk
Insulin aspart,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin aspart.,increase,risk
Insulin aspart,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin aspart.,increase,risk
Insulin aspart,Glucagon,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Glucagon.,decrease,no risk
Insulin aspart,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin aspart.,increase,risk
Insulin aspart,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Insulin aspart.,increase,risk
Insulin aspart,Goserelin,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Goserelin.,decrease,no risk
Insulin aspart,Grepafloxacin,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Grepafloxacin.,increase,no risk
Insulin aspart,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin aspart.,increase,risk
Insulin aspart,Haloperidol,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Haloperidol.,decrease,no risk
Insulin aspart,Histrelin,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Histrelin.,decrease,no risk
Insulin aspart,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin aspart.,increase,risk
Insulin aspart,Hydroxychloroquine,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Insulin aspart,Hydroxyprogesterone caproate,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Insulin aspart,Nadolol,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Nadolol.,increase,no risk
Insulin aspart,Nalidixic acid,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Nalidixic acid.,increase,no risk
Insulin aspart,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Insulin aspart.,increase,no risk
Insulin aspart,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin aspart.,increase,no risk
Insulin aspart,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Insulin aspart.,increase,risk
Insulin aspart,Nebivolol,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Nebivolol.,increase,no risk
Insulin aspart,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Insulin aspart.,increase,risk
Insulin aspart,Nelfinavir,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Nelfinavir.,decrease,no risk
Insulin aspart,Niacin,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Niacin.,decrease,no risk
Insulin aspart,Nialamide,The risk or severity of hypoglycemia can be increased when Nialamide is combined with Insulin aspart.,increase,risk
Insulin aspart,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin aspart.,increase,risk
Insulin aspart,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin aspart.,increase,risk
Insulin aspart,Nilotinib,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Nilotinib.,decrease,no risk
Insulin aspart,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin aspart.,increase,risk
Insulin aspart,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin aspart.,increase,risk
Insulin aspart,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin aspart.,increase,risk
Insulin aspart,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin aspart.,increase,risk
Insulin aspart,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin aspart.,increase,risk
Insulin aspart,Nomegestrol acetate,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Nomegestrol acetate.,decrease,no risk
Insulin aspart,Norethisterone,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Norethisterone.,decrease,no risk
Insulin aspart,Norethynodrel,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Norethynodrel.,decrease,no risk
Insulin aspart,Norfloxacin,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Norfloxacin.,increase,no risk
Insulin aspart,Norgestimate,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Norgestimate.,decrease,no risk
Insulin aspart,Norgestrel,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Norgestrel.,decrease,no risk
Insulin aspart,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Insulin aspart.,decrease,no risk
Insulin aspart,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin aspart.,increase,risk
Insulin aspart,Octreotide,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Octreotide.,decrease,no risk
Insulin aspart,Ofloxacin,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Ofloxacin.,increase,no risk
Insulin aspart,Olanzapine,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Olanzapine.,decrease,no risk
Insulin aspart,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with Insulin aspart.,increase,risk
Insulin aspart,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Insulin aspart.,increase,no risk
Insulin aspart,Oxprenolol,The therapeutic efficacy of Insulin aspart can be increased when used in combination with Oxprenolol.,increase,no risk
Insulin aspart,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Insulin aspart.,increase,no risk
Insulin aspart,Quetiapine,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Quetiapine.,decrease,no risk
Insulin aspart,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with Insulin aspart.,increase,risk
Insulin aspart,Quinestrol,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Quinestrol.,decrease,no risk
Insulin aspart,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin aspart.,increase,risk
Insulin aspart,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin aspart.,increase,risk
Insulin aspart,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Insulin aspart.,decrease,no risk
Insulin aspart,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin aspart.,increase,risk
Insulin aspart,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with Insulin aspart.,increase,risk
Insulin aspart,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin aspart.,increase,risk
Insulin aspart,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with Insulin aspart.,increase,risk
Insulin aspart,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with Insulin aspart.,increase,risk
Insulin aspart,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Insulin aspart.,increase,risk
Insulin aspart,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with Insulin aspart.,increase,risk
Insulin aspart,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin aspart.,increase,risk
Insulin aspart,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin aspart.,increase,risk
Insulin aspart,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Insulin aspart.,increase,risk
Insulin aspart,Vorinostat,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Vorinostat.,decrease,no risk
Insulin aspart,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin aspart.,increase,risk
Insulin aspart,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin aspart.,increase,risk
Insulin aspart,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Insulin aspart.,increase,risk
Insulin aspart,Ziprasidone,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Ziprasidone.,decrease,no risk
Insulin aspart,Zofenopril,The risk or severity of hypoglycemia can be increased when Zofenopril is combined with Insulin aspart.,increase,risk
Insulin aspart,Zonisamide,The risk or severity of hypoglycemia can be increased when Zonisamide is combined with Insulin aspart.,increase,risk
Insulin aspart,Zotepine,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Zotepine.,decrease,no risk
Insulin detemir,Gatifloxacin,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Gatifloxacin.,increase,no risk
Insulin detemir,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with Insulin detemir.,increase,risk
Insulin detemir,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with Insulin detemir.,increase,risk
Insulin detemir,Gemifloxacin,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Gemifloxacin.,increase,no risk
Insulin detemir,Gestrinone,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Gestrinone.,decrease,no risk
Insulin detemir,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin detemir.,increase,risk
Insulin detemir,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin detemir.,increase,risk
Insulin detemir,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin detemir.,increase,risk
Insulin detemir,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin detemir.,increase,risk
Insulin detemir,Glucagon,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Glucagon.,decrease,no risk
Insulin detemir,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin detemir.,increase,risk
Insulin detemir,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Insulin detemir.,increase,risk
Insulin detemir,Goserelin,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Goserelin.,decrease,no risk
Insulin detemir,Grepafloxacin,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Grepafloxacin.,increase,no risk
Insulin detemir,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin detemir.,increase,risk
Insulin detemir,Haloperidol,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Haloperidol.,decrease,no risk
Insulin detemir,Histrelin,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Histrelin.,decrease,no risk
Insulin detemir,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin detemir.,increase,risk
Insulin detemir,Hydroxychloroquine,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Insulin detemir,Hydroxyprogesterone caproate,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Insulin detemir,Nadolol,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Nadolol.,increase,no risk
Insulin detemir,Nalidixic acid,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Nalidixic acid.,increase,no risk
Insulin detemir,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Insulin detemir.,increase,no risk
Insulin detemir,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin detemir.,increase,no risk
Insulin detemir,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Insulin detemir.,increase,risk
Insulin detemir,Nebivolol,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Nebivolol.,increase,no risk
Insulin detemir,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Insulin detemir.,increase,risk
Insulin detemir,Nelfinavir,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Nelfinavir.,decrease,no risk
Insulin detemir,Niacin,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Niacin.,decrease,no risk
Insulin detemir,Nialamide,The risk or severity of hypoglycemia can be increased when Nialamide is combined with Insulin detemir.,increase,risk
Insulin detemir,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin detemir.,increase,risk
Insulin detemir,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin detemir.,increase,risk
Insulin detemir,Nilotinib,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Nilotinib.,decrease,no risk
Insulin detemir,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin detemir.,increase,risk
Insulin detemir,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin detemir.,increase,risk
Insulin detemir,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin detemir.,increase,risk
Insulin detemir,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin detemir.,increase,risk
Insulin detemir,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin detemir.,increase,risk
Insulin detemir,Nomegestrol acetate,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Nomegestrol acetate.,decrease,no risk
Insulin detemir,Norethisterone,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Norethisterone.,decrease,no risk
Insulin detemir,Norethynodrel,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Norethynodrel.,decrease,no risk
Insulin detemir,Norfloxacin,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Norfloxacin.,increase,no risk
Insulin detemir,Norgestimate,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Norgestimate.,decrease,no risk
Insulin detemir,Norgestrel,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Norgestrel.,decrease,no risk
Insulin detemir,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Insulin detemir.,decrease,no risk
Insulin detemir,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin detemir.,increase,risk
Insulin detemir,Octreotide,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Octreotide.,decrease,no risk
Insulin detemir,Ofloxacin,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Ofloxacin.,increase,no risk
Insulin detemir,Olanzapine,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Olanzapine.,decrease,no risk
Insulin detemir,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with Insulin detemir.,increase,risk
Insulin detemir,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Insulin detemir.,increase,no risk
Insulin detemir,Oxprenolol,The therapeutic efficacy of Insulin detemir can be increased when used in combination with Oxprenolol.,increase,no risk
Insulin detemir,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Insulin detemir.,increase,no risk
Insulin detemir,Quetiapine,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Quetiapine.,decrease,no risk
Insulin detemir,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with Insulin detemir.,increase,risk
Insulin detemir,Quinestrol,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Quinestrol.,decrease,no risk
Insulin detemir,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin detemir.,increase,risk
Insulin detemir,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin detemir.,increase,risk
Insulin detemir,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Insulin detemir.,decrease,no risk
Insulin detemir,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin detemir.,increase,risk
Insulin detemir,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with Insulin detemir.,increase,risk
Insulin detemir,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin detemir.,increase,risk
Insulin detemir,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with Insulin detemir.,increase,risk
Insulin detemir,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with Insulin detemir.,increase,risk
Insulin detemir,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Insulin detemir.,increase,risk
Insulin detemir,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with Insulin detemir.,increase,risk
Insulin detemir,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin detemir.,increase,risk
Insulin detemir,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin detemir.,increase,risk
Insulin glulisine,Gatifloxacin,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Gatifloxacin.,increase,no risk
Insulin glulisine,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Gemifloxacin,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Gemifloxacin.,increase,no risk
Insulin glulisine,Gestrinone,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Gestrinone.,decrease,no risk
Insulin glulisine,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Glucagon,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Glucagon.,decrease,no risk
Insulin glulisine,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Goserelin,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Goserelin.,decrease,no risk
Insulin glulisine,Grepafloxacin,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Grepafloxacin.,increase,no risk
Insulin glulisine,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Haloperidol,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Haloperidol.,decrease,no risk
Insulin glulisine,Histrelin,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Histrelin.,decrease,no risk
Insulin glulisine,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Hydroxychloroquine,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Insulin glulisine,Hydroxyprogesterone caproate,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Insulin glulisine,Nadolol,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Nadolol.,increase,no risk
Insulin glulisine,Nalidixic acid,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Nalidixic acid.,increase,no risk
Insulin glulisine,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Insulin glulisine.,increase,no risk
Insulin glulisine,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin glulisine.,increase,no risk
Insulin glulisine,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nebivolol,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Nebivolol.,increase,no risk
Insulin glulisine,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nelfinavir,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Nelfinavir.,decrease,no risk
Insulin glulisine,Niacin,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Niacin.,decrease,no risk
Insulin glulisine,Nialamide,The risk or severity of hypoglycemia can be increased when Nialamide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nilotinib,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Nilotinib.,decrease,no risk
Insulin glulisine,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Nomegestrol acetate,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Nomegestrol acetate.,decrease,no risk
Insulin glulisine,Norethisterone,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Norethisterone.,decrease,no risk
Insulin glulisine,Norethynodrel,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Norethynodrel.,decrease,no risk
Insulin glulisine,Norfloxacin,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Norfloxacin.,increase,no risk
Insulin glulisine,Norgestimate,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Norgestimate.,decrease,no risk
Insulin glulisine,Norgestrel,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Norgestrel.,decrease,no risk
Insulin glulisine,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Insulin glulisine.,decrease,no risk
Insulin glulisine,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Octreotide,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Octreotide.,decrease,no risk
Insulin glulisine,Ofloxacin,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Ofloxacin.,increase,no risk
Insulin glulisine,Olanzapine,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Olanzapine.,decrease,no risk
Insulin glulisine,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Insulin glulisine.,increase,no risk
Insulin glulisine,Oxprenolol,The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Oxprenolol.,increase,no risk
Insulin glulisine,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Insulin glulisine.,increase,no risk
Insulin glulisine,Quetiapine,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Quetiapine.,decrease,no risk
Insulin glulisine,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Quinestrol,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Quinestrol.,decrease,no risk
Insulin glulisine,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Insulin glulisine.,decrease,no risk
Insulin glulisine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin glulisine.,increase,risk
Insulin glulisine,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin glulisine.,increase,risk
Fosphenytoin,Belumosudil,The serum concentration of Belumosudil can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Belzutifan,The serum concentration of Fosphenytoin can be decreased when it is combined with Belzutifan.,decrease,no risk
Fosphenytoin,Bendamustine,The metabolism of Bendamustine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Benperidol,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Benperidol.,increase,risk
Fosphenytoin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Benzocaine.,increase,risk
Fosphenytoin,Benzphetamine,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Benzphetamine.,decrease,no risk
Fosphenytoin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Benzyl alcohol.,increase,risk
Fosphenytoin,Bepridil,The metabolism of Bepridil can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Berotralstat,The serum concentration of Fosphenytoin can be increased when it is combined with Berotralstat.,increase,no risk
Fosphenytoin,Betamethasone,The serum concentration of Betamethasone can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Betaxolol,The metabolism of Betaxolol can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Bexarotene,The metabolism of Fosphenytoin can be increased when combined with Bexarotene.,increase,no risk
Fosphenytoin,Bezafibrate,The metabolism of Fosphenytoin can be decreased when combined with Bezafibrate.,decrease,no risk
Fosphenytoin,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Bictegravir,The metabolism of Bictegravir can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Bifonazole,The metabolism of Fosphenytoin can be decreased when combined with Bifonazole.,decrease,no risk
Fosphenytoin,Bimekizumab,The metabolism of Fosphenytoin can be increased when combined with Bimekizumab.,increase,no risk
Fosphenytoin,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Bismuth subsalicylate,The protein binding of Fosphenytoin can be decreased when combined with Bismuth subsalicylate.,decrease,no risk
Fosphenytoin,Bisoprolol,The metabolism of Bisoprolol can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Bleomycin,The serum concentration of Fosphenytoin can be decreased when it is combined with Bleomycin.,decrease,no risk
Fosphenytoin,Boceprevir,The serum concentration of Boceprevir can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Borage oil,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Borage oil.,decrease,no risk
Fosphenytoin,Bortezomib,The metabolism of Bortezomib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Bosentan,The metabolism of Fosphenytoin can be increased when combined with Bosentan.,increase,no risk
Fosphenytoin,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Brexanolone,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Brexanolone.,increase,risk
Fosphenytoin,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Brigatinib,The metabolism of Brigatinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.,increase,no risk
Fosphenytoin,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Bromazepam,The serum concentration of Fosphenytoin can be increased when it is combined with Bromazepam.,increase,no risk
Fosphenytoin,Bromocriptine,The metabolism of Bromocriptine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Bromperidol,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Bromperidol.,increase,risk
Fosphenytoin,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Budesonide,The serum concentration of Budesonide can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Bupivacaine.,increase,risk
Fosphenytoin,Buprenorphine,Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Fosphenytoin,Bupropion,The metabolism of Bupropion can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Buspirone,The metabolism of Buspirone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Busulfan,The serum concentration of Busulfan can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Butacaine,The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Butacaine.,increase,risk
Fosphenytoin,Butalbital,The metabolism of Fosphenytoin can be increased when combined with Butalbital.,increase,no risk
Fosphenytoin,Butamben,The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Butamben.,increase,risk
Fosphenytoin,Butaperazine,The serum concentration of Fosphenytoin can be increased when it is combined with Butaperazine.,increase,no risk
Fosphenytoin,Butobarbital,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Butobarbital.,increase,risk
Fosphenytoin,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Butriptyline,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Butriptyline.,increase,risk
Fosphenytoin,Gabapentin,The metabolism of Futibatinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Galantamine,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Gabapentin enacarbil.,increase,risk
Fosphenytoin,Gallamine triethiodide,The metabolism of Galantamine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Gamolenic acid,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with gamma-Hydroxybutyric acid.,increase,risk
Fosphenytoin,Ganaxolone,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Fosphenytoin,Ganciclovir,The metabolism of Ganaxolone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Gefitinib,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Ganciclovir.,decrease,no risk
Fosphenytoin,Gemfibrozil,The metabolism of Gefitinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Gepirone,The metabolism of Fosphenytoin can be decreased when combined with Gemfibrozil.,decrease,no risk
Fosphenytoin,Gestrinone,The serum concentration of Gepirone can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Gilteritinib,The metabolism of Gestrinone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Ginkgo biloba,The metabolism of Gilteritinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Glasdegib,The metabolism of Fosphenytoin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Fosphenytoin,Glecaprevir,The serum concentration of Glasdegib can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Gliclazide,The metabolism of Fosphenytoin can be decreased when combined with Glecaprevir.,decrease,no risk
Fosphenytoin,Glimepiride,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Glipizide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Gliquidone,The therapeutic efficacy of Glipizide can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Glofitamab,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Glutethimide,The serum concentration of Fosphenytoin can be increased when it is combined with Glofitamab.,increase,no risk
Fosphenytoin,Glyburide,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Glutethimide.,increase,risk
Fosphenytoin,Glycerol phenylbutyrate,The therapeutic efficacy of Glyburide can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Golimumab,The metabolism of Fosphenytoin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Fosphenytoin,Granisetron,The metabolism of Fosphenytoin can be increased when combined with Golimumab.,increase,no risk
Fosphenytoin,Grapefruit,The metabolism of Granisetron can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Grazoprevir,The serum concentration of Fosphenytoin can be increased when it is combined with Grapefruit.,increase,no risk
Fosphenytoin,Grepafloxacin,The metabolism of Grazoprevir can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Griseofulvin,The metabolism of Grepafloxacin can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Guanabenz,The metabolism of Fosphenytoin can be increased when combined with Griseofulvin.,increase,no risk
Fosphenytoin,Guanfacine,The metabolism of Guanabenz can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Halazepam,The metabolism of Guanfacine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Halcinonide,The serum concentration of Fosphenytoin can be increased when it is combined with Halazepam.,increase,no risk
Fosphenytoin,Halofantrine,The serum concentration of Halcinonide can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Haloperidol,The metabolism of Fosphenytoin can be decreased when combined with Halofantrine.,decrease,no risk
Fosphenytoin,Halothane,The risk or severity of CNS depression can be increased when Haloperidol is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Heparin,The serum concentration of Fosphenytoin can be increased when it is combined with Halothane.,increase,no risk
Fosphenytoin,Hexafluronium,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Heparin.,increase,no risk
Fosphenytoin,Hyaluronidase,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Hyaluronidase (human recombinant),The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Hyaluronidase.,decrease,no risk
Fosphenytoin,Hyaluronidase (ovine),The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Hyaluronidase (human recombinant).,decrease,no risk
Fosphenytoin,Hydralazine,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Hyaluronidase (ovine).,decrease,no risk
Fosphenytoin,Hydrocodone,The serum concentration of Fosphenytoin can be increased when it is combined with Hydralazine.,increase,no risk
Fosphenytoin,Hydrocortamate,Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Fosphenytoin,Hydrocortisone,The metabolism of Fosphenytoin can be increased when combined with Hydrocortamate.,increase,no risk
Fosphenytoin,Hydrocortisone acetate,The serum concentration of Hydrocortisone can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Hydrocortisone butyrate,The serum concentration of Hydrocortisone acetate can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Hydrocortisone cypionate,The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Hydrocortisone phosphate,The serum concentration of Hydrocortisone cypionate can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Hydrocortisone probutate,The metabolism of Hydrocortisone phosphate can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Hydrocortisone succinate,The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Hydrocortisone valerate,The serum concentration of Hydrocortisone succinate can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Hydromorphone,The serum concentration of Hydrocortisone valerate can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Hydroxychloroquine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Hydroxyprogesterone caproate,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Fosphenytoin,Hydroxyzine,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Ketamine,The metabolism of Ixazomib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Ketazolam,The metabolism of Fosphenytoin can be decreased when combined with Ketamine.,decrease,no risk
Fosphenytoin,Ketoconazole,The serum concentration of Fosphenytoin can be increased when it is combined with Ketazolam.,increase,no risk
Fosphenytoin,Ketoprofen,The serum concentration of Fosphenytoin can be increased when it is combined with Ketoconazole.,increase,no risk
Fosphenytoin,Ketorolac,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Nabilone,The metabolism of Mycophenolic acid can be decreased when combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Nabumetone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.,increase,no risk
Fosphenytoin,Nafcillin,The metabolism of Nabumetone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nalbuphine,The metabolism of Fosphenytoin can be increased when combined with Nafcillin.,increase,no risk
Fosphenytoin,Nalidixic acid,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Naloxegol,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Fosphenytoin,Nandrolone decanoate,The metabolism of Naloxegol can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nandrolone phenpropionate,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Nandrolone decanoate.,increase,no risk
Fosphenytoin,Naproxen,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Nandrolone phenpropionate.,increase,no risk
Fosphenytoin,Naratriptan,The metabolism of Fosphenytoin can be decreased when combined with Naproxen.,decrease,no risk
Fosphenytoin,Nateglinide,The risk or severity of CNS depression can be increased when Naratriptan is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Nebivolol,The metabolism of Nateglinide can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nedaplatin,The metabolism of Nebivolol can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nefazodone,Nedaplatin can cause a decrease in the absorption of Fosphenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fosphenytoin,Nelfinavir,The metabolism of Fosphenytoin can be decreased when combined with Nefazodone.,decrease,no risk
Fosphenytoin,Neratinib,The serum concentration of Nelfinavir can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Netupitant,The metabolism of Neratinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nevirapine,The metabolism of Netupitant can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Niacin,The metabolism of Nevirapine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nialamide,The serum concentration of Fosphenytoin can be increased when it is combined with Niacin.,increase,no risk
Fosphenytoin,Nicardipine,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Nialamide.,increase,risk
Fosphenytoin,Niclosamide,The metabolism of Fosphenytoin can be decreased when combined with Nicardipine.,decrease,no risk
Fosphenytoin,Nicotine,The metabolism of Niclosamide can be decreased when combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Nifedipine,The metabolism of Nicotine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nilotinib,The serum concentration of Fosphenytoin can be increased when it is combined with Nifedipine.,increase,no risk
Fosphenytoin,Nilutamide,The metabolism of Fosphenytoin can be decreased when combined with Nilotinib.,decrease,no risk
Fosphenytoin,Nilvadipine,The metabolism of Fosphenytoin can be decreased when combined with Nilutamide.,decrease,no risk
Fosphenytoin,Nimesulide,The metabolism of Fosphenytoin can be decreased when combined with Nilvadipine.,decrease,no risk
Fosphenytoin,Nimodipine,The metabolism of Nimesulide can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nintedanib,The serum concentration of Nimodipine can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Nirmatrelvir,The metabolism of Nintedanib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nirogacestat,The metabolism of Nirmatrelvir can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nisoldipine,The serum concentration of Nirogacestat can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Nitrazepam,The serum concentration of Nisoldipine can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Nitrendipine,The metabolism of Nitrazepam can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nitrofurantoin,The metabolism of Nitrendipine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nitrous oxide,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Nitrofurantoin.,increase,no risk
Fosphenytoin,Nomegestrol,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Nitrous oxide.,increase,risk
Fosphenytoin,Nomegestrol acetate,The metabolism of Nomegestrol can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nomifensine,The metabolism of Nomegestrol acetate can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nonoxynol-9,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Nomifensine.,increase,risk
Fosphenytoin,Norelgestromin,The metabolism of Nonoxynol-9 can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Norethisterone,The metabolism of Norelgestromin can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Norethynodrel,The metabolism of Norethisterone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Norgestimate,The metabolism of Norethynodrel can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Norgestrel,The metabolism of Norgestimate can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Normethadone,The metabolism of Norgestrel can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nortriptyline,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Normethadone.,increase,risk
Fosphenytoin,Noscapine,The metabolism of Nortriptyline can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Nylidrin,The serum concentration of Fosphenytoin can be increased when it is combined with Noscapine.,increase,no risk
Fosphenytoin,Octreotide,The metabolism of Nylidrin can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Olanzapine,The serum concentration of Fosphenytoin can be increased when it is combined with Octreotide.,increase,no risk
Fosphenytoin,Olaparib,The metabolism of Fosphenytoin can be decreased when combined with Olanzapine.,decrease,no risk
Fosphenytoin,Oliceridine,The metabolism of Olaparib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Olodaterol,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Fosphenytoin is combined with Oliceridine.",increase,risk
Fosphenytoin,Olsalazine,The metabolism of Fosphenytoin can be decreased when combined with Olodaterol.,decrease,no risk
Fosphenytoin,Olutasidenib,The protein binding of Fosphenytoin can be decreased when combined with Olsalazine.,decrease,no risk
Fosphenytoin,Omaveloxolone,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Ombitasvir,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Omeprazole,The metabolism of Fosphenytoin can be decreased when combined with Ombitasvir.,decrease,no risk
Fosphenytoin,Ondansetron,The serum concentration of Fosphenytoin can be increased when it is combined with Omeprazole.,increase,no risk
Fosphenytoin,Opium,The metabolism of Ondansetron can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Oritavancin,The metabolism of Opium can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Orlistat,The metabolism of Fosphenytoin can be increased when combined with Oritavancin.,increase,no risk
Fosphenytoin,Orphenadrine,Orlistat can cause a decrease in the absorption of Fosphenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fosphenytoin,Osilodrostat,Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Fosphenytoin,Osimertinib,The serum concentration of Osilodrostat can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Ospemifene,The metabolism of Osimertinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Oxaliplatin,The metabolism of Ospemifene can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Oxandrolone,Oxaliplatin can cause a decrease in the absorption of Fosphenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fosphenytoin,Oxazepam,The metabolism of Fosphenytoin can be decreased when combined with Oxandrolone.,decrease,no risk
Fosphenytoin,Oxcarbazepine,The serum concentration of Fosphenytoin can be increased when it is combined with Oxazepam.,increase,no risk
Fosphenytoin,Oxetacaine,The metabolism of Fosphenytoin can be increased when combined with Oxcarbazepine.,increase,no risk
Fosphenytoin,Oxitriptan,The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Oxetacaine.,increase,risk
Fosphenytoin,Oxprenolol,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Oxitriptan.,increase,risk
Fosphenytoin,Oxtriphylline,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Oxprenolol.,increase,risk
Fosphenytoin,Oxybuprocaine,The serum concentration of Oxtriphylline can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Oxybutynin,The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Oxybuprocaine.,increase,risk
Fosphenytoin,Oxycodone,The serum concentration of Fosphenytoin can be increased when it is combined with Oxybutynin.,increase,no risk
Fosphenytoin,Oxymetholone,The metabolism of Oxycodone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Oxymorphone,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Oxymetholone.,increase,no risk
Fosphenytoin,Ozanimod,The metabolism of Oxymorphone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Quazepam,The metabolism of Fosphenytoin can be decreased when combined with Pyrimethamine.,decrease,no risk
Fosphenytoin,Quetiapine,The metabolism of Quazepam can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Quinestrol,The metabolism of Quetiapine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Quinidine,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Quinestrol.,decrease,no risk
Fosphenytoin,Quinine,The serum concentration of Quinidine can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Quinupramine,The serum concentration of Quinine can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Quinupristin,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Quinupramine.,increase,risk
Fosphenytoin,Quizartinib,The metabolism of Fosphenytoin can be decreased when combined with Quinupristin.,decrease,no risk
Fosphenytoin,Ubrogepant,The metabolism of Tucatinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Udenafil,The serum concentration of Ubrogepant can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Ulipristal,The metabolism of Udenafil can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Ulobetasol,The metabolism of Ulipristal can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Upadacitinib,The serum concentration of Ulobetasol can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Urethane,The metabolism of Upadacitinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vadadustat,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Urethane.,increase,risk
Fosphenytoin,Valbenazine,The serum concentration of Fosphenytoin can be increased when it is combined with Vadadustat.,increase,no risk
Fosphenytoin,Valdecoxib,The serum concentration of Valbenazine can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Valganciclovir,The metabolism of Fosphenytoin can be decreased when combined with Valdecoxib.,decrease,no risk
Fosphenytoin,Valproic acid,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Valganciclovir.,decrease,no risk
Fosphenytoin,Valsartan,The serum concentration of Fosphenytoin can be decreased when it is combined with Valproic acid.,decrease,no risk
Fosphenytoin,Vamorolone,The metabolism of Fosphenytoin can be decreased when combined with Valsartan.,decrease,no risk
Fosphenytoin,Vandetanib,The serum concentration of Vamorolone can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Vardenafil,The metabolism of Vandetanib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vecuronium,The metabolism of Vardenafil can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Velpatasvir,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Vemurafenib,The metabolism of Fosphenytoin can be decreased when combined with Velpatasvir.,decrease,no risk
Fosphenytoin,Venetoclax,The metabolism of Vemurafenib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Venlafaxine,The metabolism of Venetoclax can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Verapamil,The metabolism of Venlafaxine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vericiguat,The serum concentration of Verapamil can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Vigabatrin,The metabolism of Vericiguat can be decreased when combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Vilanterol,The serum concentration of Fosphenytoin can be decreased when it is combined with Vigabatrin.,decrease,no risk
Fosphenytoin,Vilazodone,The metabolism of Vilanterol can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Viloxazine,The metabolism of Vilazodone can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vinblastine,The metabolism of Fosphenytoin can be decreased when combined with Viloxazine.,decrease,no risk
Fosphenytoin,Vincristine,The metabolism of Vinblastine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vindesine,The serum concentration of Vincristine can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Vinflunine,The serum concentration of Fosphenytoin can be decreased when it is combined with Vindesine.,decrease,no risk
Fosphenytoin,Vinorelbine,The metabolism of Vinflunine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vitamin D,The metabolism of Vinorelbine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vitamin E,The serum concentration of Vitamin D can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Voclosporin,The metabolism of Fosphenytoin can be increased when combined with Vitamin E.,increase,no risk
Fosphenytoin,Vonoprazan,The metabolism of Voclosporin can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vorapaxar,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Fosphenytoin.,decrease,no risk
Fosphenytoin,Voriconazole,The metabolism of Vorapaxar can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Vortioxetine,The serum concentration of Voriconazole can be decreased when it is combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Voxelotor,The metabolism of Vortioxetine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Voxilaprevir,The serum concentration of Fosphenytoin can be increased when it is combined with Voxelotor.,increase,no risk
Fosphenytoin,Warfarin,The metabolism of Fosphenytoin can be decreased when combined with Voxilaprevir.,decrease,no risk
Fosphenytoin,Ximelagatran,The metabolism of Warfarin can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Xylometazoline,The metabolism of Ximelagatran can be decreased when combined with Fosphenytoin.,decrease,no risk
Fosphenytoin,Yohimbine,The serum concentration of Fosphenytoin can be increased when it is combined with Xylometazoline.,increase,no risk
Fosphenytoin,Zafirlukast,The metabolism of Yohimbine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Zaleplon,The serum concentration of Fosphenytoin can be increased when it is combined with Zafirlukast.,increase,no risk
Fosphenytoin,Zanubrutinib,The metabolism of Zaleplon can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Ziconotide,The metabolism of Zanubrutinib can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Zidovudine,The risk or severity of CNS depression can be increased when Fosphenytoin is combined with Ziconotide.,increase,risk
Fosphenytoin,Zileuton,The metabolism of Fosphenytoin can be decreased when combined with Zidovudine.,decrease,no risk
Fosphenytoin,Zimelidine,The metabolism of Zileuton can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Ziprasidone,The metabolism of Fosphenytoin can be decreased when combined with Zimelidine.,decrease,no risk
Fosphenytoin,Zolmitriptan,The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Ziprasidone.,increase,risk
Fosphenytoin,Zolpidem,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Fosphenytoin.,increase,risk
Fosphenytoin,Zonisamide,Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Fosphenytoin,Zopiclone,Fosphenytoin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fosphenytoin,Zotepine,The metabolism of Fosphenytoin can be decreased when combined with Zopiclone.,decrease,no risk
Fosphenytoin,Zuclopenthixol,The metabolism of Zotepine can be increased when combined with Fosphenytoin.,increase,no risk
Fosphenytoin,Zuranolone,The metabolism of Zuclopenthixol can be increased when combined with Fosphenytoin.,increase,no risk
Josamycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Josamycin.,decrease,no risk
Josamycin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Josamycin.,increase,no risk
Josamycin,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Josamycin.,increase,no risk
Josamycin,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Josamycin.,increase,no risk
Josamycin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Josamycin.,increase,no risk
Josamycin,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Josamycin.,increase,no risk
Josamycin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Josamycin.,increase,no risk
St. John's Wort,Bimekizumab,The metabolism of St. John's Wort can be increased when combined with Bimekizumab.,increase,no risk
St. John's Wort,Binimetinib,The serum concentration of Binimetinib can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Bisoprolol,The metabolism of Bisoprolol can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Boceprevir,The metabolism of St. John's Wort can be decreased when combined with Boceprevir.,decrease,no risk
St. John's Wort,Bortezomib,The metabolism of Bortezomib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Bosentan,The metabolism of Bosentan can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with St. John's Wort.,increase,risk
St. John's Wort,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with St. John's Wort.,increase,risk
St. John's Wort,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Brexanolone,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Brexanolone.,increase,risk
St. John's Wort,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Brigatinib,The metabolism of Brigatinib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of St. John's Wort.,increase,no risk
St. John's Wort,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Bromazepam,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Bromazepam.,increase,risk
St. John's Wort,Bromocriptine,The metabolism of Bromocriptine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Bromperidol,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Bromperidol.,increase,risk
St. John's Wort,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with St. John's Wort.,increase,risk
St. John's Wort,Budesonide,The metabolism of Budesonide can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Buprenorphine,St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
St. John's Wort,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with St. John's Wort.,increase,risk
St. John's Wort,Buspirone,The metabolism of Buspirone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Busulfan,The metabolism of Busulfan can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with St. John's Wort.,increase,risk
St. John's Wort,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with St. John's Wort.,increase,risk
St. John's Wort,Butaperazine,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Butaperazine.,increase,risk
St. John's Wort,Butobarbital,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Butobarbital.,increase,risk
St. John's Wort,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with St. John's Wort.,increase,risk
St. John's Wort,Butriptyline,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Butriptyline.,increase,risk
St. John's Wort,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with St. John's Wort.,increase,risk
St. John's Wort,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Gabapentin enacarbil.,increase,risk
St. John's Wort,Galantamine,The metabolism of Galantamine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with St. John's Wort.,increase,risk
St. John's Wort,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Gefitinib,The metabolism of Gefitinib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Gemcitabine,The serum concentration of Gemcitabine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Gemfibrozil,The metabolism of Gemfibrozil can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Gestrinone,The metabolism of Gestrinone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Glofitamab,The serum concentration of St. John's Wort can be increased when it is combined with Glofitamab.,increase,no risk
St. John's Wort,Glutethimide,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Glutethimide.,increase,risk
St. John's Wort,Glyburide,The metabolism of Glyburide can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Golimumab,The metabolism of St. John's Wort can be increased when combined with Golimumab.,increase,no risk
St. John's Wort,Granisetron,The metabolism of Granisetron can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Guanfacine,The serum concentration of Guanfacine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with St. John's Wort.,increase,risk
St. John's Wort,Halofantrine,The metabolism of Halofantrine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with St. John's Wort.,increase,risk
St. John's Wort,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with St. John's Wort.,increase,risk
St. John's Wort,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with St. John's Wort.,increase,risk
St. John's Wort,Hydrocodone,St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
St. John's Wort,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with St. John's Wort.,increase,risk
St. John's Wort,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of St. John's Wort.,increase,no risk
St. John's Wort,Ketamine,The metabolism of Ketamine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Ketazolam,The metabolism of Ketazolam can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Ketoconazole,The metabolism of St. John's Wort can be decreased when combined with Ketoconazole.,decrease,no risk
St. John's Wort,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of St. John's Wort.,increase,no risk
St. John's Wort,Nadolol,The metabolism of Nadolol can be decreased when combined with St. John's Wort.,decrease,no risk
St. John's Wort,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with St. John's Wort.,increase,risk
St. John's Wort,Naloxegol,The metabolism of Naloxegol can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with St. John's Wort.,increase,risk
St. John's Wort,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with St. John's Wort.,increase,risk
St. John's Wort,Nateglinide,The metabolism of Nateglinide can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nebivolol,The metabolism of Nebivolol can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nefazodone,The metabolism of St. John's Wort can be decreased when combined with Nefazodone.,decrease,no risk
St. John's Wort,Nelfinavir,The serum concentration of Nelfinavir can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Neratinib,The metabolism of Neratinib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Netupitant,The metabolism of Netupitant can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nevirapine,The metabolism of Nevirapine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nialamide,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Nialamide.,increase,risk
St. John's Wort,Nicardipine,The metabolism of Nicardipine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nicergoline,The metabolism of Nicergoline can be decreased when combined with St. John's Wort.,decrease,no risk
St. John's Wort,Nifedipine,The serum concentration of Nifedipine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Nilotinib,The metabolism of St. John's Wort can be decreased when combined with Nilotinib.,decrease,no risk
St. John's Wort,Nilutamide,The metabolism of St. John's Wort can be decreased when combined with Nilutamide.,decrease,no risk
St. John's Wort,Nilvadipine,The metabolism of Nilvadipine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nimesulide,The metabolism of Nimesulide can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nimodipine,The metabolism of Nimodipine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nintedanib,The metabolism of Nintedanib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nirmatrelvir,The serum concentration of Nirmatrelvir can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Nirogacestat,The serum concentration of Nirogacestat can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Nisoldipine,The metabolism of Nisoldipine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nitrazepam,The metabolism of Nitrazepam can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nitrendipine,The metabolism of Nitrendipine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nitrous oxide,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Nitrous oxide.,increase,risk
St. John's Wort,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Nomifensine,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Nomifensine.,increase,risk
St. John's Wort,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Norethisterone,The metabolism of Norethisterone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Norgestimate,The metabolism of Norgestimate can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Norgestrel,The metabolism of Norgestrel can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Normethadone,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Normethadone.,increase,risk
St. John's Wort,Nortriptyline,The serum concentration of Nortriptyline can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Nylidrin,The metabolism of Nylidrin can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with St. John's Wort.,increase,risk
St. John's Wort,Olaparib,The metabolism of Olaparib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when St. John's Wort is combined with Oliceridine.",increase,risk
St. John's Wort,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Omeprazole,The serum concentration of Omeprazole can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Ondansetron,The metabolism of Ondansetron can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Opium,The metabolism of Opium can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Oritavancin,The metabolism of St. John's Wort can be decreased when combined with Oritavancin.,decrease,no risk
St. John's Wort,Orphenadrine,St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
St. John's Wort,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Osimertinib,The metabolism of Osimertinib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Ospemifene,The metabolism of Ospemifene can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with St. John's Wort.,increase,risk
St. John's Wort,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with St. John's Wort.,increase,risk
St. John's Wort,Oxitriptan,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Oxitriptan.,increase,risk
St. John's Wort,Oxprenolol,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Oxprenolol.,increase,risk
St. John's Wort,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with St. John's Wort.,increase,risk
St. John's Wort,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Oxycodone,The metabolism of Oxycodone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Quazepam,The metabolism of Quazepam can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Quetiapine,The serum concentration of Quetiapine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Quinidine,The serum concentration of Quinidine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Quinine,The metabolism of Quinine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Quinupramine,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Quinupramine.,increase,risk
St. John's Wort,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Udenafil,The metabolism of Udenafil can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Ulipristal,The metabolism of Ulipristal can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with St. John's Wort.,decrease,no risk
St. John's Wort,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Urethane,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Urethane.,increase,risk
St. John's Wort,Vadadustat,The serum concentration of St. John's Wort can be increased when it is combined with Vadadustat.,increase,no risk
St. John's Wort,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Valproate bismuth.,increase,risk
St. John's Wort,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with St. John's Wort.,increase,risk
St. John's Wort,Vamorolone,The metabolism of Vamorolone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vandetanib,The metabolism of Vandetanib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vardenafil,The metabolism of Vardenafil can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vecuronium,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Vecuronium.,increase,risk
St. John's Wort,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vemurafenib,The serum concentration of Vemurafenib can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Venetoclax,The serum concentration of Venetoclax can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Venlafaxine,The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Venlafaxine.,increase,risk
St. John's Wort,Verapamil,The metabolism of Verapamil can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vernakalant,The metabolism of Vernakalant can be decreased when combined with St. John's Wort.,decrease,no risk
St. John's Wort,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with St. John's Wort.,increase,risk
St. John's Wort,Vilanterol,The metabolism of Vilanterol can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vilazodone,The metabolism of Vilazodone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Viloxazine,The metabolism of St. John's Wort can be decreased when combined with Viloxazine.,decrease,no risk
St. John's Wort,Vinblastine,The serum concentration of Vinblastine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Vincristine,The serum concentration of Vincristine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Vindesine,The metabolism of Vindesine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vinflunine,The serum concentration of Vinflunine can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vitamin D,The metabolism of Vitamin D can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vitamin E,The metabolism of Vitamin E can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Voclosporin,The metabolism of Voclosporin can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with St. John's Wort.,decrease,no risk
St. John's Wort,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with St. John's Wort.,decrease,no risk
St. John's Wort,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Warfarin,The metabolism of Warfarin can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Yohimbine,The metabolism of Yohimbine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zafirlukast,The metabolism of St. John's Wort can be decreased when combined with Zafirlukast.,decrease,no risk
St. John's Wort,Zaleplon,The metabolism of Zaleplon can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Ziconotide,The risk or severity of CNS depression can be increased when St. John's Wort is combined with Ziconotide.,increase,risk
St. John's Wort,Zidovudine,The metabolism of Zidovudine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zileuton,The metabolism of Zileuton can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zimelidine,The risk or severity of adverse effects can be increased when St. John's Wort is combined with Zimelidine.,increase,risk
St. John's Wort,Ziprasidone,The risk or severity of adverse effects can be increased when St. John's Wort is combined with Ziprasidone.,increase,risk
St. John's Wort,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with St. John's Wort.,increase,risk
St. John's Wort,Zolpidem,St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
St. John's Wort,Zonisamide,The metabolism of Zonisamide can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zopiclone,The metabolism of Zopiclone can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zotepine,The metabolism of Zotepine can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with St. John's Wort.,increase,no risk
St. John's Wort,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with St. John's Wort.,increase,risk
Polythiazide,Bendroflumethiazide,The therapeutic efficacy of Polythiazide can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Polythiazide,Benorilate,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Benorilate.,decrease,no risk
Polythiazide,Benoxaprofen,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Polythiazide,Benserazide,Polythiazide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Benzatropine,Polythiazide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Benzhydrocodone,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Polythiazide,Benziodarone,The therapeutic efficacy of Benziodarone can be decreased when used in combination with Polythiazide.,decrease,no risk
Polythiazide,Benznidazole,Polythiazide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Benzoic acid,The excretion of Polythiazide can be decreased when combined with Benzoic acid.,decrease,no risk
Polythiazide,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Polythiazide.,decrease,no risk
Polythiazide,Benzthiazide,The therapeutic efficacy of Polythiazide can be increased when used in combination with Benzthiazide.,increase,no risk
Polythiazide,Benzydamine,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Benzydamine.,decrease,no risk
Polythiazide,Benzylpenicillin,Polythiazide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Polythiazide,Bepotastine,Polythiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Bepridil,The therapeutic efficacy of Bepridil can be increased when used in combination with Polythiazide.,increase,no risk
Polythiazide,Betamethasone,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Polythiazide.,increase,risk
Polythiazide,Betamethasone phosphate,The risk or severity of electrolyte imbalance can be increased when Betamethasone phosphate is combined with Polythiazide.,increase,risk
Polythiazide,Betaxolol,The therapeutic efficacy of Betaxolol can be increased when used in combination with Polythiazide.,increase,no risk
Polythiazide,Bethanidine,The therapeutic efficacy of Bethanidine can be increased when used in combination with Polythiazide.,increase,no risk
Polythiazide,Betrixaban,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Polythiazide.,decrease,no risk
Polythiazide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Polythiazide.,decrease,no risk
Polythiazide,Bexarotene,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Bexarotene.,increase,risk
Polythiazide,Bicisate,Polythiazide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be increased when used in combination with Polythiazide.,increase,no risk
Polythiazide,Biperiden,The serum concentration of Polythiazide can be increased when it is combined with Biperiden.,increase,no risk
Polythiazide,Bisacodyl,The risk or severity of dehydration can be increased when Polythiazide is combined with Bisacodyl.,increase,risk
Polythiazide,Bismuth subgallate,Polythiazide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Bisoprolol,The therapeutic efficacy of Bisoprolol can be increased when used in combination with Polythiazide.,increase,no risk
Polythiazide,Bisoxatin,The risk or severity of dehydration can be increased when Polythiazide is combined with Bisoxatin.,increase,risk
Polythiazide,Bivalirudin,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Polythiazide.,decrease,no risk
Polythiazide,Bleomycin,Polythiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Blinatumomab,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Blinatumomab.,increase,risk
Polythiazide,Bortezomib,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Bortezomib.,increase,risk
Polythiazide,Bosentan,The therapeutic efficacy of Bosentan can be increased when used in combination with Polythiazide.,increase,no risk
Polythiazide,Bosutinib,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Bosutinib.,increase,risk
Polythiazide,Bretylium,The therapeutic efficacy of Bretylium can be increased when used in combination with Polythiazide.,increase,no risk
Polythiazide,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Polythiazide.,decrease,no risk
Polythiazide,Brimonidine,Brimonidine may increase the antihypertensive activities of Polythiazide.,increase,no risk
Polythiazide,Brivaracetam,Polythiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Bromazepam,Polythiazide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Polythiazide.,decrease,no risk
Polythiazide,Brompheniramine,The serum concentration of Polythiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Polythiazide,Buclizine,The serum concentration of Polythiazide can be increased when it is combined with Buclizine.,increase,no risk
Polythiazide,Budesonide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Polythiazide.,increase,risk
Polythiazide,Bumadizone,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Bumadizone.,decrease,no risk
Polythiazide,Bumetanide,The excretion of Polythiazide can be decreased when combined with Bumetanide.,decrease,no risk
Polythiazide,Bupivacaine,Bupivacaine may increase the hypotensive activities of Polythiazide.,increase,no risk
Polythiazide,Buprenorphine,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Polythiazide,Bupropion,Polythiazide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Buspirone,Polythiazide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Polythiazide,Busulfan,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Busulfan.,increase,risk
Polythiazide,Butabarbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Polythiazide.,increase,risk
Polythiazide,Butalbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Polythiazide.,increase,risk
Polythiazide,Butobarbital,The serum concentration of Polythiazide can be increased when it is combined with Butobarbital.,increase,no risk
Polythiazide,Butorphanol,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Butorphanol.,decrease,no risk
Polythiazide,Butriptyline,Butriptyline may decrease the antihypertensive activities of Polythiazide.,decrease,no risk
Polythiazide,Butylscopolamine,The serum concentration of Polythiazide can be increased when it is combined with Butylscopolamine.,increase,no risk
Cefamandole,Gabapentin enacarbil,Cefamandole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefamandole,Gadobenic acid,Cefamandole may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefamandole,Gadodiamide,Cefamandole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefamandole,Gadofosveset trisodium,Cefamandole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefamandole,Gadopentetic acid,Cefamandole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefamandole,Gadoteric acid,Cefamandole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefamandole,Gadoteridol,Cefamandole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefamandole,Ganciclovir,Cefamandole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefamandole,Gemcitabine,Cefamandole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefamandole,Gemfibrozil,Cefamandole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefamandole,Gentamicin,Cefamandole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefamandole,Gimeracil,Cefamandole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefamandole,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Givosiran.,increase,risk
Cefamandole,Glipizide,Cefamandole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefamandole,Glycerol phenylbutyrate,Cefamandole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefamandole,Golodirsen,Cefamandole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefamandole,Goserelin,Cefamandole may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefamandole,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Cefamandole.,decrease,no risk
Cefamandole,Guanethidine,Cefamandole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefamandole,Guanfacine,Cefamandole may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefamandole,Haloperidol,Cefamandole may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefamandole,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefamandole.,decrease,no risk
Cefamandole,Hydralazine,Cefamandole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefamandole,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Cefamandole.,decrease,no risk
Cefamandole,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Cefamandole.,decrease,no risk
Cefamandole,Hydromorphone,Cefamandole may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefamandole,Hydroxocobalamin,Cefamandole may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefamandole,Hydroxyethyl Starch,Cefamandole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefamandole,Kanamycin,Cefamandole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefamandole,Ketamine,Cefamandole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefamandole,Ketazolam,Cefamandole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefamandole,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefamandole.,increase,risk
Cefamandole,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefamandole.,increase,risk
Cefamandole,N-acetyltyrosine,Cefamandole may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Cefamandole,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefamandole.,increase,risk
Cefamandole,Nadolol,Cefamandole may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Cefamandole,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefamandole.,decrease,no risk
Cefamandole,Naldemedine,Cefamandole may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Cefamandole,Nalmefene,Cefamandole may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Cefamandole,Naloxone,Cefamandole may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Cefamandole,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefamandole.,increase,risk
Cefamandole,Nateglinide,Cefamandole may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Cefamandole,Nedaplatin,Cefamandole may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Cefamandole,Nedocromil,Cefamandole may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Cefamandole,Nefazodone,Cefamandole may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Cefamandole,Neomycin,The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Neomycin.,increase,risk
Cefamandole,Netilmicin,Cefamandole may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Cefamandole,Nicorandil,Cefamandole may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Cefamandole,Nifedipine,Cefamandole may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Cefamandole,Nilutamide,Cefamandole may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Cefamandole,Nimesulide,The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Nimesulide.,increase,risk
Cefamandole,Nisoldipine,Cefamandole may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Cefamandole,Nitric Oxide,Cefamandole may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Cefamandole,Nitrofurantoin,Cefamandole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Cefamandole,Nitroprusside,Cefamandole may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Cefamandole,Octinoxate,Cefamandole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefamandole,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Olsalazine.,increase,risk
Cefamandole,Opium,Cefamandole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefamandole,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Cefamandole.,decrease,no risk
Cefamandole,Oxacillin,Cefamandole may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefamandole,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefamandole.,increase,risk
Cefamandole,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefamandole.,increase,risk
Cefamandole,Oxazepam,Cefamandole may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefamandole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefamandole is combined with Oxetacaine.,increase,risk
Cefamandole,Oxybenzone,Cefamandole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefamandole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefamandole is combined with Oxybuprocaine.,increase,risk
Cefamandole,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Oxyphenbutazone.,increase,risk
Cefamandole,Oxyquinoline,Cefamandole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefamandole,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Cefamandole.,decrease,no risk
Cefamandole,Quetiapine,Cefamandole may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefamandole,Quinapril,The excretion of Quinapril can be decreased when combined with Cefamandole.,decrease,no risk
Cefamandole,Quinidine,Cefamandole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefazolin,Gabapentin enacarbil,Cefazolin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefazolin,Gadobenic acid,Cefazolin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefazolin,Gadodiamide,Cefazolin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefazolin,Gadofosveset trisodium,Cefazolin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefazolin,Gadopentetic acid,Cefazolin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefazolin,Gadoteric acid,Cefazolin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefazolin,Gadoteridol,Cefazolin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefazolin,Ganciclovir,The excretion of Cefazolin can be decreased when combined with Ganciclovir.,decrease,no risk
Cefazolin,Gemcitabine,Cefazolin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefazolin,Gemfibrozil,The excretion of Cefazolin can be decreased when combined with Gemfibrozil.,decrease,no risk
Cefazolin,Gentamicin,Cefazolin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefazolin,Gimeracil,Cefazolin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefazolin,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Givosiran.,increase,risk
Cefazolin,Glipizide,Cefazolin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefazolin,Glyburide,The excretion of Cefazolin can be decreased when combined with Glyburide.,decrease,no risk
Cefazolin,Glycerol phenylbutyrate,Cefazolin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefazolin,Golodirsen,Cefazolin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefazolin,Goserelin,Cefazolin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefazolin,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Cefazolin.,decrease,no risk
Cefazolin,Guanethidine,Cefazolin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefazolin,Guanfacine,Cefazolin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefazolin,Guanidine,The excretion of Cefazolin can be decreased when combined with Guanidine.,decrease,no risk
Cefazolin,Haloperidol,Cefazolin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefazolin,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefazolin.,decrease,no risk
Cefazolin,Hydralazine,Cefazolin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefazolin,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Cefazolin.,decrease,no risk
Cefazolin,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Cefazolin.,decrease,no risk
Cefazolin,Hydromorphone,Cefazolin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefazolin,Hydroxocobalamin,Cefazolin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefazolin,Hydroxyethyl Starch,Cefazolin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefazolin,Kanamycin,Cefazolin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefazolin,Ketamine,Cefazolin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefazolin,Ketazolam,Cefazolin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefazolin,Ketoprofen,The excretion of Cefazolin can be decreased when combined with Ketoprofen.,decrease,no risk
Cefazolin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefazolin.,increase,risk
Cefazolin,N-acetyltyrosine,Cefazolin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Cefazolin,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefazolin.,increase,risk
Cefazolin,Nadolol,Cefazolin may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Cefazolin,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefazolin.,decrease,no risk
Cefazolin,Nafcillin,The excretion of Cefazolin can be decreased when combined with Nafcillin.,decrease,no risk
Cefazolin,Naldemedine,Cefazolin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Cefazolin,Nalidixic acid,The excretion of Cefazolin can be decreased when combined with Nalidixic acid.,decrease,no risk
Cefazolin,Nalmefene,Cefazolin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Cefazolin,Naloxone,Cefazolin may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Cefazolin,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefazolin.,increase,risk
Cefazolin,Nateglinide,Cefazolin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Cefazolin,Nedaplatin,Cefazolin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Cefazolin,Nedocromil,Cefazolin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Cefazolin,Nefazodone,Cefazolin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Cefazolin,Neomycin,The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Neomycin.,increase,risk
Cefazolin,Netilmicin,Cefazolin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Cefazolin,Nicorandil,Cefazolin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Cefazolin,Nifedipine,Cefazolin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Cefazolin,Nilutamide,Cefazolin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Cefazolin,Nimesulide,The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Nimesulide.,increase,risk
Cefazolin,Nisoldipine,Cefazolin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Cefazolin,Nitric Oxide,Cefazolin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Cefazolin,Nitrofurantoin,Cefazolin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Cefazolin,Nitroprusside,Cefazolin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Cefazolin,Norfloxacin,The excretion of Cefazolin can be decreased when combined with Norfloxacin.,decrease,no risk
Cefazolin,Novobiocin,The excretion of Cefazolin can be decreased when combined with Novobiocin.,decrease,no risk
Cefazolin,Octinoxate,Cefazolin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefazolin,Ofloxacin,The excretion of Cefazolin can be decreased when combined with Ofloxacin.,decrease,no risk
Cefazolin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Olsalazine.,increase,risk
Cefazolin,Opium,Cefazolin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefazolin,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Cefazolin.,decrease,no risk
Cefazolin,Ouabain,The excretion of Cefazolin can be decreased when combined with Ouabain.,decrease,no risk
Cefazolin,Oxacillin,Cefazolin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefazolin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefazolin.,increase,risk
Cefazolin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefazolin.,increase,risk
Cefazolin,Oxazepam,Cefazolin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefazolin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefazolin is combined with Oxetacaine.,increase,risk
Cefazolin,Oxybenzone,Cefazolin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefazolin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefazolin is combined with Oxybuprocaine.,increase,risk
Cefazolin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Oxyphenbutazone.,increase,risk
Cefazolin,Oxyquinoline,Cefazolin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefazolin,Oxytetracycline,The excretion of Cefazolin can be decreased when combined with Oxytetracycline.,decrease,no risk
Cefazolin,Quetiapine,Cefazolin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefazolin,Quinapril,The excretion of Quinapril can be decreased when combined with Cefazolin.,decrease,no risk
Cefazolin,Quinidine,Cefazolin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefonicid,Gabapentin enacarbil,Cefonicid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefonicid,Gadobenic acid,Cefonicid may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefonicid,Gadodiamide,Cefonicid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefonicid,Gadofosveset trisodium,Cefonicid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefonicid,Gadopentetic acid,Cefonicid may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefonicid,Gadoteric acid,Cefonicid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefonicid,Gadoteridol,Cefonicid may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefonicid,Ganciclovir,Cefonicid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefonicid,Gemcitabine,Cefonicid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefonicid,Gemfibrozil,Cefonicid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefonicid,Gentamicin,Cefonicid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefonicid,Gimeracil,Cefonicid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefonicid,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Givosiran.,increase,risk
Cefonicid,Glipizide,Cefonicid may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefonicid,Glycerol phenylbutyrate,Cefonicid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefonicid,Golodirsen,Cefonicid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefonicid,Goserelin,Cefonicid may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefonicid,Guanethidine,Cefonicid may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefonicid,Guanfacine,Cefonicid may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefonicid,Haloperidol,Cefonicid may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefonicid,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefonicid.,decrease,no risk
Cefonicid,Hydralazine,Cefonicid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefonicid,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefonicid.,increase,risk
Cefonicid,Hydromorphone,Cefonicid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefonicid,Hydroxocobalamin,Cefonicid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefonicid,Hydroxyethyl Starch,Cefonicid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefonicid,Kanamycin,Cefonicid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefonicid,Ketamine,Cefonicid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefonicid,Ketazolam,Cefonicid may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefonicid,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefonicid.,increase,risk
Cefonicid,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefonicid.,increase,risk
Cefonicid,N-acetyltyrosine,Cefonicid may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Cefonicid,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefonicid.,increase,risk
Cefonicid,Nadolol,Cefonicid may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Cefonicid,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefonicid.,decrease,no risk
Cefonicid,Naldemedine,Cefonicid may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Cefonicid,Nalmefene,Cefonicid may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Cefonicid,Naloxone,Cefonicid may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Cefonicid,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefonicid.,increase,risk
Cefonicid,Nateglinide,Cefonicid may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Cefonicid,Nedaplatin,Cefonicid may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Cefonicid,Nedocromil,Cefonicid may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Cefonicid,Nefazodone,Cefonicid may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Cefonicid,Neomycin,The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Neomycin.,increase,risk
Cefonicid,Netilmicin,Cefonicid may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Cefonicid,Nicorandil,Cefonicid may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Cefonicid,Nifedipine,Cefonicid may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Cefonicid,Nilutamide,Cefonicid may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Cefonicid,Nimesulide,The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Nimesulide.,increase,risk
Cefonicid,Nisoldipine,Cefonicid may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Cefonicid,Nitric Oxide,Cefonicid may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Cefonicid,Nitrofurantoin,Cefonicid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Cefonicid,Nitroprusside,Cefonicid may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Cefonicid,Octinoxate,Cefonicid may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefonicid,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Olsalazine.,increase,risk
Cefonicid,Opium,Cefonicid may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefonicid,Oseltamivir,Cefonicid may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefonicid,Oxacillin,Cefonicid may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefonicid,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefonicid.,increase,risk
Cefonicid,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefonicid.,increase,risk
Cefonicid,Oxazepam,Cefonicid may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefonicid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefonicid is combined with Oxetacaine.,increase,risk
Cefonicid,Oxybenzone,Cefonicid may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefonicid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefonicid is combined with Oxybuprocaine.,increase,risk
Cefonicid,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Oxyphenbutazone.,increase,risk
Cefonicid,Oxyquinoline,Cefonicid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefonicid,Quetiapine,Cefonicid may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefonicid,Quinidine,Cefonicid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefonicid,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefonicid.,decrease,no risk
Cefonicid,Vaborbactam,Cefonicid may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefonicid,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cefonicid.,increase,risk
Cefonicid,Valbenazine,Cefonicid may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefonicid,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefonicid.,increase,risk
Cefonicid,Valganciclovir,Cefonicid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefonicid,Vancomycin,Cefonicid may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefonicid,Varenicline,Cefonicid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefonicid,Venlafaxine,Cefonicid may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefonicid,Verapamil,Cefonicid may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefonicid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefonicid.,decrease,no risk
Cefonicid,Vilanterol,Cefonicid may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefonicid,Viloxazine,Cefonicid may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefonicid,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefonicid.,decrease,no risk
Cefonicid,Vortioxetine,Cefonicid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefonicid,Warfarin,Cefonicid may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cefonicid,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefonicid.,decrease,no risk
Cefonicid,Zaleplon,Cefonicid may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefonicid,Zanamivir,Cefonicid may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefonicid,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefonicid is combined with Zoledronic acid.,increase,risk
Cefonicid,Zonisamide,Cefonicid may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gabapentin enacarbil,Cefoperazone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gadobenic acid,Cefoperazone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gadodiamide,Cefoperazone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gadofosveset trisodium,Cefoperazone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gadopentetic acid,Cefoperazone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gadoteric acid,Cefoperazone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gadoteridol,Cefoperazone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefoperazone,Ganciclovir,Cefoperazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gemcitabine,Cefoperazone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gemfibrozil,Cefoperazone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gentamicin,Cefoperazone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Gimeracil,Cefoperazone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefoperazone,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Givosiran.,increase,risk
Cefoperazone,Glipizide,Cefoperazone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefoperazone,Glycerol phenylbutyrate,Cefoperazone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefoperazone,Golodirsen,Cefoperazone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefoperazone,Goserelin,Cefoperazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Cefoperazone.,decrease,no risk
Cefoperazone,Guanethidine,Cefoperazone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Guanfacine,Cefoperazone may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Haloperidol,Cefoperazone may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefoperazone,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefoperazone.,decrease,no risk
Cefoperazone,Hydralazine,Cefoperazone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Cefoperazone.,decrease,no risk
Cefoperazone,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Cefoperazone.,decrease,no risk
Cefoperazone,Hydromorphone,Cefoperazone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefoperazone,Hydroxocobalamin,Cefoperazone may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Hydroxyethyl Starch,Cefoperazone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefoperazone,Kanamycin,Cefoperazone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Ketamine,Cefoperazone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Ketazolam,Cefoperazone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefoperazone,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefoperazone.,increase,risk
Cefoperazone,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefoperazone.,increase,risk
Cefoperazone,N-acetyltyrosine,Cefoperazone may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefoperazone.,increase,risk
Cefoperazone,Nadolol,Cefoperazone may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefoperazone.,decrease,no risk
Cefoperazone,Naldemedine,Cefoperazone may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nalmefene,Cefoperazone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Cefoperazone,Naloxone,Cefoperazone may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Cefoperazone,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefoperazone.,increase,risk
Cefoperazone,Nateglinide,Cefoperazone may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nedaplatin,Cefoperazone may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nedocromil,Cefoperazone may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nefazodone,Cefoperazone may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Cefoperazone,Neomycin,The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Neomycin.,increase,risk
Cefoperazone,Netilmicin,Cefoperazone may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nicorandil,Cefoperazone may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nifedipine,Cefoperazone may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nilutamide,Cefoperazone may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nimesulide,The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Nimesulide.,increase,risk
Cefoperazone,Nisoldipine,Cefoperazone may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nitric Oxide,Cefoperazone may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nitrofurantoin,Cefoperazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Nitroprusside,Cefoperazone may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Cefoperazone,Octinoxate,Cefoperazone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefoperazone,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Olsalazine.,increase,risk
Cefoperazone,Opium,Cefoperazone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefoperazone,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Cefoperazone.,decrease,no risk
Cefoperazone,Oxacillin,Cefoperazone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefoperazone,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefoperazone.,increase,risk
Cefoperazone,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefoperazone.,increase,risk
Cefoperazone,Oxazepam,Cefoperazone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefoperazone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefoperazone is combined with Oxetacaine.,increase,risk
Cefoperazone,Oxybenzone,Cefoperazone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefoperazone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefoperazone is combined with Oxybuprocaine.,increase,risk
Cefoperazone,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Oxyphenbutazone.,increase,risk
Cefoperazone,Oxyquinoline,Cefoperazone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefoperazone,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Cefoperazone.,decrease,no risk
Cefoperazone,Quetiapine,Cefoperazone may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefoperazone,Quinapril,The excretion of Quinapril can be decreased when combined with Cefoperazone.,decrease,no risk
Cefoperazone,Quinidine,Cefoperazone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefotetan,Gabapentin enacarbil,Cefotetan may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefotetan,Gadobenic acid,Cefotetan may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefotetan,Gadodiamide,Cefotetan may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefotetan,Gadofosveset trisodium,Cefotetan may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefotetan,Gadopentetic acid,Cefotetan may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefotetan,Gadoteric acid,Cefotetan may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefotetan,Gadoteridol,Cefotetan may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefotetan,Ganciclovir,Cefotetan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefotetan,Gemcitabine,Cefotetan may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefotetan,Gemfibrozil,Cefotetan may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefotetan,Gentamicin,Cefotetan may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefotetan,Gimeracil,Cefotetan may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefotetan,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Givosiran.,increase,risk
Cefotetan,Glipizide,Cefotetan may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefotetan,Glycerol phenylbutyrate,Cefotetan may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefotetan,Golodirsen,Cefotetan may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefotetan,Goserelin,Cefotetan may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefotetan,Guanethidine,Cefotetan may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefotetan,Guanfacine,Cefotetan may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefotetan,Haloperidol,Cefotetan may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefotetan,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefotetan.,decrease,no risk
Cefotetan,Hydralazine,Cefotetan may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefotetan,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefotetan.,increase,risk
Cefotetan,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cefotetan,Hydromorphone,Cefotetan may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefotetan,Hydroxocobalamin,Cefotetan may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefotetan,Hydroxyethyl Starch,Cefotetan may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefotetan,Kanamycin,Cefotetan may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefotetan,Ketamine,Cefotetan may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefotetan,Ketazolam,Cefotetan may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefotetan,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefotetan.,increase,risk
Cefotetan,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefotetan.,increase,risk
Cefotetan,N-acetyltyrosine,Cefotetan may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Cefotetan,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefotetan.,increase,risk
Cefotetan,Nadolol,Cefotetan may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Cefotetan,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefotetan.,decrease,no risk
Cefotetan,Naldemedine,Cefotetan may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Cefotetan,Nalmefene,Cefotetan may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Cefotetan,Naloxone,Cefotetan may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Cefotetan,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefotetan.,increase,risk
Cefotetan,Nateglinide,Cefotetan may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Cefotetan,Nedaplatin,Cefotetan may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Cefotetan,Nedocromil,Cefotetan may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Cefotetan,Nefazodone,Cefotetan may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Cefotetan,Neomycin,The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Neomycin.,increase,risk
Cefotetan,Netilmicin,Cefotetan may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Cefotetan,Nicorandil,Cefotetan may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Cefotetan,Nifedipine,Cefotetan may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Cefotetan,Nilutamide,Cefotetan may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Cefotetan,Nimesulide,The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Nimesulide.,increase,risk
Cefotetan,Nisoldipine,Cefotetan may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Cefotetan,Nitric Oxide,Cefotetan may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Cefotetan,Nitrofurantoin,Cefotetan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Cefotetan,Nitroprusside,Cefotetan may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Cefotetan,Octinoxate,Cefotetan may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefotetan,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Olsalazine.,increase,risk
Cefotetan,Opium,Cefotetan may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefotetan,Oseltamivir,Cefotetan may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefotetan,Oxacillin,Cefotetan may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefotetan,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefotetan.,increase,risk
Cefotetan,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefotetan.,increase,risk
Cefotetan,Oxazepam,Cefotetan may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefotetan,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Oxetacaine.,increase,risk
Cefotetan,Oxybenzone,Cefotetan may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefotetan,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Oxybuprocaine.,increase,risk
Cefotetan,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Oxyphenbutazone.,increase,risk
Cefotetan,Oxyquinoline,Cefotetan may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefotetan,Quetiapine,Cefotetan may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefotetan,Quinethazone,Quinethazone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cefotetan,Quinidine,Cefotetan may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefotetan,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotetan.,decrease,no risk
Cefotetan,Vaborbactam,Cefotetan may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefotetan,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cefotetan.,increase,risk
Cefotetan,Valbenazine,Cefotetan may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefotetan,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefotetan.,increase,risk
Cefotetan,Valganciclovir,Cefotetan may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefotetan,Vancomycin,Cefotetan may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefotetan,Varenicline,Cefotetan may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefotetan,Venlafaxine,Cefotetan may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefotetan,Verapamil,Cefotetan may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefotetan,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefotetan.,decrease,no risk
Cefotetan,Vilanterol,Cefotetan may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefotetan,Viloxazine,Cefotetan may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefotetan,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefotetan.,decrease,no risk
Cefotetan,Vortioxetine,Cefotetan may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefotetan,Warfarin,Cefotetan may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cefotetan,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefotetan.,decrease,no risk
Cefotetan,Zaleplon,Cefotetan may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefotetan,Zanamivir,Cefotetan may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefotetan,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Zoledronic acid.,increase,risk
Cefotetan,Zonisamide,Zonisamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cefoxitin,Gabapentin enacarbil,Cefoxitin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gadobenic acid,Cefoxitin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gadodiamide,Cefoxitin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gadofosveset trisodium,Cefoxitin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gadopentetic acid,Cefoxitin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gadoteric acid,Cefoxitin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gadoteridol,Cefoxitin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefoxitin,Ganciclovir,Cefoxitin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gemcitabine,Cefoxitin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gemfibrozil,Cefoxitin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gentamicin,Cefoxitin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Gimeracil,Cefoxitin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefoxitin,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Givosiran.,increase,risk
Cefoxitin,Glipizide,Cefoxitin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefoxitin,Glycerol phenylbutyrate,Cefoxitin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefoxitin,Golodirsen,Cefoxitin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefoxitin,Goserelin,Cefoxitin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Guanethidine,Cefoxitin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Guanfacine,Cefoxitin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Haloperidol,Cefoxitin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefoxitin,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefoxitin.,decrease,no risk
Cefoxitin,Hydralazine,Cefoxitin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefoxitin.,increase,risk
Cefoxitin,Hydromorphone,Cefoxitin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefoxitin,Hydroxocobalamin,Cefoxitin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Hydroxyethyl Starch,Cefoxitin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefoxitin,Kanamycin,Cefoxitin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Ketamine,Cefoxitin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Ketazolam,Cefoxitin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefoxitin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefoxitin.,increase,risk
Cefoxitin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefoxitin.,increase,risk
Cefoxitin,N-acetyltyrosine,Cefoxitin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefoxitin.,increase,risk
Cefoxitin,Nadolol,Cefoxitin may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefoxitin.,decrease,no risk
Cefoxitin,Naldemedine,Cefoxitin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nalmefene,Cefoxitin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Cefoxitin,Naloxone,Cefoxitin may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Cefoxitin,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefoxitin.,increase,risk
Cefoxitin,Nateglinide,Cefoxitin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nedaplatin,Cefoxitin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nedocromil,Cefoxitin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nefazodone,Cefoxitin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Cefoxitin,Neomycin,The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Neomycin.,increase,risk
Cefoxitin,Netilmicin,Cefoxitin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nicorandil,Cefoxitin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nifedipine,Cefoxitin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nilutamide,Cefoxitin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nimesulide,The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Nimesulide.,increase,risk
Cefoxitin,Nisoldipine,Cefoxitin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nitric Oxide,Cefoxitin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nitrofurantoin,Cefoxitin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Nitroprusside,Cefoxitin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Cefoxitin,Octinoxate,Cefoxitin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefoxitin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Olsalazine.,increase,risk
Cefoxitin,Opium,Cefoxitin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefoxitin,Oseltamivir,Cefoxitin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefoxitin,Oxacillin,Cefoxitin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefoxitin.,increase,risk
Cefoxitin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefoxitin.,increase,risk
Cefoxitin,Oxazepam,Cefoxitin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefoxitin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefoxitin is combined with Oxetacaine.,increase,risk
Cefoxitin,Oxybenzone,Cefoxitin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefoxitin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefoxitin is combined with Oxybuprocaine.,increase,risk
Cefoxitin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Oxyphenbutazone.,increase,risk
Cefoxitin,Oxyquinoline,Cefoxitin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefoxitin,Quetiapine,Cefoxitin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Quinidine,Cefoxitin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefoxitin.,decrease,no risk
Cefoxitin,Vaborbactam,Cefoxitin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefoxitin,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cefoxitin.,increase,risk
Cefoxitin,Valbenazine,Cefoxitin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefoxitin.,increase,risk
Cefoxitin,Valganciclovir,Cefoxitin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefoxitin,Vancomycin,Cefoxitin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Varenicline,Cefoxitin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefoxitin,Venlafaxine,Cefoxitin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Verapamil,Cefoxitin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefoxitin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefoxitin.,decrease,no risk
Cefoxitin,Vilanterol,Cefoxitin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefoxitin,Viloxazine,Cefoxitin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefoxitin.,decrease,no risk
Cefoxitin,Vortioxetine,Cefoxitin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefoxitin,Warfarin,Cefoxitin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cefoxitin,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefoxitin.,decrease,no risk
Cefoxitin,Zaleplon,Cefoxitin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefoxitin,Zanamivir,Cefoxitin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefoxitin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefoxitin is combined with Zoledronic acid.,increase,risk
Cefoxitin,Zonisamide,Cefoxitin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gabapentin enacarbil,Ceftizoxime may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gadobenic acid,Ceftizoxime may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gadodiamide,Ceftizoxime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gadofosveset trisodium,Ceftizoxime may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gadopentetic acid,Ceftizoxime may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gadoteric acid,Ceftizoxime may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gadoteridol,Ceftizoxime may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Ganciclovir,The excretion of Ceftizoxime can be decreased when combined with Ganciclovir.,decrease,no risk
Ceftizoxime,Gemcitabine,Ceftizoxime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gemfibrozil,The excretion of Ceftizoxime can be decreased when combined with Gemfibrozil.,decrease,no risk
Ceftizoxime,Gentamicin,Ceftizoxime may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Gimeracil,Ceftizoxime may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Givosiran,The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Givosiran.,increase,risk
Ceftizoxime,Glipizide,Ceftizoxime may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Glyburide,The excretion of Ceftizoxime can be decreased when combined with Glyburide.,decrease,no risk
Ceftizoxime,Glycerol phenylbutyrate,Ceftizoxime may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Golodirsen,Ceftizoxime may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Goserelin,Ceftizoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Ceftizoxime.,decrease,no risk
Ceftizoxime,Guanethidine,Ceftizoxime may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Guanfacine,Ceftizoxime may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Guanidine,The excretion of Ceftizoxime can be decreased when combined with Guanidine.,decrease,no risk
Ceftizoxime,Haloperidol,Ceftizoxime may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceftizoxime.,decrease,no risk
Ceftizoxime,Hydralazine,Ceftizoxime may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Ceftizoxime.,decrease,no risk
Ceftizoxime,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Ceftizoxime.,decrease,no risk
Ceftizoxime,Hydromorphone,Ceftizoxime may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Hydroxocobalamin,Ceftizoxime may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Hydroxyethyl Starch,Ceftizoxime may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Kanamycin,Ceftizoxime may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Ketamine,Ceftizoxime may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Ketazolam,Ceftizoxime may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Ketoprofen,The excretion of Ceftizoxime can be decreased when combined with Ketoprofen.,decrease,no risk
Ceftizoxime,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Ceftizoxime.,increase,risk
Ceftizoxime,N-acetyltyrosine,Ceftizoxime may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Ceftizoxime.,increase,risk
Ceftizoxime,Nadolol,Ceftizoxime may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Ceftizoxime.,decrease,no risk
Ceftizoxime,Nafcillin,The excretion of Ceftizoxime can be decreased when combined with Nafcillin.,decrease,no risk
Ceftizoxime,Naldemedine,Ceftizoxime may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nalidixic acid,The excretion of Ceftizoxime can be decreased when combined with Nalidixic acid.,decrease,no risk
Ceftizoxime,Nalmefene,Ceftizoxime may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Naloxone,Ceftizoxime may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Ceftizoxime.,increase,risk
Ceftizoxime,Nateglinide,Ceftizoxime may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nedaplatin,Ceftizoxime may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nedocromil,Ceftizoxime may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nefazodone,Ceftizoxime may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Neomycin,The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Neomycin.,increase,risk
Ceftizoxime,Netilmicin,Ceftizoxime may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nicorandil,Ceftizoxime may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nifedipine,Ceftizoxime may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nilutamide,Ceftizoxime may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nimesulide,The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Nimesulide.,increase,risk
Ceftizoxime,Nisoldipine,Ceftizoxime may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nitric Oxide,Ceftizoxime may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nitrofurantoin,Ceftizoxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Nitroprusside,Ceftizoxime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Norfloxacin,The excretion of Ceftizoxime can be decreased when combined with Norfloxacin.,decrease,no risk
Ceftizoxime,Novobiocin,The excretion of Ceftizoxime can be decreased when combined with Novobiocin.,decrease,no risk
Ceftizoxime,Octinoxate,Ceftizoxime may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Ofloxacin,The excretion of Ceftizoxime can be decreased when combined with Ofloxacin.,decrease,no risk
Ceftizoxime,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Olsalazine.,increase,risk
Ceftizoxime,Opium,Ceftizoxime may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Ceftizoxime.,decrease,no risk
Ceftizoxime,Ouabain,The excretion of Ceftizoxime can be decreased when combined with Ouabain.,decrease,no risk
Ceftizoxime,Oxacillin,Ceftizoxime may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ceftizoxime.,increase,risk
Ceftizoxime,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Ceftizoxime.,increase,risk
Ceftizoxime,Oxazepam,Ceftizoxime may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceftizoxime is combined with Oxetacaine.,increase,risk
Ceftizoxime,Oxybenzone,Ceftizoxime may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceftizoxime is combined with Oxybuprocaine.,increase,risk
Ceftizoxime,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Oxyphenbutazone.,increase,risk
Ceftizoxime,Oxyquinoline,Ceftizoxime may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Oxytetracycline,The excretion of Ceftizoxime can be decreased when combined with Oxytetracycline.,decrease,no risk
Ceftizoxime,Quetiapine,Ceftizoxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ceftizoxime,Quinapril,The excretion of Quinapril can be decreased when combined with Ceftizoxime.,decrease,no risk
Ceftizoxime,Quinidine,Ceftizoxime may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefradine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Cefradine.,increase,no risk
Cefradine,Brigatinib,The metabolism of Brigatinib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Brivaracetam,Cefradine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Cefradine,Bromazepam,Cefradine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Cefradine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cefradine,Budesonide,Cefradine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Cefradine,Bumadizone,The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Bumadizone.,increase,risk
Cefradine,Bumetanide,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Cefradine.,increase,risk
Cefradine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Cefradine is combined with Bupivacaine.,increase,risk
Cefradine,Bupropion,Cefradine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Cefradine,Buspirone,Cefradine may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Cefradine,Busulfan,The metabolism of Busulfan can be increased when combined with Cefradine.,increase,no risk
Cefradine,Butabarbital,Cefradine may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Cefradine,Butacaine,The risk or severity of methemoglobinemia can be increased when Cefradine is combined with Butacaine.,increase,risk
Cefradine,Butamben,The risk or severity of methemoglobinemia can be increased when Cefradine is combined with Butamben.,increase,risk
Cefradine,Gabapentin enacarbil,Cefradine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefradine,Gadobenic acid,Cefradine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefradine,Gadodiamide,Cefradine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefradine,Gadofosveset trisodium,Cefradine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefradine,Gadopentetic acid,Cefradine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefradine,Gadoteric acid,Cefradine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefradine,Gadoteridol,Cefradine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefradine,Ganciclovir,Cefradine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefradine,Gemcitabine,Cefradine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefradine,Gemfibrozil,Cefradine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefradine,Gentamicin,Cefradine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefradine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Cefradine.,increase,no risk
Cefradine,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Gimeracil,Cefradine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefradine,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Givosiran.,increase,risk
Cefradine,Glasdegib,The excretion of Cefradine can be decreased when combined with Glasdegib.,decrease,no risk
Cefradine,Glipizide,Cefradine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefradine,Glycerol phenylbutyrate,Cefradine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefradine,Golodirsen,Cefradine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefradine,Goserelin,Cefradine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefradine,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Cefradine.,decrease,no risk
Cefradine,Guanethidine,Cefradine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefradine,Guanfacine,Cefradine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefradine,Guanidine,The excretion of Cefradine can be decreased when combined with Guanidine.,decrease,no risk
Cefradine,Haloperidol,Cefradine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefradine,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefradine.,decrease,no risk
Cefradine,Hydralazine,Cefradine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefradine,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefradine.,increase,risk
Cefradine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cefradine,Hydromorphone,Cefradine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefradine,Hydroxocobalamin,Cefradine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefradine,Hydroxyethyl Starch,Cefradine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefradine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Cefradine.,increase,no risk
Cefradine,Kanamycin,Cefradine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefradine,Ketamine,Cefradine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefradine,Ketazolam,Cefradine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefradine,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefradine.,increase,risk
Cefradine,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefradine.,increase,risk
Cefradine,N-acetyltyrosine,Cefradine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Cefradine,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefradine.,increase,risk
Cefradine,Nadolol,Cefradine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Cefradine,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefradine.,decrease,no risk
Cefradine,Naldemedine,Cefradine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Cefradine,Nalmefene,Cefradine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Cefradine,Naloxone,Cefradine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Cefradine,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefradine.,increase,risk
Cefradine,Nateglinide,Cefradine may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Cefradine,Nedaplatin,Cefradine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Cefradine,Nedocromil,Cefradine may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Cefradine,Nefazodone,Cefradine may decrease the excretion rate of Nefazodone which could result in a higher serum level.,decrease,no risk
Cefradine,Neomycin,The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Neomycin.,increase,risk
Cefradine,Neratinib,The metabolism of Neratinib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Netilmicin,Cefradine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Cefradine,Netupitant,The metabolism of Netupitant can be increased when combined with Cefradine.,increase,no risk
Cefradine,Nicorandil,Cefradine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Cefradine,Nifedipine,Cefradine may decrease the excretion rate of Nifedipine which could result in a higher serum level.,decrease,no risk
Cefradine,Nilotinib,The metabolism of Nilotinib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Nilutamide,Cefradine may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Cefradine,Nimesulide,The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Nimesulide.,increase,risk
Cefradine,Nintedanib,The metabolism of Nintedanib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Nisoldipine,Cefradine may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Cefradine,Nitric Oxide,Cefradine may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Cefradine,Nitrofurantoin,Cefradine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Cefradine,Nitroprusside,Cefradine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Cefradine,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Cefradine.,increase,no risk
Cefradine,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Cefradine.,increase,no risk
Cefradine,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Cefradine.,increase,no risk
Cefradine,Norethisterone,The metabolism of Norethisterone can be increased when combined with Cefradine.,increase,no risk
Cefradine,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Cefradine.,increase,no risk
Cefradine,Norgestimate,The metabolism of Norgestimate can be increased when combined with Cefradine.,increase,no risk
Cefradine,Norgestrel,The metabolism of Norgestrel can be increased when combined with Cefradine.,increase,no risk
Cefradine,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Cefradine.,increase,no risk
Cefradine,Octinoxate,Cefradine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefradine,Olaparib,The metabolism of Olaparib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Cefradine.,decrease,no risk
Cefradine,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Olsalazine.,increase,risk
Cefradine,Opium,Cefradine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefradine,Oseltamivir,Cefradine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefradine,Osimertinib,The metabolism of Osimertinib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Oxacillin,Cefradine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefradine,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefradine.,increase,risk
Cefradine,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefradine.,increase,risk
Cefradine,Oxazepam,Cefradine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefradine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefradine is combined with Oxetacaine.,increase,risk
Cefradine,Oxybenzone,Cefradine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefradine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefradine is combined with Oxybuprocaine.,increase,risk
Cefradine,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Oxyphenbutazone.,increase,risk
Cefradine,Oxyquinoline,Cefradine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefradine,Quetiapine,Cefradine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefradine,Quinethazone,Quinethazone may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cefradine,Quinidine,The metabolism of Quinidine can be increased when combined with Cefradine.,increase,no risk
Cefradine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Cefradine.,increase,no risk
Cefradine,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefradine.,decrease,no risk
Cefradine,Vaborbactam,Cefradine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefradine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Cefradine.,increase,no risk
Cefradine,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cefradine.,increase,risk
Cefradine,Valbenazine,Cefradine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefradine,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefradine.,increase,risk
Cefradine,Valganciclovir,Cefradine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefradine,Vancomycin,Cefradine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefradine,Vandetanib,The metabolism of Vandetanib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Varenicline,Cefradine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefradine,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Venetoclax,The metabolism of Venetoclax can be increased when combined with Cefradine.,increase,no risk
Cefradine,Venlafaxine,Cefradine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefradine,Verapamil,Cefradine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefradine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefradine.,decrease,no risk
Cefradine,Vilanterol,Cefradine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefradine,Viloxazine,Cefradine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefradine,Vinblastine,The metabolism of Vinblastine can be increased when combined with Cefradine.,increase,no risk
Cefradine,Vincristine,The metabolism of Vincristine can be increased when combined with Cefradine.,increase,no risk
Cefradine,Vindesine,The metabolism of Vindesine can be increased when combined with Cefradine.,increase,no risk
Cefradine,Vinflunine,The metabolism of Vinflunine can be increased when combined with Cefradine.,increase,no risk
Cefradine,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Cefradine.,increase,no risk
Cefradine,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Cefradine.,increase,no risk
Cefradine,Vortioxetine,Cefradine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefradine,Warfarin,The metabolism of Warfarin can be increased when combined with Cefradine.,increase,no risk
Cefradine,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefradine.,decrease,no risk
Cefradine,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Cefradine.,decrease,no risk
Cefradine,Zaleplon,Cefradine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefradine,Zanamivir,Cefradine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefradine,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Cefradine.,increase,no risk
Cefradine,Zidovudine,The excretion of Zidovudine can be decreased when combined with Cefradine.,decrease,no risk
Cefradine,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Cefradine.,increase,no risk
Cefradine,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefradine is combined with Zoledronic acid.,increase,risk
Cefradine,Zolpidem,The metabolism of Zolpidem can be increased when combined with Cefradine.,increase,no risk
Cefradine,Zonisamide,Zonisamide may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cefradine,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Cefradine.,increase,no risk
Cefradine,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Cefradine.,decrease,no risk
Metocurine,Gabapentin,Furosemide may decrease the neuromuscular blocking activities of Metocurine.,decrease,no risk
Metocurine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin is combined with Metocurine.,increase,risk
Metocurine,Galantamine,The risk or severity of CNS depression can be increased when Metocurine is combined with Gabapentin enacarbil.,increase,risk
Metocurine,Gallamine triethiodide,The therapeutic efficacy of Metocurine can be decreased when used in combination with Galantamine.,decrease,no risk
Metocurine,Ganaxolone,The risk or severity of CNS depression can be increased when Metocurine is combined with gamma-Hydroxybutyric acid.,increase,risk
Metocurine,Gentamicin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Metocurine is combined with Ganaxolone.",increase,risk
Metocurine,Gepirone,The therapeutic efficacy of Metocurine can be increased when used in combination with Gentamicin.,increase,no risk
Metocurine,Ginkgo biloba,The risk or severity of CNS depression can be increased when Metocurine is combined with Gepirone.,increase,risk
Metocurine,Glucagon,The therapeutic efficacy of Metocurine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Metocurine,Glutethimide,Metocurine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Metocurine,Glycerin,The risk or severity of CNS depression can be increased when Metocurine is combined with Glutethimide.,increase,risk
Metocurine,Glycopyrronium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Metocurine.,decrease,no risk
Metocurine,Granisetron,The risk or severity of adverse effects can be increased when Metocurine is combined with Glycopyrronium.,increase,risk
Metocurine,Guanabenz,The risk or severity of CNS depression can be increased when Granisetron is combined with Metocurine.,increase,risk
Pancuronium,Butriptyline,The risk or severity of CNS depression can be increased when Pancuronium is combined with Butriptyline.,increase,risk
Pancuronium,Butylscopolamine,The risk or severity of adverse effects can be increased when Pancuronium is combined with Butylscopolamine.,increase,risk
Pipecuronium,Gabapentin,Furosemide may decrease the neuromuscular blocking activities of Pipecuronium.,decrease,no risk
Pipecuronium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin is combined with Pipecuronium.,increase,risk
Pipecuronium,Galantamine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Gabapentin enacarbil.,increase,risk
Pipecuronium,Gallamine triethiodide,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Galantamine.,decrease,no risk
Pipecuronium,Ganaxolone,The risk or severity of CNS depression can be increased when Pipecuronium is combined with gamma-Hydroxybutyric acid.,increase,risk
Pipecuronium,Gentamicin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pipecuronium is combined with Ganaxolone.",increase,risk
Pipecuronium,Gepirone,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Gentamicin.,increase,no risk
Pipecuronium,Ginkgo biloba,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Gepirone.,increase,risk
Pipecuronium,Glucagon,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Pipecuronium,Glutethimide,Pipecuronium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Pipecuronium,Glycerin,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Glutethimide.,increase,risk
Pipecuronium,Glycopyrronium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Pipecuronium.,decrease,no risk
Pipecuronium,Granisetron,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Glycopyrronium.,increase,risk
Pipecuronium,Guanabenz,The risk or severity of CNS depression can be increased when Granisetron is combined with Pipecuronium.,increase,risk
Pipecuronium,Guanfacine,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Pipecuronium.,increase,risk
Pipecuronium,Halazepam,The risk or severity of CNS depression can be increased when Guanfacine is combined with Pipecuronium.,increase,risk
Pipecuronium,Haloperidol,The risk or severity of CNS depression can be increased when Halazepam is combined with Pipecuronium.,increase,risk
Pipecuronium,Halothane,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pipecuronium.,increase,risk
Pipecuronium,Hetacillin,The risk or severity of CNS depression can be increased when Halothane is combined with Pipecuronium.,increase,risk
Pipecuronium,Hexafluronium,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Hetacillin.,increase,no risk
Pipecuronium,Hexocyclium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Pipecuronium.,increase,risk
Pipecuronium,Homatropine,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Hexocyclium.,increase,risk
Pipecuronium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Homatropine.,increase,risk
Pipecuronium,Huperzine A,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Pipecuronium.,increase,risk
Pipecuronium,Hydrochlorothiazide,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Huperzine A.,decrease,no risk
Pipecuronium,Hydrocodone,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Pipecuronium,Hydrocortisone,Pipecuronium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pipecuronium,Hydrocortisone acetate,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Pipecuronium,Hydrocortisone butyrate,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Pipecuronium,Hydrocortisone cypionate,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Pipecuronium,Hydrocortisone succinate,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Pipecuronium,Hydroflumethiazide,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Pipecuronium,Hydromorphone,The serum concentration of Hydroflumethiazide can be increased when it is combined with Pipecuronium.,increase,no risk
Pipecuronium,Hydroxyzine,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Hydromorphone.,increase,risk
Pipecuronium,Hyoscyamine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pipecuronium.,increase,no risk
Pipecuronium,Kanamycin,Isradipine may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Ketamine,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Kanamycin.,increase,no risk
Pipecuronium,Ketazolam,The risk or severity of CNS depression can be increased when Ketamine is combined with Pipecuronium.,increase,risk
Pipecuronium,Ketoconazole,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Ketazolam.,increase,risk
Pipecuronium,Ketorolac,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Ketoconazole.,increase,no risk
Pipecuronium,Nabilone,The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Moxonidine.,increase,risk
Pipecuronium,Nadolol,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Pipecuronium.,increase,no risk
Pipecuronium,Nafcillin,Pipecuronium may increase the bradycardic activities of Nadolol.,increase,no risk
Pipecuronium,Nalbuphine,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Nafcillin.,increase,no risk
Pipecuronium,Naloxegol,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Nalbuphine.,increase,risk
Pipecuronium,Naltrexone,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Naloxegol.,increase,risk
Pipecuronium,Naphazoline,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Naltrexone.,increase,risk
Pipecuronium,Naratriptan,The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Naphazoline.,increase,risk
Pipecuronium,Nebivolol,The risk or severity of CNS depression can be increased when Naratriptan is combined with Pipecuronium.,increase,risk
Pipecuronium,Nefazodone,Pipecuronium may increase the bradycardic activities of Nebivolol.,increase,no risk
Pipecuronium,Neomycin,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Nefazodone.,increase,risk
Pipecuronium,Neostigmine,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Neomycin.,increase,no risk
Pipecuronium,Netilmicin,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Neostigmine.,decrease,no risk
Pipecuronium,Nialamide,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Netilmicin.,increase,no risk
Pipecuronium,Nicardipine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Nialamide.,increase,risk
Pipecuronium,Nicotine,Nicardipine may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Nifedipine,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Nicotine.,increase,risk
Pipecuronium,Nilvadipine,Nifedipine may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Nimesulide,Nilvadipine may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Nimodipine,Nimesulide may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Nisoldipine,Nimodipine may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Nitrazepam,Nisoldipine may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Nitrendipine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Nitrazepam.,increase,risk
Pipecuronium,Nitrous oxide,Nitrendipine may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Nizatidine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Nitrous oxide.,increase,risk
Pipecuronium,Nomifensine,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Nizatidine.,decrease,no risk
Pipecuronium,Norepinephrine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Nomifensine.,increase,risk
Pipecuronium,Normethadone,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Pipecuronium.,increase,risk
Pipecuronium,Nortriptyline,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Normethadone.,increase,risk
Pipecuronium,Nylidrin,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Pipecuronium.,increase,risk
Pipecuronium,Olanzapine,Nylidrin may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Oliceridine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Pipecuronium.,increase,risk
Pipecuronium,Olodaterol,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pipecuronium is combined with Oliceridine.",increase,risk
Pipecuronium,Ondansetron,The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Olodaterol.,increase,risk
Pipecuronium,Opium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Pipecuronium.,increase,risk
Pipecuronium,Orciprenaline,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Opium.,increase,risk
Pipecuronium,Orphenadrine,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Pipecuronium.,increase,risk
Pipecuronium,Ouabain,Pipecuronium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pipecuronium,Oxacillin,The risk or severity of Cardiac Arrhythmia can be increased when Pipecuronium is combined with Ouabain.,increase,risk
Pipecuronium,Oxazepam,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Oxacillin.,increase,no risk
Pipecuronium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Pipecuronium.,increase,risk
Pipecuronium,Oxitriptan,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Pipecuronium.,increase,risk
Pipecuronium,Oxprenolol,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Oxitriptan.,increase,risk
Pipecuronium,Oxybuprocaine,Pipecuronium may increase the bradycardic activities of Oxprenolol.,increase,no risk
Pipecuronium,Oxybutynin,Pipecuronium may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Pipecuronium,Oxycodone,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pipecuronium.,increase,risk
Pipecuronium,Oxymetazoline,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Oxycodone.,increase,risk
Pipecuronium,Oxymorphone,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Pipecuronium.,increase,risk
Pipecuronium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Oxymorphone.,increase,risk
Pipecuronium,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Pipecuronium.,increase,risk
Pipecuronium,Oxyphenonium,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Pipecuronium.,decrease,no risk
Pipecuronium,Oxytetracycline,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pipecuronium.,increase,risk
Pipecuronium,Quazepam,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Pyridostigmine.,decrease,no risk
Pipecuronium,Quetiapine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Quazepam.,increase,risk
Pipecuronium,Quinethazone,The risk or severity of CNS depression can be increased when Quetiapine is combined with Pipecuronium.,increase,risk
Pipecuronium,Quinidine,The serum concentration of Quinethazone can be increased when it is combined with Pipecuronium.,increase,no risk
Pipecuronium,Quinine,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Quinidine.,increase,no risk
Pipecuronium,Quinupramine,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Quinine.,increase,no risk
Pipecuronium,Umeclidinium,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Tyrothricin.,decrease,no risk
Pipecuronium,Urethane,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Umeclidinium.,increase,risk
Pipecuronium,Valproic acid,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Urethane.,increase,risk
Pipecuronium,Vamorolone,The risk or severity of CNS depression can be increased when Valproic acid is combined with Pipecuronium.,increase,risk
Pipecuronium,Vancomycin,The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Vamorolone.,decrease,no risk
Pipecuronium,Varenicline,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Vancomycin.,increase,no risk
Pipecuronium,Vecuronium,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Varenicline.,increase,risk
Pipecuronium,Venlafaxine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Vecuronium.,increase,risk
Pipecuronium,Verapamil,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Pipecuronium.,increase,risk
Pipecuronium,Vigabatrin,Verapamil may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Vilanterol,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Pipecuronium.,increase,risk
Pipecuronium,Vilazodone,The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Vilanterol.,increase,risk
Pipecuronium,Viloxazine,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Vilazodone.,increase,risk
Pipecuronium,Viomycin,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Viloxazine.,increase,risk
Pipecuronium,Vortioxetine,The therapeutic efficacy of Pipecuronium can be increased when used in combination with Viomycin.,increase,no risk
Pipecuronium,Xamoterol,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Vortioxetine.,increase,risk
Pipecuronium,Xylometazoline,The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Xamoterol.,increase,risk
Pipecuronium,Yohimbine,Xylometazoline may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Zaleplon,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Yohimbine.,increase,risk
Pipecuronium,Ziconotide,The risk or severity of CNS depression can be increased when Zaleplon is combined with Pipecuronium.,increase,risk
Pipecuronium,Zimelidine,Ziconotide may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Ziprasidone,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Zimelidine.,increase,risk
Pipecuronium,Zolmitriptan,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Ziprasidone.,increase,risk
Pipecuronium,Zolpidem,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Pipecuronium.,increase,risk
Pipecuronium,Zonisamide,Pipecuronium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Pipecuronium,Zopiclone,Zonisamide may increase the neuromuscular blocking activities of Pipecuronium.,increase,no risk
Pipecuronium,Zotepine,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Zopiclone.,increase,risk
Pipecuronium,Zuclopenthixol,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Zotepine.,increase,risk
Pipecuronium,Zuranolone,The risk or severity of CNS depression can be increased when Pipecuronium is combined with Zuclopenthixol.,increase,risk
Vecuronium,Gabapentin,Furosemide may decrease the neuromuscular blocking activities of Vecuronium.,decrease,no risk
Vecuronium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vecuronium.,increase,risk
Vecuronium,Galantamine,The risk or severity of CNS depression can be increased when Vecuronium is combined with Gabapentin enacarbil.,increase,risk
Vecuronium,Gallamine triethiodide,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Galantamine.,decrease,no risk
Vecuronium,Ganaxolone,The risk or severity of CNS depression can be increased when Vecuronium is combined with gamma-Hydroxybutyric acid.,increase,risk
Vecuronium,Gentamicin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vecuronium is combined with Ganaxolone.",increase,risk
Vecuronium,Gepirone,The therapeutic efficacy of Vecuronium can be increased when used in combination with Gentamicin.,increase,no risk
Vecuronium,Ginkgo biloba,The risk or severity of CNS depression can be increased when Vecuronium is combined with Gepirone.,increase,risk
Vecuronium,Glutethimide,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Vecuronium,Glycerin,The risk or severity of CNS depression can be increased when Vecuronium is combined with Glutethimide.,increase,risk
Vecuronium,Glycopyrronium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Vecuronium.,decrease,no risk
Vecuronium,Granisetron,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Vecuronium.,increase,risk
Vecuronium,Guanfacine,The risk or severity of CNS depression can be increased when Granisetron is combined with Vecuronium.,increase,risk
Vecuronium,Halazepam,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vecuronium.,increase,risk
Vecuronium,Haloperidol,The risk or severity of CNS depression can be increased when Halazepam is combined with Vecuronium.,increase,risk
Vecuronium,Halothane,The risk or severity of CNS depression can be increased when Haloperidol is combined with Vecuronium.,increase,risk
Vecuronium,Hetacillin,The risk or severity of CNS depression can be increased when Halothane is combined with Vecuronium.,increase,risk
Vecuronium,Hexafluronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Hetacillin.,increase,no risk
Vecuronium,Hexocyclium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vecuronium.,increase,risk
Vecuronium,Homatropine,The risk or severity of adverse effects can be increased when Vecuronium is combined with Hexocyclium.,increase,risk
Vecuronium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Vecuronium is combined with Homatropine.,increase,risk
Vecuronium,Huperzine A,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Vecuronium.,increase,risk
Vecuronium,Hydrochlorothiazide,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Huperzine A.,decrease,no risk
Vecuronium,Hydrocodone,The therapeutic efficacy of Vecuronium can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Vecuronium,Hydrocortisone,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Vecuronium,Hydrocortisone acetate,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone.,increase,risk
Vecuronium,Hydrocortisone butyrate,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone acetate.,increase,risk
Vecuronium,Hydrocortisone cypionate,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone butyrate.,increase,risk
Vecuronium,Hydrocortisone succinate,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone cypionate.,increase,risk
Vecuronium,Hydroflumethiazide,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone succinate.,increase,risk
Vecuronium,Hydromorphone,The serum concentration of Hydroflumethiazide can be increased when it is combined with Vecuronium.,increase,no risk
Vecuronium,Hydroxyzine,The risk or severity of adverse effects can be increased when Vecuronium is combined with Hydromorphone.,increase,risk
Vecuronium,Hyoscyamine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Vecuronium,Kanamycin,Isradipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Ketamine,The therapeutic efficacy of Vecuronium can be increased when used in combination with Kanamycin.,increase,no risk
Vecuronium,Ketazolam,The risk or severity of CNS depression can be increased when Ketamine is combined with Vecuronium.,increase,risk
Vecuronium,Ketoconazole,The risk or severity of CNS depression can be increased when Vecuronium is combined with Ketazolam.,increase,risk
Vecuronium,Ketorolac,The therapeutic efficacy of Vecuronium can be increased when used in combination with Ketoconazole.,increase,no risk
Vecuronium,Nabilone,The risk or severity of adverse effects can be increased when Vecuronium is combined with Morphine.,increase,risk
Vecuronium,Nafcillin,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Vecuronium,Nalbuphine,The therapeutic efficacy of Vecuronium can be increased when used in combination with Nafcillin.,increase,no risk
Vecuronium,Naloxegol,The risk or severity of adverse effects can be increased when Vecuronium is combined with Nalbuphine.,increase,risk
Vecuronium,Naltrexone,The risk or severity of adverse effects can be increased when Vecuronium is combined with Naloxegol.,increase,risk
Vecuronium,Naratriptan,The risk or severity of adverse effects can be increased when Vecuronium is combined with Naltrexone.,increase,risk
Vecuronium,Nefazodone,The risk or severity of CNS depression can be increased when Naratriptan is combined with Vecuronium.,increase,risk
Vecuronium,Neomycin,The risk or severity of adverse effects can be increased when Vecuronium is combined with Nefazodone.,increase,risk
Vecuronium,Neostigmine,The therapeutic efficacy of Vecuronium can be increased when used in combination with Neomycin.,increase,no risk
Vecuronium,Netilmicin,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Neostigmine.,decrease,no risk
Vecuronium,Nialamide,The therapeutic efficacy of Vecuronium can be increased when used in combination with Netilmicin.,increase,no risk
Vecuronium,Nicardipine,The risk or severity of CNS depression can be increased when Vecuronium is combined with Nialamide.,increase,risk
Vecuronium,Nifedipine,Nicardipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Nilvadipine,Nifedipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Nimesulide,Nilvadipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Nimodipine,Nimesulide may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Nisoldipine,Nimodipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Nitrazepam,Nisoldipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Nitrendipine,The risk or severity of CNS depression can be increased when Vecuronium is combined with Nitrazepam.,increase,risk
Vecuronium,Nitrous oxide,Nitrendipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Nizatidine,The risk or severity of CNS depression can be increased when Vecuronium is combined with Nitrous oxide.,increase,risk
Vecuronium,Nomifensine,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Nizatidine.,decrease,no risk
Vecuronium,Normethadone,The risk or severity of CNS depression can be increased when Vecuronium is combined with Nomifensine.,increase,risk
Vecuronium,Nortriptyline,The risk or severity of adverse effects can be increased when Vecuronium is combined with Normethadone.,increase,risk
Vecuronium,Nylidrin,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Vecuronium.,increase,risk
Vecuronium,Olanzapine,Nylidrin may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Vecuronium,Oliceridine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Vecuronium.,increase,risk
Vecuronium,Ondansetron,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Vecuronium is combined with Oliceridine.",increase,risk
Vecuronium,Opium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Vecuronium.,increase,risk
Vecuronium,Orphenadrine,The risk or severity of adverse effects can be increased when Vecuronium is combined with Opium.,increase,risk
Vecuronium,Ouabain,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Vecuronium,Oxacillin,The risk or severity of Cardiac Arrhythmia can be increased when Vecuronium is combined with Ouabain.,increase,risk
Vecuronium,Oxazepam,The therapeutic efficacy of Vecuronium can be increased when used in combination with Oxacillin.,increase,no risk
Vecuronium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxazepam is combined with Vecuronium.,increase,risk
Vecuronium,Oxitriptan,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Vecuronium.,increase,risk
Vecuronium,Oxprenolol,The risk or severity of CNS depression can be increased when Vecuronium is combined with Oxitriptan.,increase,risk
Vecuronium,Oxybuprocaine,The risk or severity of CNS depression can be increased when Vecuronium is combined with Oxprenolol.,increase,risk
Vecuronium,Oxybutynin,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Vecuronium.,increase,risk
Vecuronium,Oxycodone,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Vecuronium.,increase,risk
Vecuronium,Oxymorphone,The risk or severity of adverse effects can be increased when Vecuronium is combined with Oxycodone.,increase,risk
Vecuronium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Vecuronium is combined with Oxymorphone.,increase,risk
Vecuronium,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Vecuronium.,increase,risk
Vecuronium,Oxyphenonium,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Vecuronium.,decrease,no risk
Vecuronium,Oxytetracycline,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Vecuronium.,increase,risk
Vecuronium,Quazepam,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Pyridostigmine.,decrease,no risk
Vecuronium,Quetiapine,The risk or severity of CNS depression can be increased when Vecuronium is combined with Quazepam.,increase,risk
Vecuronium,Quinethazone,The risk or severity of CNS depression can be increased when Quetiapine is combined with Vecuronium.,increase,risk
Vecuronium,Quinidine,The serum concentration of Quinethazone can be increased when it is combined with Vecuronium.,increase,no risk
Vecuronium,Quinine,The therapeutic efficacy of Vecuronium can be increased when used in combination with Quinidine.,increase,no risk
Vecuronium,Quinupramine,The therapeutic efficacy of Vecuronium can be increased when used in combination with Quinine.,increase,no risk
Cilazapril,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Cilazapril.",increase,risk
Cilazapril,Guanabenz,Guanabenz may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Guanadrel,Guanadrel may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Guanethidine,Guanethidine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Guanfacine,Guanfacine may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Guanoxan,Cilazapril may increase the hypotensive activities of Guanoxan.,increase,no risk
Cilazapril,Halothane,Halothane may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Heparin,The risk or severity of hyperkalemia can be increased when Cilazapril is combined with Heparin.,increase,risk
Cilazapril,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Cilazapril is combined with Holcus lanatus pollen.,increase,risk
Cilazapril,Hydralazine,Hydralazine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Hydroflumethiazide,The therapeutic efficacy of Cilazapril can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Cilazapril,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Cilazapril.,increase,risk
Cilazapril,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Cilazapril.",increase,risk
Cilazapril,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Cilazapril.",increase,risk
Cilazapril,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Cilazapril is combined with Koeleria macrantha pollen.,increase,risk
Cilazapril,Nabilone,The risk or severity of adverse effects can be increased when Nabilone is combined with Cilazapril.,increase,risk
Cilazapril,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Cilazapril.",increase,risk
Cilazapril,Nadolol,Nadolol may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nadroparin,The risk or severity of hyperkalemia can be increased when Cilazapril is combined with Nadroparin.,increase,risk
Cilazapril,Naphazoline,Naphazoline may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Naproxen is combined with Cilazapril.",increase,risk
Cilazapril,Naratriptan,Naratriptan may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Naxitamab,Naxitamab may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Nebivolol,Cilazapril may increase the hypotensive activities of Nebivolol.,increase,no risk
Cilazapril,Nefazodone,Nefazodone may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Nesiritide,The risk or severity of adverse effects can be increased when Cilazapril is combined with Nesiritide.,increase,risk
Cilazapril,Nialamide,Nialamide may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nicardipine,Nicardipine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nicergoline,Nicergoline may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Nicorandil,Nicorandil may increase the vasodilatory activities of Cilazapril.,increase,no risk
Cilazapril,Nifedipine,The risk or severity of adverse effects can be increased when Nifedipine is combined with Cilazapril.,increase,risk
Cilazapril,Nilvadipine,Cilazapril may increase the hypotensive activities of Nilvadipine.,increase,no risk
Cilazapril,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nimesulide is combined with Cilazapril.",increase,risk
Cilazapril,Nimodipine,Nimodipine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nisoldipine,Nisoldipine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nitrendipine,Nitrendipine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Cilazapril.,increase,risk
Cilazapril,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Cilazapril.,increase,risk
Cilazapril,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nitroprusside,Nitroprusside may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Nitrous acid,The risk or severity of adverse effects can be increased when Cilazapril is combined with Nitrous acid.,increase,risk
Cilazapril,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Nylidrin,Nylidrin may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Obinutuzumab,Cilazapril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Cilazapril,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Cilazapril.,increase,risk
Cilazapril,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Cilazapril is combined with Olmesartan.",increase,risk
Cilazapril,Olodaterol,Olodaterol may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Cilazapril.,increase,risk
Cilazapril,Opicapone,The risk or severity of adverse effects can be increased when Cilazapril is combined with Opicapone.,increase,risk
Cilazapril,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Cilazapril.",increase,risk
Cilazapril,Oxprenolol,Cilazapril may increase the hypotensive activities of Oxprenolol.,increase,no risk
Cilazapril,Oxymetazoline,The therapeutic efficacy of Cilazapril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Cilazapril,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Cilazapril.",increase,risk
Cilazapril,Quetiapine,Quetiapine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Cilazapril.,increase,risk
Cilazapril,Quinethazone,The risk or severity of hypotension can be increased when Quinethazone is combined with Cilazapril.,increase,risk
Cilazapril,Quinidine,Quinidine may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Quinine,Quinine may increase the hypotensive activities of Cilazapril.,increase,no risk
Cilazapril,Quinupramine,Quinupramine may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Udenafil,Udenafil may increase the antihypertensive activities of Cilazapril.,increase,no risk
Cilazapril,Unoprostone,Cilazapril may increase the hypotensive activities of Unoprostone.,increase,no risk
Cilazapril,Urochloa mutica pollen,The risk or severity of adverse effects can be increased when Cilazapril is combined with Urochloa mutica pollen.,increase,risk
Cilazapril,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Cilazapril.,increase,risk
Cilazapril,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Cilazapril.",increase,risk
Cilazapril,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Cilazapril is combined with Valsartan.",increase,risk
Cilazapril,Vardenafil,Vardenafil may increase the antihypertensive activities of Cilazapril.,increase,no risk
Cilazapril,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Cilazapril.,increase,risk
Cilazapril,Vericiguat,The risk or severity of adverse effects can be increased when Cilazapril is combined with Vericiguat.,increase,risk
Cilazapril,Vilanterol,Vilanterol may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Vilazodone,Vilazodone may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Cilazapril.,increase,risk
Cilazapril,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Xamoterol,Xamoterol may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Yohimbine,Yohimbine may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Cilazapril.,increase,no risk
Cilazapril,Zofenopril,The risk or severity of angioedema can be increased when Cilazapril is combined with Zofenopril.,increase,risk
Cilazapril,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Cilazapril,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Cilazapril.,increase,risk
Cilazapril,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Cilazapril.,decrease,no risk
Forasartan,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Forasartan.,increase,risk
Forasartan,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Ketoprofen.",increase,risk
Forasartan,Ketorolac,The therapeutic efficacy of Forasartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Forasartan,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Nabumetone.",increase,risk
Forasartan,Nadolol,The risk or severity of hyperkalemia can be increased when Nadolol is combined with Forasartan.,increase,risk
Forasartan,Nadroparin,The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Forasartan.,increase,risk
Forasartan,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Naproxen.",increase,risk
Forasartan,Nebivolol,The risk or severity of hyperkalemia can be increased when Forasartan is combined with Nebivolol.,increase,risk
Forasartan,Nicardipine,The risk or severity of hyperkalemia can be increased when Nicardipine is combined with Forasartan.,increase,risk
Forasartan,Nicorandil,The risk or severity of hyperkalemia can be increased when Nicorandil is combined with Forasartan.,increase,risk
Forasartan,Nifedipine,The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Forasartan.,increase,risk
Forasartan,Nilvadipine,The risk or severity of hyperkalemia can be increased when Forasartan is combined with Nilvadipine.,increase,risk
Forasartan,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Nimesulide.",increase,risk
Forasartan,Nimodipine,The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Forasartan.,increase,risk
Forasartan,Nisoldipine,The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Forasartan.,increase,risk
Forasartan,Nitrendipine,The risk or severity of hyperkalemia can be increased when Nitrendipine is combined with Forasartan.,increase,risk
Forasartan,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Forasartan.,increase,risk
Forasartan,Nylidrin,The risk or severity of hyperkalemia can be increased when Forasartan is combined with Nylidrin.,increase,risk
Forasartan,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Olmesartan is combined with Forasartan.",increase,risk
Forasartan,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Oxaprozin.",increase,risk
Forasartan,Oxprenolol,The risk or severity of hyperkalemia can be increased when Forasartan is combined with Oxprenolol.,increase,risk
Forasartan,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Oxyphenbutazone.",increase,risk
Forasartan,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Forasartan.",increase,risk
Forasartan,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Forasartan.,increase,risk
Forasartan,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Valdecoxib.",increase,risk
Forasartan,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Forasartan.",increase,risk
Forasartan,Vildagliptin,The risk or severity of angioedema can be increased when Forasartan is combined with Vildagliptin.,increase,risk
Forasartan,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Forasartan.",increase,risk
Forasartan,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Forasartan.,increase,risk
Tolevamer,Bismuth subnitrate,The risk or severity of adverse effects can be increased when Tolevamer is combined with Bismuth subnitrate.,increase,risk
Tolevamer,Hydrotalcite,The risk or severity of adverse effects can be increased when Tolevamer is combined with Hydrotalcite.,increase,risk
Tolevamer,Nizatidine,The therapeutic efficacy of Tolevamer can be decreased when used in combination with Nizatidine.,decrease,no risk
Tolevamer,Omeprazole,The therapeutic efficacy of Tolevamer can be decreased when used in combination with Omeprazole.,decrease,no risk
Tolevamer,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Ouabain.,increase,risk
Tolevamer,Vonoprazan,The therapeutic efficacy of Tolevamer can be decreased when used in combination with Vonoprazan.,decrease,no risk
Saprisartan,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Glycol salicylate.",increase,risk
Saprisartan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Guanadrel,Guanadrel may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Guanethidine,Guanethidine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Guanoxan,Saprisartan may increase the hypotensive activities of Guanoxan.,increase,no risk
Saprisartan,Halothane,Halothane may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Saprisartan.,increase,risk
Saprisartan,Hydralazine,Hydralazine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Hydrochlorothiazide,The therapeutic efficacy of Saprisartan can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Saprisartan,Hydroflumethiazide,The therapeutic efficacy of Saprisartan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Saprisartan,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Saprisartan.,increase,risk
Saprisartan,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Ketoprofen.",increase,risk
Saprisartan,Ketorolac,The therapeutic efficacy of Saprisartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Saprisartan,Nabilone,Nabilone may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Nabumetone.",increase,risk
Saprisartan,Nadolol,Nadolol may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nadroparin,The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Saprisartan.,increase,risk
Saprisartan,Naphazoline,Naphazoline may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Naproxen.",increase,risk
Saprisartan,Naratriptan,Naratriptan may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Naxitamab,Naxitamab may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Nebivolol,Saprisartan may increase the hypotensive activities of Nebivolol.,increase,no risk
Saprisartan,Nefazodone,Nefazodone may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Nesiritide,Nesiritide may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nialamide,Nialamide may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nicardipine,Nicardipine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nicergoline,Nicergoline may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Nicorandil,The risk or severity of hyperkalemia can be increased when Nicorandil is combined with Saprisartan.,increase,risk
Saprisartan,Nifedipine,The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Saprisartan.,increase,risk
Saprisartan,Nilvadipine,Saprisartan may increase the hypotensive activities of Nilvadipine.,increase,no risk
Saprisartan,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Nimesulide.",increase,risk
Saprisartan,Nimodipine,Nimodipine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nisoldipine,Nisoldipine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nitrendipine,Nitrendipine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nitric Oxide,Nitric Oxide may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Saprisartan.,increase,risk
Saprisartan,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nitroprusside,Nitroprusside may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nitrous acid,Nitrous acid may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Nylidrin,Nylidrin may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Obinutuzumab,Saprisartan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Saprisartan,Olanzapine,Olanzapine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Olmesartan is combined with Saprisartan.",increase,risk
Saprisartan,Olodaterol,Olodaterol may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Opicapone,Opicapone may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Oxaprozin.",increase,risk
Saprisartan,Oxprenolol,Saprisartan may increase the hypotensive activities of Oxprenolol.,increase,no risk
Saprisartan,Oxymetazoline,The therapeutic efficacy of Saprisartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Saprisartan,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Oxyphenbutazone.",increase,risk
Saprisartan,Quetiapine,Quetiapine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Saprisartan.",increase,risk
Saprisartan,Quinidine,Quinidine may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Quinine,Quinine may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Quinupramine,Quinupramine may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Udenafil,Udenafil may increase the antihypertensive activities of Saprisartan.,increase,no risk
Saprisartan,Unoprostone,Saprisartan may increase the hypotensive activities of Unoprostone.,increase,no risk
Saprisartan,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Saprisartan.,increase,risk
Saprisartan,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Valdecoxib.",increase,risk
Saprisartan,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Saprisartan.",increase,risk
Saprisartan,Vardenafil,Vardenafil may increase the antihypertensive activities of Saprisartan.,increase,no risk
Saprisartan,Verapamil,Verapamil may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Vericiguat,Vericiguat may increase the hypotensive activities of Saprisartan.,increase,no risk
Saprisartan,Vilanterol,Vilanterol may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Vilazodone,Vilazodone may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Vildagliptin,The risk or severity of angioedema can be increased when Saprisartan is combined with Vildagliptin.,increase,risk
Saprisartan,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Xamoterol,Xamoterol may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Yohimbine,Yohimbine may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Saprisartan.,increase,no risk
Saprisartan,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Saprisartan.",increase,risk
Saprisartan,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Saprisartan,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Saprisartan.,increase,risk
Saprisartan,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Saprisartan.,decrease,no risk
Spirapril,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Spirapril.",increase,risk
Spirapril,Guanabenz,Guanabenz may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Guanadrel,Guanadrel may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Guanethidine,Guanethidine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Guanfacine,Guanfacine may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Guanoxan,Spirapril may increase the hypotensive activities of Guanoxan.,increase,no risk
Spirapril,Halothane,Halothane may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Heparin,The risk or severity of hyperkalemia can be increased when Spirapril is combined with Heparin.,increase,risk
Spirapril,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Spirapril is combined with Holcus lanatus pollen.,increase,risk
Spirapril,Hydralazine,Hydralazine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Hydrochlorothiazide,The therapeutic efficacy of Spirapril can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Spirapril,Hydroflumethiazide,The therapeutic efficacy of Spirapril can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Spirapril,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Spirapril.,increase,risk
Spirapril,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Spirapril.",increase,risk
Spirapril,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Spirapril.",increase,risk
Spirapril,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Spirapril is combined with Koeleria macrantha pollen.,increase,risk
Spirapril,Nabilone,Nabilone may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Spirapril.",increase,risk
Spirapril,Nadolol,Nadolol may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nadroparin,The risk or severity of hyperkalemia can be increased when Spirapril is combined with Nadroparin.,increase,risk
Spirapril,Naphazoline,Naphazoline may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Naproxen is combined with Spirapril.",increase,risk
Spirapril,Naratriptan,Naratriptan may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Naxitamab,Naxitamab may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Nebivolol,Spirapril may increase the hypotensive activities of Nebivolol.,increase,no risk
Spirapril,Nefazodone,Nefazodone may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Nesiritide,Nesiritide may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nialamide,Nialamide may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nicardipine,Nicardipine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nicergoline,Nicergoline may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Nicorandil,Nicorandil may increase the vasodilatory activities of Spirapril.,increase,no risk
Spirapril,Nifedipine,The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Spirapril.,increase,risk
Spirapril,Nilvadipine,Spirapril may increase the hypotensive activities of Nilvadipine.,increase,no risk
Spirapril,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nimesulide is combined with Spirapril.",increase,risk
Spirapril,Nimodipine,Nimodipine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nisoldipine,Nisoldipine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nitrendipine,Nitrendipine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nitric Oxide,Nitric Oxide may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Spirapril.,increase,risk
Spirapril,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nitroprusside,Nitroprusside may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nitrous acid,Nitrous acid may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Nortriptyline,Nortriptyline may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Nylidrin,Nylidrin may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Obinutuzumab,Spirapril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Spirapril,Olanzapine,Olanzapine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Olmesartan.",increase,risk
Spirapril,Olodaterol,Olodaterol may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Spirapril.,increase,risk
Spirapril,Opicapone,Opicapone may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Spirapril.",increase,risk
Spirapril,Oxprenolol,Spirapril may increase the hypotensive activities of Oxprenolol.,increase,no risk
Spirapril,Oxymetazoline,The therapeutic efficacy of Spirapril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Spirapril,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Spirapril.",increase,risk
Spirapril,Quetiapine,Quetiapine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Spirapril.,increase,risk
Spirapril,Quinethazone,The risk or severity of hypotension can be increased when Quinethazone is combined with Spirapril.,increase,risk
Spirapril,Quinidine,Quinidine may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Quinine,Quinine may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Quinupramine,Quinupramine may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Udenafil,Udenafil may increase the antihypertensive activities of Spirapril.,increase,no risk
Spirapril,Unoprostone,Spirapril may increase the hypotensive activities of Unoprostone.,increase,no risk
Spirapril,Urochloa mutica pollen,The risk or severity of adverse effects can be increased when Spirapril is combined with Urochloa mutica pollen.,increase,risk
Spirapril,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Spirapril.,increase,risk
Spirapril,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Spirapril.",increase,risk
Spirapril,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Valsartan.",increase,risk
Spirapril,Vardenafil,Vardenafil may increase the antihypertensive activities of Spirapril.,increase,no risk
Spirapril,Verapamil,Verapamil may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Vericiguat,Vericiguat may increase the hypotensive activities of Spirapril.,increase,no risk
Spirapril,Vilanterol,Vilanterol may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Vilazodone,Vilazodone may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Spirapril.,increase,risk
Spirapril,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Xamoterol,Xamoterol may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Yohimbine,Yohimbine may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Spirapril.,increase,no risk
Spirapril,Zofenopril,The risk or severity of angioedema can be increased when Spirapril is combined with Zofenopril.,increase,risk
Spirapril,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Spirapril,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Spirapril.,increase,risk
Spirapril,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Spirapril.,decrease,no risk
Tasosartan,Glofitamab,The serum concentration of Tasosartan can be increased when it is combined with Glofitamab.,increase,no risk
Tasosartan,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Glycol salicylate.",increase,risk
Tasosartan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tasosartan.,increase,no risk
Tasosartan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Tasosartan.,increase,risk
Tasosartan,Hydrochlorothiazide,Hydrochlorothiazide may increase the hypotensive and Electrolyte Disturbance activities of Tasosartan.,increase,no risk
Tasosartan,Hydroflumethiazide,Hydroflumethiazide may increase the hypotensive and Electrolyte Disturbance activities of Tasosartan.,increase,no risk
Tasosartan,Ketoconazole,The metabolism of Tasosartan can be decreased when combined with Ketoconazole.,decrease,no risk
Tasosartan,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Ketoprofen.",increase,risk
Tasosartan,Ketorolac,The therapeutic efficacy of Tasosartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Tasosartan,Nabumetone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Nabumetone.",increase,risk
Tasosartan,Nadolol,The risk or severity of hyperkalemia can be increased when Nadolol is combined with Tasosartan.,increase,risk
Tasosartan,Nadroparin,The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Tasosartan.,increase,risk
Tasosartan,Naproxen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Naproxen.",increase,risk
Tasosartan,Nebivolol,The risk or severity of hyperkalemia can be increased when Tasosartan is combined with Nebivolol.,increase,risk
Tasosartan,Nefazodone,The metabolism of Tasosartan can be decreased when combined with Nefazodone.,decrease,no risk
Tasosartan,Nelfinavir,The metabolism of Tasosartan can be decreased when combined with Nelfinavir.,decrease,no risk
Tasosartan,Netupitant,The metabolism of Tasosartan can be decreased when combined with Netupitant.,decrease,no risk
Tasosartan,Nicardipine,The metabolism of Tasosartan can be decreased when combined with Nicardipine.,decrease,no risk
Tasosartan,Nicorandil,The risk or severity of hyperkalemia can be increased when Nicorandil is combined with Tasosartan.,increase,risk
Tasosartan,Nifedipine,The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Tasosartan.,increase,risk
Tasosartan,Nilotinib,The metabolism of Tasosartan can be decreased when combined with Nilotinib.,decrease,no risk
Tasosartan,Nilvadipine,The metabolism of Tasosartan can be decreased when combined with Nilvadipine.,decrease,no risk
Tasosartan,Nimesulide,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Nimesulide.",increase,risk
Tasosartan,Nimodipine,The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Tasosartan.,increase,risk
Tasosartan,Nisoldipine,The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Tasosartan.,increase,risk
Tasosartan,Nitrendipine,The risk or severity of hyperkalemia can be increased when Nitrendipine is combined with Tasosartan.,increase,risk
Tasosartan,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tasosartan.,increase,risk
Tasosartan,Nylidrin,The risk or severity of hyperkalemia can be increased when Tasosartan is combined with Nylidrin.,increase,risk
Tasosartan,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Olmesartan is combined with Tasosartan.",increase,risk
Tasosartan,Omaveloxolone,The serum concentration of Tasosartan can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tasosartan,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Oxaprozin.",increase,risk
Tasosartan,Oxprenolol,The risk or severity of hyperkalemia can be increased when Tasosartan is combined with Oxprenolol.,increase,risk
Tasosartan,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Oxyphenbutazone.",increase,risk
Tasosartan,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Tasosartan.",increase,risk
Tasosartan,Vadadustat,The serum concentration of Tasosartan can be increased when it is combined with Vadadustat.,increase,no risk
Tasosartan,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Valdecoxib.",increase,risk
Tasosartan,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Tasosartan.",increase,risk
Tasosartan,Venetoclax,The metabolism of Tasosartan can be decreased when combined with Venetoclax.,decrease,no risk
Tasosartan,Verapamil,The metabolism of Tasosartan can be decreased when combined with Verapamil.,decrease,no risk
Tasosartan,Viloxazine,The metabolism of Tasosartan can be decreased when combined with Viloxazine.,decrease,no risk
Tasosartan,Voriconazole,The metabolism of Tasosartan can be decreased when combined with Voriconazole.,decrease,no risk
Tasosartan,Zimelidine,The metabolism of Tasosartan can be decreased when combined with Zimelidine.,decrease,no risk
Tasosartan,Ziprasidone,The metabolism of Tasosartan can be decreased when combined with Ziprasidone.,decrease,no risk
Tasosartan,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Tasosartan.",increase,risk
Tasosartan,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Tasosartan.,increase,risk
Amobarbital,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Amobarbital.,increase,risk
Amobarbital,Busulfan,The metabolism of Busulfan can be increased when combined with Amobarbital.,increase,no risk
Amobarbital,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Amobarbital.,increase,risk
Amobarbital,Butacaine,The risk or severity of methemoglobinemia can be increased when Amobarbital is combined with Butacaine.,increase,risk
Amobarbital,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Amobarbital.,increase,risk
Amobarbital,Butamben,The risk or severity of methemoglobinemia can be increased when Amobarbital is combined with Butamben.,increase,risk
Amobarbital,Butaperazine,The risk or severity of CNS depression can be increased when Amobarbital is combined with Butaperazine.,increase,risk
Amobarbital,Butobarbital,The risk or severity of CNS depression can be increased when Amobarbital is combined with Butobarbital.,increase,risk
Amobarbital,Butorphanol,The risk or severity of adverse effects can be increased when Amobarbital is combined with Butorphanol.,increase,risk
Amobarbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Amobarbital.,increase,no risk
Amobarbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Amobarbital is combined with Butylscopolamine.,increase,risk
Aprobarbital,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Aprobarbital.,increase,risk
Aprobarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Gabapentin enacarbil.,increase,risk
Aprobarbital,Galantamine,The therapeutic efficacy of Aprobarbital can be decreased when used in combination with Galantamine.,decrease,no risk
Aprobarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Aprobarbital.,increase,risk
Aprobarbital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Aprobarbital is combined with Ganaxolone.",increase,risk
Aprobarbital,Gepirone,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Gepirone.,increase,risk
Aprobarbital,Gestrinone,The metabolism of Gestrinone can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Ginkgo biloba,The therapeutic efficacy of Aprobarbital can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Aprobarbital,Glutethimide,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Glutethimide.,increase,risk
Aprobarbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Aprobarbital.,decrease,no risk
Aprobarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Aprobarbital.,increase,risk
Aprobarbital,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Aprobarbital.,increase,risk
Aprobarbital,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Aprobarbital.,increase,risk
Aprobarbital,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Aprobarbital.,increase,risk
Aprobarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Aprobarbital.,increase,risk
Aprobarbital,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Aprobarbital.,increase,risk
Aprobarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Aprobarbital.,increase,risk
Aprobarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Hexocyclium.,increase,risk
Aprobarbital,Homatropine,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Homatropine.,increase,risk
Aprobarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Aprobarbital.,increase,risk
Aprobarbital,Huperzine A,The therapeutic efficacy of Aprobarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Aprobarbital,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Aprobarbital.,increase,no risk
Aprobarbital,Hydrocodone,Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Aprobarbital,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Aprobarbital.,increase,no risk
Aprobarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Hydromorphone.,increase,risk
Aprobarbital,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Aprobarbital.,increase,no risk
Aprobarbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Aprobarbital.,increase,risk
Aprobarbital,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Aprobarbital.,increase,risk
Aprobarbital,Ketazolam,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Ketazolam.,increase,risk
Aprobarbital,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Aprobarbital.,increase,no risk
Aprobarbital,Nalbuphine,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Nalbuphine.,increase,risk
Aprobarbital,Naloxegol,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Naloxegol.,increase,risk
Aprobarbital,Naltrexone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Naltrexone.,increase,risk
Aprobarbital,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Aprobarbital.,increase,risk
Aprobarbital,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Aprobarbital.,increase,risk
Aprobarbital,Nefazodone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Nefazodone.,increase,risk
Aprobarbital,Neostigmine,The therapeutic efficacy of Aprobarbital can be decreased when used in combination with Neostigmine.,decrease,no risk
Aprobarbital,Neratinib,The metabolism of Neratinib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Netupitant,The metabolism of Netupitant can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Nialamide,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Nialamide.,increase,risk
Aprobarbital,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Aprobarbital.,increase,risk
Aprobarbital,Nilotinib,The metabolism of Nilotinib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Nintedanib,The metabolism of Nintedanib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Nitrazepam,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Nitrazepam.,increase,risk
Aprobarbital,Nitrous oxide,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Nitrous oxide.,increase,risk
Aprobarbital,Nizatidine,The therapeutic efficacy of Aprobarbital can be decreased when used in combination with Nizatidine.,decrease,no risk
Aprobarbital,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Nomifensine,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Nomifensine.,increase,risk
Aprobarbital,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Norethisterone,The metabolism of Norethisterone can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Norgestimate,The metabolism of Norgestimate can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Norgestrel,The metabolism of Norgestrel can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Normethadone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Normethadone.,increase,risk
Aprobarbital,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Aprobarbital.,increase,risk
Aprobarbital,Olaparib,The metabolism of Olaparib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Aprobarbital is combined with Oliceridine.",increase,risk
Aprobarbital,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Aprobarbital.,increase,risk
Aprobarbital,Opium,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Opium.,increase,risk
Aprobarbital,Orphenadrine,Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Aprobarbital,Osimertinib,The metabolism of Osimertinib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Aprobarbital.,increase,risk
Aprobarbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Aprobarbital.,increase,risk
Aprobarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Oxitriptan.,increase,risk
Aprobarbital,Oxprenolol,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Oxprenolol.,increase,risk
Aprobarbital,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Aprobarbital.,increase,risk
Aprobarbital,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Aprobarbital.,increase,risk
Aprobarbital,Oxycodone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Oxycodone.,increase,risk
Aprobarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Oxymorphone.,increase,risk
Aprobarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Aprobarbital.,increase,risk
Aprobarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Aprobarbital.,decrease,no risk
Aprobarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Aprobarbital.,increase,risk
Aprobarbital,Quazepam,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Quazepam.,increase,risk
Aprobarbital,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Aprobarbital.,increase,risk
Aprobarbital,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Aprobarbital.,increase,no risk
Aprobarbital,Quinidine,The metabolism of Quinidine can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Aprobarbital.,increase,risk
Aprobarbital,Quinupramine,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Quinupramine.,increase,risk
Aprobarbital,Ulipristal,The metabolism of Ulipristal can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Umeclidinium.,increase,risk
Aprobarbital,Urethane,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Urethane.,increase,risk
Aprobarbital,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Aprobarbital.,increase,risk
Aprobarbital,Vandetanib,The metabolism of Vandetanib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Aprobarbital.,increase,risk
Aprobarbital,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Venetoclax,The metabolism of Venetoclax can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Aprobarbital.,increase,risk
Aprobarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Aprobarbital.,increase,risk
Aprobarbital,Vilazodone,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Vilazodone.,increase,risk
Aprobarbital,Viloxazine,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Viloxazine.,increase,risk
Aprobarbital,Vinblastine,The metabolism of Vinblastine can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Vincristine,The metabolism of Vincristine can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Vindesine,The metabolism of Vindesine can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Vinflunine,The metabolism of Vinflunine can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Vortioxetine,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Vortioxetine.,increase,risk
Aprobarbital,Warfarin,The metabolism of Warfarin can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Yohimbine,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Yohimbine.,increase,risk
Aprobarbital,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Aprobarbital.,increase,risk
Aprobarbital,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Aprobarbital.,increase,no risk
Aprobarbital,Ziconotide,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Ziconotide.,increase,risk
Aprobarbital,Zimelidine,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Zimelidine.,increase,risk
Aprobarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Ziprasidone.,increase,risk
Aprobarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Aprobarbital.,increase,risk
Aprobarbital,Zolpidem,Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Aprobarbital,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Aprobarbital.,increase,risk
Aprobarbital,Zopiclone,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Zopiclone.,increase,risk
Aprobarbital,Zotepine,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Zotepine.,increase,risk
Aprobarbital,Zuclopenthixol,The risk or severity of CNS depression can be increased when Aprobarbital is combined with Zuclopenthixol.,increase,risk
Aprobarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Aprobarbital.,increase,risk
Butobarbital,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Butobarbital.,increase,risk
Butobarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Butobarbital is combined with Gabapentin enacarbil.,increase,risk
Butobarbital,Galantamine,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Galantamine.,decrease,no risk
Butobarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Butobarbital.,increase,risk
Butobarbital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Butobarbital is combined with Ganaxolone.",increase,risk
Butobarbital,Gepirone,The risk or severity of CNS depression can be increased when Butobarbital is combined with Gepirone.,increase,risk
Butobarbital,Ginkgo biloba,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Butobarbital,Glutethimide,The risk or severity of CNS depression can be increased when Butobarbital is combined with Glutethimide.,increase,risk
Butobarbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Butobarbital.,decrease,no risk
Butobarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Butobarbital.,increase,risk
Butobarbital,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Butobarbital.,increase,risk
Butobarbital,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Butobarbital.,increase,risk
Butobarbital,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Butobarbital.,increase,risk
Butobarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Butobarbital.,increase,risk
Butobarbital,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Butobarbital.,increase,risk
Butobarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Butobarbital.,increase,risk
Butobarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Butobarbital is combined with Hexocyclium.,increase,risk
Butobarbital,Homatropine,The risk or severity of adverse effects can be increased when Butobarbital is combined with Homatropine.,increase,risk
Butobarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Butobarbital.,increase,risk
Butobarbital,Huperzine A,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Butobarbital,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Butobarbital.,increase,no risk
Butobarbital,Hydrocodone,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Butobarbital,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Butobarbital.,increase,no risk
Butobarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Hydromorphone.,increase,risk
Butobarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.,increase,no risk
Butobarbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Butobarbital.,increase,risk
Butobarbital,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Butobarbital.,increase,risk
Butobarbital,Ketazolam,The risk or severity of CNS depression can be increased when Butobarbital is combined with Ketazolam.,increase,risk
Butobarbital,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.,increase,no risk
Butobarbital,Nalbuphine,The risk or severity of adverse effects can be increased when Butobarbital is combined with Nalbuphine.,increase,risk
Butobarbital,Naloxegol,The risk or severity of adverse effects can be increased when Butobarbital is combined with Naloxegol.,increase,risk
Butobarbital,Naltrexone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Naltrexone.,increase,risk
Butobarbital,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Butobarbital.,increase,risk
Butobarbital,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Butobarbital.,increase,risk
Butobarbital,Nefazodone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Nefazodone.,increase,risk
Butobarbital,Neostigmine,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Neostigmine.,decrease,no risk
Butobarbital,Nialamide,The risk or severity of CNS depression can be increased when Butobarbital is combined with Nialamide.,increase,risk
Butobarbital,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Butobarbital.,increase,risk
Butobarbital,Nitrazepam,The risk or severity of CNS depression can be increased when Butobarbital is combined with Nitrazepam.,increase,risk
Butobarbital,Nitrous oxide,The risk or severity of CNS depression can be increased when Butobarbital is combined with Nitrous oxide.,increase,risk
Butobarbital,Nizatidine,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Nizatidine.,decrease,no risk
Butobarbital,Nomifensine,The risk or severity of CNS depression can be increased when Butobarbital is combined with Nomifensine.,increase,risk
Butobarbital,Normethadone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Normethadone.,increase,risk
Butobarbital,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Butobarbital.,increase,risk
Butobarbital,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Butobarbital.,increase,risk
Butobarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Butobarbital is combined with Oliceridine.",increase,risk
Butobarbital,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Butobarbital.,increase,risk
Butobarbital,Opium,The risk or severity of adverse effects can be increased when Butobarbital is combined with Opium.,increase,risk
Butobarbital,Orphenadrine,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Butobarbital,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Butobarbital.,increase,risk
Butobarbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Butobarbital.,increase,risk
Butobarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Butobarbital is combined with Oxitriptan.,increase,risk
Butobarbital,Oxprenolol,The risk or severity of CNS depression can be increased when Butobarbital is combined with Oxprenolol.,increase,risk
Butobarbital,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Butobarbital.,increase,risk
Butobarbital,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Butobarbital.,increase,risk
Butobarbital,Oxycodone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Oxycodone.,increase,risk
Butobarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Oxymorphone.,increase,risk
Butobarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Butobarbital.,increase,risk
Butobarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Butobarbital.,decrease,no risk
Butobarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Butobarbital.,increase,risk
Butobarbital,Quazepam,The risk or severity of CNS depression can be increased when Butobarbital is combined with Quazepam.,increase,risk
Butobarbital,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Butobarbital.,increase,risk
Butobarbital,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Butobarbital.,increase,no risk
Butobarbital,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Butobarbital.,increase,risk
Butobarbital,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Butobarbital.,increase,risk
Butobarbital,Quinupramine,The risk or severity of CNS depression can be increased when Butobarbital is combined with Quinupramine.,increase,risk
Butobarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Butobarbital is combined with Umeclidinium.,increase,risk
Butobarbital,Urethane,The risk or severity of CNS depression can be increased when Butobarbital is combined with Urethane.,increase,risk
Butobarbital,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Butobarbital.,increase,risk
Butobarbital,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Butobarbital.,increase,risk
Butobarbital,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Butobarbital.,increase,risk
Butobarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Butobarbital.,increase,risk
Butobarbital,Vilazodone,The risk or severity of CNS depression can be increased when Butobarbital is combined with Vilazodone.,increase,risk
Butobarbital,Viloxazine,The risk or severity of CNS depression can be increased when Butobarbital is combined with Viloxazine.,increase,risk
Butobarbital,Vortioxetine,The risk or severity of CNS depression can be increased when Butobarbital is combined with Vortioxetine.,increase,risk
Butobarbital,Yohimbine,The risk or severity of CNS depression can be increased when Butobarbital is combined with Yohimbine.,increase,risk
Butobarbital,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Butobarbital.,increase,risk
Butobarbital,Ziconotide,The risk or severity of CNS depression can be increased when Butobarbital is combined with Ziconotide.,increase,risk
Butobarbital,Zimelidine,The risk or severity of adverse effects can be increased when Butobarbital is combined with Zimelidine.,increase,risk
Butobarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Ziprasidone.,increase,risk
Butobarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Butobarbital.,increase,risk
Butobarbital,Zolpidem,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Butobarbital,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butobarbital.,increase,risk
Butobarbital,Zopiclone,The risk or severity of adverse effects can be increased when Butobarbital is combined with Zopiclone.,increase,risk
Butobarbital,Zotepine,The risk or severity of CNS depression can be increased when Butobarbital is combined with Zotepine.,increase,risk
Butobarbital,Zuclopenthixol,The risk or severity of CNS depression can be increased when Butobarbital is combined with Zuclopenthixol.,increase,risk
Butobarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Butobarbital.,increase,risk
Heptabarbital,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Heptabarbital.,increase,risk
Heptabarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Gabapentin enacarbil.,increase,risk
Heptabarbital,Galantamine,The therapeutic efficacy of Heptabarbital can be decreased when used in combination with Galantamine.,decrease,no risk
Heptabarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Heptabarbital.,increase,risk
Heptabarbital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Heptabarbital is combined with Ganaxolone.",increase,risk
Heptabarbital,Gepirone,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Gepirone.,increase,risk
Heptabarbital,Ginkgo biloba,The therapeutic efficacy of Heptabarbital can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Heptabarbital,Glutethimide,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Glutethimide.,increase,risk
Heptabarbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Heptabarbital.,decrease,no risk
Heptabarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Heptabarbital.,increase,risk
Heptabarbital,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Heptabarbital.,increase,risk
Heptabarbital,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Heptabarbital.,increase,risk
Heptabarbital,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Heptabarbital.,increase,risk
Heptabarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Heptabarbital.,increase,risk
Heptabarbital,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Heptabarbital.,increase,risk
Heptabarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Heptabarbital.,increase,risk
Heptabarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Hexocyclium.,increase,risk
Heptabarbital,Homatropine,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Homatropine.,increase,risk
Heptabarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Heptabarbital.,increase,risk
Heptabarbital,Huperzine A,The therapeutic efficacy of Heptabarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Heptabarbital,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Heptabarbital.,increase,no risk
Heptabarbital,Hydrocodone,Heptabarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Heptabarbital,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Heptabarbital.,increase,no risk
Heptabarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Hydromorphone.,increase,risk
Heptabarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Heptabarbital.,increase,no risk
Heptabarbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Heptabarbital.,increase,risk
Heptabarbital,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Heptabarbital.,increase,risk
Heptabarbital,Ketazolam,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Ketazolam.,increase,risk
Heptabarbital,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Heptabarbital.,increase,no risk
Heptabarbital,Nalbuphine,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Nalbuphine.,increase,risk
Heptabarbital,Naloxegol,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Naloxegol.,increase,risk
Heptabarbital,Naltrexone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Naltrexone.,increase,risk
Heptabarbital,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Heptabarbital.,increase,risk
Heptabarbital,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Heptabarbital.,increase,risk
Heptabarbital,Nefazodone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Nefazodone.,increase,risk
Heptabarbital,Neostigmine,The therapeutic efficacy of Heptabarbital can be decreased when used in combination with Neostigmine.,decrease,no risk
Heptabarbital,Nialamide,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Nialamide.,increase,risk
Heptabarbital,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Heptabarbital.,increase,risk
Heptabarbital,Nitrazepam,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Nitrazepam.,increase,risk
Heptabarbital,Nitrous oxide,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Nitrous oxide.,increase,risk
Heptabarbital,Nizatidine,The therapeutic efficacy of Heptabarbital can be decreased when used in combination with Nizatidine.,decrease,no risk
Heptabarbital,Nomifensine,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Nomifensine.,increase,risk
Heptabarbital,Normethadone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Normethadone.,increase,risk
Heptabarbital,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Heptabarbital.,increase,risk
Heptabarbital,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Heptabarbital.,increase,risk
Heptabarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Heptabarbital is combined with Oliceridine.",increase,risk
Heptabarbital,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Heptabarbital.,increase,risk
Heptabarbital,Opium,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Opium.,increase,risk
Heptabarbital,Orphenadrine,Heptabarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Heptabarbital,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Heptabarbital.,increase,risk
Heptabarbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Heptabarbital.,increase,risk
Heptabarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Oxitriptan.,increase,risk
Heptabarbital,Oxprenolol,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Oxprenolol.,increase,risk
Heptabarbital,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Heptabarbital.,increase,risk
Heptabarbital,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Heptabarbital.,increase,risk
Heptabarbital,Oxycodone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Oxycodone.,increase,risk
Heptabarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Oxymorphone.,increase,risk
Heptabarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Heptabarbital.,increase,risk
Heptabarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Heptabarbital.,decrease,no risk
Heptabarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Heptabarbital.,increase,risk
Heptabarbital,Quazepam,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Quazepam.,increase,risk
Heptabarbital,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Heptabarbital.,increase,risk
Heptabarbital,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Heptabarbital.,increase,no risk
Heptabarbital,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Heptabarbital.,increase,risk
Heptabarbital,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Heptabarbital.,increase,risk
Heptabarbital,Quinupramine,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Quinupramine.,increase,risk
Heptabarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Umeclidinium.,increase,risk
Heptabarbital,Urethane,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Urethane.,increase,risk
Heptabarbital,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Heptabarbital.,increase,risk
Heptabarbital,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Heptabarbital.,increase,risk
Heptabarbital,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Heptabarbital.,increase,risk
Heptabarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Heptabarbital.,increase,risk
Heptabarbital,Vilazodone,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Vilazodone.,increase,risk
Heptabarbital,Viloxazine,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Viloxazine.,increase,risk
Heptabarbital,Vortioxetine,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Vortioxetine.,increase,risk
Heptabarbital,Yohimbine,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Yohimbine.,increase,risk
Heptabarbital,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Heptabarbital.,increase,risk
Heptabarbital,Ziconotide,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Ziconotide.,increase,risk
Heptabarbital,Zimelidine,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Zimelidine.,increase,risk
Heptabarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Ziprasidone.,increase,risk
Heptabarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Heptabarbital.,increase,risk
Heptabarbital,Zolpidem,Heptabarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Heptabarbital,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Heptabarbital.,increase,risk
Heptabarbital,Zopiclone,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Zopiclone.,increase,risk
Heptabarbital,Zotepine,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Zotepine.,increase,risk
Heptabarbital,Zuclopenthixol,The risk or severity of CNS depression can be increased when Heptabarbital is combined with Zuclopenthixol.,increase,risk
Heptabarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Heptabarbital.,increase,risk
Hexobarbital,Bisoprolol,Hexobarbital may increase the hypotensive activities of Bisoprolol.,increase,no risk
Hexobarbital,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Hexobarbital.,decrease,no risk
Hexobarbital,Borage oil,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Borage oil.,decrease,no risk
Hexobarbital,Bortezomib,The metabolism of Hexobarbital can be decreased when combined with Bortezomib.,decrease,no risk
Hexobarbital,Bosentan,The metabolism of Hexobarbital can be increased when combined with Bosentan.,increase,no risk
Hexobarbital,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Botulinum toxin type A.,increase,risk
Hexobarbital,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Botulinum toxin type B.,increase,risk
Hexobarbital,Bretylium,Hexobarbital may increase the hypotensive activities of Bretylium.,increase,no risk
Hexobarbital,Brexanolone,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Brexanolone.,increase,risk
Hexobarbital,Brexpiprazole,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Brexpiprazole.,increase,risk
Hexobarbital,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.,increase,no risk
Hexobarbital,Brivaracetam,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Brivaracetam.,increase,risk
Hexobarbital,Bromazepam,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Bromazepam.,increase,risk
Hexobarbital,Bromocriptine,Hexobarbital may increase the hypotensive activities of Bromocriptine.,increase,no risk
Hexobarbital,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Hexobarbital.,decrease,no risk
Hexobarbital,Bromperidol,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Bromperidol.,increase,risk
Hexobarbital,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Hexobarbital.,increase,risk
Hexobarbital,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Hexobarbital.,increase,risk
Hexobarbital,Bumetanide,Hexobarbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Hexobarbital,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Hexobarbital is combined with Bupivacaine.,increase,risk
Hexobarbital,Buprenorphine,Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Hexobarbital,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Hexobarbital.,increase,risk
Hexobarbital,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Hexobarbital.,increase,risk
Hexobarbital,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Hexobarbital.,increase,risk
Hexobarbital,Butacaine,The risk or severity of methemoglobinemia can be increased when Hexobarbital is combined with Butacaine.,increase,risk
Hexobarbital,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Hexobarbital.,increase,risk
Hexobarbital,Butamben,The risk or severity of methemoglobinemia can be increased when Hexobarbital is combined with Butamben.,increase,risk
Hexobarbital,Butaperazine,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Butaperazine.,increase,risk
Hexobarbital,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Hexobarbital.,increase,risk
Hexobarbital,Butorphanol,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Butorphanol.,increase,risk
Hexobarbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Butylscopolamine.,increase,risk
Hexobarbital,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Hexobarbital.,increase,risk
Hexobarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Gabapentin enacarbil.,increase,risk
Hexobarbital,Galantamine,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Galantamine.,decrease,no risk
Hexobarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Hexobarbital.,increase,risk
Hexobarbital,Gamolenic acid,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Hexobarbital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Hexobarbital is combined with Ganaxolone.",increase,risk
Hexobarbital,Ganciclovir,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Ganciclovir.,decrease,no risk
Hexobarbital,Gemfibrozil,The metabolism of Hexobarbital can be decreased when combined with Gemfibrozil.,decrease,no risk
Hexobarbital,Gepirone,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Gepirone.,increase,risk
Hexobarbital,Gestrinone,The metabolism of Gestrinone can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Ginkgo biloba,The metabolism of Hexobarbital can be decreased when combined with Ginkgo biloba.,decrease,no risk
Hexobarbital,Gliclazide,The metabolism of Hexobarbital can be decreased when combined with Gliclazide.,decrease,no risk
Hexobarbital,Glimepiride,The metabolism of Hexobarbital can be decreased when combined with Glimepiride.,decrease,no risk
Hexobarbital,Glipizide,The metabolism of Hexobarbital can be decreased when combined with Glipizide.,decrease,no risk
Hexobarbital,Gliquidone,The metabolism of Hexobarbital can be decreased when combined with Gliquidone.,decrease,no risk
Hexobarbital,Glofitamab,The serum concentration of Hexobarbital can be increased when it is combined with Glofitamab.,increase,no risk
Hexobarbital,Glutethimide,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Glutethimide.,increase,risk
Hexobarbital,Glyburide,The metabolism of Hexobarbital can be decreased when combined with Glyburide.,decrease,no risk
Hexobarbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hexobarbital.,decrease,no risk
Hexobarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Hexobarbital.,increase,risk
Hexobarbital,Golimumab,The metabolism of Hexobarbital can be increased when combined with Golimumab.,increase,no risk
Hexobarbital,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Hexobarbital.,increase,risk
Hexobarbital,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Hexobarbital.,decrease,no risk
Hexobarbital,Guanfacine,Hexobarbital may increase the hypotensive activities of Guanfacine.,increase,no risk
Hexobarbital,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Hexobarbital.,increase,risk
Hexobarbital,Halofantrine,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Halofantrine.,decrease,no risk
Hexobarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Hexobarbital.,increase,risk
Hexobarbital,Halothane,Hexobarbital may increase the hypotensive activities of Halothane.,increase,no risk
Hexobarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Hexobarbital.,increase,risk
Hexobarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Hexocyclium.,increase,risk
Hexobarbital,Homatropine,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Homatropine.,increase,risk
Hexobarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Hexobarbital.,increase,risk
Hexobarbital,Huperzine A,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Hexobarbital,Hydralazine,Hexobarbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Hexobarbital,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Hexobarbital is combined with Hydrochlorothiazide.,increase,risk
Hexobarbital,Hydrocodone,Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hexobarbital,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Hexobarbital is combined with Hydroflumethiazide.,increase,risk
Hexobarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Hydromorphone.,increase,risk
Hexobarbital,Hydroxychloroquine,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hexobarbital,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.,increase,no risk
Hexobarbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hexobarbital.,increase,risk
Hexobarbital,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Hexobarbital.,increase,risk
Hexobarbital,Ketazolam,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Ketazolam.,increase,risk
Hexobarbital,Ketorolac,The metabolism of Hexobarbital can be decreased when combined with Ketorolac.,decrease,no risk
Hexobarbital,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.,increase,no risk
Hexobarbital,Nabumetone,The metabolism of Hexobarbital can be decreased when combined with Nabumetone.,decrease,no risk
Hexobarbital,Nadolol,Hexobarbital may increase the hypotensive activities of Nadolol.,increase,no risk
Hexobarbital,Nalbuphine,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Nalbuphine.,increase,risk
Hexobarbital,Nalidixic acid,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Hexobarbital,Naloxegol,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Naloxegol.,increase,risk
Hexobarbital,Naltrexone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Naltrexone.,increase,risk
Hexobarbital,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Hexobarbital.,increase,risk
Hexobarbital,Naproxen,The metabolism of Hexobarbital can be decreased when combined with Naproxen.,decrease,no risk
Hexobarbital,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Hexobarbital.,increase,risk
Hexobarbital,Nateglinide,The metabolism of Hexobarbital can be decreased when combined with Nateglinide.,decrease,no risk
Hexobarbital,Nebivolol,Hexobarbital may increase the hypotensive activities of Nebivolol.,increase,no risk
Hexobarbital,Nefazodone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Nefazodone.,increase,risk
Hexobarbital,Neostigmine,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Neostigmine.,decrease,no risk
Hexobarbital,Nesiritide,Hexobarbital may increase the hypotensive activities of Nesiritide.,increase,no risk
Hexobarbital,Netupitant,The metabolism of Netupitant can be decreased when combined with Hexobarbital.,decrease,no risk
Hexobarbital,Nevirapine,The metabolism of Hexobarbital can be decreased when combined with Nevirapine.,decrease,no risk
Hexobarbital,Nialamide,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Nialamide.,increase,risk
Hexobarbital,Nicardipine,The metabolism of Hexobarbital can be decreased when combined with Nicardipine.,decrease,no risk
Hexobarbital,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Hexobarbital.,decrease,no risk
Hexobarbital,Nifedipine,Hexobarbital may increase the hypotensive activities of Nifedipine.,increase,no risk
Hexobarbital,Nilutamide,The metabolism of Hexobarbital can be decreased when combined with Nilutamide.,decrease,no risk
Hexobarbital,Nilvadipine,Hexobarbital may increase the hypotensive activities of Nilvadipine.,increase,no risk
Hexobarbital,Nimesulide,The metabolism of Nimesulide can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Nimodipine,Hexobarbital may increase the hypotensive activities of Nimodipine.,increase,no risk
Hexobarbital,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Hexobarbital.,decrease,no risk
Hexobarbital,Nisoldipine,Hexobarbital may increase the hypotensive activities of Nisoldipine.,increase,no risk
Hexobarbital,Nitrazepam,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Nitrazepam.,increase,risk
Hexobarbital,Nitrendipine,Hexobarbital may increase the hypotensive activities of Nitrendipine.,increase,no risk
Hexobarbital,Nitric Oxide,Hexobarbital may increase the hypotensive activities of Nitric Oxide.,increase,no risk
Hexobarbital,Nitroglycerin,Hexobarbital may increase the hypotensive activities of Nitroglycerin.,increase,no risk
Hexobarbital,Nitroprusside,Hexobarbital may increase the hypotensive activities of Nitroprusside.,increase,no risk
Hexobarbital,Nitrous acid,Hexobarbital may increase the hypotensive activities of Nitrous acid.,increase,no risk
Hexobarbital,Nitrous oxide,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Nitrous oxide.,increase,risk
Hexobarbital,Nizatidine,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Nizatidine.,decrease,no risk
Hexobarbital,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Nomifensine,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Nomifensine.,increase,risk
Hexobarbital,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Norethisterone,The metabolism of Norethisterone can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Norgestimate,The metabolism of Norgestimate can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Norgestrel,The metabolism of Norgestrel can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Normethadone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Normethadone.,increase,risk
Hexobarbital,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Noscapine,The metabolism of Hexobarbital can be decreased when combined with Noscapine.,decrease,no risk
Hexobarbital,Nylidrin,The metabolism of Nylidrin can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Obinutuzumab,Hexobarbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Hexobarbital,Olanzapine,Hexobarbital may increase the hypotensive activities of Olanzapine.,increase,no risk
Hexobarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Hexobarbital is combined with Oliceridine.",increase,risk
Hexobarbital,Olmesartan,Hexobarbital may increase the hypotensive activities of Olmesartan.,increase,no risk
Hexobarbital,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Hexobarbital.,decrease,no risk
Hexobarbital,Omeprazole,The metabolism of Hexobarbital can be decreased when combined with Omeprazole.,decrease,no risk
Hexobarbital,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Hexobarbital.,increase,risk
Hexobarbital,Opicapone,Hexobarbital may increase the hypotensive activities of Opicapone.,increase,no risk
Hexobarbital,Opium,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Opium.,increase,risk
Hexobarbital,Oritavancin,The metabolism of Hexobarbital can be decreased when combined with Oritavancin.,decrease,no risk
Hexobarbital,Orlistat,Orlistat can cause a decrease in the absorption of Hexobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Hexobarbital,Orphenadrine,Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Hexobarbital,Osilodrostat,The metabolism of Hexobarbital can be decreased when combined with Osilodrostat.,decrease,no risk
Hexobarbital,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Hexobarbital.,decrease,no risk
Hexobarbital,Oxandrolone,The metabolism of Hexobarbital can be decreased when combined with Oxandrolone.,decrease,no risk
Hexobarbital,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Hexobarbital.,increase,risk
Hexobarbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Hexobarbital.,increase,risk
Hexobarbital,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Hexobarbital is combined with Oxetacaine.,increase,risk
Hexobarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Oxitriptan.,increase,risk
Hexobarbital,Oxprenolol,Hexobarbital may increase the hypotensive activities of Oxprenolol.,increase,no risk
Hexobarbital,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Hexobarbital.,decrease,no risk
Hexobarbital,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Hexobarbital is combined with Oxybuprocaine.,increase,risk
Hexobarbital,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hexobarbital.,increase,risk
Hexobarbital,Oxycodone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Oxycodone.,increase,risk
Hexobarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Oxymorphone.,increase,risk
Hexobarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hexobarbital.,increase,risk
Hexobarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hexobarbital.,decrease,no risk
Hexobarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hexobarbital.,increase,risk
Hexobarbital,Quazepam,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Quazepam.,increase,risk
Hexobarbital,Quetiapine,Hexobarbital may increase the hypotensive activities of Quetiapine.,increase,no risk
Hexobarbital,Quinapril,Hexobarbital may increase the hypotensive activities of Quinapril.,increase,no risk
Hexobarbital,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Hexobarbital is combined with Quinethazone.,increase,risk
Hexobarbital,Quinidine,The metabolism of Hexobarbital can be decreased when combined with Quinidine.,decrease,no risk
Hexobarbital,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Hexobarbital.,increase,risk
Hexobarbital,Quinupramine,The metabolism of Quinupramine can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Hexobarbital.,decrease,no risk
Hexobarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Umeclidinium.,increase,risk
Hexobarbital,Urethane,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Urethane.,increase,risk
Hexobarbital,Vadadustat,The metabolism of Hexobarbital can be decreased when combined with Vadadustat.,decrease,no risk
Hexobarbital,Valdecoxib,The metabolism of Hexobarbital can be decreased when combined with Valdecoxib.,decrease,no risk
Hexobarbital,Valganciclovir,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Valganciclovir.,decrease,no risk
Hexobarbital,Valproic acid,The serum concentration of Hexobarbital can be increased when it is combined with Valproic acid.,increase,no risk
Hexobarbital,Valsartan,Hexobarbital may increase the hypotensive activities of Valsartan.,increase,no risk
Hexobarbital,Vardenafil,The metabolism of Hexobarbital can be decreased when combined with Vardenafil.,decrease,no risk
Hexobarbital,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Hexobarbital.,increase,risk
Hexobarbital,Vemurafenib,The metabolism of Hexobarbital can be decreased when combined with Vemurafenib.,decrease,no risk
Hexobarbital,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Hexobarbital.,increase,risk
Hexobarbital,Verapamil,Hexobarbital may increase the hypotensive activities of Verapamil.,increase,no risk
Hexobarbital,Vericiguat,Hexobarbital may increase the hypotensive activities of Vericiguat.,increase,no risk
Hexobarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Hexobarbital.,increase,risk
Hexobarbital,Vilazodone,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Vilazodone.,increase,risk
Hexobarbital,Viloxazine,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Viloxazine.,increase,risk
Hexobarbital,Vonoprazan,The metabolism of Hexobarbital can be decreased when combined with Vonoprazan.,decrease,no risk
Hexobarbital,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Hexobarbital.,decrease,no risk
Hexobarbital,Vortioxetine,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Vortioxetine.,increase,risk
Hexobarbital,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Hexobarbital.,decrease,no risk
Hexobarbital,Warfarin,The metabolism of Warfarin can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Hexobarbital.,decrease,no risk
Hexobarbital,Xylometazoline,The metabolism of Xylometazoline can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Yohimbine,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Yohimbine.,increase,risk
Hexobarbital,Zafirlukast,The metabolism of Hexobarbital can be decreased when combined with Zafirlukast.,decrease,no risk
Hexobarbital,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Hexobarbital.,increase,risk
Hexobarbital,Ziconotide,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Ziconotide.,increase,risk
Hexobarbital,Zidovudine,The metabolism of Hexobarbital can be decreased when combined with Zidovudine.,decrease,no risk
Hexobarbital,Zileuton,The metabolism of Hexobarbital can be decreased when combined with Zileuton.,decrease,no risk
Hexobarbital,Zimelidine,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Zimelidine.,increase,risk
Hexobarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Ziprasidone.,increase,risk
Hexobarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Hexobarbital.,increase,risk
Hexobarbital,Zolpidem,Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Hexobarbital,Zonisamide,The metabolism of Zonisamide can be increased when combined with Hexobarbital.,increase,no risk
Hexobarbital,Zopiclone,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Zopiclone.,increase,risk
Hexobarbital,Zotepine,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Zotepine.,increase,risk
Hexobarbital,Zuclopenthixol,The risk or severity of CNS depression can be increased when Hexobarbital is combined with Zuclopenthixol.,increase,risk
Hexobarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Hexobarbital.,increase,risk
Lithium cation,Bismuth subcitrate potassium,Lithium cation may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Lithium cation,Bismuth subgallate,Lithium cation may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lithium cation,Bismuth subnitrate,Lithium cation may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Lithium cation,Bisoprolol,Lithium cation may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Lithium cation,Bisoxatin,Lithium cation may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lithium cation,Bleomycin,Lithium cation may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Lithium cation,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Lithium cation.,increase,risk
Lithium cation,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Lithium cation.,increase,risk
Lithium cation,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Lithium cation.,increase,risk
Lithium cation,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lithium cation.,increase,risk
Lithium cation,Brexanolone,The risk or severity of CNS depression can be increased when Lithium cation is combined with Brexanolone.,increase,risk
Lithium cation,Brexpiprazole,The risk or severity of adverse effects can be increased when Lithium cation is combined with Brexpiprazole.,increase,risk
Lithium cation,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Lithium cation.,increase,no risk
Lithium cation,Brivaracetam,The risk or severity of CNS depression can be increased when Lithium cation is combined with Brivaracetam.,increase,risk
Lithium cation,Bromazepam,The risk or severity of CNS depression can be increased when Lithium cation is combined with Bromazepam.,increase,risk
Lithium cation,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Lithium cation.,increase,risk
Lithium cation,Bromperidol,The risk or severity of adverse effects can be increased when Lithium cation is combined with Bromperidol.,increase,risk
Lithium cation,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Lithium cation.,increase,risk
Lithium cation,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Lithium cation.,increase,risk
Lithium cation,Budesonide,Lithium cation may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Lithium cation,Bumadizone,The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Bumadizone.,increase,risk
Lithium cation,Bumetanide,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Lithium cation.,increase,risk
Lithium cation,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Lithium cation.,increase,risk
Lithium cation,Buprenorphine,Lithium cation may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Lithium cation,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Lithium cation.,increase,risk
Lithium cation,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Lithium cation.,increase,risk
Lithium cation,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Lithium cation.,increase,risk
Lithium cation,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Lithium cation.,increase,risk
Lithium cation,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Lithium cation.,increase,risk
Lithium cation,Butaperazine,The risk or severity of adverse effects can be increased when Lithium cation is combined with Butaperazine.,increase,risk
Lithium cation,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Lithium cation.,increase,risk
Lithium cation,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Lithium cation.,increase,risk
Lithium cation,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Lithium cation.,increase,risk
Lithium cation,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Lithium cation.,increase,risk
Lithium cation,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Lithium cation is combined with Gabapentin enacarbil.,increase,risk
Lithium cation,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Lithium cation.,increase,risk
Lithium cation,Gadodiamide,Lithium cation may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Lithium cation,Gadofosveset trisodium,Lithium cation may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Lithium cation,Gadopentetic acid,Lithium cation may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Lithium cation,Gadoteric acid,Lithium cation may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Lithium cation,Gadoteridol,Lithium cation may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Lithium cation,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lithium cation.,increase,risk
Lithium cation,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Lithium cation.,increase,risk
Lithium cation,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Lithium cation is combined with Ganaxolone.",increase,risk
Lithium cation,Ganciclovir,Lithium cation may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Lithium cation,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lithium cation.,increase,risk
Lithium cation,Gemcitabine,Lithium cation may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Lithium cation,Gemfibrozil,Lithium cation may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Lithium cation,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Lithium cation.,increase,risk
Lithium cation,Gentamicin,Lithium cation may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Lithium cation,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Lithium cation.,increase,risk
Lithium cation,Gilteritinib,The therapeutic efficacy of Lithium cation can be decreased when used in combination with Gilteritinib.,decrease,no risk
Lithium cation,Gimeracil,Lithium cation may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Lithium cation,Givosiran,The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Givosiran.,increase,risk
Lithium cation,Glasdegib,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Glasdegib.,increase,risk
Lithium cation,Glipizide,Lithium cation may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Lithium cation,Glutethimide,The risk or severity of CNS depression can be increased when Lithium cation is combined with Glutethimide.,increase,risk
Lithium cation,Glycerol phenylbutyrate,Lithium cation may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Lithium cation,Golodirsen,Lithium cation may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Lithium cation,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lithium cation.,increase,risk
Lithium cation,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Lithium cation.,increase,risk
Lithium cation,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Lithium cation.,increase,risk
Lithium cation,Guanethidine,Lithium cation may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Lithium cation,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Lithium cation.,increase,risk
Lithium cation,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Lithium cation.,increase,risk
Lithium cation,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Lithium cation.,increase,risk
Lithium cation,Haloperidol,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Haloperidol.,increase,risk
Lithium cation,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Lithium cation.,increase,risk
Lithium cation,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Lithium cation.,increase,risk
Lithium cation,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lithium cation.,increase,risk
Lithium cation,Hydralazine,Lithium cation may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Lithium cation,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Lithium cation.,increase,risk
Lithium cation,Hydrocodone,Lithium cation may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lithium cation,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Lithium cation.,increase,risk
Lithium cation,Hydroxocobalamin,Lithium cation may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Lithium cation,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Lithium cation.,increase,risk
Lithium cation,Hydroxyethyl Starch,Lithium cation may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Lithium cation,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Hydroxyzine.,increase,risk
Lithium cation,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lithium cation.,increase,risk
Lithium cation,Kanamycin,Lithium cation may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Lithium cation,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Lithium cation.,increase,risk
Lithium cation,Ketazolam,The risk or severity of CNS depression can be increased when Lithium cation is combined with Ketazolam.,increase,risk
Lithium cation,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Lithium cation.,increase,risk
Lithium cation,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Lithium cation.,increase,risk
Lithium cation,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Lithium cation.,increase,risk
Lithium cation,N-acetyltyrosine,Lithium cation may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Lithium cation,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Lithium cation.,increase,no risk
Lithium cation,Nabumetone,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Lithium cation.,increase,risk
Lithium cation,Nadolol,Lithium cation may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Lithium cation,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Lithium cation.,increase,risk
Lithium cation,Naldemedine,Lithium cation may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Lithium cation,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Lithium cation.,increase,risk
Lithium cation,Nalmefene,Lithium cation may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Lithium cation,Naloxone,Lithium cation may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Lithium cation,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lithium cation.,increase,risk
Lithium cation,Naproxen,The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Lithium cation.,increase,risk
Lithium cation,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Lithium cation.,increase,risk
Lithium cation,Nateglinide,Lithium cation may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Lithium cation,Naxitamab,Lithium cation may increase the neurotoxic activities of Naxitamab.,increase,no risk
Lithium cation,Nedaplatin,Lithium cation may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Lithium cation,Nedocromil,Lithium cation may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Lithium cation,Nefazodone,The risk or severity of adverse effects can be increased when Lithium cation is combined with Nefazodone.,increase,risk
Lithium cation,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Lithium cation.,increase,risk
Lithium cation,Neomycin,The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Neomycin.,increase,risk
Lithium cation,Netilmicin,Lithium cation may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Lithium cation,Nialamide,The risk or severity of CNS depression can be increased when Lithium cation is combined with Nialamide.,increase,risk
Lithium cation,Nicardipine,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Lithium cation.,increase,risk
Lithium cation,Nicorandil,Lithium cation may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Lithium cation,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Lithium cation.,increase,risk
Lithium cation,Nilotinib,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Nilotinib.,increase,risk
Lithium cation,Nilutamide,Lithium cation may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Lithium cation,Nilvadipine,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Lithium cation.,increase,risk
Lithium cation,Nimesulide,The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Nimesulide.,increase,risk
Lithium cation,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Lithium cation.,increase,risk
Lithium cation,Nisoldipine,Lithium cation may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Lithium cation,Nitrazepam,The risk or severity of CNS depression can be increased when Lithium cation is combined with Nitrazepam.,increase,risk
Lithium cation,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Lithium cation.,increase,risk
Lithium cation,Nitric Oxide,Lithium cation may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Lithium cation,Nitrofurantoin,Lithium cation may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Lithium cation,Nitroprusside,Lithium cation may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Lithium cation,Nitrous oxide,The risk or severity of CNS depression can be increased when Lithium cation is combined with Nitrous oxide.,increase,risk
Lithium cation,Nomifensine,The risk or severity of CNS depression can be increased when Lithium cation is combined with Nomifensine.,increase,risk
Lithium cation,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Lithium cation.,increase,risk
Lithium cation,Normethadone,The risk or severity of CNS depression can be increased when Lithium cation is combined with Normethadone.,increase,risk
Lithium cation,Nortriptyline,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Lithium cation.,increase,risk
Lithium cation,Octinoxate,Lithium cation may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Lithium cation,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lithium cation.,increase,risk
Lithium cation,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Lithium cation.,increase,risk
Lithium cation,Olanzapine,The risk or severity of adverse effects can be increased when Lithium cation is combined with Olanzapine.,increase,risk
Lithium cation,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lithium cation is combined with Oliceridine.",increase,risk
Lithium cation,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Lithium cation.,increase,risk
Lithium cation,Olsalazine,The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Olsalazine.,increase,risk
Lithium cation,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lithium cation.,increase,risk
Lithium cation,Opium,The risk or severity of CNS depression can be increased when Lithium cation is combined with Opium.,increase,risk
Lithium cation,Orphenadrine,Lithium cation may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Lithium cation,Oseltamivir,Lithium cation may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Lithium cation,Oxacillin,Lithium cation may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Lithium cation,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Lithium cation.,increase,risk
Lithium cation,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Lithium cation.,increase,risk
Lithium cation,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Lithium cation.,increase,risk
Lithium cation,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Lithium cation.,increase,risk
Lithium cation,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Lithium cation.,increase,risk
Lithium cation,Oxitriptan,The risk or severity of CNS depression can be increased when Lithium cation is combined with Oxitriptan.,increase,risk
Lithium cation,Oxprenolol,The risk or severity of CNS depression can be increased when Lithium cation is combined with Oxprenolol.,increase,risk
Lithium cation,Oxybenzone,Lithium cation may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Lithium cation,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Lithium cation.,increase,risk
Lithium cation,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Lithium cation.,increase,risk
Lithium cation,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Lithium cation.,increase,risk
Lithium cation,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Oxyphenbutazone.,increase,risk
Lithium cation,Oxyquinoline,Lithium cation may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Lithium cation,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lithium cation.,increase,risk
Lithium cation,Quazepam,The risk or severity of CNS depression can be increased when Lithium cation is combined with Quazepam.,increase,risk
Lithium cation,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Lithium cation.,increase,risk
Lithium cation,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Lithium cation.,decrease,no risk
Lithium cation,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Lithium cation.,increase,risk
Lithium cation,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Lithium cation.,increase,risk
Lithium cation,Quinupramine,The risk or severity of CNS depression can be increased when Lithium cation is combined with Quinupramine.,increase,risk
Lithium cation,Quizartinib,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Quizartinib.,increase,risk
Lithium cation,Urethane,The risk or severity of CNS depression can be increased when Lithium cation is combined with Urethane.,increase,risk
Lithium cation,Vaborbactam,Lithium cation may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Lithium cation,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Lithium cation.,increase,risk
Lithium cation,Valbenazine,Lithium cation may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Lithium cation,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Lithium cation.,increase,risk
Lithium cation,Valganciclovir,Lithium cation may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Lithium cation,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Valproate bismuth.,increase,risk
Lithium cation,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Lithium cation.,increase,risk
Lithium cation,Vancomycin,Lithium cation may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Lithium cation,Vandetanib,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Vandetanib.,increase,risk
Lithium cation,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lithium cation.,increase,risk
Lithium cation,Varenicline,Lithium cation may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Lithium cation,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Lithium cation.,increase,risk
Lithium cation,Vemurafenib,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Vemurafenib.,increase,risk
Lithium cation,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Venlafaxine.,increase,risk
Lithium cation,Verapamil,Lithium cation may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Lithium cation,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lithium cation.,increase,risk
Lithium cation,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Lithium cation.,increase,risk
Lithium cation,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Lithium cation.,increase,risk
Lithium cation,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Lithium cation.,increase,risk
Lithium cation,Viloxazine,The risk or severity of CNS depression can be increased when Lithium cation is combined with Viloxazine.,increase,risk
Lithium cation,Vincristine,Vincristine may increase the neurotoxic activities of Lithium cation.,increase,no risk
Lithium cation,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Lithium cation.,increase,no risk
Lithium cation,Viomycin,Lithium cation may increase the neurotoxic activities of Viomycin.,increase,no risk
Lithium cation,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Lithium cation.,increase,risk
Lithium cation,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Lithium cation.,increase,risk
Lithium cation,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lithium cation.,increase,risk
Lithium cation,Warfarin,Lithium cation may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Lithium cation,Yohimbine,The risk or severity of CNS depression can be increased when Lithium cation is combined with Yohimbine.,increase,risk
Lithium cation,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Lithium cation.,increase,risk
Lithium cation,Zanamivir,Lithium cation may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Lithium cation,Ziconotide,The risk or severity of CNS depression can be increased when Lithium cation is combined with Ziconotide.,increase,risk
Lithium cation,Zimelidine,The risk or severity of adverse effects can be increased when Lithium cation is combined with Zimelidine.,increase,risk
Lithium cation,Ziprasidone,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Ziprasidone.,increase,risk
Lithium cation,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Zoledronic acid.,increase,risk
Lithium cation,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lithium cation.,increase,risk
Lithium cation,Zolpidem,Lithium cation may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Lithium cation,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Lithium cation.,increase,risk
Lithium cation,Zopiclone,The risk or severity of adverse effects can be increased when Lithium cation is combined with Zopiclone.,increase,risk
Lithium cation,Zotepine,The risk or severity of adverse effects can be increased when Lithium cation is combined with Zotepine.,increase,risk
Lithium cation,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Zuclopenthixol.,increase,risk
Lithium cation,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Lithium cation.,increase,risk
Mestranol,Bimekizumab,The metabolism of Mestranol can be increased when combined with Bimekizumab.,increase,no risk
Mestranol,Bivalirudin,The risk or severity of adverse effects can be increased when Mestranol is combined with Bivalirudin.,increase,risk
Mestranol,Blinatumomab,Mestranol may increase the thrombogenic activities of Blinatumomab.,increase,no risk
Mestranol,Boceprevir,The serum concentration of Mestranol can be increased when it is combined with Boceprevir.,increase,no risk
Mestranol,Bortezomib,The metabolism of Mestranol can be decreased when combined with Bortezomib.,decrease,no risk
Mestranol,Bosentan,The serum concentration of Mestranol can be decreased when it is combined with Bosentan.,decrease,no risk
Mestranol,Bosutinib,The metabolism of Mestranol can be decreased when combined with Bosutinib.,decrease,no risk
Mestranol,Brentuximab vedotin,Mestranol may increase the thrombogenic activities of Brentuximab vedotin.,increase,no risk
Mestranol,Brexanolone,The metabolism of Mestranol can be increased when combined with Brexanolone.,increase,no risk
Mestranol,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Brivaracetam,The metabolism of Mestranol can be increased when combined with Brivaracetam.,increase,no risk
Mestranol,Brodalumab,Mestranol may increase the thrombogenic activities of Brodalumab.,increase,no risk
Mestranol,Brolucizumab,Mestranol may increase the thrombogenic activities of Brolucizumab.,increase,no risk
Mestranol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Buprenorphine,The metabolism of Mestranol can be decreased when combined with Buprenorphine.,decrease,no risk
Mestranol,Bupropion,The metabolism of Mestranol can be decreased when combined with Bupropion.,decrease,no risk
Mestranol,Burosumab,Mestranol may increase the thrombogenic activities of Burosumab.,increase,no risk
Mestranol,Butabarbital,The therapeutic efficacy of Mestranol can be decreased when used in combination with Butabarbital.,decrease,no risk
Mestranol,Butalbital,The metabolism of Mestranol can be increased when combined with Butalbital.,increase,no risk
Mestranol,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Gabapentin,The metabolism of Mestranol can be decreased when combined with Fusidic acid.,decrease,no risk
Mestranol,Galcanezumab,The metabolism of Mestranol can be increased when combined with Gabapentin.,increase,no risk
Mestranol,Ganaxolone,Mestranol may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Mestranol,Gemfibrozil,The metabolism of Mestranol can be increased when combined with Ganaxolone.,increase,no risk
Mestranol,Gemtuzumab ozogamicin,The metabolism of Mestranol can be decreased when combined with Gemfibrozil.,decrease,no risk
Mestranol,Ginkgo biloba,Mestranol may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Mestranol,Glasdegib,The metabolism of Mestranol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Mestranol,Gliclazide,The metabolism of Glasdegib can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Glimepiride,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Glipizide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Gliquidone,The therapeutic efficacy of Glipizide can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Glofitamab,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Glyburide,The serum concentration of Mestranol can be increased when it is combined with Glofitamab.,increase,no risk
Mestranol,Glycerol phenylbutyrate,The therapeutic efficacy of Glyburide can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Glymidine,The metabolism of Mestranol can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Mestranol,Golimumab,The therapeutic efficacy of Glymidine can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Griseofulvin,The metabolism of Mestranol can be increased when combined with Golimumab.,increase,no risk
Mestranol,Guselkumab,The metabolism of Mestranol can be increased when combined with Griseofulvin.,increase,no risk
Mestranol,Halofantrine,Mestranol may increase the thrombogenic activities of Guselkumab.,increase,no risk
Mestranol,Haloperidol,The metabolism of Mestranol can be decreased when combined with Halofantrine.,decrease,no risk
Mestranol,Halothane,The serum concentration of Haloperidol can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Heparin,The metabolism of Mestranol can be decreased when combined with Halothane.,decrease,no risk
Mestranol,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Mestranol is combined with Heparin.,increase,risk
Mestranol,Hetacillin,Mestranol may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Mestranol,Human cytomegalovirus immune globulin,The therapeutic efficacy of Mestranol can be decreased when used in combination with Hetacillin.,decrease,no risk
Mestranol,Human immunoglobulin G,Mestranol may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Mestranol,Human Rho(D) immune globulin,Mestranol may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Mestranol,Human varicella-zoster immune globulin,Mestranol may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Mestranol,Hyaluronidase,Mestranol may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Mestranol,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Hydrocortamate,The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Hydrocortisone,The metabolism of Mestranol can be increased when combined with Hydrocortamate.,increase,no risk
Mestranol,Hydrocortisone acetate,The serum concentration of Hydrocortisone can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Hydrocortisone butyrate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Hydrocortisone cypionate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Hydrocortisone succinate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Hydromorphone,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Hydroxychloroquine,The metabolism of Mestranol can be decreased when combined with Hydromorphone.,decrease,no risk
Mestranol,Ketamine,Mestranol may increase the thrombogenic activities of Ixekizumab.,increase,no risk
Mestranol,Ketoconazole,The metabolism of Mestranol can be decreased when combined with Ketamine.,decrease,no risk
Mestranol,Ketoprofen,The metabolism of Mestranol can be decreased when combined with Ketoconazole.,decrease,no risk
Mestranol,Ketorolac,The metabolism of Mestranol can be decreased when combined with Ketoprofen.,decrease,no risk
Mestranol,Nabilone,The serum concentration of Mestranol can be decreased when it is combined with Mycophenolic acid.,decrease,no risk
Mestranol,Nabumetone,The metabolism of Mestranol can be decreased when combined with Nabilone.,decrease,no risk
Mestranol,Nadroparin,Nabumetone may increase the thrombogenic activities of Mestranol.,increase,no risk
Mestranol,Nafcillin,The risk or severity of adverse effects can be increased when Mestranol is combined with Nadroparin.,increase,risk
Mestranol,Naproxen,The metabolism of Mestranol can be increased when combined with Nafcillin.,increase,no risk
Mestranol,Natalizumab,The metabolism of Mestranol can be decreased when combined with Naproxen.,decrease,no risk
Mestranol,Nateglinide,Mestranol may increase the thrombogenic activities of Natalizumab.,increase,no risk
Mestranol,Necitumumab,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Nefazodone,Mestranol may increase the thrombogenic activities of Necitumumab.,increase,no risk
Mestranol,Nelfinavir,The metabolism of Mestranol can be decreased when combined with Nefazodone.,decrease,no risk
Mestranol,Netupitant,The metabolism of Mestranol can be decreased when combined with Nelfinavir.,decrease,no risk
Mestranol,Nevirapine,The metabolism of Mestranol can be decreased when combined with Netupitant.,decrease,no risk
Mestranol,Niacinamide ascorbate,The metabolism of Mestranol can be decreased when combined with Nevirapine.,decrease,no risk
Mestranol,Nicardipine,The serum concentration of Niacinamide ascorbate can be decreased when it is combined with Mestranol.,decrease,no risk
Mestranol,Niclosamide,The metabolism of Mestranol can be decreased when combined with Nicardipine.,decrease,no risk
Mestranol,Nilotinib,The metabolism of Niclosamide can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Nilutamide,The metabolism of Mestranol can be decreased when combined with Nilotinib.,decrease,no risk
Mestranol,Nilvadipine,The metabolism of Mestranol can be decreased when combined with Nilutamide.,decrease,no risk
Mestranol,Nimesulide,The metabolism of Mestranol can be decreased when combined with Nilvadipine.,decrease,no risk
Mestranol,Nirogacestat,Nimesulide may increase the thrombogenic activities of Mestranol.,increase,no risk
Mestranol,Nitrazepam,The metabolism of Mestranol can be increased when combined with Nirogacestat.,increase,no risk
Mestranol,Nitrofurantoin,The metabolism of Mestranol can be increased when combined with Nitrazepam.,increase,no risk
Mestranol,Nivolumab,The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Norgestimate,Mestranol may increase the thrombogenic activities of Nivolumab.,increase,no risk
Mestranol,Nortriptyline,The metabolism of Mestranol can be increased when combined with Norgestimate.,increase,no risk
Mestranol,Noscapine,The serum concentration of Nortriptyline can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Obeticholic acid,The metabolism of Mestranol can be decreased when combined with Noscapine.,decrease,no risk
Mestranol,Obiltoxaximab,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Obinutuzumab,Mestranol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Mestranol,Ocrelizumab,Mestranol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Mestranol,Octreotide,Mestranol may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Mestranol,Odesivimab,The therapeutic efficacy of Mestranol can be decreased when used in combination with Octreotide.,decrease,no risk
Mestranol,Ofatumumab,Mestranol may increase the thrombogenic activities of Odesivimab.,increase,no risk
Mestranol,Olanzapine,Mestranol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Mestranol,Olaratumab,The metabolism of Mestranol can be decreased when combined with Olanzapine.,decrease,no risk
Mestranol,Olodaterol,Mestranol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Mestranol,Olutasidenib,The metabolism of Olodaterol can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Omadacycline,The metabolism of Mestranol can be increased when combined with Olutasidenib.,increase,no risk
Mestranol,Omalizumab,The serum concentration of Mestranol can be decreased when it is combined with Omadacycline.,decrease,no risk
Mestranol,Omaveloxolone,Mestranol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Mestranol,Ombitasvir,The therapeutic efficacy of Mestranol can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Mestranol,Ondansetron,The risk or severity of liver enzyme elevations can be increased when Mestranol is combined with Ombitasvir.,increase,risk
Mestranol,Oritavancin,The metabolism of Mestranol can be decreased when combined with Ondansetron.,decrease,no risk
Mestranol,Ospemifene,The metabolism of Mestranol can be increased when combined with Oritavancin.,increase,no risk
Mestranol,Ox bile extract,The risk or severity of adverse effects can be increased when Mestranol is combined with Ospemifene.,increase,risk
Mestranol,Oxacillin,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Oxandrolone,The therapeutic efficacy of Mestranol can be decreased when used in combination with Oxacillin.,decrease,no risk
Mestranol,Oxcarbazepine,The metabolism of Mestranol can be decreased when combined with Oxandrolone.,decrease,no risk
Mestranol,Oxybutynin,The metabolism of Mestranol can be increased when combined with Oxcarbazepine.,increase,no risk
Mestranol,Oxytetracycline,The metabolism of Mestranol can be decreased when combined with Oxybutynin.,decrease,no risk
Mestranol,Ozanimod,The serum concentration of Mestranol can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Mestranol,Quinidine,The metabolism of Mestranol can be decreased when combined with Pyrimethamine.,decrease,no risk
Mestranol,Quinine,The metabolism of Mestranol can be decreased when combined with Quinidine.,decrease,no risk
Mestranol,Quinupramine,The therapeutic efficacy of Quinine can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Ublituximab,The metabolism of Tucatinib can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Urokinase,Mestranol may increase the thrombogenic activities of Ublituximab.,increase,no risk
Mestranol,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Mestranol is combined with Urokinase.,increase,risk
Mestranol,Ustekinumab,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Vadadustat,Mestranol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Mestranol,Valdecoxib,The serum concentration of Mestranol can be increased when it is combined with Vadadustat.,increase,no risk
Mestranol,Valproic acid,Valdecoxib may increase the thrombogenic activities of Mestranol.,increase,no risk
Mestranol,Valsartan,The metabolism of Mestranol can be increased when combined with Valproic acid.,increase,no risk
Mestranol,Vamorolone,The metabolism of Mestranol can be decreased when combined with Valsartan.,decrease,no risk
Mestranol,Vardenafil,The serum concentration of Vamorolone can be increased when it is combined with Mestranol.,increase,no risk
Mestranol,Vedolizumab,The metabolism of Mestranol can be decreased when combined with Vardenafil.,decrease,no risk
Mestranol,Velpatasvir,Mestranol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Mestranol,Vemurafenib,The metabolism of Velpatasvir can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Venetoclax,The metabolism of Mestranol can be increased when combined with Vemurafenib.,increase,no risk
Mestranol,Verapamil,The metabolism of Mestranol can be decreased when combined with Venetoclax.,decrease,no risk
Mestranol,Vigabatrin,The metabolism of Mestranol can be decreased when combined with Verapamil.,decrease,no risk
Mestranol,Vildagliptin,The metabolism of Mestranol can be increased when combined with Vigabatrin.,increase,no risk
Mestranol,Viloxazine,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Mestranol.,decrease,no risk
Mestranol,Vinblastine,The metabolism of Mestranol can be decreased when combined with Viloxazine.,decrease,no risk
Mestranol,Vitamin A,The metabolism of Mestranol can be increased when combined with Vinblastine.,increase,no risk
Mestranol,Vitamin E,The therapeutic efficacy of Mestranol can be decreased when used in combination with Vitamin A.,decrease,no risk
Mestranol,Vorapaxar,The metabolism of Mestranol can be increased when combined with Vitamin E.,increase,no risk
Mestranol,Voriconazole,The risk or severity of adverse effects can be increased when Mestranol is combined with Vorapaxar.,increase,risk
Mestranol,Vortioxetine,The metabolism of Mestranol can be decreased when combined with Voriconazole.,decrease,no risk
Mestranol,Voxelotor,The metabolism of Vortioxetine can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Voxilaprevir,The metabolism of Voxelotor can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Warfarin,The metabolism of Voxilaprevir can be decreased when combined with Mestranol.,decrease,no risk
Mestranol,Ximelagatran,The risk or severity of adverse effects can be increased when Mestranol is combined with Warfarin.,increase,risk
Mestranol,Zafirlukast,The risk or severity of adverse effects can be increased when Mestranol is combined with Ximelagatran.,increase,risk
Mestranol,Zaleplon,The metabolism of Mestranol can be decreased when combined with Zafirlukast.,decrease,no risk
Mestranol,Zidovudine,The metabolism of Mestranol can be increased when combined with Zaleplon.,increase,no risk
Mestranol,Zileuton,The metabolism of Mestranol can be decreased when combined with Zidovudine.,decrease,no risk
Mestranol,Zimelidine,The metabolism of Mestranol can be decreased when combined with Zileuton.,decrease,no risk
Mestranol,Zinc ascorbate,The metabolism of Mestranol can be decreased when combined with Zimelidine.,decrease,no risk
Mestranol,Ziprasidone,The serum concentration of Zinc ascorbate can be decreased when it is combined with Mestranol.,decrease,no risk
Mestranol,Zolpidem,The metabolism of Mestranol can be decreased when combined with Ziprasidone.,decrease,no risk
Mestranol,Zonisamide,The metabolism of Mestranol can be decreased when combined with Zolpidem.,decrease,no risk
Mestranol,Zopiclone,The metabolism of Mestranol can be increased when combined with Zonisamide.,increase,no risk
Penbutolol,Bacitracin,Bacitracin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,decrease,no risk
Penbutolol,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Penbutolol.,increase,risk
Penbutolol,Balsalazide,Balsalazide may decrease the antihypertensive activities of Penbutolol.,decrease,no risk
Penbutolol,Baricitinib,Penbutolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Penbutolol,Bemiparin,The risk or severity of hyperkalemia can be increased when Penbutolol is combined with Bemiparin.,increase,risk
Penbutolol,Benazepril,Benazepril may increase the hypotensive activities of Penbutolol.,increase,no risk
Penbutolol,Bendroflumethiazide,The therapeutic efficacy of Penbutolol can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Penbutolol,Benorilate,Benorilate may decrease the antihypertensive activities of Penbutolol.,decrease,no risk
Penbutolol,Benoxaprofen,Benoxaprofen may decrease the antihypertensive activities of Penbutolol.,decrease,no risk
Penbutolol,Benperidol,The risk or severity of CNS depression can be increased when Penbutolol is combined with Benperidol.,increase,risk
Penbutolol,Benserazide,Penbutolol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Penbutolol,Benzatropine,Benzatropine may decrease the excretion rate of Penbutolol which could result in a higher serum level.,decrease,no risk
Penbutolol,Benznidazole,Penbutolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Penbutolol,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Penbutolol.,increase,risk
Penbutolol,Benzphetamine,The therapeutic efficacy of Penbutolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Penbutolol,Benzthiazide,The therapeutic efficacy of Penbutolol can be increased when used in combination with Benzthiazide.,increase,no risk
Penbutolol,Benzydamine,Benzydamine may decrease the antihypertensive activities of Penbutolol.,decrease,no risk
Penbutolol,Benzyl alcohol,The risk or severity of CNS depression can be increased when Penbutolol is combined with Benzyl alcohol.,increase,risk
Penbutolol,Bepotastine,Penbutolol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Penbutolol,Bepridil,The risk or severity of bradycardia can be increased when Bepridil is combined with Penbutolol.,increase,risk
Penbutolol,Beractant,Penbutolol may increase the bradycardic activities of Beractant.,increase,no risk
Penbutolol,Berotralstat,The metabolism of Penbutolol can be decreased when combined with Berotralstat.,decrease,no risk
Penbutolol,Betaine,Betaine may increase the bradycardic activities of Penbutolol.,increase,no risk
Penbutolol,Betaxolol,Betaxolol may increase the hypotensive activities of Penbutolol.,increase,no risk
Penbutolol,Bethanechol,The risk or severity of adverse effects can be increased when Penbutolol is combined with Bethanechol.,increase,risk
Penbutolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Penbutolol.,decrease,no risk
Penbutolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Penbutolol.,increase,no risk
Penbutolol,Bicisate,Penbutolol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Penbutolol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Penbutolol.,increase,no risk
Penbutolol,Bimekizumab,The metabolism of Penbutolol can be increased when combined with Bimekizumab.,increase,no risk
Penbutolol,Biperiden,The metabolism of Penbutolol can be decreased when combined with Biperiden.,decrease,no risk
Penbutolol,Bismuth subgallate,Penbutolol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Penbutolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Penbutolol.,increase,risk
Penbutolol,Bisoxatin,Penbutolol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Penbutolol,Bleomycin,Bleomycin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,decrease,no risk
Penbutolol,Bortezomib,The metabolism of Penbutolol can be decreased when combined with Bortezomib.,decrease,no risk
Penbutolol,Bosentan,Bosentan may increase the hypotensive activities of Penbutolol.,increase,no risk
Penbutolol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Penbutolol.,increase,risk
Penbutolol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Penbutolol.,increase,risk
Penbutolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Penbutolol.,increase,risk
Penbutolol,Bretylium,Bretylium may increase the hypotensive activities of Penbutolol.,increase,no risk
Penbutolol,Brexanolone,The risk or severity of CNS depression can be increased when Penbutolol is combined with Brexanolone.,increase,risk
Penbutolol,Brexpiprazole,Penbutolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Penbutolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Penbutolol.,increase,no risk
Penbutolol,Brivaracetam,The risk or severity of CNS depression can be increased when Penbutolol is combined with Brivaracetam.,increase,risk
Penbutolol,Bromazepam,The risk or severity of CNS depression can be increased when Penbutolol is combined with Bromazepam.,increase,risk
Penbutolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Penbutolol.,increase,no risk
Penbutolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Penbutolol is combined with Bromotheophylline.,increase,risk
Penbutolol,Bromperidol,The risk or severity of CNS depression can be increased when Penbutolol is combined with Bromperidol.,increase,risk
Penbutolol,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Penbutolol.,increase,risk
Penbutolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Penbutolol.,increase,risk
Penbutolol,Budesonide,Budesonide may decrease the excretion rate of Penbutolol which could result in a higher serum level.,decrease,no risk
Penbutolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Penbutolol.,decrease,no risk
Penbutolol,Bumetanide,Bumetanide may increase the excretion rate of Penbutolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Penbutolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Penbutolol.,increase,no risk
Penbutolol,Buprenorphine,Penbutolol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Penbutolol,Bupropion,The metabolism of Penbutolol can be decreased when combined with Bupropion.,decrease,no risk
Penbutolol,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Penbutolol.,increase,risk
Penbutolol,Butabarbital,Butabarbital may increase the hypotensive activities of Penbutolol.,increase,no risk
Penbutolol,Butalbital,Butalbital may increase the hypotensive activities of Penbutolol.,increase,no risk
Penbutolol,Butaperazine,The serum concentration of Penbutolol can be increased when it is combined with Butaperazine.,increase,no risk
Penbutolol,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Penbutolol.,increase,risk
Penbutolol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Penbutolol.,increase,risk
Penbutolol,Butriptyline,The risk or severity of CNS depression can be increased when Penbutolol is combined with Butriptyline.,increase,risk
Iohexol,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Iohexol.,increase,risk
Iohexol,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Iohexol.,increase,risk
Iohexol,Nitrazepam,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Iohexol.,decrease,no risk
Iohexol,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Iohexol.,decrease,no risk
Ephedra,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Ephedra sinica root.,increase,risk
Ephedra,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ephedra sinica root.,increase,risk
Ephedra,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Guanabenz,Ephedra sinica root may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Ephedra,Guanadrel,Ephedra sinica root may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Ephedra,Guanethidine,Ephedra sinica root may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Ephedra,Guanfacine,Ephedra sinica root may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Ephedra,Guanoxan,Ephedra sinica root may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Ephedra,Halothane,Halothane may increase the arrhythmogenic activities of Ephedra sinica root.,increase,no risk
Ephedra,Hexocyclium,The risk or severity of Tachycardia can be increased when Ephedra sinica root is combined with Hexocyclium.,increase,risk
Ephedra,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Ephedra sinica root.,increase,risk
Ephedra,Hydralazine,Ephedra sinica root may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ephedra,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Ephedra sinica root is combined with Hydrochlorothiazide.,increase,risk
Ephedra,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Ephedra sinica root.,increase,risk
Ephedra,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Ephedra sinica root.,increase,risk
Ephedra,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Ephedra sinica root.,increase,risk
Ephedra,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Ephedra sinica root.,increase,risk
Ephedra,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Ephedra sinica root.,increase,risk
Ephedra,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Ephedra sinica root is combined with Hydroflumethiazide.,increase,risk
Ephedra,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ephedra sinica root.,increase,risk
Ephedra,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Ephedra sinica root.,increase,risk
Ephedra,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Ephedra sinica root.,increase,risk
Ephedra,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Ephedra sinica root.,increase,risk
Ephedra,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Ephedra sinica root.,increase,risk
Ephedra,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Ephedra sinica root.,increase,risk
Ephedra,Nadolol,Nadolol may decrease the bronchodilatory activities of Ephedra sinica root.,decrease,no risk
Ephedra,Naphazoline,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Naphazoline.,increase,risk
Ephedra,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Ephedra sinica root.,increase,risk
Ephedra,Naratriptan,The metabolism of Naratriptan can be decreased when combined with Ephedra sinica root.,decrease,no risk
Ephedra,Nateglinide,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Naxitamab,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Naxitamab.,increase,risk
Ephedra,Nebivolol,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Nebivolol.,decrease,no risk
Ephedra,Nefazodone,Nefazodone may increase the tachycardic activities of Ephedra sinica root.,increase,no risk
Ephedra,Nialamide,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Nialamide.,increase,risk
Ephedra,Nicardipine,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Nicardipine.,decrease,no risk
Ephedra,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Ephedra sinica root.,increase,no risk
Ephedra,Nicorandil,Ephedra sinica root may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Ephedra,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Ephedra sinica root.,increase,risk
Ephedra,Nilvadipine,Ephedra sinica root may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Ephedra,Nimesulide,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Nimesulide.,increase,risk
Ephedra,Nimodipine,Ephedra sinica root may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Ephedra,Nisoldipine,Ephedra sinica root may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Ephedra,Nitrendipine,Ephedra sinica root may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Ephedra,Nitroglycerin,Ephedra sinica root may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Ephedra,Nitroprusside,Ephedra sinica root may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Ephedra,Nitrous oxide,Nitrous oxide may increase the arrhythmogenic activities of Ephedra sinica root.,increase,no risk
Ephedra,Norepinephrine,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Ephedra sinica root.,increase,risk
Ephedra,Nortriptyline,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Nortriptyline.,decrease,no risk
Ephedra,Nylidrin,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Nylidrin.,increase,risk
Ephedra,Olanzapine,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Olanzapine.,decrease,no risk
Ephedra,Olmesartan,Ephedra sinica root may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Ephedra,Olodaterol,The risk or severity of adverse effects can be increased when Ephedra sinica root is combined with Olodaterol.,increase,risk
Ephedra,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Ephedra sinica root.,increase,risk
Ephedra,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Ephedra sinica root.,increase,risk
Ephedra,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Ephedra sinica root.,increase,risk
Ephedra,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Ephedra sinica root.,decrease,no risk
Ephedra,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Ephedra sinica root.,increase,risk
Ephedra,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Ephedra sinica root.,increase,risk
Ephedra,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Ephedra sinica root.,increase,risk
Ephedra,Oxyphenbutazone,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Oxyphenbutazone.,increase,risk
Ephedra,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Ephedra sinica root.,increase,risk
Ephedra,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ephedra sinica root.,increase,risk
Ephedra,Quetiapine,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Quetiapine.,decrease,no risk
Ephedra,Quinapril,Ephedra sinica root may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Ephedra,Quinethazone,Ephedra sinica root may increase the hypokalemic activities of Quinethazone.,increase,no risk
Ephedra,Quinidine,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Quinidine.,decrease,no risk
Ephedra,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Ephedra sinica root.,increase,risk
Ephedra,Umeclidinium,The risk or severity of Tachycardia can be increased when Ephedra sinica root is combined with Umeclidinium.,increase,risk
Ephedra,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Ephedra sinica root.,increase,risk
Ephedra,Valsartan,Ephedra sinica root may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Ephedra,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Ephedra sinica root.,increase,risk
Ephedra,Venlafaxine,Venlafaxine may increase the tachycardic activities of Ephedra sinica root.,increase,no risk
Ephedra,Verapamil,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Verapamil.,decrease,no risk
Ephedra,Vilanterol,The risk or severity of adverse effects can be increased when Ephedra sinica root is combined with Vilanterol.,increase,risk
Ephedra,Vilazodone,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Vilazodone.,increase,risk
Ephedra,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Ephedra sinica root.,decrease,no risk
Ephedra,Vortioxetine,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Vortioxetine.,increase,risk
Ephedra,Xamoterol,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Xamoterol.,increase,risk
Ephedra,Xylometazoline,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Xylometazoline.,increase,risk
Ephedra,Yohimbine,The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Yohimbine.,increase,risk
Ephedra,Ziprasidone,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ephedra,Zofenopril,Ephedra sinica root may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Ephedra,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Ephedra sinica root.,decrease,no risk
Ephedra,Zuclopenthixol,The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Ephedrine,Galantamine,The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Furosemide.,increase,risk
Ephedrine,Gallamine triethiodide,Galantamine may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Ginkgo biloba,Gallamine triethiodide may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Glyburide,Ginkgo biloba may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Glycopyrronium,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ephedrine.,decrease,no risk
Ephedrine,Guanabenz,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ephedrine.,increase,risk
Ephedrine,Guanadrel,Ephedrine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Ephedrine,Guanethidine,Ephedrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Ephedrine,Guanfacine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ephedrine.,decrease,no risk
Ephedrine,Guanoxan,Ephedrine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Ephedrine,Halothane,Ephedrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Ephedrine,Hexafluronium,Ephedrine may increase the arrhythmogenic activities of Halothane.,increase,no risk
Ephedrine,Hexocyclium,Hexafluronium may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Ephedrine is combined with Hexocyclium.,increase,risk
Ephedrine,Huperzine A,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Ephedrine.,increase,risk
Ephedrine,Hyaluronidase,Huperzine A may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Ephedrine.,increase,risk
Ephedrine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Ephedrine.,increase,risk
Ephedrine,Hydralazine,The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Ephedrine.,increase,risk
Ephedrine,Hydrochlorothiazide,Ephedrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ephedrine,Hydrocortisone,The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Hydrochlorothiazide.,increase,risk
Ephedrine,Hydrocortisone acetate,Ephedrine may increase the excretion rate of Hydrocortisone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ephedrine,Hydrocortisone butyrate,Ephedrine may increase the excretion rate of Hydrocortisone acetate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ephedrine,Hydrocortisone cypionate,Ephedrine may increase the excretion rate of Hydrocortisone butyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ephedrine,Hydrocortisone succinate,Ephedrine may increase the excretion rate of Hydrocortisone cypionate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ephedrine,Hydroflumethiazide,Ephedrine may increase the excretion rate of Hydrocortisone succinate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ephedrine,Hyoscyamine,The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Hydroflumethiazide.,increase,risk
Ephedrine,Ketamine,Ephedrine may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Ephedrine,Ketoprofen,Ketamine may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Ketorolac,The risk or severity of hypertension can be increased when Ketoprofen is combined with Ephedrine.,increase,risk
Ephedrine,Ketotifen,The risk or severity of hypertension can be increased when Ketorolac is combined with Ephedrine.,increase,risk
Ephedrine,Nabilone,The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Muzolimine.,increase,risk
Ephedrine,Nabumetone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Ephedrine.,increase,risk
Ephedrine,Nadolol,The risk or severity of hypertension can be increased when Nabumetone is combined with Ephedrine.,increase,risk
Ephedrine,Naproxen,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Nadolol.,decrease,no risk
Ephedrine,Naratriptan,The risk or severity of hypertension can be increased when Naproxen is combined with Ephedrine.,increase,risk
Ephedrine,Naxitamab,The risk or severity of hypertension can be increased when Naratriptan is combined with Ephedrine.,increase,risk
Ephedrine,Nebivolol,The risk or severity of hypertension can be increased when Ephedrine is combined with Naxitamab.,increase,risk
Ephedrine,Nefazodone,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Nebivolol.,decrease,no risk
Ephedrine,Neostigmine,Nefazodone may increase the tachycardic activities of Ephedrine.,increase,no risk
Ephedrine,Nialamide,Neostigmine may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Nicardipine,The risk or severity of hypertension can be increased when Ephedrine is combined with Nialamide.,increase,risk
Ephedrine,Nicergoline,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Nicardipine.,decrease,no risk
Ephedrine,Nicorandil,Nicergoline may increase the hypertensive and vasoconstricting activities of Ephedrine.,increase,no risk
Ephedrine,Nicotine,Ephedrine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Ephedrine,Nilvadipine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Ephedrine.,increase,risk
Ephedrine,Nimesulide,Ephedrine may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Ephedrine,Nimodipine,The risk or severity of hypertension can be increased when Ephedrine is combined with Nimesulide.,increase,risk
Ephedrine,Nisoldipine,Ephedrine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Ephedrine,Nitrendipine,Ephedrine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Ephedrine,Nitroglycerin,Ephedrine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Ephedrine,Nitroprusside,Ephedrine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Ephedrine,Nitrous oxide,Ephedrine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Ephedrine,Nizatidine,Ephedrine may increase the arrhythmogenic activities of Nitrous oxide.,increase,no risk
Ephedrine,Norepinephrine,Nizatidine may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Nortriptyline,The therapeutic efficacy of Ephedrine can be increased when used in combination with Norepinephrine.,increase,no risk
Ephedrine,Nylidrin,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Nortriptyline.,decrease,no risk
Ephedrine,Olanzapine,The therapeutic efficacy of Nylidrin can be increased when used in combination with Ephedrine.,increase,no risk
Ephedrine,Olmesartan,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Ephedrine,Olodaterol,Ephedrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Ephedrine,Orciprenaline,The risk or severity of hypertension can be increased when Ephedrine is combined with Olodaterol.,increase,risk
Ephedrine,Orphenadrine,The therapeutic efficacy of Orciprenaline can be increased when used in combination with Ephedrine.,increase,no risk
Ephedrine,Ouabain,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Ephedrine.,increase,risk
Ephedrine,Oxaprozin,The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Ouabain.,increase,risk
Ephedrine,Oxatomide,The risk or severity of hypertension can be increased when Oxaprozin is combined with Ephedrine.,increase,risk
Ephedrine,Oxprenolol,The therapeutic efficacy of Ephedrine can be increased when used in combination with Oxatomide.,increase,no risk
Ephedrine,Oxtriphylline,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Ephedrine,Oxybuprocaine,The risk or severity of adverse effects can be increased when Ephedrine is combined with Oxtriphylline.,increase,risk
Ephedrine,Oxybutynin,The serum concentration of Ephedrine can be increased when it is combined with Oxybuprocaine.,increase,no risk
Ephedrine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Ephedrine.,increase,risk
Ephedrine,Oxyphenbutazone,The absorption of Ephedrine can be decreased when combined with Oxymetazoline.,decrease,no risk
Ephedrine,Oxyphencyclimine,The risk or severity of hypertension can be increased when Ephedrine is combined with Oxyphenbutazone.,increase,risk
Ephedrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Ephedrine.,increase,risk
Ephedrine,Oxytocin,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ephedrine.,increase,risk
Ephedrine,Quetiapine,Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Quinapril,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Quetiapine.,decrease,no risk
Ephedrine,Quinethazone,Ephedrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Ephedrine,Quinidine,The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Quinethazone.,increase,risk
Ephedrine,Quinupramine,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Quinidine.,decrease,no risk
Ephedrine,Ulobetasol,Tyrothricin may increase the neuromuscular blocking activities of Ephedrine.,increase,no risk
Ephedrine,Umeclidinium,Ephedrine may increase the excretion rate of Ulobetasol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ephedrine,Valdecoxib,The risk or severity of Tachycardia can be increased when Ephedrine is combined with Umeclidinium.,increase,risk
Ephedrine,Valsartan,The risk or severity of hypertension can be increased when Valdecoxib is combined with Ephedrine.,increase,risk
Ephedrine,Vamorolone,Ephedrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Ephedrine,Venlafaxine,Ephedrine may increase the excretion rate of Vamorolone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ephedrine,Verapamil,Venlafaxine may increase the tachycardic activities of Ephedrine.,increase,no risk
Ephedrine,Vilanterol,Verapamil may decrease the hypertensive activities of Ephedrine.,decrease,no risk
Ephedrine,Vilazodone,The risk or severity of hypertension can be increased when Ephedrine is combined with Vilanterol.,increase,risk
Ephedrine,Vortioxetine,The risk or severity of hypertension can be increased when Ephedrine is combined with Vilazodone.,increase,risk
Ephedrine,Xamoterol,The risk or severity of hypertension can be increased when Ephedrine is combined with Vortioxetine.,increase,risk
Ephedrine,Xylometazoline,The risk or severity of hypertension can be increased when Ephedrine is combined with Xamoterol.,increase,risk
Ephedrine,Yohimbine,The risk or severity of hypertension can be increased when Ephedrine is combined with Xylometazoline.,increase,risk
Ephedrine,Ziprasidone,Yohimbine may decrease the hypertensive activities of Ephedrine.,decrease,no risk
Ephedrine,Zofenopril,The therapeutic efficacy of Ephedrine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ephedrine,Zolmitriptan,Ephedrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Ephedrine,Zonisamide,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ephedrine.,increase,risk
Ephedrine,Zuclopenthixol,The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Zonisamide.,increase,risk
Mephentermine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Mephentermine.,increase,risk
Mephentermine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Mephentermine.,increase,risk
Mephentermine,Glutamic acid,The serum concentration of Mephentermine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Mephentermine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Mephentermine.,increase,risk
Mephentermine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Mephentermine.,increase,risk
Mephentermine,Guanabenz,Mephentermine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Mephentermine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Guanethidine,The serum concentration of Mephentermine can be decreased when it is combined with Guanethidine.,decrease,no risk
Mephentermine,Guanfacine,Mephentermine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Mephentermine,Guanoxan,Mephentermine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Mephentermine,Haloperidol,The therapeutic efficacy of Mephentermine can be decreased when used in combination with Haloperidol.,decrease,no risk
Mephentermine,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Mephentermine.,increase,risk
Mephentermine,Hexocyclium,The risk or severity of Tachycardia can be increased when Mephentermine is combined with Hexocyclium.,increase,risk
Mephentermine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Mephentermine.,increase,risk
Mephentermine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Mephentermine.,increase,risk
Mephentermine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Mephentermine.,increase,risk
Mephentermine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Mephentermine.,increase,risk
Mephentermine,Hydralazine,Mephentermine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Mephentermine,Hydrochlorothiazide,Mephentermine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Mephentermine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Mephentermine.,increase,risk
Mephentermine,Hydroflumethiazide,Mephentermine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Mephentermine,Hydromorphone,Mephentermine may increase the analgesic activities of Hydromorphone.,increase,no risk
Mephentermine,Hydrotalcite,The serum concentration of Mephentermine can be increased when it is combined with Hydrotalcite.,increase,no risk
Mephentermine,Hydroxyzine,Mephentermine may decrease the sedative activities of Hydroxyzine.,decrease,no risk
Mephentermine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Mephentermine.,increase,risk
Mephentermine,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Mephentermine.,increase,risk
Mephentermine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Mephentermine.,increase,risk
Mephentermine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Mephentermine.,increase,risk
Mephentermine,Ketotifen,Mephentermine may decrease the sedative activities of Ketotifen.,decrease,no risk
Mephentermine,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Mephentermine.,increase,risk
Mephentermine,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Mephentermine.,increase,risk
Mephentermine,Nadolol,The therapeutic efficacy of Nadolol can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Nalbuphine,Mephentermine may increase the analgesic activities of Nalbuphine.,increase,no risk
Mephentermine,Naloxegol,Mephentermine may increase the analgesic activities of Naloxegol.,increase,no risk
Mephentermine,Naltrexone,Mephentermine may increase the analgesic activities of Naltrexone.,increase,no risk
Mephentermine,Naphazoline,The risk or severity of hypertension can be increased when Mephentermine is combined with Naphazoline.,increase,risk
Mephentermine,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Mephentermine.,increase,risk
Mephentermine,Naratriptan,The risk or severity of serotonin syndrome can be increased when Naratriptan is combined with Mephentermine.,increase,risk
Mephentermine,Naxitamab,The risk or severity of hypertension can be increased when Mephentermine is combined with Naxitamab.,increase,risk
Mephentermine,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Nefazodone,The therapeutic efficacy of Nefazodone can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Niacinamide ascorbate,The serum concentration of Mephentermine can be decreased when it is combined with Niacinamide ascorbate.,decrease,no risk
Mephentermine,Nialamide,Nialamide may increase the hypertensive activities of Mephentermine.,increase,no risk
Mephentermine,Nicardipine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Nicergoline,The therapeutic efficacy of Nicergoline can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Nicorandil,Mephentermine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Mephentermine,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Mephentermine.,increase,risk
Mephentermine,Nilvadipine,Mephentermine may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Mephentermine,Nimesulide,The risk or severity of hypertension can be increased when Mephentermine is combined with Nimesulide.,increase,risk
Mephentermine,Nimodipine,Mephentermine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Mephentermine,Nisoldipine,Mephentermine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Mephentermine,Nitrendipine,Mephentermine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Mephentermine,Nitroglycerin,Mephentermine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Mephentermine,Nitroprusside,Mephentermine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Mephentermine,Nitrous oxide,The risk or severity of hypertension can be increased when Mephentermine is combined with Nitrous oxide.,increase,risk
Mephentermine,Nizatidine,Mephentermine may decrease the sedative activities of Nizatidine.,decrease,no risk
Mephentermine,Norepinephrine,The therapeutic efficacy of Mephentermine can be increased when used in combination with Norepinephrine.,increase,no risk
Mephentermine,Normethadone,Mephentermine may increase the analgesic activities of Normethadone.,increase,no risk
Mephentermine,Nortriptyline,Mephentermine may decrease the sedative activities of Nortriptyline.,decrease,no risk
Mephentermine,Nylidrin,The risk or severity of hypertension can be increased when Mephentermine is combined with Nylidrin.,increase,risk
Mephentermine,Olanzapine,Mephentermine may decrease the sedative activities of Olanzapine.,decrease,no risk
Mephentermine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Oliceridine.,increase,risk
Mephentermine,Olmesartan,Mephentermine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Mephentermine,Olodaterol,The risk or severity of hypertension can be increased when Mephentermine is combined with Olodaterol.,increase,risk
Mephentermine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Mephentermine.,increase,risk
Mephentermine,Opium,Mephentermine may increase the analgesic activities of Opium.,increase,no risk
Mephentermine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Mephentermine.,increase,risk
Mephentermine,Orphenadrine,Mephentermine may decrease the sedative activities of Orphenadrine.,decrease,no risk
Mephentermine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Mephentermine.,increase,risk
Mephentermine,Oxatomide,Mephentermine may decrease the sedative activities of Oxatomide.,decrease,no risk
Mephentermine,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Oxtriphylline,The risk or severity of adverse effects can be increased when Mephentermine is combined with Oxtriphylline.,increase,risk
Mephentermine,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Mephentermine.,increase,risk
Mephentermine,Oxycodone,Mephentermine may increase the analgesic activities of Oxycodone.,increase,no risk
Mephentermine,Oxymetazoline,Mephentermine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Mephentermine,Oxymorphone,Mephentermine may increase the analgesic activities of Oxymorphone.,increase,no risk
Mephentermine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Mephentermine is combined with Oxyphenbutazone.,increase,risk
Mephentermine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Mephentermine.,increase,risk
Mephentermine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Mephentermine.,increase,risk
Mephentermine,Oxytocin,The risk or severity of hypertension can be increased when Mephentermine is combined with Oxytocin.,increase,risk
Mephentermine,Quetiapine,Mephentermine may decrease the sedative activities of Quetiapine.,decrease,no risk
Mephentermine,Quinapril,Mephentermine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Mephentermine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Mephentermine.,decrease,no risk
Mephentermine,Quinupramine,The therapeutic efficacy of Quinupramine can be increased when used in combination with Mephentermine.,increase,no risk
Procaterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Procaterol.,increase,risk
Procaterol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Procaterol.,decrease,no risk
Procaterol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Procaterol.,increase,risk
Procaterol,Guanabenz,Procaterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Procaterol,Guanadrel,Procaterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Procaterol,Guanethidine,Procaterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Procaterol,Guanfacine,Procaterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Procaterol,Guanoxan,Procaterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Procaterol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Procaterol.,increase,risk
Procaterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Procaterol is combined with Hexocyclium.,increase,risk
Procaterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Procaterol.,increase,risk
Procaterol,Hydralazine,Procaterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Procaterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Procaterol is combined with Hydrochlorothiazide.,increase,risk
Procaterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Procaterol.,increase,risk
Procaterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Procaterol.,increase,risk
Procaterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Procaterol.,increase,risk
Procaterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Procaterol.,increase,risk
Procaterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Procaterol.,increase,risk
Procaterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Procaterol is combined with Hydroflumethiazide.,increase,risk
Procaterol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Procaterol.,increase,risk
Procaterol,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Procaterol.,increase,risk
Procaterol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Procaterol.,increase,risk
Procaterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Procaterol.,increase,risk
Procaterol,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Procaterol.,increase,risk
Procaterol,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Procaterol.,increase,risk
Procaterol,Nadolol,Nadolol may decrease the bronchodilatory activities of Procaterol.,decrease,no risk
Procaterol,Naphazoline,The risk or severity of hypertension can be increased when Procaterol is combined with Naphazoline.,increase,risk
Procaterol,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Procaterol.,increase,risk
Procaterol,Naratriptan,The risk or severity of hypertension can be increased when Naratriptan is combined with Procaterol.,increase,risk
Procaterol,Naxitamab,The risk or severity of hypertension can be increased when Procaterol is combined with Naxitamab.,increase,risk
Procaterol,Nebivolol,The therapeutic efficacy of Procaterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Procaterol,Nefazodone,Nefazodone may increase the tachycardic activities of Procaterol.,increase,no risk
Procaterol,Nialamide,The risk or severity of hypertension can be increased when Procaterol is combined with Nialamide.,increase,risk
Procaterol,Nicardipine,The therapeutic efficacy of Procaterol can be decreased when used in combination with Nicardipine.,decrease,no risk
Procaterol,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Procaterol.,increase,no risk
Procaterol,Nicorandil,Procaterol may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Procaterol,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Procaterol.,increase,risk
Procaterol,Nilvadipine,Procaterol may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Procaterol,Nimesulide,The risk or severity of hypertension can be increased when Procaterol is combined with Nimesulide.,increase,risk
Procaterol,Nimodipine,Procaterol may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Procaterol,Nisoldipine,Procaterol may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Procaterol,Nitrendipine,Procaterol may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Procaterol,Nitroglycerin,Procaterol may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Procaterol,Nitroprusside,Procaterol may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Procaterol,Nitrous oxide,The risk or severity of hypertension can be increased when Procaterol is combined with Nitrous oxide.,increase,risk
Procaterol,Norepinephrine,The therapeutic efficacy of Procaterol can be increased when used in combination with Norepinephrine.,increase,no risk
Procaterol,Nortriptyline,The therapeutic efficacy of Procaterol can be decreased when used in combination with Nortriptyline.,decrease,no risk
Procaterol,Nylidrin,The risk or severity of hypertension can be increased when Procaterol is combined with Nylidrin.,increase,risk
Procaterol,Olanzapine,The therapeutic efficacy of Procaterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Procaterol,Olmesartan,Procaterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Procaterol,Olodaterol,The risk or severity of adverse effects can be increased when Procaterol is combined with Olodaterol.,increase,risk
Procaterol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Procaterol.,increase,risk
Procaterol,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Procaterol.,increase,risk
Procaterol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Procaterol.,increase,risk
Procaterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Procaterol.,decrease,no risk
Procaterol,Oxtriphylline,The risk or severity of adverse effects can be increased when Procaterol is combined with Oxtriphylline.,increase,risk
Procaterol,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Procaterol.,increase,risk
Procaterol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Procaterol.,increase,risk
Procaterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Procaterol is combined with Oxyphenbutazone.,increase,risk
Procaterol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Procaterol.,increase,risk
Procaterol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Procaterol.,increase,risk
Procaterol,Quetiapine,The therapeutic efficacy of Procaterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Procaterol,Quinapril,Procaterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Procaterol,Quinethazone,Procaterol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Procaterol,Quinidine,The therapeutic efficacy of Procaterol can be decreased when used in combination with Quinidine.,decrease,no risk
Procaterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Procaterol.,increase,risk
Procaterol,Umeclidinium,The risk or severity of Tachycardia can be increased when Procaterol is combined with Umeclidinium.,increase,risk
Procaterol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Procaterol.,increase,risk
Procaterol,Valsartan,Procaterol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Procaterol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Procaterol.,increase,risk
Procaterol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Procaterol.,increase,no risk
Procaterol,Verapamil,The therapeutic efficacy of Procaterol can be decreased when used in combination with Verapamil.,decrease,no risk
Procaterol,Vilanterol,The risk or severity of adverse effects can be increased when Procaterol is combined with Vilanterol.,increase,risk
Procaterol,Vilazodone,The risk or severity of hypertension can be increased when Procaterol is combined with Vilazodone.,increase,risk
Procaterol,Vortioxetine,The risk or severity of hypertension can be increased when Procaterol is combined with Vortioxetine.,increase,risk
Procaterol,Xamoterol,The risk or severity of hypertension can be increased when Procaterol is combined with Xamoterol.,increase,risk
Procaterol,Xylometazoline,The risk or severity of hypertension can be increased when Procaterol is combined with Xylometazoline.,increase,risk
Procaterol,Yohimbine,The risk or severity of hypertension can be increased when Procaterol is combined with Yohimbine.,increase,risk
Procaterol,Ziprasidone,The therapeutic efficacy of Procaterol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Procaterol,Zofenopril,Procaterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Procaterol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Procaterol.,increase,risk
Procaterol,Zuclopenthixol,The therapeutic efficacy of Procaterol can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Rasagiline,Bacitracin,Bacitracin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Baclofen,The risk or severity of hypotension can be increased when Baclofen is combined with Rasagiline.,increase,risk
Rasagiline,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Rasagiline.,increase,risk
Rasagiline,Baricitinib,Rasagiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Rasagiline,Belinostat,The metabolism of Rasagiline can be increased when combined with Belinostat.,increase,no risk
Rasagiline,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Bemiparin.,increase,risk
Rasagiline,Benazepril,Rasagiline may increase the hypotensive activities of Benazepril.,increase,no risk
Rasagiline,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Bendroflumethiazide,Rasagiline may increase the hypotensive activities of Bendroflumethiazide.,increase,no risk
Rasagiline,Benorilate,The risk or severity of hypertension can be increased when Rasagiline is combined with Benorilate.,increase,risk
Rasagiline,Benoxaprofen,The risk or severity of hypertension can be increased when Rasagiline is combined with Benoxaprofen.,increase,risk
Rasagiline,Benperidol,The risk or severity of adverse effects can be increased when Rasagiline is combined with Benperidol.,increase,risk
Rasagiline,Benserazide,Rasagiline may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Rasagiline,Benzatropine,Benzatropine may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Benznidazole,Rasagiline may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Rasagiline,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Rasagiline.,increase,risk
Rasagiline,Benzphetamine,Rasagiline may increase the hypertensive activities of Benzphetamine.,increase,no risk
Rasagiline,Benzthiazide,Benzthiazide may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rasagiline,Benzydamine,The risk or severity of hypertension can be increased when Rasagiline is combined with Benzydamine.,increase,risk
Rasagiline,Benzyl alcohol,The risk or severity of CNS depression can be increased when Rasagiline is combined with Benzyl alcohol.,increase,risk
Rasagiline,Bepotastine,Rasagiline may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Rasagiline,Bepridil,Rasagiline may increase the hypotensive activities of Bepridil.,increase,no risk
Rasagiline,Betahistine,The metabolism of Betahistine can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Betaxolol,Rasagiline may increase the hypotensive activities of Betaxolol.,increase,no risk
Rasagiline,Bethanidine,Rasagiline may increase the hypotensive activities of Bethanidine.,increase,no risk
Rasagiline,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Betrixaban.,increase,risk
Rasagiline,Bexagliflozin,Rasagiline may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Rasagiline,Bezafibrate,Rasagiline may increase the hepatotoxic activities of Bezafibrate.,increase,no risk
Rasagiline,Bicisate,Rasagiline may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Rasagiline,Bimekizumab,The metabolism of Rasagiline can be increased when combined with Bimekizumab.,increase,no risk
Rasagiline,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Bismuth subgallate,Rasagiline may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Rasagiline,Bisoprolol,Rasagiline may increase the hypotensive activities of Bisoprolol.,increase,no risk
Rasagiline,Bisoxatin,Rasagiline may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Rasagiline,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Bivalirudin.,increase,risk
Rasagiline,Bleomycin,Bleomycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Bortezomib,The metabolism of Rasagiline can be decreased when combined with Bortezomib.,decrease,no risk
Rasagiline,Bosentan,Rasagiline may increase the hypotensive activities of Bosentan.,increase,no risk
Rasagiline,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Rasagiline.,increase,risk
Rasagiline,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Rasagiline.,increase,risk
Rasagiline,Bretylium,Rasagiline may increase the hypotensive activities of Bretylium.,increase,no risk
Rasagiline,Brexanolone,The risk or severity of CNS depression can be increased when Rasagiline is combined with Brexanolone.,increase,risk
Rasagiline,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Brimonidine,The metabolism of Brimonidine can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Brivaracetam,The risk or severity of CNS depression can be increased when Rasagiline is combined with Brivaracetam.,increase,risk
Rasagiline,Bromazepam,The risk or severity of CNS depression can be increased when Rasagiline is combined with Bromazepam.,increase,risk
Rasagiline,Bromocriptine,Rasagiline may increase the hypertensive activities of Bromocriptine.,increase,no risk
Rasagiline,Bromotheophylline,Bromotheophylline may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rasagiline,Bromperidol,The risk or severity of adverse effects can be increased when Rasagiline is combined with Bromperidol.,increase,risk
Rasagiline,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Rasagiline.,increase,risk
Rasagiline,Budesonide,Budesonide may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Bumadizone,The risk or severity of hypertension can be increased when Rasagiline is combined with Bumadizone.,increase,risk
Rasagiline,Bumetanide,Rasagiline may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Rasagiline,Bupivacaine,Rasagiline may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Rasagiline,Buprenorphine,Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Rasagiline,Bupropion,The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.,increase,risk
Rasagiline,Buspirone,The risk or severity of hypertension can be increased when Rasagiline is combined with Buspirone.,increase,risk
Rasagiline,Butabarbital,Butabarbital may increase the hypotensive activities of Rasagiline.,increase,no risk
Rasagiline,Butalbital,Butalbital may increase the hypotensive activities of Rasagiline.,increase,no risk
Rasagiline,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Rasagiline is combined with Butaperazine.,increase,risk
Rasagiline,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Rasagiline.,increase,risk
Rasagiline,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Rasagiline.,increase,risk
Rasagiline,Butriptyline,Rasagiline may increase the serotonergic activities of Butriptyline.,increase,no risk
Rasagiline,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Rasagiline.,increase,risk
Rasagiline,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Rasagiline is combined with Gabapentin enacarbil.,increase,risk
Rasagiline,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Gadodiamide,Gadodiamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Gadofosveset trisodium,Rasagiline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Rasagiline,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Gadoteric acid,Rasagiline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Rasagiline,Gadoteridol,Gadoteridol may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Rasagiline.,increase,risk
Rasagiline,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Rasagiline is combined with Ganaxolone.",increase,risk
Rasagiline,Ganciclovir,Ganciclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Gatifloxacin,The metabolism of Rasagiline can be decreased when combined with Gatifloxacin.,decrease,no risk
Rasagiline,Gemcitabine,Gemcitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Gemfibrozil,The metabolism of Rasagiline can be decreased when combined with Gemfibrozil.,decrease,no risk
Rasagiline,Gemifloxacin,The metabolism of Rasagiline can be decreased when combined with Gemifloxacin.,decrease,no risk
Rasagiline,Gentamicin,Rasagiline may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Rasagiline,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Rasagiline.,increase,risk
Rasagiline,Gilteritinib,The therapeutic efficacy of Rasagiline can be decreased when used in combination with Gilteritinib.,decrease,no risk
Rasagiline,Gimeracil,Rasagiline may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Rasagiline,Givosiran,The serum concentration of Rasagiline can be increased when it is combined with Givosiran.,increase,no risk
Rasagiline,Gliclazide,Rasagiline may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Rasagiline,Glimepiride,Rasagiline may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Rasagiline,Glipizide,Rasagiline may increase the hypoglycemic activities of Glipizide.,increase,no risk
Rasagiline,Gliquidone,Rasagiline may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Rasagiline,Glofitamab,The serum concentration of Rasagiline can be increased when it is combined with Glofitamab.,increase,no risk
Rasagiline,Glutethimide,The risk or severity of CNS depression can be increased when Rasagiline is combined with Glutethimide.,increase,risk
Rasagiline,Glyburide,Rasagiline may increase the hypoglycemic activities of Glyburide.,increase,no risk
Rasagiline,Glycerol phenylbutyrate,Rasagiline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Rasagiline,Glymidine,Rasagiline may increase the hypoglycemic activities of Glymidine.,increase,no risk
Rasagiline,Golimumab,The metabolism of Rasagiline can be increased when combined with Golimumab.,increase,no risk
Rasagiline,Golodirsen,Rasagiline may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Rasagiline,Goserelin,Goserelin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Rasagiline.,increase,risk
Rasagiline,Grepafloxacin,The metabolism of Rasagiline can be decreased when combined with Grepafloxacin.,decrease,no risk
Rasagiline,Guanabenz,Rasagiline may increase the hypotensive activities of Guanabenz.,increase,no risk
Rasagiline,Guanadrel,Rasagiline may increase the hypotensive activities of Guanadrel.,increase,no risk
Rasagiline,Guanethidine,Rasagiline may increase the hypotensive activities of Guanethidine.,increase,no risk
Rasagiline,Guanfacine,Rasagiline may increase the hypotensive activities of Guanfacine.,increase,no risk
Rasagiline,Guanoxan,Rasagiline may increase the hypotensive activities of Guanoxan.,increase,no risk
Rasagiline,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Rasagiline.,increase,risk
Rasagiline,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Rasagiline.,increase,risk
Rasagiline,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Rasagiline.,increase,risk
Rasagiline,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Heparin.,increase,risk
Rasagiline,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Rasagiline.,increase,risk
Rasagiline,Hydralazine,Rasagiline may increase the hypotensive activities of Hydralazine.,increase,no risk
Rasagiline,Hydrochlorothiazide,Rasagiline may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Rasagiline,Hydrocodone,Rasagiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Rasagiline,Hydroflumethiazide,Rasagiline may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Rasagiline,Hydromorphone,Rasagiline may increase the serotonergic activities of Hydromorphone.,increase,no risk
Rasagiline,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Rasagiline.,increase,risk
Rasagiline,Hydroxyethyl Starch,Rasagiline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Rasagiline,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.,increase,no risk
Rasagiline,Hyoscyamine,Rasagiline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Rasagiline,Kanamycin,Rasagiline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Rasagiline,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Rasagiline.,increase,risk
Rasagiline,Ketazolam,The risk or severity of CNS depression can be increased when Rasagiline is combined with Ketazolam.,increase,risk
Rasagiline,Ketoconazole,The metabolism of Rasagiline can be decreased when combined with Ketoconazole.,decrease,no risk
Rasagiline,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Rasagiline.,increase,risk
Rasagiline,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Rasagiline.,increase,risk
Rasagiline,N-acetyltyrosine,Rasagiline may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Rasagiline,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.,increase,no risk
Rasagiline,Nabumetone,The metabolism of Rasagiline can be decreased when combined with Nabumetone.,decrease,no risk
Rasagiline,Nadolol,Rasagiline may increase the hypotensive activities of Nadolol.,increase,no risk
Rasagiline,Nadroparin,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Nadroparin.,increase,risk
Rasagiline,Nafcillin,The metabolism of Rasagiline can be increased when combined with Nafcillin.,increase,no risk
Rasagiline,Nalbuphine,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rasagiline.,increase,risk
Rasagiline,Naldemedine,Rasagiline may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Rasagiline,Nalidixic acid,The metabolism of Rasagiline can be decreased when combined with Nalidixic acid.,decrease,no risk
Rasagiline,Nalmefene,Rasagiline may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Rasagiline,Naloxone,Naloxone may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Rasagiline.,increase,risk
Rasagiline,Naphazoline,Rasagiline may increase the hypertensive activities of Naphazoline.,increase,no risk
Rasagiline,Naproxen,The metabolism of Rasagiline can be decreased when combined with Naproxen.,decrease,no risk
Rasagiline,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Rasagiline.,increase,risk
Rasagiline,Nateglinide,Rasagiline may increase the hypoglycemic activities of Nateglinide.,increase,no risk
Rasagiline,Naxitamab,The risk or severity of hypertension can be increased when Rasagiline is combined with Naxitamab.,increase,risk
Rasagiline,Nebivolol,Rasagiline may increase the hypotensive activities of Nebivolol.,increase,no risk
Rasagiline,Nedaplatin,Rasagiline may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Rasagiline,Nedocromil,Nedocromil may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Nefazodone,Rasagiline may increase the serotonergic activities of Nefazodone.,increase,no risk
Rasagiline,Neomycin,Rasagiline may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Rasagiline,Nesiritide,Rasagiline may increase the orthostatic hypotensive activities of Nesiritide.,increase,no risk
Rasagiline,Netilmicin,Rasagiline may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Rasagiline,Nevirapine,The metabolism of Rasagiline can be decreased when combined with Nevirapine.,decrease,no risk
Rasagiline,Nialamide,The risk or severity of adverse effects can be increased when Rasagiline is combined with Nialamide.,increase,risk
Rasagiline,Nicardipine,Rasagiline may increase the hypotensive activities of Nicardipine.,increase,no risk
Rasagiline,Nicergoline,The risk or severity of hypertension can be increased when Nicergoline is combined with Rasagiline.,increase,risk
Rasagiline,Niclosamide,The metabolism of Rasagiline can be decreased when combined with Niclosamide.,decrease,no risk
Rasagiline,Nicorandil,Nicorandil may increase the hypotensive activities of Rasagiline.,increase,no risk
Rasagiline,Nifedipine,Rasagiline may increase the orthostatic hypotensive activities of Nifedipine.,increase,no risk
Rasagiline,Nilutamide,Nilutamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Nilvadipine,Rasagiline may increase the hypotensive activities of Nilvadipine.,increase,no risk
Rasagiline,Nimesulide,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Nimesulide.,increase,risk
Rasagiline,Nimodipine,Rasagiline may increase the hypotensive activities of Nimodipine.,increase,no risk
Rasagiline,Nisoldipine,Rasagiline may increase the hypotensive activities of Nisoldipine.,increase,no risk
Rasagiline,Nitrazepam,The risk or severity of CNS depression can be increased when Rasagiline is combined with Nitrazepam.,increase,risk
Rasagiline,Nitrendipine,Rasagiline may increase the hypotensive activities of Nitrendipine.,increase,no risk
Rasagiline,Nitric Oxide,Rasagiline may increase the orthostatic hypotensive activities of Nitric Oxide.,increase,no risk
Rasagiline,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Nitroglycerin,Rasagiline may increase the hypotensive activities of Nitroglycerin.,increase,no risk
Rasagiline,Nitroprusside,Rasagiline may increase the hypotensive activities of Nitroprusside.,increase,no risk
Rasagiline,Nitrous acid,Rasagiline may increase the orthostatic hypotensive activities of Nitrous acid.,increase,no risk
Rasagiline,Nitrous oxide,The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Rasagiline.,increase,risk
Rasagiline,Nomifensine,The risk or severity of CNS depression can be increased when Rasagiline is combined with Nomifensine.,increase,risk
Rasagiline,Norepinephrine,Rasagiline may increase the hypertensive activities of Norepinephrine.,increase,no risk
Rasagiline,Norfloxacin,The metabolism of Rasagiline can be decreased when combined with Norfloxacin.,decrease,no risk
Rasagiline,Normethadone,The risk or severity of adverse effects can be increased when Normethadone is combined with Rasagiline.,increase,risk
Rasagiline,Nortriptyline,Rasagiline may increase the serotonergic activities of Nortriptyline.,increase,no risk
Rasagiline,Nylidrin,The risk or severity of hypertension can be increased when Rasagiline is combined with Nylidrin.,increase,risk
Rasagiline,Obeticholic acid,The metabolism of Rasagiline can be decreased when combined with Obeticholic acid.,decrease,no risk
Rasagiline,Obinutuzumab,Rasagiline may increase the orthostatic hypotensive activities of Obinutuzumab.,increase,no risk
Rasagiline,Octinoxate,Rasagiline may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Rasagiline,Olanzapine,The therapeutic efficacy of Rasagiline can be decreased when used in combination with Olanzapine.,decrease,no risk
Rasagiline,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Rasagiline is combined with Oliceridine.",increase,risk
Rasagiline,Olmesartan,Rasagiline may increase the hypotensive activities of Olmesartan.,increase,no risk
Rasagiline,Olodaterol,The risk or severity of hypertension can be increased when Rasagiline is combined with Olodaterol.,increase,risk
Rasagiline,Olsalazine,Olsalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Rasagiline.,increase,risk
Rasagiline,Opicapone,Rasagiline may increase the orthostatic hypotensive activities of Opicapone.,increase,no risk
Rasagiline,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Rasagiline.,increase,risk
Rasagiline,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Rasagiline.,increase,risk
Rasagiline,Orphenadrine,Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Rasagiline,Oseltamivir,Oseltamivir may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Osilodrostat,The metabolism of Rasagiline can be decreased when combined with Osilodrostat.,decrease,no risk
Rasagiline,Osimertinib,The serum concentration of Rasagiline can be decreased when it is combined with Osimertinib.,decrease,no risk
Rasagiline,Oxacillin,Oxacillin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Rasagiline.,increase,risk
Rasagiline,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Rasagiline.,increase,risk
Rasagiline,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Rasagiline.,increase,risk
Rasagiline,Oxitriptan,The risk or severity of CNS depression can be increased when Rasagiline is combined with Oxitriptan.,increase,risk
Rasagiline,Oxprenolol,Rasagiline may increase the hypotensive activities of Oxprenolol.,increase,no risk
Rasagiline,Oxtriphylline,The metabolism of Rasagiline can be decreased when combined with Oxtriphylline.,decrease,no risk
Rasagiline,Oxybenzone,Rasagiline may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Rasagiline,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Rasagiline.,increase,risk
Rasagiline,Oxycodone,Rasagiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Rasagiline,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Rasagiline.,increase,no risk
Rasagiline,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Rasagiline.,increase,risk
Rasagiline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Rasagiline is combined with Oxyphenbutazone.,increase,risk
Rasagiline,Oxyquinoline,Rasagiline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Rasagiline,Quazepam,The risk or severity of CNS depression can be increased when Rasagiline is combined with Quazepam.,increase,risk
Rasagiline,Quetiapine,The therapeutic efficacy of Rasagiline can be decreased when used in combination with Quetiapine.,decrease,no risk
Rasagiline,Quinapril,Rasagiline may increase the hypotensive activities of Quinapril.,increase,no risk
Rasagiline,Quinethazone,Quinethazone may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rasagiline,Quinidine,The serum concentration of Rasagiline can be increased when it is combined with Quinidine.,increase,no risk
Rasagiline,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Rasagiline.,increase,risk
Rasagiline,Quinupramine,Rasagiline may increase the serotonergic activities of Quinupramine.,increase,no risk
Rasagiline,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Rasagiline.,increase,risk
Rasagiline,Urethane,The risk or severity of CNS depression can be increased when Rasagiline is combined with Urethane.,increase,risk
Rasagiline,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Urokinase.,increase,risk
Rasagiline,Vaborbactam,Rasagiline may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Rasagiline,Valaciclovir,Valaciclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Valbenazine,The risk or severity of adverse effects can be increased when Rasagiline is combined with Valbenazine.,increase,risk
Rasagiline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Rasagiline.,increase,risk
Rasagiline,Valganciclovir,Rasagiline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Rasagiline,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Valproate bismuth.,increase,risk
Rasagiline,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Rasagiline.,increase,risk
Rasagiline,Valsartan,Rasagiline may increase the hypotensive activities of Valsartan.,increase,no risk
Rasagiline,Vancomycin,Rasagiline may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Rasagiline,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Rasagiline.,increase,risk
Rasagiline,Varenicline,Varenicline may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Rasagiline.,increase,risk
Rasagiline,Vemurafenib,The serum concentration of Rasagiline can be increased when it is combined with Vemurafenib.,increase,no risk
Rasagiline,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Venlafaxine.,increase,risk
Rasagiline,Verapamil,Rasagiline may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Rasagiline,Vericiguat,Rasagiline may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Rasagiline,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Rasagiline.,increase,risk
Rasagiline,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Rasagiline is combined with Vilanterol.,increase,risk
Rasagiline,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Vildagliptin,Rasagiline may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Rasagiline,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Rasagiline.,increase,risk
Rasagiline,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Vorapaxar.,increase,risk
Rasagiline,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Rasagiline.,decrease,no risk
Rasagiline,Warfarin,Rasagiline may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Rasagiline,Xamoterol,The risk or severity of hypertension can be increased when Rasagiline is combined with Xamoterol.,increase,risk
Rasagiline,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Ximelagatran.,increase,risk
Rasagiline,Xylometazoline,Rasagiline may increase the hypertensive activities of Xylometazoline.,increase,no risk
Rasagiline,Yohimbine,The risk or severity of CNS depression can be increased when Rasagiline is combined with Yohimbine.,increase,risk
Rasagiline,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Rasagiline.,increase,risk
Rasagiline,Zanamivir,Zanamivir may decrease the excretion rate of Rasagiline which could result in a higher serum level.,decrease,no risk
Rasagiline,Ziconotide,The risk or severity of CNS depression can be increased when Rasagiline is combined with Ziconotide.,increase,risk
Rasagiline,Zileuton,The metabolism of Rasagiline can be decreased when combined with Zileuton.,decrease,no risk
Rasagiline,Zimelidine,Rasagiline may increase the serotonergic activities of Zimelidine.,increase,no risk
Rasagiline,Ziprasidone,The risk or severity of adverse effects can be increased when Rasagiline is combined with Ziprasidone.,increase,risk
Rasagiline,Zofenopril,Rasagiline may increase the hypotensive activities of Zofenopril.,increase,no risk
Rasagiline,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Zolmitriptan.,increase,risk
Rasagiline,Zolpidem,Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Rasagiline,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Rasagiline.,increase,risk
Rasagiline,Zopiclone,The risk or severity of adverse effects can be increased when Rasagiline is combined with Zopiclone.,increase,risk
Rasagiline,Zotepine,The therapeutic efficacy of Rasagiline can be decreased when used in combination with Zotepine.,decrease,no risk
Rasagiline,Zuclopenthixol,The therapeutic efficacy of Rasagiline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Rasagiline,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Rasagiline.,increase,risk
Quinupristin,Neratinib,The metabolism of Neratinib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Netupitant,The metabolism of Netupitant can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Olaparib,The metabolism of Olaparib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Oxetacaine.,increase,risk
Quinupristin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Oxybuprocaine.,increase,risk
Quinupristin,Quinidine,The metabolism of Quinidine can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Quinupristin.,increase,no risk
Quinupristin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Quinupristin.,decrease,no risk
Quinupristin,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vincristine,The metabolism of Vincristine can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vindesine,The metabolism of Vindesine can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Quinupristin.,increase,no risk
Quinupristin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Quinupristin.,increase,no risk
Quinupristin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Quinupristin.,decrease,no risk
Quinupristin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Quinupristin.,decrease,no risk
Aluminium,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Aluminium.,decrease,no risk
Aluminium,Butaperazine,Aluminium can cause a decrease in the absorption of Butaperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminium,Naproxen,Naproxen can cause a decrease in the absorption of Aluminium resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminium,Nelfinavir,Aluminium can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminium,Nirogacestat,The serum concentration of Nirogacestat can be decreased when it is combined with Aluminium.,decrease,no risk
Aluminium,Octreotide,Aluminium can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminium,Omadacycline,Aluminium can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminium,Oxytetracycline,Aluminium can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminium,Quinidine,Aluminium may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Aluminium,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Aluminium.,decrease,no risk
Aluminium,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Aluminium.,decrease,no risk
Calcium,Nadolol,The therapeutic efficacy of Nadolol can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nadroparin,The therapeutic efficacy of Calcium can be decreased when used in combination with Nadroparin.,decrease,no risk
Calcium,Nalidixic acid,Calcium can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nicardipine,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nifedipine,The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nilvadipine,The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nimesulide,The therapeutic efficacy of Nimesulide can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nimodipine,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nisoldipine,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Nitrendipine,The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Norfloxacin,Calcium can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium,Nylidrin,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Ofloxacin,Calcium can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium,Omadacycline,The serum concentration of Omadacycline can be decreased when it is combined with Calcium.,decrease,no risk
Calcium,Ouabain,Calcium may increase the arrhythmogenic and cardiotoxic activities of Ouabain.,increase,no risk
Calcium,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Oxytetracycline,The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium.,decrease,no risk
Calcium,Quinethazone,Quinethazone may decrease the excretion rate of Calcium which could result in a higher serum level.,decrease,no risk
Calcium,Urokinase,The therapeutic efficacy of Calcium can be decreased when used in combination with Urokinase.,decrease,no risk
Calcium,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Vorapaxar,The therapeutic efficacy of Calcium can be decreased when used in combination with Vorapaxar.,decrease,no risk
Calcium,Warfarin,The therapeutic efficacy of Calcium can be decreased when used in combination with Warfarin.,decrease,no risk
Calcium,Ximelagatran,The therapeutic efficacy of Calcium can be decreased when used in combination with Ximelagatran.,decrease,no risk
Calcium,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Ziconotide,The therapeutic efficacy of Ziconotide can be decreased when used in combination with Calcium.,decrease,no risk
Calcium,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium.,decrease,no risk
Calcium,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Calcium.,decrease,no risk
Magnesium oxide,Gabapentin,The bioavailability of Gabapentin can be decreased when combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Gabapentin enacarbil,The serum concentration of Gabapentin enacarbil can be decreased when it is combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Magnesium oxide.,increase,no risk
Magnesium oxide,Gatifloxacin,Magnesium oxide can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Gefitinib,Magnesium oxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Gemifloxacin,The absorption of Gemifloxacin can be decreased when combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Magnesium oxide.,decrease,no risk
Magnesium oxide,Glycopyrronium,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Magnesium oxide,Grepafloxacin,Magnesium oxide can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Halofantrine,Magnesium oxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Hexafluronium,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hexafluronium.,decrease,no risk
Magnesium oxide,Hexocyclium,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hexocyclium.,decrease,no risk
Magnesium oxide,Homatropine,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Homatropine.,decrease,no risk
Magnesium oxide,Homatropine methylbromide,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Magnesium oxide,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Hydrocodone,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Magnesium oxide,Hydrocortisone,The bioavailability of Hydrocortisone can be decreased when combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Hydrocortisone butyrate,The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Hydrocortisone cypionate,The bioavailability of Hydrocortisone cypionate can be decreased when combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Hydromorphone,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hydromorphone.,decrease,no risk
Magnesium oxide,Hydrotalcite,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hydrotalcite.,decrease,no risk
Magnesium oxide,Hydroxychloroquine,Magnesium oxide can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Hyoscyamine,Magnesium oxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Ketoconazole,Magnesium oxide can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Nalbuphine,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Nalbuphine.,decrease,no risk
Magnesium oxide,Nalidixic acid,Magnesium oxide can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Naloxegol,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Naloxegol.,decrease,no risk
Magnesium oxide,Naltrexone,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Naltrexone.,decrease,no risk
Magnesium oxide,Naproxen,Naproxen can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Nelfinavir,Magnesium oxide can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Neomycin,The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Netilmicin,The risk or severity of neuromuscular blockade can be increased when Netilmicin is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Nicardipine,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nicardipine.,increase,risk
Magnesium oxide,Nicotine,The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Nicotine.,increase,risk
Magnesium oxide,Nifedipine,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nifedipine.,increase,risk
Magnesium oxide,Nilvadipine,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nilvadipine.,increase,risk
Magnesium oxide,Nimesulide,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nimesulide.,increase,risk
Magnesium oxide,Nimodipine,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nimodipine.,increase,risk
Magnesium oxide,Nirogacestat,The serum concentration of Nirogacestat can be decreased when it is combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Nisoldipine,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nisoldipine.,increase,risk
Magnesium oxide,Nitrendipine,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nitrendipine.,increase,risk
Magnesium oxide,Norfloxacin,Magnesium oxide can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Normethadone,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Normethadone.,decrease,no risk
Magnesium oxide,Nortriptyline,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Nortriptyline.,decrease,no risk
Magnesium oxide,Nylidrin,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Nylidrin.,increase,risk
Magnesium oxide,Octreotide,Magnesium oxide can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Ofloxacin,Magnesium oxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Olanzapine,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Olanzapine.,decrease,no risk
Magnesium oxide,Oliceridine,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oliceridine.,decrease,no risk
Magnesium oxide,Omadacycline,Magnesium oxide can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Opium,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Opium.,decrease,no risk
Magnesium oxide,Orphenadrine,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Orphenadrine.,decrease,no risk
Magnesium oxide,Oteseconazole,Magnesium oxide can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Oxybutynin,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxybutynin.,decrease,no risk
Magnesium oxide,Oxycodone,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxycodone.,decrease,no risk
Magnesium oxide,Oxymorphone,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Magnesium oxide,Oxyphencyclimine,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Magnesium oxide,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Oxyphenisatin acetate.,increase,risk
Magnesium oxide,Oxyphenonium,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Magnesium oxide,Oxytetracycline,Magnesium oxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Quetiapine,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Quetiapine.,decrease,no risk
Magnesium oxide,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Quinidine,Magnesium oxide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Magnesium oxide,Quinine,Magnesium oxide can cause a decrease in the absorption of Quinine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Umeclidinium,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Umeclidinium.,decrease,no risk
Magnesium oxide,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Vamorolone,The bioavailability of Vamorolone can be decreased when combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Magnesium oxide.,increase,risk
Magnesium oxide,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium oxide.,increase,no risk
Magnesium oxide,Verapamil,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Verapamil.,increase,risk
Magnesium oxide,Viomycin,The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Viomycin.,increase,risk
Magnesium oxide,Voriconazole,Magnesium oxide can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium oxide,Xylometazoline,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Xylometazoline.,decrease,no risk
Magnesium oxide,Ziconotide,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Ziconotide.,increase,risk
Magnesium oxide,Ziprasidone,The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Magnesium oxide,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium oxide.,decrease,no risk
Magnesium oxide,Zonisamide,The risk or severity of hypotension can be increased when Magnesium oxide is combined with Zonisamide.,increase,risk
Magnesium cation,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Magnesium cation.,increase,no risk
Magnesium cation,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Magnesium cation.,increase,risk
Magnesium cation,Glycerin,The risk or severity of adverse effects can be increased when Magnesium cation is combined with Glycerin.,increase,risk
Magnesium cation,Glycopyrronium,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Magnesium cation,Hexafluronium,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Hexafluronium.,decrease,no risk
Magnesium cation,Hexocyclium,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Hexocyclium.,decrease,no risk
Magnesium cation,Homatropine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Homatropine.,decrease,no risk
Magnesium cation,Homatropine methylbromide,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Magnesium cation,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Magnesium cation.,increase,risk
Magnesium cation,Hydrocodone,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Hydrocodone.,decrease,no risk
Magnesium cation,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Magnesium cation.,increase,risk
Magnesium cation,Hydromorphone,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Hydromorphone.,decrease,no risk
Magnesium cation,Hydrotalcite,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Hydrotalcite.,decrease,no risk
Magnesium cation,Hyoscyamine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Magnesium cation,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Magnesium cation.,increase,risk
Magnesium cation,Nalbuphine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nalbuphine.,decrease,no risk
Magnesium cation,Naloxegol,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Naloxegol.,decrease,no risk
Magnesium cation,Naltrexone,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Naltrexone.,decrease,no risk
Magnesium cation,Neomycin,The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium cation.,increase,risk
Magnesium cation,Netilmicin,The risk or severity of neuromuscular blockade can be increased when Netilmicin is combined with Magnesium cation.,increase,risk
Magnesium cation,Nicardipine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nicardipine.,decrease,no risk
Magnesium cation,Nicotine,The risk or severity of adverse effects can be increased when Magnesium cation is combined with Nicotine.,increase,risk
Magnesium cation,Nifedipine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nifedipine.,decrease,no risk
Magnesium cation,Nilvadipine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nilvadipine.,decrease,no risk
Magnesium cation,Nimesulide,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nimesulide.,decrease,no risk
Magnesium cation,Nimodipine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nimodipine.,decrease,no risk
Magnesium cation,Nisoldipine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nisoldipine.,decrease,no risk
Magnesium cation,Nitrendipine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nitrendipine.,decrease,no risk
Magnesium cation,Normethadone,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Normethadone.,decrease,no risk
Magnesium cation,Nortriptyline,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nortriptyline.,decrease,no risk
Magnesium cation,Nylidrin,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nylidrin.,decrease,no risk
Magnesium cation,Olanzapine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Olanzapine.,decrease,no risk
Magnesium cation,Oliceridine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Oliceridine.,decrease,no risk
Magnesium cation,Opium,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Opium.,decrease,no risk
Magnesium cation,Orphenadrine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Orphenadrine.,decrease,no risk
Magnesium cation,Oxybutynin,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Oxybutynin.,decrease,no risk
Magnesium cation,Oxycodone,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Oxycodone.,decrease,no risk
Magnesium cation,Oxymorphone,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Oxymorphone.,decrease,no risk
Magnesium cation,Oxyphencyclimine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Magnesium cation,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Magnesium cation is combined with Oxyphenisatin acetate.,increase,risk
Magnesium cation,Oxyphenonium,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Magnesium cation,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Magnesium cation.,increase,risk
Magnesium cation,Quetiapine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Quetiapine.,decrease,no risk
Magnesium cation,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Magnesium cation.,increase,risk
Magnesium cation,Quinidine,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Quinidine.,decrease,no risk
Magnesium cation,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Magnesium cation.,increase,risk
Magnesium cation,Umeclidinium,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Umeclidinium.,decrease,no risk
Magnesium cation,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Magnesium cation.,increase,risk
Magnesium cation,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium cation.,increase,no risk
Magnesium cation,Verapamil,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Verapamil.,decrease,no risk
Magnesium cation,Viomycin,The risk or severity of neuromuscular blockade can be increased when Magnesium cation is combined with Viomycin.,increase,risk
Magnesium cation,Xylometazoline,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Xylometazoline.,decrease,no risk
Magnesium cation,Ziconotide,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Ziconotide.,decrease,no risk
Magnesium cation,Ziprasidone,The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Ziprasidone.,decrease,no risk
Magnesium cation,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Magnesium cation.,increase,risk
Cortisone acetate,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Bimekizumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Bimekizumab.,increase,risk
Cortisone acetate,Bismuth subsalicylate,The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Cortisone acetate.,decrease,no risk
Cortisone acetate,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Blinatumomab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Blinatumomab.,increase,risk
Cortisone acetate,Boceprevir,The metabolism of Cortisone acetate can be decreased when combined with Boceprevir.,decrease,no risk
Cortisone acetate,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Cortisone acetate.",decrease,no risk
Cortisone acetate,Bortezomib,The metabolism of Bortezomib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Bosutinib,The metabolism of Bosutinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Brigatinib,The metabolism of Brigatinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Brodalumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Brodalumab.,increase,risk
Cortisone acetate,Bromocriptine,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Bromocriptine.,increase,risk
Cortisone acetate,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Bumadizone.,increase,risk
Cortisone acetate,Bumetanide,The risk or severity of hypokalemia can be increased when Cortisone acetate is combined with Bumetanide.,increase,risk
Cortisone acetate,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Buspirone,The metabolism of Buspirone can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Busulfan,The metabolism of Busulfan can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Gatifloxacin,The risk or severity of tendinopathy can be increased when Cortisone acetate is combined with Gatifloxacin.,increase,risk
Cortisone acetate,Gefitinib,The metabolism of Gefitinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Gemifloxacin,The risk or severity of tendinopathy can be increased when Cortisone acetate is combined with Gemifloxacin.,increase,risk
Cortisone acetate,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Gestrinone,The serum concentration of Cortisone acetate can be increased when it is combined with Gestrinone.,increase,no risk
Cortisone acetate,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Glatiramer,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Glatiramer.,increase,risk
Cortisone acetate,Gliclazide,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Gliclazide.,increase,risk
Cortisone acetate,Glimepiride,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Glimepiride.,increase,risk
Cortisone acetate,Glipizide,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Glipizide.,increase,risk
Cortisone acetate,Gliquidone,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Gliquidone.,increase,risk
Cortisone acetate,Glofitamab,The serum concentration of Cortisone acetate can be increased when it is combined with Glofitamab.,increase,no risk
Cortisone acetate,Glyburide,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Glyburide.,increase,risk
Cortisone acetate,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Glycol salicylate.,increase,risk
Cortisone acetate,Glymidine,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Glymidine.,increase,risk
Cortisone acetate,Golimumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Golimumab.,increase,risk
Cortisone acetate,Grepafloxacin,The risk or severity of tendinopathy can be increased when Cortisone acetate is combined with Grepafloxacin.,increase,risk
Cortisone acetate,Guselkumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Guselkumab.,increase,risk
Cortisone acetate,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Halofantrine,The metabolism of Halofantrine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Cortisone acetate is combined with Hydrochlorothiazide.,increase,risk
Cortisone acetate,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Hydrocortisone acetate.,increase,risk
Cortisone acetate,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Hydrocortisone butyrate.,increase,risk
Cortisone acetate,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Hydrocortisone succinate.,increase,risk
Cortisone acetate,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Cortisone acetate is combined with Hydroflumethiazide.,increase,risk
Cortisone acetate,Hydrotalcite,The bioavailability of Cortisone acetate can be decreased when combined with Hydrotalcite.,decrease,no risk
Cortisone acetate,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Hydroxychloroquine.,increase,risk
Cortisone acetate,Hydroxyprogesterone caproate,The serum concentration of Cortisone acetate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Cortisone acetate,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Ketoconazole,The metabolism of Cortisone acetate can be decreased when combined with Ketoconazole.,decrease,no risk
Cortisone acetate,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Ketoprofen.,increase,risk
Cortisone acetate,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Ketorolac.,increase,risk
Cortisone acetate,Nabumetone,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Nabumetone.,increase,risk
Cortisone acetate,Nalidixic acid,The risk or severity of tendinopathy can be increased when Cortisone acetate is combined with Nalidixic acid.,increase,risk
Cortisone acetate,Nandrolone decanoate,The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Nandrolone phenpropionate,The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Naproxen,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Naproxen.,increase,risk
Cortisone acetate,Natalizumab,The risk or severity of immunosuppression can be increased when Cortisone acetate is combined with Natalizumab.,increase,risk
Cortisone acetate,Nateglinide,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Nateglinide.,increase,risk
Cortisone acetate,Nefazodone,The metabolism of Cortisone acetate can be decreased when combined with Nefazodone.,decrease,no risk
Cortisone acetate,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Nelfinavir,The metabolism of Cortisone acetate can be decreased when combined with Nelfinavir.,decrease,no risk
Cortisone acetate,Neostigmine,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Neratinib,The metabolism of Neratinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Netupitant,The metabolism of Cortisone acetate can be decreased when combined with Netupitant.,decrease,no risk
Cortisone acetate,Nevirapine,The metabolism of Nevirapine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Nicardipine,The metabolism of Cortisone acetate can be decreased when combined with Nicardipine.,decrease,no risk
Cortisone acetate,Nicorandil,The risk or severity of ulceration can be increased when Cortisone acetate is combined with Nicorandil.,increase,risk
Cortisone acetate,Nifedipine,The metabolism of Nifedipine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Nilotinib,The metabolism of Cortisone acetate can be decreased when combined with Nilotinib.,decrease,no risk
Cortisone acetate,Nilvadipine,The metabolism of Cortisone acetate can be decreased when combined with Nilvadipine.,decrease,no risk
Cortisone acetate,Nimesulide,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Nimesulide.,increase,risk
Cortisone acetate,Nintedanib,The metabolism of Nintedanib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Nisoldipine,The metabolism of Nisoldipine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Nitrendipine,The metabolism of Nitrendipine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Nizatidine,The therapeutic efficacy of Nizatidine can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Nomegestrol,The serum concentration of Cortisone acetate can be increased when it is combined with Nomegestrol.,increase,no risk
Cortisone acetate,Nomegestrol acetate,The serum concentration of Cortisone acetate can be increased when it is combined with Nomegestrol acetate.,increase,no risk
Cortisone acetate,Norelgestromin,The serum concentration of Cortisone acetate can be increased when it is combined with Norelgestromin.,increase,no risk
Cortisone acetate,Norepinephrine,The risk or severity of hypokalemia can be increased when Cortisone acetate is combined with Norepinephrine.,increase,risk
Cortisone acetate,Norethisterone,The serum concentration of Cortisone acetate can be increased when it is combined with Norethisterone.,increase,no risk
Cortisone acetate,Norethynodrel,The serum concentration of Cortisone acetate can be increased when it is combined with Norethynodrel.,increase,no risk
Cortisone acetate,Norfloxacin,The risk or severity of tendinopathy can be increased when Cortisone acetate is combined with Norfloxacin.,increase,risk
Cortisone acetate,Norgestimate,The serum concentration of Cortisone acetate can be increased when it is combined with Norgestimate.,increase,no risk
Cortisone acetate,Norgestrel,The serum concentration of Cortisone acetate can be increased when it is combined with Norgestrel.,increase,no risk
Cortisone acetate,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Obinutuzumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Obinutuzumab.,increase,risk
Cortisone acetate,Ocrelizumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Ocrelizumab.,increase,risk
Cortisone acetate,Ofatumumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Ofatumumab.,increase,risk
Cortisone acetate,Ofloxacin,The risk or severity of tendinopathy can be increased when Cortisone acetate is combined with Ofloxacin.,increase,risk
Cortisone acetate,Olaparib,The metabolism of Olaparib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Cortisone acetate.,decrease,no risk
Cortisone acetate,Olodaterol,The risk or severity of hypokalemia can be increased when Cortisone acetate is combined with Olodaterol.,increase,risk
Cortisone acetate,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Cortisone acetate.,decrease,no risk
Cortisone acetate,Omaveloxolone,The serum concentration of Cortisone acetate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cortisone acetate,Ondansetron,The metabolism of Ondansetron can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Orciprenaline,The risk or severity of hypokalemia can be increased when Cortisone acetate is combined with Orciprenaline.,increase,risk
Cortisone acetate,Osimertinib,The metabolism of Osimertinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Oxandrolone,The risk or severity of fluid retention can be increased when Cortisone acetate is combined with Oxandrolone.,increase,risk
Cortisone acetate,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Oxaprozin.,increase,risk
Cortisone acetate,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Oxycodone,The metabolism of Oxycodone can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Oxymetholone,The risk or severity of fluid retention can be increased when Cortisone acetate is combined with Oxymetholone.,increase,risk
Cortisone acetate,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Oxyphenbutazone.,increase,risk
Cortisone acetate,Ozanimod,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Ozanimod.,increase,risk
Cortisone acetate,Quetiapine,The metabolism of Quetiapine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Quinestrol,The serum concentration of Cortisone acetate can be increased when it is combined with Quinestrol.,increase,no risk
Cortisone acetate,Quinethazone,Cortisone acetate may increase the hypokalemic activities of Quinethazone.,increase,no risk
Cortisone acetate,Quinidine,The metabolism of Quinidine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Quinine,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Quinine.,increase,risk
Cortisone acetate,Quizartinib,The metabolism of Quizartinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Udenafil,The metabolism of Udenafil can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Ulipristal,The serum concentration of Cortisone acetate can be increased when it is combined with Ulipristal.,increase,no risk
Cortisone acetate,Upadacitinib,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Upadacitinib.,increase,risk
Cortisone acetate,Vadadustat,The serum concentration of Cortisone acetate can be increased when it is combined with Vadadustat.,increase,no risk
Cortisone acetate,Valbenazine,The metabolism of Valbenazine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Valdecoxib.,increase,risk
Cortisone acetate,Vandetanib,The metabolism of Vandetanib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Vardenafil,The metabolism of Vardenafil can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Vedolizumab,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Vedolizumab.,increase,risk
Cortisone acetate,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Venetoclax,The metabolism of Venetoclax can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Verapamil,The metabolism of Cortisone acetate can be decreased when combined with Verapamil.,decrease,no risk
Cortisone acetate,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Vilanterol,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Vilanterol.,increase,risk
Cortisone acetate,Vildagliptin,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Vildagliptin.,increase,risk
Cortisone acetate,Viloxazine,The metabolism of Cortisone acetate can be decreased when combined with Viloxazine.,decrease,no risk
Cortisone acetate,Vinblastine,The metabolism of Vinblastine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Vincristine,The metabolism of Vincristine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Vindesine,The metabolism of Vindesine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Vinflunine,The metabolism of Vinflunine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Voclosporin,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Voclosporin.,increase,risk
Cortisone acetate,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Voriconazole,The serum concentration of Cortisone acetate can be increased when it is combined with Voriconazole.,increase,no risk
Cortisone acetate,Vorinostat,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Vorinostat.,increase,risk
Cortisone acetate,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Warfarin,Cortisone acetate may increase the anticoagulant activities of Warfarin.,increase,no risk
Cortisone acetate,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Cortisone acetate.,decrease,no risk
Cortisone acetate,Zaleplon,The metabolism of Zaleplon can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Cortisone acetate.,increase,risk
Cortisone acetate,Zimelidine,The metabolism of Cortisone acetate can be decreased when combined with Zimelidine.,decrease,no risk
Cortisone acetate,Ziprasidone,The metabolism of Cortisone acetate can be decreased when combined with Ziprasidone.,decrease,no risk
Cortisone acetate,Zolpidem,The metabolism of Zolpidem can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Zonisamide,The metabolism of Zonisamide can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Cortisone acetate.,increase,no risk
Cortisone acetate,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Cortisone acetate.,decrease,no risk
Ginkgo biloba,Gallamine triethiodide,The metabolism of Fruquintinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Gilteritinib,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Gliclazide,The metabolism of Gilteritinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Glimepiride,The metabolism of Gliclazide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Glipizide,The metabolism of Glimepiride can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Gliquidone,The metabolism of Glipizide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Glyburide,The metabolism of Gliquidone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Glycopyrronium,The metabolism of Glyburide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Haloperidol,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Halothane,The metabolism of Haloperidol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Heparin,The metabolism of Halothane can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Hexafluronium,Ginkgo biloba may increase the anticoagulant activities of Heparin.,increase,no risk
Ginkgo biloba,Hexocyclium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Homatropine methylbromide,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Hydrocortisone,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Hydrocortisone acetate,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Ginkgo biloba,Hydrocortisone butyrate,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Ginkgo biloba,Hydrocortisone cypionate,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Ginkgo biloba,Hydrocortisone succinate,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Ginkgo biloba,Hydromorphone,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Ginkgo biloba,Hyoscyamine,The metabolism of Hydromorphone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Ketamine,The metabolism of Ixazomib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Ketorolac,The metabolism of Ketamine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nabilone,Ginkgo biloba may increase the neuromuscular blocking activities of Moxisylyte.,increase,no risk
Ginkgo biloba,Nabumetone,The metabolism of Nabilone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nadolol,The metabolism of Nabumetone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nadroparin,Ginkgo biloba may increase the bradycardic activities of Nadolol.,increase,no risk
Ginkgo biloba,Naproxen,Ginkgo biloba may increase the anticoagulant activities of Nadroparin.,increase,no risk
Ginkgo biloba,Naratriptan,The metabolism of Naproxen can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nateglinide,The metabolism of Naratriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nebivolol,The metabolism of Nateglinide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Neratinib,Ginkgo biloba may increase the bradycardic activities of Nebivolol.,increase,no risk
Ginkgo biloba,Netupitant,The metabolism of Neratinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nevirapine,The metabolism of Netupitant can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nicardipine,The metabolism of Nevirapine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Niclosamide,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nicotine,The metabolism of Niclosamide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nilotinib,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Nicotine.,increase,risk
Ginkgo biloba,Nimesulide,The metabolism of Nilotinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nintedanib,Ginkgo biloba may increase the antiplatelet activities of Nimesulide.,increase,no risk
Ginkgo biloba,Nirogacestat,The metabolism of Nintedanib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Norethisterone,The metabolism of Nirogacestat can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Norgestimate,The metabolism of Norethisterone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Nortriptyline,The metabolism of Norgestimate can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Olanzapine,The metabolism of Nortriptyline can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Olaparib,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Olodaterol,The metabolism of Olaparib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Olsalazine,The metabolism of Olodaterol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Ondansetron,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Olsalazine.,increase,risk
Ginkgo biloba,Orphenadrine,The metabolism of Ondansetron can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Osimertinib,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Ospemifene,The metabolism of Osimertinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Oxprenolol,The metabolism of Ospemifene can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Oxybuprocaine,Ginkgo biloba may increase the bradycardic activities of Oxprenolol.,increase,no risk
Ginkgo biloba,Oxybutynin,Ginkgo biloba may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Ginkgo biloba,Oxyphencyclimine,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Oxyphenonium,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Quetiapine,Ginkgo biloba may increase the anticoagulant activities of Protein S human.,increase,no risk
Ginkgo biloba,Quinidine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Quinine,The metabolism of Quinidine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Ubrogepant,Ginkgo biloba may increase the neuromuscular blocking activities of Tubocurarine.,increase,no risk
Ginkgo biloba,Umeclidinium,The serum concentration of Ubrogepant can be increased when it is combined with Ginkgo biloba.,increase,no risk
Ginkgo biloba,Urokinase,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Valdecoxib,Ginkgo biloba may increase the anticoagulant activities of Urokinase.,increase,no risk
Ginkgo biloba,Valproic acid,The metabolism of Valdecoxib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Valsartan,The metabolism of Valproic acid can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vamorolone,The metabolism of Valsartan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vandetanib,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Vamorolone.,decrease,no risk
Ginkgo biloba,Vardenafil,The metabolism of Vandetanib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Varenicline,The metabolism of Vardenafil can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vecuronium,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Varenicline.,increase,risk
Ginkgo biloba,Vemurafenib,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Venetoclax,The metabolism of Vemurafenib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vinblastine,The metabolism of Venetoclax can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vincristine,The metabolism of Vinblastine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vindesine,The metabolism of Vincristine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vinflunine,The metabolism of Vindesine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vinorelbine,The metabolism of Vinflunine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Vorapaxar,The metabolism of Vinorelbine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Voriconazole,Ginkgo biloba may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Ginkgo biloba,Vortioxetine,The metabolism of Voriconazole can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Voxelotor,The metabolism of Vortioxetine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Warfarin,The metabolism of Voxelotor can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Ximelagatran,Ginkgo biloba may increase the anticoagulant activities of Warfarin.,increase,no risk
Ginkgo biloba,Zafirlukast,Ginkgo biloba may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Ginkgo biloba,Zanubrutinib,The metabolism of Zafirlukast can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Zidovudine,The metabolism of Zanubrutinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Zileuton,The metabolism of Zidovudine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Ziprasidone,The metabolism of Zileuton can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Zolmitriptan,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Zolpidem,The metabolism of Zolmitriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Zopiclone,The metabolism of Zolpidem can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ginkgo biloba,Zuclopenthixol,The metabolism of Zopiclone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Glymidine,Gatifloxacin,The therapeutic efficacy of Glymidine can be increased when used in combination with Gatifloxacin.,increase,no risk
Glymidine,Gefapixant,The therapeutic efficacy of Glymidine can be increased when used in combination with Gefapixant.,increase,no risk
Glymidine,Gemifloxacin,The therapeutic efficacy of Glymidine can be increased when used in combination with Gemifloxacin.,increase,no risk
Glymidine,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Glymidine.,increase,risk
Glymidine,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Glymidine.,increase,risk
Glymidine,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Glymidine.,increase,risk
Glymidine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Glymidine.,increase,no risk
Glymidine,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Glymidine.,increase,risk
Glymidine,Goserelin,The therapeutic efficacy of Glymidine can be decreased when used in combination with Goserelin.,decrease,no risk
Glymidine,Grepafloxacin,The therapeutic efficacy of Glymidine can be increased when used in combination with Grepafloxacin.,increase,no risk
Glymidine,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Glymidine.,increase,risk
Glymidine,Haloperidol,The therapeutic efficacy of Glymidine can be decreased when used in combination with Haloperidol.,decrease,no risk
Glymidine,Histrelin,The therapeutic efficacy of Glymidine can be decreased when used in combination with Histrelin.,decrease,no risk
Glymidine,Hydrochlorothiazide,The therapeutic efficacy of Glymidine can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Glymidine,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Glymidine.,increase,risk
Glymidine,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Glymidine.,increase,risk
Glymidine,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glymidine.,increase,risk
Glymidine,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Glymidine.,increase,risk
Glymidine,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Glymidine.,increase,risk
Glymidine,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Glymidine.,increase,risk
Glymidine,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glymidine.,increase,risk
Glymidine,Hydroflumethiazide,The therapeutic efficacy of Glymidine can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Glymidine,Hydroxychloroquine,The therapeutic efficacy of Glymidine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Glymidine,Hydroxyprogesterone caproate,The therapeutic efficacy of Glymidine can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Glymidine,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Glymidine.,increase,risk
Glymidine,Ketotifen,The risk or severity of thrombocytopenia can be increased when Glymidine is combined with Ketotifen.,increase,risk
Glymidine,Nadolol,The therapeutic efficacy of Glymidine can be increased when used in combination with Nadolol.,increase,no risk
Glymidine,Nalidixic acid,The therapeutic efficacy of Glymidine can be increased when used in combination with Nalidixic acid.,increase,no risk
Glymidine,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Glymidine.,increase,no risk
Glymidine,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Glymidine.,increase,no risk
Glymidine,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Glymidine.,increase,risk
Glymidine,Nebivolol,The therapeutic efficacy of Glymidine can be increased when used in combination with Nebivolol.,increase,no risk
Glymidine,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Glymidine.,increase,risk
Glymidine,Nelfinavir,The therapeutic efficacy of Glymidine can be decreased when used in combination with Nelfinavir.,decrease,no risk
Glymidine,Niacin,The therapeutic efficacy of Glymidine can be decreased when used in combination with Niacin.,decrease,no risk
Glymidine,Nialamide,Nialamide may increase the hypoglycemic activities of Glymidine.,increase,no risk
Glymidine,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Glymidine.,increase,risk
Glymidine,Nicotine,The risk or severity of adverse effects can be increased when Glymidine is combined with Nicotine.,increase,risk
Glymidine,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Glymidine.,increase,risk
Glymidine,Nilotinib,The therapeutic efficacy of Glymidine can be decreased when used in combination with Nilotinib.,decrease,no risk
Glymidine,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Glymidine.,increase,risk
Glymidine,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Glymidine.,increase,risk
Glymidine,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Glymidine.,increase,risk
Glymidine,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Glymidine.,increase,risk
Glymidine,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Glymidine.,increase,risk
Glymidine,Norethisterone,The therapeutic efficacy of Glymidine can be decreased when used in combination with Norethisterone.,decrease,no risk
Glymidine,Norfloxacin,The therapeutic efficacy of Glymidine can be increased when used in combination with Norfloxacin.,increase,no risk
Glymidine,Norgestimate,The therapeutic efficacy of Glymidine can be decreased when used in combination with Norgestimate.,decrease,no risk
Glymidine,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Glymidine,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glymidine.,increase,risk
Glymidine,Octreotide,The therapeutic efficacy of Glymidine can be decreased when used in combination with Octreotide.,decrease,no risk
Glymidine,Ofloxacin,The therapeutic efficacy of Glymidine can be increased when used in combination with Ofloxacin.,increase,no risk
Glymidine,Olanzapine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Olanzapine.,decrease,no risk
Glymidine,Olsalazine,Olsalazine may increase the hypoglycemic activities of Glymidine.,increase,no risk
Glymidine,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Glymidine.,increase,no risk
Glymidine,Oxprenolol,The therapeutic efficacy of Glymidine can be increased when used in combination with Oxprenolol.,increase,no risk
Glymidine,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Glymidine.,increase,no risk
Glymidine,Quetiapine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Quetiapine.,decrease,no risk
Glymidine,Quinethazone,The therapeutic efficacy of Glymidine can be decreased when used in combination with Quinethazone.,decrease,no risk
Glymidine,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Glymidine.,increase,risk
Glymidine,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Glymidine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Glymidine.,increase,risk
Glymidine,Udenafil,The therapeutic efficacy of Glymidine can be increased when used in combination with Udenafil.,increase,no risk
Glymidine,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glymidine.,increase,risk
Glymidine,Valdecoxib,The therapeutic efficacy of Glymidine can be increased when used in combination with Valdecoxib.,increase,no risk
Glymidine,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Glymidine.,increase,risk
Glymidine,Vemurafenib,The therapeutic efficacy of Glymidine can be increased when used in combination with Vemurafenib.,increase,no risk
Glymidine,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glymidine.,increase,risk
Glymidine,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Glymidine.,increase,risk
Glymidine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Glymidine.,increase,no risk
Glymidine,Vorinostat,The therapeutic efficacy of Glymidine can be decreased when used in combination with Vorinostat.,decrease,no risk
Glymidine,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Glymidine.,increase,risk
Glymidine,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Glymidine.,increase,risk
Glymidine,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Glymidine.,increase,risk
Glymidine,Ziprasidone,The therapeutic efficacy of Glymidine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Glymidine,Zonisamide,The therapeutic efficacy of Glymidine can be increased when used in combination with Zonisamide.,increase,no risk
Paramethasone,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Paramethasone.,increase,risk
Paramethasone,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Bimekizumab,The risk or severity of adverse effects can be increased when Paramethasone is combined with Bimekizumab.,increase,risk
Paramethasone,Bismuth subsalicylate,The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Paramethasone.,decrease,no risk
Paramethasone,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Paramethasone.,increase,risk
Paramethasone,Blinatumomab,The risk or severity of adverse effects can be increased when Paramethasone is combined with Blinatumomab.,increase,risk
Paramethasone,Boceprevir,The metabolism of Paramethasone can be decreased when combined with Boceprevir.,decrease,no risk
Paramethasone,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Paramethasone.",decrease,no risk
Paramethasone,Bortezomib,The metabolism of Bortezomib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Bosutinib,The metabolism of Bosutinib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Paramethasone.,increase,risk
Paramethasone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Brigatinib,The metabolism of Brigatinib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Brodalumab,The risk or severity of adverse effects can be increased when Paramethasone is combined with Brodalumab.,increase,risk
Paramethasone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Bromocriptine.,increase,risk
Paramethasone,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Paramethasone.,increase,risk
Paramethasone,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Bumadizone.,increase,risk
Paramethasone,Bumetanide,The risk or severity of hypokalemia can be increased when Paramethasone is combined with Bumetanide.,increase,risk
Paramethasone,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Buspirone,The metabolism of Buspirone can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Busulfan,The metabolism of Busulfan can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Gatifloxacin,The risk or severity of tendinopathy can be increased when Paramethasone is combined with Gatifloxacin.,increase,risk
Paramethasone,Gefitinib,The metabolism of Gefitinib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Paramethasone.,increase,risk
Paramethasone,Gemifloxacin,The risk or severity of tendinopathy can be increased when Paramethasone is combined with Gemifloxacin.,increase,risk
Paramethasone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Paramethasone.,increase,risk
Paramethasone,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Paramethasone.,increase,no risk
Paramethasone,Gestrinone,The serum concentration of Paramethasone can be increased when it is combined with Gestrinone.,increase,no risk
Paramethasone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Glatiramer,The risk or severity of adverse effects can be increased when Paramethasone is combined with Glatiramer.,increase,risk
Paramethasone,Gliclazide,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Gliclazide.,increase,risk
Paramethasone,Glimepiride,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Glimepiride.,increase,risk
Paramethasone,Glipizide,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Glipizide.,increase,risk
Paramethasone,Gliquidone,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Gliquidone.,increase,risk
Paramethasone,Glofitamab,The serum concentration of Paramethasone can be increased when it is combined with Glofitamab.,increase,no risk
Paramethasone,Glyburide,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Glyburide.,increase,risk
Paramethasone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Glycol salicylate.,increase,risk
Paramethasone,Glymidine,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Glymidine.,increase,risk
Paramethasone,Golimumab,The risk or severity of adverse effects can be increased when Paramethasone is combined with Golimumab.,increase,risk
Paramethasone,Grepafloxacin,The risk or severity of tendinopathy can be increased when Paramethasone is combined with Grepafloxacin.,increase,risk
Paramethasone,Guselkumab,The risk or severity of adverse effects can be increased when Paramethasone is combined with Guselkumab.,increase,risk
Paramethasone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Halofantrine,The metabolism of Halofantrine can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Paramethasone.,increase,no risk
Paramethasone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Paramethasone is combined with Hydrochlorothiazide.,increase,risk
Paramethasone,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Paramethasone is combined with Hydrocortisone acetate.,increase,risk
Paramethasone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Paramethasone is combined with Hydrocortisone butyrate.,increase,risk
Paramethasone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Paramethasone is combined with Hydrocortisone succinate.,increase,risk
Paramethasone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Paramethasone is combined with Hydroflumethiazide.,increase,risk
Paramethasone,Hydrotalcite,The bioavailability of Paramethasone can be decreased when combined with Hydrotalcite.,decrease,no risk
Paramethasone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Paramethasone is combined with Hydroxychloroquine.,increase,risk
Paramethasone,Hydroxyprogesterone caproate,The serum concentration of Paramethasone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Paramethasone,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Paramethasone.,increase,risk
Paramethasone,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Ketoconazole,The metabolism of Paramethasone can be decreased when combined with Ketoconazole.,decrease,no risk
Paramethasone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Ketoprofen.,increase,risk
Paramethasone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Ketorolac.,increase,risk
Paramethasone,Nabumetone,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Nabumetone.,increase,risk
Paramethasone,Nalidixic acid,The risk or severity of tendinopathy can be increased when Paramethasone is combined with Nalidixic acid.,increase,risk
Paramethasone,Nandrolone decanoate,The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Paramethasone.,increase,risk
Paramethasone,Nandrolone phenpropionate,The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Paramethasone.,increase,risk
Paramethasone,Naproxen,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Naproxen.,increase,risk
Paramethasone,Natalizumab,The risk or severity of immunosuppression can be increased when Paramethasone is combined with Natalizumab.,increase,risk
Paramethasone,Nateglinide,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Nateglinide.,increase,risk
Paramethasone,Nefazodone,The metabolism of Paramethasone can be decreased when combined with Nefazodone.,decrease,no risk
Paramethasone,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Paramethasone.,increase,risk
Paramethasone,Nelfinavir,The metabolism of Paramethasone can be decreased when combined with Nelfinavir.,decrease,no risk
Paramethasone,Neostigmine,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Neratinib,The metabolism of Neratinib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Netupitant,The metabolism of Paramethasone can be decreased when combined with Netupitant.,decrease,no risk
Paramethasone,Nevirapine,The metabolism of Nevirapine can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Nicardipine,The metabolism of Paramethasone can be decreased when combined with Nicardipine.,decrease,no risk
Paramethasone,Nicorandil,The risk or severity of ulceration can be increased when Paramethasone is combined with Nicorandil.,increase,risk
Paramethasone,Nifedipine,The metabolism of Nifedipine can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Nilotinib,The metabolism of Paramethasone can be decreased when combined with Nilotinib.,decrease,no risk
Paramethasone,Nilvadipine,The metabolism of Paramethasone can be decreased when combined with Nilvadipine.,decrease,no risk
Paramethasone,Nimesulide,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Nimesulide.,increase,risk
Paramethasone,Nintedanib,The metabolism of Nintedanib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Nisoldipine,The metabolism of Nisoldipine can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Nitrendipine,The metabolism of Nitrendipine can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Nizatidine,The therapeutic efficacy of Nizatidine can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Nomegestrol,The serum concentration of Paramethasone can be increased when it is combined with Nomegestrol.,increase,no risk
Paramethasone,Nomegestrol acetate,The serum concentration of Paramethasone can be increased when it is combined with Nomegestrol acetate.,increase,no risk
Paramethasone,Norelgestromin,The serum concentration of Paramethasone can be increased when it is combined with Norelgestromin.,increase,no risk
Paramethasone,Norepinephrine,The risk or severity of hypokalemia can be increased when Paramethasone is combined with Norepinephrine.,increase,risk
Paramethasone,Norethisterone,The serum concentration of Paramethasone can be increased when it is combined with Norethisterone.,increase,no risk
Paramethasone,Norethynodrel,The serum concentration of Paramethasone can be increased when it is combined with Norethynodrel.,increase,no risk
Paramethasone,Norfloxacin,The risk or severity of tendinopathy can be increased when Paramethasone is combined with Norfloxacin.,increase,risk
Paramethasone,Norgestimate,The serum concentration of Paramethasone can be increased when it is combined with Norgestimate.,increase,no risk
Paramethasone,Norgestrel,The serum concentration of Paramethasone can be increased when it is combined with Norgestrel.,increase,no risk
Paramethasone,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Paramethasone.,decrease,no risk
Paramethasone,Obinutuzumab,The risk or severity of adverse effects can be increased when Paramethasone is combined with Obinutuzumab.,increase,risk
Paramethasone,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Paramethasone.,increase,no risk
Paramethasone,Ofatumumab,The risk or severity of adverse effects can be increased when Paramethasone is combined with Ofatumumab.,increase,risk
Paramethasone,Ofloxacin,The risk or severity of tendinopathy can be increased when Paramethasone is combined with Ofloxacin.,increase,risk
Paramethasone,Olaparib,The metabolism of Olaparib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Paramethasone.,decrease,no risk
Paramethasone,Olodaterol,The risk or severity of hypokalemia can be increased when Paramethasone is combined with Olodaterol.,increase,risk
Paramethasone,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Paramethasone.,decrease,no risk
Paramethasone,Omaveloxolone,The serum concentration of Paramethasone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Paramethasone,Ondansetron,The metabolism of Ondansetron can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Orciprenaline,The risk or severity of hypokalemia can be increased when Paramethasone is combined with Orciprenaline.,increase,risk
Paramethasone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Paramethasone.,increase,risk
Paramethasone,Oxandrolone,The risk or severity of fluid retention can be increased when Paramethasone is combined with Oxandrolone.,increase,risk
Paramethasone,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Oxaprozin.,increase,risk
Paramethasone,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Oxycodone,The metabolism of Oxycodone can be increased when combined with Paramethasone.,increase,no risk
Paramethasone,Oxymetholone,The risk or severity of fluid retention can be increased when Paramethasone is combined with Oxymetholone.,increase,risk
Paramethasone,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Oxyphenbutazone.,increase,risk
Paramethasone,Ozanimod,The risk or severity of adverse effects can be increased when Paramethasone is combined with Ozanimod.,increase,risk
Mibefradil,Bendroflumethiazide,The therapeutic efficacy of Mibefradil can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Mibefradil,Benorilate,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Benorilate.,decrease,no risk
Mibefradil,Benoxaprofen,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Mibefradil,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Benzthiazide,The therapeutic efficacy of Mibefradil can be increased when used in combination with Benzthiazide.,increase,no risk
Mibefradil,Benzydamine,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Benzydamine.,decrease,no risk
Mibefradil,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Bepridil,Bepridil may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Beractant,Mibefradil may increase the bradycardic activities of Beractant.,increase,no risk
Mibefradil,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Bethanidine,Bethanidine may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Bexagliflozin.,increase,risk
Mibefradil,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Mibefradil.,increase,no risk
Mibefradil,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Mibefradil.,increase,risk
Mibefradil,Bimatoprost,Bimatoprost may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Bioallethrin,Mibefradil may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Mibefradil,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Mibefradil.,decrease,no risk
Mibefradil,Bisoprolol,The therapeutic efficacy of Mibefradil can be increased when used in combination with Bisoprolol.,increase,no risk
Mibefradil,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Mibefradil.,decrease,no risk
Mibefradil,Boceprevir,The serum concentration of Mibefradil can be increased when it is combined with Boceprevir.,increase,no risk
Mibefradil,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Bosentan,Bosentan may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Bretylium,Bretylium may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Brimonidine,Brimonidine may increase the antihypertensive activities of Mibefradil.,increase,no risk
Mibefradil,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Bromocriptine,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Bromocriptine.,increase,risk
Mibefradil,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Mibefradil.,increase,risk
Mibefradil,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Mibefradil.,increase,risk
Mibefradil,Bumadizone,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Bumadizone.,decrease,no risk
Mibefradil,Bumetanide,Bumetanide may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mibefradil.,increase,risk
Mibefradil,Buspirone,The metabolism of Buspirone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Butabarbital,The metabolism of Mibefradil can be increased when combined with Butabarbital.,increase,no risk
Mibefradil,Butalbital,The metabolism of Mibefradil can be increased when combined with Butalbital.,increase,no risk
Mibefradil,Butriptyline,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Butriptyline.,increase,risk
Mibefradil,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Mibefradil.,increase,risk
Mibefradil,Galantamine,The metabolism of Galantamine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Gallamine triethiodide,Mibefradil may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Mibefradil,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mibefradil.,increase,risk
Mibefradil,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Mibefradil.,increase,risk
Mibefradil,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Gilteritinib,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Gilteritinib.,increase,risk
Mibefradil,Glasdegib,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Glasdegib.,increase,risk
Mibefradil,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Gliclazide,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Gliclazide.,increase,risk
Mibefradil,Glimepiride,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Glimepiride.,increase,risk
Mibefradil,Glipizide,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Glipizide.,increase,risk
Mibefradil,Gliquidone,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Gliquidone.,increase,risk
Mibefradil,Glofitamab,The serum concentration of Mibefradil can be increased when it is combined with Glofitamab.,increase,no risk
Mibefradil,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Mibefradil.,decrease,no risk
Mibefradil,Glyburide,The metabolism of Glyburide can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Mibefradil.,decrease,no risk
Mibefradil,Glycol salicylate,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Mibefradil,Glymidine,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Glymidine.,increase,risk
Mibefradil,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mibefradil.,increase,risk
Mibefradil,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Mibefradil.,increase,risk
Mibefradil,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Grepafloxacin.,increase,risk
Mibefradil,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Guanadrel,Guanadrel may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Guanethidine,Guanethidine may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Guanfacine,Guanfacine may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Guanoxan,Mibefradil may increase the hypotensive activities of Guanoxan.,increase,no risk
Mibefradil,Halofantrine,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Halofantrine.,increase,risk
Mibefradil,Haloperidol,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Haloperidol.,increase,risk
Mibefradil,Halothane,Halothane may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Mibefradil.,increase,risk
Mibefradil,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mibefradil.,increase,risk
Mibefradil,Hydralazine,Hydralazine may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Hydrochlorothiazide,The therapeutic efficacy of Mibefradil can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Mibefradil,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydroflumethiazide,The therapeutic efficacy of Mibefradil can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Mibefradil,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Mibefradil.,increase,risk
Mibefradil,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Hydroxyzine.,increase,risk
Mibefradil,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Ketoconazole,The metabolism of Mibefradil can be decreased when combined with Ketoconazole.,decrease,no risk
Mibefradil,Ketoprofen,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Ketoprofen.,decrease,no risk
Mibefradil,Ketorolac,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Ketorolac.,decrease,no risk
Mibefradil,Nabilone,Nabilone may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Nabumetone,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Nabumetone.,decrease,no risk
Mibefradil,Nadolol,Nadolol may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Nadroparin,The risk or severity of hyperkalemia can be increased when Mibefradil is combined with Nadroparin.,increase,risk
Mibefradil,Nafcillin,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Nafcillin.,decrease,no risk
Mibefradil,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Mibefradil.,increase,risk
Mibefradil,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Naphazoline,Naphazoline may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Naproxen,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Naproxen.,decrease,no risk
Mibefradil,Naratriptan,Naratriptan may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Naxitamab,Naxitamab may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Nebivolol,Mibefradil may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Mibefradil,Nefazodone,The metabolism of Mibefradil can be decreased when combined with Nefazodone.,decrease,no risk
Mibefradil,Nelfinavir,The metabolism of Mibefradil can be decreased when combined with Nelfinavir.,decrease,no risk
Mibefradil,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Nesiritide,Nesiritide may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Netupitant,The metabolism of Mibefradil can be decreased when combined with Netupitant.,decrease,no risk
Mibefradil,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Nialamide,Nialamide may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Nicergoline,The metabolism of Nicergoline can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Nicorandil,Mibefradil may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Mibefradil,Nifedipine,Nifedipine may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Nilotinib,The metabolism of Mibefradil can be decreased when combined with Nilotinib.,decrease,no risk
Mibefradil,Nilvadipine,Mibefradil may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Mibefradil,Nimesulide,Mibefradil may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Mibefradil,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Nitrendipine,Nitrendipine may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Nitric Oxide,Nitric Oxide may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mibefradil.,increase,risk
Mibefradil,Nitroglycerin,Mibefradil may increase the vasodilatory activities of Nitroglycerin.,increase,no risk
Mibefradil,Nitroprusside,Mibefradil may increase the hypotensive activities of Nitroprusside.,increase,no risk
Mibefradil,Nitrous acid,Nitrous acid may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Mibefradil.,increase,risk
Mibefradil,Norgestimate,The serum concentration of Mibefradil can be increased when it is combined with Norgestimate.,increase,no risk
Mibefradil,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Nylidrin,Mibefradil may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Mibefradil,Obinutuzumab,Mibefradil may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Mibefradil,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Mibefradil.,increase,no risk
Mibefradil,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Mibefradil.,increase,risk
Mibefradil,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Olmesartan,Olmesartan may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Olodaterol,Olodaterol may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Omaveloxolone,The serum concentration of Mibefradil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Mibefradil,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mibefradil.,increase,risk
Mibefradil,Opicapone,Opicapone may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Opium,The metabolism of Opium can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Mibefradil.,increase,risk
Mibefradil,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Mibefradil.,increase,no risk
Mibefradil,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mibefradil.,increase,risk
Mibefradil,Oxaprozin,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Oxaprozin.,decrease,no risk
Mibefradil,Oxatomide,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Oxatomide.,increase,risk
Mibefradil,Oxprenolol,Mibefradil may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Mibefradil,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Oxymetazoline,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Mibefradil,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Oxyphenbutazone,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Mibefradil,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Mibefradil.,decrease,no risk
Mibefradil,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mibefradil.,increase,risk
Mibefradil,Quetiapine,Quetiapine may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Quinapril,Quinapril may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Quinidine,Quinidine may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Quinine,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Quinine.,increase,risk
Mibefradil,Quinupramine,Quinupramine may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Quizartinib,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Quizartinib.,increase,risk
Mibefradil,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Udenafil,The metabolism of Udenafil can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Umbralisib,The serum concentration of Mibefradil can be increased when it is combined with Umbralisib.,increase,no risk
Mibefradil,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Unoprostone,Mibefradil may increase the hypotensive activities of Unoprostone.,increase,no risk
Mibefradil,Vadadustat,The serum concentration of Mibefradil can be increased when it is combined with Vadadustat.,increase,no risk
Mibefradil,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Valdecoxib,The therapeutic efficacy of Mibefradil can be decreased when used in combination with Valdecoxib.,decrease,no risk
Mibefradil,Valproic acid,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Valproic acid.,increase,risk
Mibefradil,Valsartan,Valsartan may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Vecuronium,Mibefradil may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Mibefradil,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Vemurafenib,The serum concentration of Mibefradil can be increased when it is combined with Vemurafenib.,increase,no risk
Mibefradil,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Verapamil,Verapamil may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Vericiguat,Vericiguat may increase the hypotensive activities of Mibefradil.,increase,no risk
Mibefradil,Vernakalant,Mibefradil may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Mibefradil,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Mibefradil.,increase,risk
Mibefradil,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Vildagliptin,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Vildagliptin.,increase,risk
Mibefradil,Viloxazine,The metabolism of Mibefradil can be decreased when combined with Viloxazine.,decrease,no risk
Mibefradil,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Vincristine,The excretion of Vincristine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Vorapaxar,The serum concentration of Mibefradil can be increased when it is combined with Vorapaxar.,increase,no risk
Mibefradil,Voriconazole,The metabolism of Mibefradil can be decreased when combined with Voriconazole.,decrease,no risk
Mibefradil,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mibefradil.,increase,risk
Mibefradil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Xamoterol,Xamoterol may decrease the antihypertensive activities of Mibefradil.,decrease,no risk
Mibefradil,Xylometazoline,Mibefradil may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Mibefradil,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Mibefradil.,increase,no risk
Mibefradil,Ziconotide,Mibefradil may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Mibefradil,Zileuton,The metabolism of Zileuton can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Zimelidine,The metabolism of Mibefradil can be decreased when combined with Zimelidine.,decrease,no risk
Mibefradil,Ziprasidone,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Ziprasidone.,increase,risk
Mibefradil,Zofenopril,Mibefradil may increase the hypotensive activities of Zofenopril.,increase,no risk
Mibefradil,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Mibefradil.,increase,no risk
Mibefradil,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Zotepine,The metabolism of Zotepine can be decreased when combined with Mibefradil.,decrease,no risk
Mibefradil,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Zuclopenthixol.,increase,risk
Yohimbine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Yohimbine.,increase,risk
Yohimbine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Yohimbine.,increase,risk
Yohimbine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Yohimbine.,increase,risk
Yohimbine,Butaperazine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Butaperazine.,increase,risk
Yohimbine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Yohimbine.,increase,risk
Yohimbine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Yohimbine.,increase,risk
Yohimbine,Butriptyline,The therapeutic efficacy of Butriptyline can be increased when used in combination with Yohimbine.,increase,no risk
Yohimbine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Yohimbine.,increase,risk
Yohimbine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Yohimbine is combined with Gabapentin enacarbil.,increase,risk
Yohimbine,Galantamine,The metabolism of Yohimbine can be decreased when combined with Galantamine.,decrease,no risk
Yohimbine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Yohimbine.,increase,risk
Yohimbine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Yohimbine is combined with Ganaxolone.",increase,risk
Yohimbine,Gefitinib,The metabolism of Yohimbine can be decreased when combined with Gefitinib.,decrease,no risk
Yohimbine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Yohimbine.,increase,risk
Yohimbine,Gilteritinib,The therapeutic efficacy of Yohimbine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Yohimbine,Givosiran,The serum concentration of Yohimbine can be increased when it is combined with Givosiran.,increase,no risk
Yohimbine,Glofitamab,The serum concentration of Yohimbine can be increased when it is combined with Glofitamab.,increase,no risk
Yohimbine,Glutethimide,The risk or severity of CNS depression can be increased when Yohimbine is combined with Glutethimide.,increase,risk
Yohimbine,Glycerol phenylbutyrate,The metabolism of Yohimbine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Yohimbine,Golimumab,The metabolism of Yohimbine can be increased when combined with Golimumab.,increase,no risk
Yohimbine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Yohimbine.,increase,risk
Yohimbine,Guanabenz,Yohimbine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Yohimbine,Guanadrel,Yohimbine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Yohimbine,Guanethidine,Yohimbine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Yohimbine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Yohimbine.,increase,risk
Yohimbine,Guanoxan,Yohimbine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Yohimbine,Halazepam,The therapeutic efficacy of Halazepam can be increased when used in combination with Yohimbine.,increase,no risk
Yohimbine,Halofantrine,The metabolism of Yohimbine can be decreased when combined with Halofantrine.,decrease,no risk
Yohimbine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Yohimbine.,increase,risk
Yohimbine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Yohimbine.,increase,risk
Yohimbine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Yohimbine.,increase,risk
Yohimbine,Hydralazine,Yohimbine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Yohimbine,Hydrochlorothiazide,Yohimbine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Yohimbine,Hydrocodone,Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Yohimbine,Hydroflumethiazide,Yohimbine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Yohimbine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Yohimbine.,increase,risk
Yohimbine,Hydroxychloroquine,The metabolism of Yohimbine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Yohimbine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Yohimbine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Yohimbine.,increase,risk
Yohimbine,Ketazolam,The therapeutic efficacy of Ketazolam can be increased when used in combination with Yohimbine.,increase,no risk
Yohimbine,Ketoconazole,The metabolism of Yohimbine can be decreased when combined with Ketoconazole.,decrease,no risk
Yohimbine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Yohimbine.,increase,risk
Bezafibrate,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Bezafibrate.",increase,risk
Bezafibrate,Gemfibrozil,The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Bezafibrate.,increase,risk
Bezafibrate,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Gliclazide,The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Gliclazide.,increase,risk
Bezafibrate,Glimepiride,The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Glimepiride.,increase,risk
Bezafibrate,Glipizide,The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Glipizide.,increase,risk
Bezafibrate,Gliquidone,The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Gliquidone.,increase,risk
Bezafibrate,Glofitamab,The serum concentration of Bezafibrate can be increased when it is combined with Glofitamab.,increase,no risk
Bezafibrate,Glyburide,The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Glyburide.,increase,risk
Bezafibrate,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Bezafibrate.,increase,no risk
Bezafibrate,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Ketamine,The metabolism of Ketamine can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Ketoconazole,The metabolism of Bezafibrate can be decreased when combined with Ketoconazole.,decrease,no risk
Bezafibrate,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Bezafibrate.",increase,risk
Bezafibrate,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Bezafibrate.",increase,risk
Bezafibrate,Naproxen,The metabolism of Naproxen can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Nefazodone,The metabolism of Bezafibrate can be decreased when combined with Nefazodone.,decrease,no risk
Bezafibrate,Nelfinavir,The metabolism of Bezafibrate can be decreased when combined with Nelfinavir.,decrease,no risk
Bezafibrate,Netupitant,The metabolism of Bezafibrate can be decreased when combined with Netupitant.,decrease,no risk
Bezafibrate,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Bezafibrate.",increase,risk
Bezafibrate,Nialamide,Nialamide may increase the hepatotoxic activities of Bezafibrate.,increase,no risk
Bezafibrate,Nicardipine,The metabolism of Bezafibrate can be decreased when combined with Nicardipine.,decrease,no risk
Bezafibrate,Nilotinib,The metabolism of Bezafibrate can be decreased when combined with Nilotinib.,decrease,no risk
Bezafibrate,Nilvadipine,The metabolism of Bezafibrate can be decreased when combined with Nilvadipine.,decrease,no risk
Bezafibrate,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Bezafibrate.",increase,risk
Bezafibrate,Norfloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Norfloxacin is combined with Bezafibrate.",increase,risk
Bezafibrate,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Bezafibrate.,decrease,no risk
Bezafibrate,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Bezafibrate.",increase,risk
Bezafibrate,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Omaveloxolone,The serum concentration of Bezafibrate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Bezafibrate,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Ouabain,The excretion of Ouabain can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Quinine,The metabolism of Quinine can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bezafibrate is combined with Ubidecarenone.",increase,risk
Bezafibrate,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Bezafibrate.,decrease,no risk
Bezafibrate,Vadadustat,The serum concentration of Bezafibrate can be increased when it is combined with Vadadustat.,increase,no risk
Bezafibrate,Valsartan,The excretion of Valsartan can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Venetoclax,The metabolism of Bezafibrate can be decreased when combined with Venetoclax.,decrease,no risk
Bezafibrate,Verapamil,The metabolism of Bezafibrate can be decreased when combined with Verapamil.,decrease,no risk
Bezafibrate,Viloxazine,The metabolism of Bezafibrate can be decreased when combined with Viloxazine.,decrease,no risk
Bezafibrate,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Bezafibrate.",increase,risk
Bezafibrate,Voriconazole,The metabolism of Bezafibrate can be decreased when combined with Voriconazole.,decrease,no risk
Bezafibrate,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Bezafibrate.,decrease,no risk
Bezafibrate,Warfarin,The risk or severity of bleeding can be increased when Bezafibrate is combined with Warfarin.,increase,risk
Bezafibrate,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Bezafibrate.",increase,risk
Bezafibrate,Zimelidine,The metabolism of Bezafibrate can be decreased when combined with Zimelidine.,decrease,no risk
Bezafibrate,Ziprasidone,The metabolism of Bezafibrate can be decreased when combined with Ziprasidone.,decrease,no risk
Bezafibrate,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Bezafibrate.,decrease,no risk
Colchicine,Brivaracetam,Colchicine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Colchicine,Bromazepam,Colchicine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Colchicine,Bromocriptine,The metabolism of Colchicine can be decreased when combined with Bromocriptine.,decrease,no risk
Colchicine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Colchicine,Budesonide,Budesonide may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Bumadizone,Bumadizone may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Bumetanide,Bumetanide may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Colchicine,Buprenorphine,The metabolism of Colchicine can be decreased when combined with Buprenorphine.,decrease,no risk
Colchicine,Bupropion,Bupropion may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Buspirone,Buspirone may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Butabarbital,Butabarbital may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Gabapentin enacarbil,Colchicine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Colchicine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Gadodiamide,Gadodiamide may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Gadofosveset trisodium,Colchicine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Colchicine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Gadoteric acid,Colchicine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Colchicine,Gadoteridol,Gadoteridol may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Colchicine.",increase,risk
Colchicine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Gemfibrozil,The risk or severity of myopathy can be increased when Gemfibrozil is combined with Colchicine.,increase,risk
Colchicine,Gentamicin,Colchicine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Colchicine,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Gimeracil,Colchicine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Colchicine,Givosiran,Givosiran may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Glasdegib,The serum concentration of Colchicine can be increased when it is combined with Glasdegib.,increase,no risk
Colchicine,Glecaprevir,The serum concentration of Colchicine can be increased when it is combined with Glecaprevir.,increase,no risk
Colchicine,Glipizide,Glipizide may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Glofitamab,The serum concentration of Colchicine can be increased when it is combined with Glofitamab.,increase,no risk
Colchicine,Glyburide,The metabolism of Colchicine can be decreased when combined with Glyburide.,decrease,no risk
Colchicine,Glycerol phenylbutyrate,Colchicine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Colchicine,Golodirsen,Colchicine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Colchicine,Goserelin,Goserelin may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Guanethidine,Guanethidine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Guanfacine,Guanfacine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Haloperidol,The metabolism of Colchicine can be decreased when combined with Haloperidol.,decrease,no risk
Colchicine,Hydralazine,The metabolism of Colchicine can be decreased when combined with Hydralazine.,decrease,no risk
Colchicine,Hydrochlorothiazide,The therapeutic efficacy of Colchicine can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Colchicine,Hydroflumethiazide,The therapeutic efficacy of Colchicine can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Colchicine,Hydromorphone,Hydromorphone may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Hydroxyethyl Starch,Colchicine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Colchicine,Kanamycin,Colchicine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Colchicine,Ketamine,Ketamine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Ketazolam,The metabolism of Colchicine can be decreased when combined with Ketazolam.,decrease,no risk
Colchicine,Ketoconazole,The serum concentration of Colchicine can be increased when it is combined with Ketoconazole.,increase,no risk
Colchicine,Ketoprofen,Ketoprofen may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Ketorolac,Ketorolac may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,N-acetyltyrosine,Colchicine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Colchicine,Nabumetone,Nabumetone may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nadolol,Nadolol may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nafarelin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Colchicine.",increase,risk
Colchicine,Naldemedine,Colchicine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Colchicine,Nalmefene,Colchicine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Colchicine,Naloxone,Naloxone may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Naltrexone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Colchicine.",increase,risk
Colchicine,Naproxen,Naproxen may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nateglinide,Nateglinide may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nedaplatin,Colchicine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Colchicine,Nedocromil,Nedocromil may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nefazodone,The metabolism of Colchicine can be decreased when combined with Nefazodone.,decrease,no risk
Colchicine,Nelfinavir,The serum concentration of Colchicine can be increased when it is combined with Nelfinavir.,increase,no risk
Colchicine,Neomycin,Colchicine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Colchicine,Neratinib,The serum concentration of Colchicine can be increased when it is combined with Neratinib.,increase,no risk
Colchicine,Netilmicin,Colchicine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Colchicine,Netupitant,The serum concentration of Colchicine can be increased when it is combined with Netupitant.,increase,no risk
Colchicine,Niacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Colchicine.",increase,risk
Colchicine,Nicardipine,The metabolism of Colchicine can be decreased when combined with Nicardipine.,decrease,no risk
Colchicine,Nicorandil,Colchicine may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Colchicine,Nifedipine,Nifedipine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nilotinib,The serum concentration of Colchicine can be increased when it is combined with Nilotinib.,increase,no risk
Colchicine,Nilutamide,Nilutamide may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nilvadipine,The metabolism of Colchicine can be decreased when combined with Nilvadipine.,decrease,no risk
Colchicine,Nimesulide,Nimesulide may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Nirogacestat,The serum concentration of Colchicine can be increased when it is combined with Nirogacestat.,increase,no risk
Colchicine,Nisoldipine,Nisoldipine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nitric Oxide,The metabolism of Colchicine can be decreased when combined with Nitric Oxide.,decrease,no risk
Colchicine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nitroprusside,Nitroprusside may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Nizatidine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Colchicine.",increase,risk
Colchicine,Norfloxacin,The metabolism of Colchicine can be decreased when combined with Norfloxacin.,decrease,no risk
Colchicine,Norgestimate,The serum concentration of Colchicine can be increased when it is combined with Norgestimate.,increase,no risk
Colchicine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Noscapine,The metabolism of Colchicine can be decreased when combined with Noscapine.,decrease,no risk
Colchicine,Octinoxate,Colchicine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Colchicine,Octreotide,The metabolism of Colchicine can be decreased when combined with Octreotide.,decrease,no risk
Colchicine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Colchicine.",increase,risk
Colchicine,Olaparib,The metabolism of Colchicine can be decreased when combined with Olaparib.,decrease,no risk
Colchicine,Olsalazine,Olsalazine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Olutasidenib,The therapeutic efficacy of Colchicine can be decreased when used in combination with Olutasidenib.,decrease,no risk
Colchicine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Omaveloxolone,The serum concentration of Colchicine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Colchicine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Opium,Colchicine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Colchicine,Orphenadrine,The metabolism of Colchicine can be decreased when combined with Orphenadrine.,decrease,no risk
Colchicine,Oseltamivir,Oseltamivir may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Osilodrostat,The metabolism of Colchicine can be decreased when combined with Osilodrostat.,decrease,no risk
Colchicine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Oxacillin,Oxacillin may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Oxaprozin,Oxaprozin may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Oxazepam,Oxazepam may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Oxetacaine,The metabolism of Colchicine can be decreased when combined with Oxetacaine.,decrease,no risk
Colchicine,Oxybenzone,Colchicine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Colchicine,Oxybutynin,The metabolism of Colchicine can be decreased when combined with Oxybutynin.,decrease,no risk
Colchicine,Oxymetholone,The metabolism of Colchicine can be decreased when combined with Oxymetholone.,decrease,no risk
Colchicine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Oxyquinoline,Colchicine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Colchicine,Quetiapine,Quetiapine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Quinethazone,Quinethazone may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Colchicine,Quinidine,The serum concentration of Colchicine can be increased when it is combined with Quinidine.,increase,no risk
Colchicine,Quinine,The serum concentration of Colchicine can be increased when it is combined with Quinine.,increase,no risk
Colchicine,Quinupristin,The metabolism of Colchicine can be decreased when combined with Quinupristin.,decrease,no risk
Colchicine,Quizartinib,The serum concentration of Colchicine can be increased when it is combined with Quizartinib.,increase,no risk
Colchicine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Ubidecarenone.",increase,risk
Colchicine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Umbralisib,The serum concentration of Colchicine can be increased when it is combined with Umbralisib.,increase,no risk
Colchicine,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Vaborbactam,Colchicine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Colchicine,Vadadustat,The serum concentration of Colchicine can be increased when it is combined with Vadadustat.,increase,no risk
Colchicine,Valaciclovir,Valaciclovir may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Valbenazine,Colchicine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Colchicine,Valdecoxib,Valdecoxib may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Valganciclovir,Colchicine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Colchicine,Valproic acid,The metabolism of Colchicine can be decreased when combined with Valproic acid.,decrease,no risk
Colchicine,Vancomycin,Colchicine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Colchicine,Vandetanib,The serum concentration of Colchicine can be increased when it is combined with Vandetanib.,increase,no risk
Colchicine,Vardenafil,The serum concentration of Colchicine can be increased when it is combined with Vardenafil.,increase,no risk
Colchicine,Varenicline,Varenicline may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Velpatasvir,The serum concentration of Colchicine can be increased when it is combined with Velpatasvir.,increase,no risk
Colchicine,Vemurafenib,The serum concentration of Colchicine can be increased when it is combined with Vemurafenib.,increase,no risk
Colchicine,Venetoclax,The serum concentration of Colchicine can be increased when it is combined with Venetoclax.,increase,no risk
Colchicine,Venlafaxine,Venlafaxine may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Verapamil,The serum concentration of Colchicine can be increased when it is combined with Verapamil.,increase,no risk
Colchicine,Vilanterol,Colchicine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Colchicine,Viloxazine,The metabolism of Colchicine can be decreased when combined with Viloxazine.,decrease,no risk
Colchicine,Vinblastine,The metabolism of Colchicine can be decreased when combined with Vinblastine.,decrease,no risk
Colchicine,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Colchicine.",increase,risk
Colchicine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Colchicine.,increase,no risk
Colchicine,Voclosporin,The serum concentration of Colchicine can be increased when it is combined with Voclosporin.,increase,no risk
Colchicine,Vorapaxar,The serum concentration of Colchicine can be increased when it is combined with Vorapaxar.,increase,no risk
Colchicine,Voriconazole,The metabolism of Colchicine can be decreased when combined with Voriconazole.,decrease,no risk
Colchicine,Vortioxetine,Colchicine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Colchicine,Voxilaprevir,The serum concentration of Colchicine can be increased when it is combined with Voxilaprevir.,increase,no risk
Colchicine,Warfarin,Colchicine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Colchicine,Zafirlukast,The metabolism of Colchicine can be decreased when combined with Zafirlukast.,decrease,no risk
Colchicine,Zaleplon,Zaleplon may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Zanamivir,Zanamivir may decrease the excretion rate of Colchicine which could result in a higher serum level.,decrease,no risk
Colchicine,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Colchicine.",increase,risk
Colchicine,Zimelidine,The metabolism of Colchicine can be decreased when combined with Zimelidine.,decrease,no risk
Colchicine,Ziprasidone,The metabolism of Colchicine can be decreased when combined with Ziprasidone.,decrease,no risk
Colchicine,Zonisamide,The serum concentration of Colchicine can be increased when it is combined with Zonisamide.,increase,no risk
Drospirenone,Benzatropine,Drospirenone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Benzhydrocodone,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Drospirenone,Benznidazole,Drospirenone may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Benzydamine,The risk or severity of hyperkalemia can be increased when Benzydamine is combined with Drospirenone.,increase,risk
Drospirenone,Benzylpenicillin,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Benzylpenicillin.,decrease,no risk
Drospirenone,Benzylpenicilloyl polylysine,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Drospirenone,Bepotastine,Drospirenone may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Bepridil,The risk or severity of hyperkalemia can be increased when Bepridil is combined with Drospirenone.,increase,risk
Drospirenone,Berotralstat,The metabolism of Drospirenone can be decreased when combined with Berotralstat.,decrease,no risk
Drospirenone,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Drospirenone.,increase,no risk
Drospirenone,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be increased when it is combined with Drospirenone.,increase,no risk
Drospirenone,Betaxolol,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Drospirenone.,increase,risk
Drospirenone,Betrixaban,The risk or severity of adverse effects can be increased when Drospirenone is combined with Betrixaban.,increase,risk
Drospirenone,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Drospirenone.,decrease,no risk
Drospirenone,Bexarotene,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Bexarotene.,decrease,no risk
Drospirenone,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Drospirenone.,decrease,no risk
Drospirenone,Bicisate,Drospirenone may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Bifonazole,The metabolism of Drospirenone can be decreased when combined with Bifonazole.,decrease,no risk
Drospirenone,Bimekizumab,The metabolism of Drospirenone can be increased when combined with Bimekizumab.,increase,no risk
Drospirenone,Bisacodyl,The risk or severity of dehydration can be increased when Drospirenone is combined with Bisacodyl.,increase,risk
Drospirenone,Bismuth subgallate,Drospirenone may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Bisoprolol,Drospirenone may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Bisoxatin,The risk or severity of dehydration can be increased when Drospirenone is combined with Bisoxatin.,increase,risk
Drospirenone,Bivalirudin,The risk or severity of adverse effects can be increased when Drospirenone is combined with Bivalirudin.,increase,risk
Drospirenone,Bleomycin,Drospirenone may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Boceprevir,The serum concentration of Drospirenone can be increased when it is combined with Boceprevir.,increase,no risk
Drospirenone,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Drospirenone.,decrease,no risk
Drospirenone,Bosentan,The serum concentration of Drospirenone can be decreased when it is combined with Bosentan.,decrease,no risk
Drospirenone,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Drospirenone.,decrease,no risk
Drospirenone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Drospirenone.,decrease,no risk
Drospirenone,Brexanolone,The metabolism of Drospirenone can be increased when combined with Brexanolone.,increase,no risk
Drospirenone,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Drospirenone.,decrease,no risk
Drospirenone,Brivaracetam,The metabolism of Drospirenone can be increased when combined with Brivaracetam.,increase,no risk
Drospirenone,Bromazepam,Drospirenone may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Drospirenone.,decrease,no risk
Drospirenone,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Drospirenone.,increase,no risk
Drospirenone,Bumadizone,The risk or severity of hyperkalemia can be increased when Bumadizone is combined with Drospirenone.,increase,risk
Drospirenone,Bumetanide,Drospirenone may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Buprenorphine,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Buprenorphine.,decrease,no risk
Drospirenone,Bupropion,Drospirenone may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Buspirone,Drospirenone may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Busulfan,The metabolism of Busulfan can be decreased when combined with Drospirenone.,decrease,no risk
Drospirenone,Butabarbital,Drospirenone may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Drospirenone,Butalbital,The metabolism of Drospirenone can be increased when combined with Butalbital.,increase,no risk
Drospirenone,Butorphanol,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Butorphanol.,decrease,no risk
Digitoxin,Boceprevir,The metabolism of Digitoxin can be decreased when combined with Boceprevir.,decrease,no risk
Digitoxin,Bortezomib,The serum concentration of Digitoxin can be increased when it is combined with Bortezomib.,increase,no risk
Digitoxin,Bosentan,The metabolism of Digitoxin can be increased when combined with Bosentan.,increase,no risk
Digitoxin,Bosutinib,The metabolism of Digitoxin can be decreased when combined with Bosutinib.,decrease,no risk
Digitoxin,Botulinum toxin type A,The risk or severity of Cardiac Arrhythmia can be increased when Botulinum toxin type A is combined with Digitoxin.,increase,risk
Digitoxin,Brentuximab vedotin,The serum concentration of Digitoxin can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Digitoxin,Bretylium,Bretylium may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Brimonidine,Brimonidine may increase the bradycardic activities of Digitoxin.,increase,no risk
Digitoxin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Digitoxin.,increase,risk
Digitoxin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Digitoxin.,increase,risk
Digitoxin,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Digitoxin.,increase,risk
Digitoxin,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Digitoxin.,increase,risk
Digitoxin,Buprenorphine,The metabolism of Digitoxin can be decreased when combined with Buprenorphine.,decrease,no risk
Digitoxin,Buserelin,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Buserelin.,increase,risk
Digitoxin,Busulfan,Digitoxin may decrease the cardiotoxic activities of Busulfan.,decrease,no risk
Digitoxin,Butalbital,The metabolism of Digitoxin can be increased when combined with Butalbital.,increase,no risk
Digitoxin,Butriptyline,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Butriptyline.,increase,risk
Digitoxin,Gadobenic acid,The serum concentration of Digitoxin can be increased when it is combined with Futibatinib.,increase,no risk
Digitoxin,Galantamine,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Gadobenic acid.,increase,risk
Digitoxin,Gallamine triethiodide,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Digitoxin.,increase,risk
Digitoxin,Gatifloxacin,The risk or severity of Cardiac Arrhythmia can be increased when Gallamine triethiodide is combined with Digitoxin.,increase,risk
Digitoxin,Gemcitabine,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Digitoxin.,increase,risk
Digitoxin,Gemifloxacin,The serum concentration of Digitoxin can be increased when it is combined with Gemcitabine.,increase,no risk
Digitoxin,Gentamicin,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Gemifloxacin.,increase,risk
Digitoxin,Gepirone,The risk or severity of adverse effects can be increased when Gentamicin is combined with Digitoxin.,increase,risk
Digitoxin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Digitoxin.,increase,risk
Digitoxin,Ginkgo biloba,The metabolism of Digitoxin can be decreased when combined with Gilteritinib.,decrease,no risk
Digitoxin,Glasdegib,The metabolism of Digitoxin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Digitoxin,Glecaprevir,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Glasdegib.,increase,risk
Digitoxin,Glofitamab,The serum concentration of Digitoxin can be increased when it is combined with Glecaprevir.,increase,no risk
Digitoxin,Glyburide,The serum concentration of Digitoxin can be increased when it is combined with Glofitamab.,increase,no risk
Digitoxin,Glycerol phenylbutyrate,The metabolism of Digitoxin can be decreased when combined with Glyburide.,decrease,no risk
Digitoxin,Glycine,The metabolism of Digitoxin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Digitoxin,Golimumab,The risk or severity of adverse effects can be increased when Glycine is combined with Digitoxin.,increase,risk
Digitoxin,Goserelin,The metabolism of Digitoxin can be increased when combined with Golimumab.,increase,no risk
Digitoxin,Granisetron,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Goserelin.,increase,risk
Digitoxin,Grapefruit,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Granisetron.,increase,risk
Digitoxin,Grazoprevir,The serum concentration of Digitoxin can be increased when it is combined with Grapefruit.,increase,no risk
Digitoxin,Grepafloxacin,The serum concentration of Digitoxin can be increased when it is combined with Grazoprevir.,increase,no risk
Digitoxin,Griseofulvin,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Grepafloxacin.,increase,risk
Digitoxin,Halcinonide,The metabolism of Digitoxin can be increased when combined with Griseofulvin.,increase,no risk
Digitoxin,Halofantrine,The risk or severity of adverse effects can be increased when Halcinonide is combined with Digitoxin.,increase,risk
Digitoxin,Haloperidol,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Halofantrine.,increase,risk
Digitoxin,Histrelin,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Haloperidol.,increase,risk
Digitoxin,Hydralazine,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Histrelin.,increase,risk
Digitoxin,Hydrochlorothiazide,The serum concentration of Digitoxin can be increased when it is combined with Hydralazine.,increase,no risk
Digitoxin,Hydrocortamate,Hydrochlorothiazide may increase the hypokalemic activities of Digitoxin.,increase,no risk
Digitoxin,Hydrocortisone,The metabolism of Digitoxin can be increased when combined with Hydrocortamate.,increase,no risk
Digitoxin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Digitoxin.,increase,risk
Digitoxin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Hydrocortisone acetate is combined with Digitoxin.,increase,risk
Digitoxin,Hydrocortisone cypionate,The risk or severity of adverse effects can be increased when Hydrocortisone butyrate is combined with Digitoxin.,increase,risk
Digitoxin,Hydrocortisone probutate,The risk or severity of adverse effects can be increased when Hydrocortisone cypionate is combined with Digitoxin.,increase,risk
Digitoxin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Hydrocortisone probutate is combined with Digitoxin.,increase,risk
Digitoxin,Hydrocortisone valerate,The risk or severity of adverse effects can be increased when Hydrocortisone succinate is combined with Digitoxin.,increase,risk
Digitoxin,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydrocortisone valerate is combined with Digitoxin.,increase,risk
Digitoxin,Hydroxychloroquine,Hydroflumethiazide may increase the hypokalemic activities of Digitoxin.,increase,no risk
Digitoxin,Hydroxyzine,The serum concentration of Digitoxin can be increased when it is combined with Hydroxychloroquine.,increase,no risk
Digitoxin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Hydroxyzine.,increase,risk
Digitoxin,Kanamycin,The serum concentration of Digitoxin can be increased when it is combined with Ixabepilone.,increase,no risk
Digitoxin,Kaolin,The risk or severity of adverse effects can be increased when Kanamycin is combined with Digitoxin.,increase,risk
Digitoxin,Ketazolam,The serum concentration of Digitoxin can be decreased when it is combined with Kaolin.,decrease,no risk
Digitoxin,Ketoconazole,The serum concentration of Digitoxin can be increased when it is combined with Ketazolam.,increase,no risk
Digitoxin,Nadolol,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Moxifloxacin.,increase,risk
Digitoxin,Nafcillin,Nadolol may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Nalidixic acid,The metabolism of Digitoxin can be increased when combined with Nafcillin.,increase,no risk
Digitoxin,Naphazoline,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Nalidixic acid.,increase,risk
Digitoxin,Nebivolol,The risk or severity of Cardiac Arrhythmia can be increased when Naphazoline is combined with Digitoxin.,increase,risk
Digitoxin,Nefazodone,Digitoxin may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Digitoxin,Nelfinavir,The metabolism of Digitoxin can be decreased when combined with Nefazodone.,decrease,no risk
Digitoxin,Neomycin,The metabolism of Digitoxin can be decreased when combined with Nelfinavir.,decrease,no risk
Digitoxin,Neratinib,The risk or severity of adverse effects can be increased when Neomycin is combined with Digitoxin.,increase,risk
Digitoxin,Netilmicin,The serum concentration of Digitoxin can be increased when it is combined with Neratinib.,increase,no risk
Digitoxin,Netupitant,The risk or severity of adverse effects can be increased when Netilmicin is combined with Digitoxin.,increase,risk
Digitoxin,Niacin,The serum concentration of Digitoxin can be increased when it is combined with Netupitant.,increase,no risk
Digitoxin,Nicardipine,The serum concentration of Digitoxin can be increased when it is combined with Niacin.,increase,no risk
Digitoxin,Nicorandil,Nicardipine may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Nifedipine,Digitoxin may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Digitoxin,Nilotinib,Nifedipine may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Nilvadipine,The metabolism of Digitoxin can be decreased when combined with Nilotinib.,decrease,no risk
Digitoxin,Nimesulide,Digitoxin may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Digitoxin,Nimodipine,Digitoxin may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Digitoxin,Nintedanib,Nimodipine may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Nirogacestat,The metabolism of Digitoxin can be decreased when combined with Nintedanib.,decrease,no risk
Digitoxin,Nisoldipine,The serum concentration of Digitoxin can be increased when it is combined with Nirogacestat.,increase,no risk
Digitoxin,Nitrendipine,Nisoldipine may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Norepinephrine,Nitrendipine may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Norethisterone,The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Digitoxin.,increase,risk
Digitoxin,Norfloxacin,The metabolism of Digitoxin can be decreased when combined with Norethisterone.,decrease,no risk
Digitoxin,Norgestimate,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Digitoxin.,increase,risk
Digitoxin,Nortriptyline,The serum concentration of Digitoxin can be increased when it is combined with Norgestimate.,increase,no risk
Digitoxin,Noscapine,The serum concentration of Nortriptyline can be increased when it is combined with Digitoxin.,increase,no risk
Digitoxin,Nylidrin,The serum concentration of Digitoxin can be increased when it is combined with Noscapine.,increase,no risk
Digitoxin,Octreotide,Digitoxin may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Digitoxin,Ofloxacin,The serum concentration of Digitoxin can be increased when it is combined with Octreotide.,increase,no risk
Digitoxin,Olanzapine,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Ofloxacin.,increase,risk
Digitoxin,Olaparib,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Digitoxin.,increase,risk
Digitoxin,Olodaterol,The metabolism of Digitoxin can be decreased when combined with Olaparib.,decrease,no risk
Digitoxin,Olsalazine,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Olodaterol.,increase,risk
Digitoxin,Olutasidenib,The serum concentration of Digitoxin can be decreased when it is combined with Olsalazine.,decrease,no risk
Digitoxin,Omadacycline,The metabolism of Digitoxin can be increased when combined with Olutasidenib.,increase,no risk
Digitoxin,Omaveloxolone,The serum concentration of Digitoxin can be increased when it is combined with Omadacycline.,increase,no risk
Digitoxin,Ombitasvir,The serum concentration of Digitoxin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Digitoxin,Ondansetron,The serum concentration of Digitoxin can be increased when it is combined with Ombitasvir.,increase,no risk
Digitoxin,Oritavancin,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Ondansetron.,increase,risk
Digitoxin,Orphenadrine,The metabolism of Digitoxin can be increased when combined with Oritavancin.,increase,no risk
Digitoxin,Osilodrostat,The metabolism of Digitoxin can be decreased when combined with Orphenadrine.,decrease,no risk
Digitoxin,Osimertinib,The metabolism of Digitoxin can be decreased when combined with Osilodrostat.,decrease,no risk
Digitoxin,Oxaliplatin,The metabolism of Digitoxin can be decreased when combined with Osimertinib.,decrease,no risk
Digitoxin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Digitoxin.,increase,risk
Digitoxin,Oxcarbazepine,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Oxatomide.,increase,risk
Digitoxin,Oxprenolol,The metabolism of Digitoxin can be increased when combined with Oxcarbazepine.,increase,no risk
Digitoxin,Oxybutynin,Digitoxin may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Digitoxin,Oxymetazoline,The serum concentration of Digitoxin can be increased when it is combined with Oxybutynin.,increase,no risk
Digitoxin,Oxytocin,The therapeutic efficacy of Digitoxin can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Digitoxin,Quetiapine,The risk or severity of Cardiac Arrhythmia can be increased when Pyrantel is combined with Digitoxin.,increase,risk
Digitoxin,Quinethazone,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Quetiapine.,increase,risk
Digitoxin,Quinidine,The risk or severity of adverse effects can be increased when Quinethazone is combined with Digitoxin.,increase,risk
Digitoxin,Quinine,The serum concentration of Digitoxin can be increased when it is combined with Quinidine.,increase,no risk
Digitoxin,Quinupristin,The serum concentration of Digitoxin can be increased when it is combined with Quinine.,increase,no risk
Digitoxin,Quizartinib,The metabolism of Digitoxin can be decreased when combined with Quinupristin.,decrease,no risk
Digitoxin,Ubrogepant,Tucatinib may decrease the excretion rate of Digitoxin which could result in a higher serum level.,decrease,no risk
Digitoxin,Ulobetasol,The serum concentration of Digitoxin can be increased when it is combined with Ubrogepant.,increase,no risk
Digitoxin,Umbralisib,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Digitoxin.,increase,risk
Digitoxin,Umeclidinium,The serum concentration of Digitoxin can be increased when it is combined with Umbralisib.,increase,no risk
Digitoxin,Vadadustat,The serum concentration of Digitoxin can be increased when it is combined with Umeclidinium.,increase,no risk
Digitoxin,Valproic acid,The serum concentration of Digitoxin can be increased when it is combined with Vadadustat.,increase,no risk
Digitoxin,Vamorolone,The serum concentration of Digitoxin can be increased when it is combined with Valproic acid.,increase,no risk
Digitoxin,Vandetanib,The risk or severity of adverse effects can be increased when Vamorolone is combined with Digitoxin.,increase,risk
Digitoxin,Vardenafil,The serum concentration of Digitoxin can be increased when it is combined with Vandetanib.,increase,no risk
Digitoxin,Vecuronium,The serum concentration of Digitoxin can be increased when it is combined with Vardenafil.,increase,no risk
Digitoxin,Velpatasvir,The risk or severity of Cardiac Arrhythmia can be increased when Vecuronium is combined with Digitoxin.,increase,risk
Digitoxin,Vemurafenib,The serum concentration of Digitoxin can be increased when it is combined with Velpatasvir.,increase,no risk
Digitoxin,Venetoclax,The serum concentration of Digitoxin can be increased when it is combined with Vemurafenib.,increase,no risk
Digitoxin,Verapamil,The serum concentration of Digitoxin can be increased when it is combined with Venetoclax.,increase,no risk
Digitoxin,Vernakalant,Verapamil may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Digitoxin,Vilanterol,Digitoxin may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Digitoxin,Viloxazine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Digitoxin.,increase,risk
Digitoxin,Vinblastine,The metabolism of Digitoxin can be decreased when combined with Viloxazine.,decrease,no risk
Digitoxin,Vincristine,The metabolism of Digitoxin can be increased when combined with Vinblastine.,increase,no risk
Digitoxin,Vindesine,The serum concentration of Digitoxin can be increased when it is combined with Vincristine.,increase,no risk
Digitoxin,Vinflunine,Digitoxin may decrease the cardiotoxic activities of Vindesine.,decrease,no risk
Digitoxin,Vinorelbine,The serum concentration of Vinflunine can be increased when it is combined with Digitoxin.,increase,no risk
Digitoxin,Vitamin D,Digitoxin may decrease the cardiotoxic activities of Vinorelbine.,decrease,no risk
Digitoxin,Vitamin E,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Vitamin D is combined with Digitoxin.,increase,risk
Digitoxin,Voclosporin,The metabolism of Digitoxin can be increased when combined with Vitamin E.,increase,no risk
Digitoxin,Vorapaxar,The serum concentration of Digitoxin can be increased when it is combined with Voclosporin.,increase,no risk
Digitoxin,Voriconazole,The serum concentration of Digitoxin can be increased when it is combined with Vorapaxar.,increase,no risk
Digitoxin,Vorinostat,The metabolism of Digitoxin can be decreased when combined with Voriconazole.,decrease,no risk
Digitoxin,Voxelotor,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Vorinostat.,increase,risk
Digitoxin,Voxilaprevir,The serum concentration of Digitoxin can be increased when it is combined with Voxelotor.,increase,no risk
Digitoxin,Warfarin,The serum concentration of Digitoxin can be increased when it is combined with Voxilaprevir.,increase,no risk
Digitoxin,Xylometazoline,The metabolism of Digitoxin can be increased when combined with Warfarin.,increase,no risk
Digitoxin,Zafirlukast,Digitoxin may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Digitoxin,Ziconotide,The serum concentration of Digitoxin can be increased when it is combined with Zafirlukast.,increase,no risk
Digitoxin,Zimelidine,Digitoxin may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Digitoxin,Ziprasidone,The metabolism of Digitoxin can be decreased when combined with Zimelidine.,decrease,no risk
Digitoxin,Zonisamide,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Ziprasidone.,increase,risk
Digitoxin,Zuclopenthixol,Zonisamide may increase the arrhythmogenic activities of Digitoxin.,increase,no risk
Magnesium salicylate,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Bismuth subgallate,Magnesium salicylate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Bisoprolol,Magnesium salicylate may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Magnesium salicylate,Bisoxatin,Magnesium salicylate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Bivalirudin.,increase,risk
Magnesium salicylate,Bleomycin,Magnesium salicylate may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Brexpiprazole,The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Brexpiprazole.,increase,risk
Magnesium salicylate,Brivaracetam,Magnesium salicylate may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Bromazepam,Magnesium salicylate may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Bufexamac,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Bufexamac.,increase,risk
Magnesium salicylate,Bumadizone,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Bumadizone.,increase,risk
Magnesium salicylate,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Bupropion,Magnesium salicylate may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Butabarbital,Magnesium salicylate may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Gabapentin enacarbil,The therapeutic efficacy of Furosemide can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Gadobenic acid,Magnesium salicylate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gadodiamide,Magnesium salicylate may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gadofosveset trisodium,Magnesium salicylate may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gadopentetic acid,Magnesium salicylate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gadoteric acid,Magnesium salicylate may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gadoteridol,Magnesium salicylate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Ganciclovir,Magnesium salicylate may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gatifloxacin,Magnesium salicylate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gemcitabine,Magnesium salicylate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Gemfibrozil,Magnesium salicylate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gemifloxacin,Magnesium salicylate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gentamicin,The absorption of Gemifloxacin can be decreased when combined with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Gimeracil,Magnesium salicylate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Givosiran,Magnesium salicylate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Gliclazide,The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Givosiran.,increase,risk
Magnesium salicylate,Glimepiride,The protein binding of Gliclazide can be decreased when combined with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Glipizide,The protein binding of Glimepiride can be decreased when combined with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Gliquidone,The protein binding of Glipizide can be decreased when combined with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Glyburide,The protein binding of Gliquidone can be decreased when combined with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Glycerol phenylbutyrate,The protein binding of Glyburide can be decreased when combined with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Glycol salicylate,Magnesium salicylate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Golodirsen,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Glycol salicylate.,increase,risk
Magnesium salicylate,Goserelin,Magnesium salicylate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Grepafloxacin,Magnesium salicylate may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Guanabenz,Magnesium salicylate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Guanadrel,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Guanethidine,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Guanfacine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Guanoxan,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Halofantrine,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Haloperidol,Magnesium salicylate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Halothane,The therapeutic efficacy of Haloperidol can be increased when used in combination with Magnesium salicylate.,increase,no risk
Magnesium salicylate,Heparin,The risk or severity of hypertension can be increased when Halothane is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Hydralazine,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Heparin.,increase,risk
Magnesium salicylate,Hydrochlorothiazide,Magnesium salicylate may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Magnesium salicylate,Hydrocortisone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Hydroflumethiazide,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Hydromorphone,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Hydroxocobalamin,Magnesium salicylate may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Hydroxyethyl Starch,Magnesium salicylate may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Kanamycin,Magnesium salicylate may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Ketamine,Magnesium salicylate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Ketazolam,Magnesium salicylate may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Ketoconazole,Magnesium salicylate may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Ketorolac,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,N-acetyltyrosine,Magnesium salicylate may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nabumetone,Magnesium salicylate may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nadolol,The risk or severity of adverse effects can be increased when Nabumetone is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Nadroparin,Magnesium salicylate may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Magnesium salicylate,Naldemedine,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Nadroparin.,increase,risk
Magnesium salicylate,Nalidixic acid,Magnesium salicylate may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nalmefene,Magnesium salicylate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Naloxone,Magnesium salicylate may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Naphazoline,Magnesium salicylate may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Naproxen,The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Naphazoline.,increase,risk
Magnesium salicylate,Naratriptan,The risk or severity of adverse effects can be increased when Naproxen is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Nateglinide,The risk or severity of hypertension can be increased when Naratriptan is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Naxitamab,Magnesium salicylate may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nebivolol,The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Naxitamab.,increase,risk
Magnesium salicylate,Nedaplatin,Magnesium salicylate may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Magnesium salicylate,Nedocromil,Magnesium salicylate may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nefazodone,Magnesium salicylate may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Neomycin,The risk or severity of gastrointestinal bleeding can be increased when Nefazodone is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Nepafenac,The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Neomycin.,increase,risk
Magnesium salicylate,Netilmicin,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Nepafenac.,increase,risk
Magnesium salicylate,Nialamide,Magnesium salicylate may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nicardipine,The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Nialamide.,increase,risk
Magnesium salicylate,Nicergoline,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nicardipine.,increase,risk
Magnesium salicylate,Nicorandil,The risk or severity of hypertension can be increased when Nicergoline is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Nifedipine,The therapeutic efficacy of Nicorandil can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Nilutamide,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nifedipine.,increase,risk
Magnesium salicylate,Nilvadipine,Magnesium salicylate may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nimesulide,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nilvadipine.,increase,risk
Magnesium salicylate,Nimodipine,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nimesulide.,increase,risk
Magnesium salicylate,Nisoldipine,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nimodipine.,increase,risk
Magnesium salicylate,Nitrendipine,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nisoldipine.,increase,risk
Magnesium salicylate,Nitric Oxide,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nitrendipine.,increase,risk
Magnesium salicylate,Nitrofurantoin,Magnesium salicylate may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Nitroglycerin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Nitroprusside,The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Nitrous oxide,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Norepinephrine,The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Nitrous oxide.,increase,risk
Magnesium salicylate,Norfloxacin,The risk or severity of hypertension can be increased when Norepinephrine is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Nortriptyline,Magnesium salicylate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Nylidrin,The risk or severity of gastrointestinal bleeding can be increased when Nortriptyline is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Octinoxate,The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Nylidrin.,increase,risk
Magnesium salicylate,Ofloxacin,Magnesium salicylate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Olmesartan,Magnesium salicylate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Olodaterol,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Magnesium salicylate.",increase,risk
Magnesium salicylate,Olsalazine,The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Olodaterol.,increase,risk
Magnesium salicylate,Omacetaxine mepesuccinate,The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Olsalazine.,increase,risk
Magnesium salicylate,Omadacycline,The risk or severity of bleeding can be increased when Magnesium salicylate is combined with Omacetaxine mepesuccinate.,increase,risk
Magnesium salicylate,Opium,Magnesium salicylate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Orciprenaline,Magnesium salicylate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Oseltamivir,The risk or severity of hypertension can be increased when Orciprenaline is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Oxacillin,Magnesium salicylate may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Oxaliplatin,Magnesium salicylate may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Oxazepam,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Oxprenolol,Magnesium salicylate may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Oxybenzone,Magnesium salicylate may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Magnesium salicylate,Oxymetazoline,Magnesium salicylate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Oxyquinoline,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Oxyphenbutazone.,increase,risk
Magnesium salicylate,Oxytetracycline,Magnesium salicylate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Quetiapine,Magnesium salicylate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Quinapril,The risk or severity of hypertension can be increased when Quetiapine is combined with Magnesium salicylate.,increase,risk
Magnesium salicylate,Quinethazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Magnesium salicylate is combined with Quinapril.",increase,risk
Magnesium salicylate,Quinidine,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Magnesium salicylate,Quinupramine,Magnesium salicylate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Magnesium salicylate,Unoprostone,Magnesium salicylate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magnesium salicylate,Urokinase,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Magnesium salicylate.,decrease,no risk
Salsalate,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Bismuth subgallate,Salsalate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Salsalate,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Bisoprolol,Salsalate may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Salsalate,Bisoxatin,Salsalate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Salsalate,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Bivalirudin.,increase,risk
Salsalate,Bleomycin,Salsalate may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Salsalate,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Brexpiprazole,The risk or severity of hypertension can be increased when Salsalate is combined with Brexpiprazole.,increase,risk
Salsalate,Brivaracetam,Salsalate may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Salsalate,Bromazepam,Salsalate may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Salsalate,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Salsalate.,increase,risk
Salsalate,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Salsalate.,increase,risk
Salsalate,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Salsalate.,increase,risk
Salsalate,Bufexamac,The risk or severity of adverse effects can be increased when Salsalate is combined with Bufexamac.,increase,risk
Salsalate,Bumadizone,The risk or severity of adverse effects can be increased when Salsalate is combined with Bumadizone.,increase,risk
Salsalate,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Bupropion,Salsalate may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Salsalate,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Salsalate.,increase,risk
Salsalate,Butabarbital,Salsalate may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Salsalate,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Salsalate.,increase,risk
Salsalate,Gabapentin enacarbil,The therapeutic efficacy of Furosemide can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Gadobenic acid,Salsalate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Salsalate,Gadodiamide,Salsalate may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Salsalate,Gadofosveset trisodium,Salsalate may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Salsalate,Gadopentetic acid,Salsalate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Salsalate,Gadoteric acid,Salsalate may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Salsalate,Gadoteridol,Salsalate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Salsalate,Ganciclovir,Salsalate may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Salsalate,Gatifloxacin,Salsalate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Salsalate,Gemcitabine,Salsalate may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Salsalate,Gemfibrozil,Salsalate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Salsalate,Gemifloxacin,Salsalate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Salsalate,Gentamicin,Salsalate may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Salsalate,Gimeracil,Salsalate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Salsalate,Givosiran,Salsalate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Salsalate,Gliclazide,The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Givosiran.,increase,risk
Salsalate,Glimepiride,The protein binding of Gliclazide can be decreased when combined with Salsalate.,decrease,no risk
Salsalate,Glipizide,The protein binding of Glimepiride can be decreased when combined with Salsalate.,decrease,no risk
Salsalate,Gliquidone,The protein binding of Glipizide can be decreased when combined with Salsalate.,decrease,no risk
Salsalate,Glyburide,The protein binding of Gliquidone can be decreased when combined with Salsalate.,decrease,no risk
Salsalate,Glycerol phenylbutyrate,The protein binding of Glyburide can be decreased when combined with Salsalate.,decrease,no risk
Salsalate,Glycol salicylate,Salsalate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Salsalate,Golodirsen,The risk or severity of adverse effects can be increased when Salsalate is combined with Glycol salicylate.,increase,risk
Salsalate,Goserelin,Salsalate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Salsalate,Grepafloxacin,Salsalate may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Salsalate,Guanabenz,Salsalate may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Salsalate,Guanadrel,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Guanethidine,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Guanfacine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Guanoxan,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Haloperidol,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Halothane,The therapeutic efficacy of Haloperidol can be increased when used in combination with Salsalate.,increase,no risk
Salsalate,Heparin,The risk or severity of hypertension can be increased when Halothane is combined with Salsalate.,increase,risk
Salsalate,Hydralazine,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Heparin.,increase,risk
Salsalate,Hydrochlorothiazide,Salsalate may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Salsalate,Hydrocortisone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Salsalate.,increase,risk
Salsalate,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Salsalate.,increase,risk
Salsalate,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Salsalate.,increase,risk
Salsalate,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Salsalate.,increase,risk
Salsalate,Hydroflumethiazide,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Salsalate.,increase,risk
Salsalate,Hydromorphone,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Hydroxocobalamin,Salsalate may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Salsalate,Hydroxyethyl Starch,Salsalate may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Salsalate,Kanamycin,Salsalate may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Salsalate,Ketamine,Salsalate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Salsalate,Ketazolam,Salsalate may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Salsalate,Ketoconazole,Salsalate may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Salsalate,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Salsalate.,increase,risk
Salsalate,Ketorolac,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Salsalate.,increase,risk
Salsalate,N-acetyltyrosine,Salsalate may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Salsalate,Nabumetone,Salsalate may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Salsalate,Nadolol,The risk or severity of adverse effects can be increased when Nabumetone is combined with Salsalate.,increase,risk
Salsalate,Nadroparin,Salsalate may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Salsalate,Naldemedine,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Nadroparin.,increase,risk
Salsalate,Nalidixic acid,Salsalate may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Salsalate,Nalmefene,Salsalate may increase the neuroexcitatory activities of Nalidixic acid.,increase,no risk
Salsalate,Naloxone,Salsalate may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Salsalate,Naphazoline,Salsalate may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Salsalate,Naproxen,The risk or severity of hypertension can be increased when Salsalate is combined with Naphazoline.,increase,risk
Salsalate,Naratriptan,The risk or severity of adverse effects can be increased when Naproxen is combined with Salsalate.,increase,risk
Salsalate,Nateglinide,The risk or severity of hypertension can be increased when Naratriptan is combined with Salsalate.,increase,risk
Salsalate,Naxitamab,Salsalate may decrease the excretion rate of Nateglinide which could result in a higher serum level.,decrease,no risk
Salsalate,Nebivolol,The risk or severity of hypertension can be increased when Salsalate is combined with Naxitamab.,increase,risk
Salsalate,Nedaplatin,Salsalate may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Salsalate,Nedocromil,Salsalate may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Salsalate,Nefazodone,Salsalate may decrease the excretion rate of Nedocromil which could result in a higher serum level.,decrease,no risk
Salsalate,Neomycin,The risk or severity of gastrointestinal bleeding can be increased when Nefazodone is combined with Salsalate.,increase,risk
Salsalate,Nepafenac,The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Neomycin.,increase,risk
Salsalate,Netilmicin,The risk or severity of adverse effects can be increased when Salsalate is combined with Nepafenac.,increase,risk
Salsalate,Nialamide,Salsalate may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Salsalate,Nicardipine,The risk or severity of hypertension can be increased when Salsalate is combined with Nialamide.,increase,risk
Salsalate,Nicergoline,The therapeutic efficacy of Nicardipine can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Nicorandil,The risk or severity of hypertension can be increased when Nicergoline is combined with Salsalate.,increase,risk
Salsalate,Nifedipine,The therapeutic efficacy of Nicorandil can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Nilutamide,The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Salsalate.,increase,risk
Salsalate,Nilvadipine,Salsalate may decrease the excretion rate of Nilutamide which could result in a higher serum level.,decrease,no risk
Salsalate,Nimesulide,The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Nimodipine,The risk or severity of adverse effects can be increased when Salsalate is combined with Nimesulide.,increase,risk
Salsalate,Nisoldipine,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Nitrendipine,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Nitric Oxide,The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Nitrofurantoin,Salsalate may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Salsalate,Nitroglycerin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salsalate.,increase,risk
Salsalate,Nitroprusside,The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Nitrous oxide,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Norepinephrine,The risk or severity of hypertension can be increased when Salsalate is combined with Nitrous oxide.,increase,risk
Salsalate,Norfloxacin,The risk or severity of hypertension can be increased when Norepinephrine is combined with Salsalate.,increase,risk
Salsalate,Nortriptyline,Salsalate may increase the neuroexcitatory activities of Norfloxacin.,increase,no risk
Salsalate,Nylidrin,The risk or severity of gastrointestinal bleeding can be increased when Nortriptyline is combined with Salsalate.,increase,risk
Salsalate,Octinoxate,The risk or severity of hypertension can be increased when Salsalate is combined with Nylidrin.,increase,risk
Salsalate,Ofloxacin,Salsalate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Salsalate,Olmesartan,Salsalate may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Salsalate,Olodaterol,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Salsalate.",increase,risk
Salsalate,Olsalazine,The risk or severity of hypertension can be increased when Salsalate is combined with Olodaterol.,increase,risk
Salsalate,Omacetaxine mepesuccinate,The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Olsalazine.,increase,risk
Salsalate,Opium,The risk or severity of bleeding can be increased when Salsalate is combined with Omacetaxine mepesuccinate.,increase,risk
Salsalate,Orciprenaline,Salsalate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Salsalate,Oseltamivir,The risk or severity of hypertension can be increased when Orciprenaline is combined with Salsalate.,increase,risk
Salsalate,Oxacillin,Salsalate may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Salsalate,Oxaliplatin,Salsalate may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Salsalate,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Salsalate.,increase,risk
Salsalate,Oxazepam,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Salsalate.,increase,risk
Salsalate,Oxprenolol,Salsalate may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Salsalate,Oxybenzone,Salsalate may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Salsalate,Oxymetazoline,Salsalate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Salsalate,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Salsalate.,increase,risk
Salsalate,Oxyquinoline,The risk or severity of adverse effects can be increased when Salsalate is combined with Oxyphenbutazone.,increase,risk
Salsalate,Quetiapine,Salsalate may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Salsalate,Quinapril,The risk or severity of hypertension can be increased when Quetiapine is combined with Salsalate.,increase,risk
Salsalate,Quinethazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salsalate is combined with Quinapril.",increase,risk
Salsalate,Quinidine,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Quinupramine,Salsalate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Salsalate,Unoprostone,Salsalate may increase the neuroexcitatory activities of Trovafloxacin.,increase,no risk
Salsalate,Urokinase,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Salsalate.,decrease,no risk
Salsalate,Vaborbactam,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Urokinase.,increase,risk
Salsalate,Valaciclovir,Salsalate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Salsalate,Valbenazine,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Salsalate.,increase,risk
Salsalate,Valdecoxib,Salsalate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Salsalate,Valganciclovir,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Salsalate.,increase,risk
Salsalate,Valproic acid,Salsalate may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Salsalate,Valsartan,The protein binding of Valproic acid can be decreased when combined with Salsalate.,decrease,no risk
